This is a Validated Antibody Database (VAD) review about mouse CD8, based on 1387 published articles (read how Labome selects the articles), using CD8 antibody in all methods. It is aimed to help Labome visitors find the most suited CD8 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD8 synonym: BB154331; Ly-2; Ly-35; Ly-B; Lyt-2

BioLegend
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend CD8 antibody (BioLegend, 100728) was used in flow cytometry on mouse samples at 1:200. elife (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6e, 6f, 6g, 6h
BioLegend CD8 antibody (BioLegend, 100711) was used in flow cytometry on mouse samples (fig 6e, 6f, 6g, 6h). Allergy Asthma Immunol Res (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . J Exp Med (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BioLegend CD8 antibody (BioLegend, 100730) was used in flow cytometry on mouse samples . Vaccine (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4b, s4b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4b, s4b). Front Cell Infect Microbiol (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s5a). Leukemia (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s4
BioLegend CD8 antibody (Biolegend, 100741) was used in flow cytometry on mouse samples at 1:200 (fig s4). PLoS Biol (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3
BioLegend CD8 antibody (BioLegend, 100711) was used in flow cytometry on mouse samples (fig s3). J Clin Invest (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). Front Immunol (2022) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6g
BioLegend CD8 antibody (BioLegend, 100777) was used in immunohistochemistry - frozen section on mouse samples (fig 6g). Sci Adv (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 7d
BioLegend CD8 antibody (Biolgend, 100712) was used in flow cytometry on mouse samples at 1:100 (fig 7d). Nat Commun (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2c
BioLegend CD8 antibody (Biolegend, 100712) was used in flow cytometry on mouse samples (fig 2c). iScience (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2f
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2f). Theranostics (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2k
BioLegend CD8 antibody (Biolegend, 100734) was used in flow cytometry on mouse samples (fig 2k). Cell Rep (2022) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; 10 ug/ml; loading ...; fig 6b
  • flow cytometry; mouse; loading ...; fig 1a, 4e, s4a
BioLegend CD8 antibody (BioLegend, 53.6-7) was used in blocking or activating experiments on mouse samples at 10 ug/ml (fig 6b) and in flow cytometry on mouse samples (fig 1a, 4e, s4a). Proc Natl Acad Sci U S A (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig 1f
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig 1f). Nat Commun (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3d, 4b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3d, 4b). Int J Mol Sci (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a, 4c
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s1a, 4c). J Immunother Cancer (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:800; fig 3c, 4c
BioLegend CD8 antibody (BioLegend, 100722) was used in flow cytometry on mouse samples at 1:800 (fig 3c, 4c). Cell Rep (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). Oncoimmunology (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5g, 5h, s1f
BioLegend CD8 antibody (BioLegend, 100730) was used in flow cytometry on mouse samples (fig 5g, 5h, s1f). Cell Rep Med (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend CD8 antibody (Biolegend, 100749) was used in flow cytometry on mouse samples (fig 5c). Oncoimmunology (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3). In Vivo (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5e, s6a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s5e, s6a). Nat Commun (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50; loading ...; fig 6h, s8
BioLegend CD8 antibody (Biolegend, 100730) was used in flow cytometry on mouse samples at 1:50 (fig 6h, s8). Nat Commun (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 3a, 4b, 5a
BioLegend CD8 antibody (BioLegend, 100711) was used in flow cytometry on mouse samples at 1:200 (fig 3a, 4b, 5a). J Immunother Cancer (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b, 4c
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2b, 4c). Basic Res Cardiol (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6e
BioLegend CD8 antibody (BioLegend, 100734) was used in flow cytometry on mouse samples (fig 6e). J Immunol (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2e, 3c
BioLegend CD8 antibody (BioLegend, 100752) was used in flow cytometry on mouse samples (fig 2e, 3c). J Immunother Cancer (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 2.5 ug/ml; loading ...; fig 4a
BioLegend CD8 antibody (BioLegend, 100743) was used in flow cytometry on mouse samples at 2.5 ug/ml (fig 4a). Sci Transl Med (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2d, 1k
BioLegend CD8 antibody (BioLegend, 100743) was used in flow cytometry on mouse samples (fig s2d, 1k). J Immunother Cancer (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig 4c
BioLegend CD8 antibody (BioLegend, 100713) was used in flow cytometry on mouse samples at 1:100 (fig 4c). J Biol Chem (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...; fig s7j
BioLegend CD8 antibody (BioLegend, 100712) was used in flow cytometry on human samples (fig s7j). J Clin Invest (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6e
BioLegend CD8 antibody (BioLegend, 100708) was used in flow cytometry on mouse samples (fig 6e). J Immunother Cancer (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2h
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2h). JCI Insight (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5c, s8f
BioLegend CD8 antibody (BioLegend, 100712) was used in flow cytometry on mouse samples (fig 5c, s8f). J Clin Invest (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4c, 4g, 4i
BioLegend CD8 antibody (Biolegend, 100708) was used in flow cytometry on mouse samples (fig 4c, 4g, 4i). Nat Commun (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1d
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1d). Oncoimmunology (2022) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:200; fig s7i
  • flow cytometry; mouse; 1:100; loading ...
BioLegend CD8 antibody (Biolegend, 100733) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s7i) and in flow cytometry on mouse samples at 1:100. Nat Nanotechnol (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD8 antibody (BioLegend, 100708) was used in flow cytometry on mouse samples (fig 2a). Front Oncol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend CD8 antibody (BioLegend, 100704) was used in flow cytometry on mouse samples (fig 1b). Sci Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; loading ...; fig 2d
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:500 (fig 2d). Mol Psychiatry (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD8 antibody (BioLegend, 100722) was used in flow cytometry on mouse samples (fig s2a). iScience (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . Sci Adv (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend CD8 antibody (BioLegend, 53?C6.7) was used in flow cytometry on mouse samples at 1:200. J Immunother Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Commun Biol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; loading ...; fig s2d
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:1000 (fig s2d). Sci Adv (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 100704) was used in flow cytometry on mouse samples . Immunity (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; fig s6g
BioLegend CD8 antibody (Biolegend, 100708) was used in flow cytometry on mouse samples at 1:1000 (fig s6g). Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s13b
BioLegend CD8 antibody (Biolegend., 53-6.7) was used in flow cytometry on mouse samples (fig s13b). J Immunother Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6a
BioLegend CD8 antibody (Biolegend, 100705) was used in flow cytometry on mouse samples (fig 6a). Cell Death Dis (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 1c
BioLegend CD8 antibody (Biolegend, 100748) was used in flow cytometry on mouse samples at 1:400 (fig 1c). Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . Am J Physiol Endocrinol Metab (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . PLoS Pathog (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend CD8 antibody (Biolegend, 100712) was used in flow cytometry on mouse samples at 1:200. Aging Cell (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 500 ug/ml; loading ...; fig 2e
BioLegend CD8 antibody (BioLegend, 100706) was used in flow cytometry on mouse samples at 500 ug/ml (fig 2e). Sci Rep (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5b, 5h
BioLegend CD8 antibody (Biolegend, 100732) was used in flow cytometry on mouse samples (fig 5b, 5h). J Immunother Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s7h
BioLegend CD8 antibody (Biolegend, 100748) was used in flow cytometry on mouse samples at 1:100 (fig s7h). Cell Rep (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 4a, s3a
BioLegend CD8 antibody (Biolegend, 100759) was used in flow cytometry on mouse samples at 1:100 (fig 4a, s3a). Clin Exp Metastasis (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; loading ...
BioLegend CD8 antibody (Biolegend, 100706) was used in flow cytometry on mouse samples at 1:500. Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; loading ...; fig 6a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples at 1:500 (fig 6a). Acta Neuropathol Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2f
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2f). Animals (Basel) (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend CD8 antibody (Biolegend, 100711) was used in flow cytometry on mouse samples (fig 3b). Int J Mol Sci (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 6a). BMC Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200
BioLegend CD8 antibody (Biolegend, 100723) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5e
BioLegend CD8 antibody (BioLegend, 100734) was used in flow cytometry on mouse samples (fig 5e). Am J Cancer Res (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4b). Front Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD8 antibody (Biolegend, 100709) was used in flow cytometry on mouse samples (fig 2a). Transl Oncol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; loading ...; fig e6a
BioLegend CD8 antibody (Biolegend, 100708) was used in flow cytometry on mouse samples at 1:1000 (fig e6a). Nat Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s11
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s11). J Clin Invest (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3
BioLegend CD8 antibody (Biolegend, 100751) was used in flow cytometry on mouse samples (fig s3). J Clin Invest (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:800; loading ...; fig 1s2a
BioLegend CD8 antibody (Biolegend, 100712) was used in flow cytometry on mouse samples at 1:800 (fig 1s2a). elife (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4d). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...
BioLegend CD8 antibody (Biolegend, 100706) was used in flow cytometry on human samples . Aging (Albany NY) (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 5a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig 5a). Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 5b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 5b). Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; loading ...; fig 1b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:1000 (fig 1b). Sci Rep (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD8 antibody (BioLegend, 100762) was used in flow cytometry on mouse samples (fig 1c). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...
BioLegend CD8 antibody (Biolegend, 100744) was used in flow cytometry on human samples . J Immunother Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • mass cytometry; mouse; loading ...
BioLegend CD8 antibody (BioLegend, 100702) was used in mass cytometry on mouse samples . Br J Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6f
BioLegend CD8 antibody (Biolegend, 100,708) was used in flow cytometry on mouse samples (fig 6f). Am J Cancer Res (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend CD8 antibody (BioLegend, 100733) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). JCI Insight (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:100. J Am Heart Assoc (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; fig 2f
BioLegend CD8 antibody (BioLegend, 100,733) was used in flow cytometry on mouse samples at 1:200 (fig 2f). Acta Neuropathol Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4c, s6d
BioLegend CD8 antibody (Biolegend, 100758) was used in flow cytometry on mouse samples (fig s4c, s6d). JCI Insight (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; loading ...; fig 1c
BioLegend CD8 antibody (Biolegend, 100725) was used in flow cytometry on mouse samples at 1:1000 (fig 1c). PLoS Biol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend CD8 antibody (Biolegend, 100711) was used in flow cytometry on mouse samples (fig 4a). Front Cell Dev Biol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2c, s4a, s4b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2c, s4a, s4b). J Immunother Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend CD8 antibody (Biolegend, 100714) was used in flow cytometry on mouse samples (fig 4b). Front Immunol (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:100. Nat Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s16a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig s16a). Sci Transl Med (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
BioLegend CD8 antibody (BioLegend, 100732) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2021) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; rat; 1:100; loading ...; fig 7f
BioLegend CD8 antibody (Biolegend, 10070) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 7f). Front Cell Neurosci (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...
BioLegend CD8 antibody (BioLegend, 100706) was used in flow cytometry on mouse samples at 1:400. Nature (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s9b
BioLegend CD8 antibody (BioLegend, 100730) was used in flow cytometry on mouse samples (fig s9b). Sci Adv (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6d
BioLegend CD8 antibody (BioLegend, 100707) was used in flow cytometry on mouse samples (fig 6d). Neoplasia (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s2f
BioLegend CD8 antibody (Biolegend, 100708) was used in flow cytometry on mouse samples (fig s2f). Sci Adv (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s1a). J Immunother Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3e
BioLegend CD8 antibody (Biolegend, 100722) was used in flow cytometry on mouse samples (fig 3e). Theranostics (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 7c, 9d
BioLegend CD8 antibody (Biolegend, 100722) was used in flow cytometry on mouse samples (fig 7c, 9d). Sci Rep (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 3b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig 3b). Science (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s3g
BioLegend CD8 antibody (Biolegend, 100729) was used in flow cytometry on mouse samples at 1:200 (fig s3g). Proc Natl Acad Sci U S A (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BioLegend CD8 antibody (Biolegend, 100721) was used in flow cytometry on mouse samples . J Hematol Oncol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a, s2b
BioLegend CD8 antibody (Biolegend, 100708) was used in flow cytometry on mouse samples (fig 2a, s2b). Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 100704) was used in flow cytometry on mouse samples . J Clin Invest (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend CD8 antibody (Biolegend, 100722) was used in flow cytometry on mouse samples (fig 4d). Theranostics (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a, 4b, s2
BioLegend CD8 antibody (Biolegend, 100732) was used in flow cytometry on mouse samples (fig 4a, 4b, s2). Diabetes (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5e
BioLegend CD8 antibody (Biolegend, 100706) was used in flow cytometry on mouse samples (fig s5e). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2g
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig 2g). Nature (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a, 3e, 3f
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2a, 3e, 3f). Antioxidants (Basel) (2020) ncbi
rat monoclonal (5H10-1)
  • flow cytometry; mouse; 1:400; loading ...
BioLegend CD8 antibody (Biolegend, 5H10-1) was used in flow cytometry on mouse samples at 1:400. elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; fig 5a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 5a). Hepatol Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...; fig 7g
BioLegend CD8 antibody (BioLegend, 100730) was used in flow cytometry on human samples (fig 7g). Cancer Res (2021) ncbi
rat monoclonal (53-6.7)
BioLegend CD8 antibody (BioLegend, 100714) was used . Antioxidants (Basel) (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s18, s20
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s18, s20). J Clin Invest (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BioLegend CD8 antibody (Biolegend, 53-C6.7) was used in flow cytometry on mouse samples . elife (2020) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; 1:200; loading ...
BioLegend CD8 antibody (Biolegend, 100730) was used in immunohistochemistry on mouse samples at 1:200. elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2d
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2d). Proc Natl Acad Sci U S A (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend CD8 antibody (Biolegend, 100733) was used in flow cytometry on mouse samples (fig 3f). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:250; loading ...; fig 4g
  • immunohistochemistry; mouse; loading ...; fig 2a
BioLegend CD8 antibody (Biolegend, 100713) was used in flow cytometry on mouse samples at 1:250 (fig 4g) and in immunohistochemistry on mouse samples (fig 2a). elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1s1a
BioLegend CD8 antibody (Biolegend, 100712) was used in flow cytometry on mouse samples (fig 1s1a). elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1d). Am J Transplant (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1s3, 4c
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1s3, 4c). elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD8 antibody (Biolegend, 53 - 6.7) was used in flow cytometry on mouse samples (fig 2a). J Immunother Cancer (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 9b
BioLegend CD8 antibody (BioLegend, 100721) was used in flow cytometry on mouse samples at 1:100 (fig 9b). elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2d). Adv Sci (Weinh) (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:800; loading ...; fig 2a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:800 (fig 2a). elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; fig 1j
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 1j). J Allergy Clin Immunol (2021) ncbi
rat monoclonal (53-6.7)
BioLegend CD8 antibody (BioLegend, 53-6.7) was used . Nature (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3g
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3g). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD8 antibody (Biolegend, 53-C6.7) was used in flow cytometry on mouse samples (fig 2b). BMC Immunol (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s17
BioLegend CD8 antibody (BioLegend, 100727) was used in flow cytometry on mouse samples (fig s17). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s3d
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig s3d). Commun Biol (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). BMC Biol (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 8c
BioLegend CD8 antibody (BioLegend, 100707) was used in flow cytometry on mouse samples (fig 8c). Oncoimmunology (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s4b). Sci Adv (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD8 antibody (Biolegend, 100734) was used in flow cytometry on mouse samples (fig 1c). Cell Rep (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c, 1d, 6a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1c, 1d, 6a). elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; loading ...; fig 2e
BioLegend CD8 antibody (Biolegend, 100730) was used in flow cytometry on mouse samples at 1:1000 (fig 2e). elife (2020) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4d
  • flow cytometry; mouse; loading ...; fig 4a, 4b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 4d) and in flow cytometry on mouse samples (fig 4a, 4b). BMC Immunol (2020) ncbi
rat monoclonal (53-6.7)
  • immunocytochemistry; mouse; loading ...; fig e5b
BioLegend CD8 antibody (Biolegend, 100711) was used in immunocytochemistry on mouse samples (fig e5b). Nature (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1 ug/ml; loading ...
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples at 1 ug/ml. Science (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 5, s11
BioLegend CD8 antibody (BioLegend, 100730) was used in flow cytometry on mouse samples at 1:100 (fig 5, s11). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 5d
BioLegend CD8 antibody (BioLegend, 100712) was used in flow cytometry on mouse samples at 1:100 (fig 5d). Proc Natl Acad Sci U S A (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3a, s3b, s3c, s4a
BioLegend CD8 antibody (BioLegend, 100708) was used in flow cytometry on mouse samples (fig s3a, s3b, s3c, s4a). Cancers (Basel) (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 3a
BioLegend CD8 antibody (BioLegend, 100725) was used in flow cytometry on mouse samples at 1:200 (fig 3a). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s17b
BioLegend CD8 antibody (Biolegend, 100738) was used in flow cytometry on mouse samples at 1:100 (fig s17b). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s16d
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s16d). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 7b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 7b). elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s19d
BioLegend CD8 antibody (Biolegend, 100711) was used in flow cytometry on mouse samples at 1:100 (fig s19d). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a, s4e
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s1a, s4e). J Neuroinflammation (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1a
BioLegend CD8 antibody (BioLegend, 100714) was used in flow cytometry on mouse samples at 1:200 (fig 1a). elife (2019) ncbi
rat monoclonal (53-6.7)
  • mass cytometry; mouse; 3 ug/ml; loading ...; fig 5d
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in mass cytometry on mouse samples at 3 ug/ml (fig 5d). Science (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d, s3a, s3b
BioLegend CD8 antibody (Biolegend, 100752) was used in flow cytometry on mouse samples (fig 2d, s3a, s3b). Cell Rep (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend CD8 antibody (Biolegend, 100748) was used in flow cytometry on mouse samples at 1:200. JCI Insight (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig e2a, e5h
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig e2a, e5h). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a, 2f
BioLegend CD8 antibody (BioLegend, 100708) was used in flow cytometry on mouse samples (fig 2a, 2f). J Exp Med (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend CD8 antibody (Biolegend, 100712) was used in flow cytometry on mouse samples (fig 4a). elife (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s4). Aging (Albany NY) (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig e10
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig e10). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a, 1c, 1d, 5d, s5a
BioLegend CD8 antibody (BioLegend, 100722) was used in flow cytometry on mouse samples (fig 1a, 1c, 1d, 5d, s5a). Cell Rep (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5
BioLegend CD8 antibody (BioLegend, 53-C6.7) was used in flow cytometry on mouse samples (fig s5). Br J Cancer (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; fig 4d
BioLegend CD8 antibody (Biolegend, 100712) was used in flow cytometry on mouse samples at 1:400 (fig 4d). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend CD8 antibody (BioLegend, 100755) was used in flow cytometry on mouse samples (fig s1c). Cell (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 3f, 5c
BioLegend CD8 antibody (BioLegend, 100706) was used in flow cytometry on mouse samples at 1:100 (fig 3f, 5c). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). JCI Insight (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2k
BioLegend CD8 antibody (BioLegend, 100722) was used in flow cytometry on mouse samples (fig s2k). Sci Adv (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig e7b
BioLegend CD8 antibody (Biolegend, 100705) was used in flow cytometry on mouse samples at 1:100 (fig e7b). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2e). J Clin Invest (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3b
BioLegend CD8 antibody (BioLegend, 100740) was used in flow cytometry on mouse samples (fig s3b). Cell (2019) ncbi
rat monoclonal (53-6.7)
  • other; mouse; loading ...; fig 2b
BioLegend CD8 antibody (BioLegend, 100707) was used in other on mouse samples (fig 2b). Int Immunol (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD8 antibody (BioLegend, 100712) was used in flow cytometry on mouse samples (fig 1a). Immunity (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig ex4a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig ex4a). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend CD8 antibody (Biolegend, 100730) was used in flow cytometry on mouse samples (fig s2b). Cell Rep (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s7e
BioLegend CD8 antibody (Biolegend, 100748) was used in flow cytometry on mouse samples at 1:100 (fig s7e). Cancer Cell (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). Cell Rep (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a, 3b
BioLegend CD8 antibody (BioLegend, 100750) was used in flow cytometry on mouse samples (fig 3a, 3b). Immunity (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3e
BioLegend CD8 antibody (Biolegend, 100766) was used in flow cytometry on mouse samples (fig 3e). Sci Rep (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig e3p
BioLegend CD8 antibody (Biolegend, 100744) was used in flow cytometry on mouse samples (fig e3p). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD8 antibody (Biolegend, 100707) was used in flow cytometry on mouse samples (fig 3a). Front Oncol (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s1d
BioLegend CD8 antibody (Biolegend, 100737) was used in flow cytometry on mouse samples at 1:100 (fig s1d). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 3b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 3b). Nat Med (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s8a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s8a). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 5 ug/ml; loading ...; fig s12
BioLegend CD8 antibody (BioLegend, 100744) was used in flow cytometry on mouse samples at 5 ug/ml (fig s12). Science (2019) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6g
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 6g). Eur J Immunol (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s2o
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig s2o). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig ex2e
BioLegend CD8 antibody (eBioscience, 100706) was used in flow cytometry on mouse samples (fig ex2e). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s9a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s9a). Eur J Immunol (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s8b
BioLegend CD8 antibody (BioLegend, 100747) was used in flow cytometry on mouse samples (fig s8b). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3s1b
BioLegend CD8 antibody (Biolegend, 100708) was used in flow cytometry on mouse samples (fig 3s1b). elife (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4b
BioLegend CD8 antibody (Biolegend, 100733) was used in flow cytometry on mouse samples (fig s4b). Cell Rep (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2a). Science (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig e1b, e1c, e1d
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig e1b, e1c, e1d). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s5b). Science (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 5d
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 5d). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; rhesus macaque; loading ...; fig 2e
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on rhesus macaque samples (fig 2e). J Virol (2019) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6g
BioLegend CD8 antibody (Biolegend, 100702) was used in immunohistochemistry - paraffin section on mouse samples (fig 6g). Cell Rep (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a, 2g, s2j
BioLegend CD8 antibody (Biolegend, 100730) was used in flow cytometry on mouse samples (fig 2a, 2g, s2j). Cell Rep (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2a). Front Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a, s2b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2a, s2b). JCI Insight (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD8 antibody (Biolegend, 52-6.7) was used in flow cytometry on mouse samples (fig 1c). Transl Oncol (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend CD8 antibody (BioLegend, 100722) was used in flow cytometry on mouse samples (fig 5c). Br J Cancer (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a, 4b, 4c
BioLegend CD8 antibody (BioLegend, 100725) was used in flow cytometry on mouse samples (fig 4a, 4b, 4c). Invest Ophthalmol Vis Sci (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). Front Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD8 antibody (BioLegend, 53-C6.7) was used in flow cytometry on mouse samples (fig s2a). PLoS ONE (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD8 antibody (BioLegend, 53-7.7) was used in flow cytometry on mouse samples (fig 1a). J Exp Med (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c, 2b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1c, 2b). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). J Neuroinflammation (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 2.5 ug/ml; loading ...; fig s4
BioLegend CD8 antibody (Biolegend, 100751) was used in flow cytometry on mouse samples at 2.5 ug/ml (fig s4). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1h
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1h). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend CD8 antibody (BioLegend, 100737) was used in flow cytometry on mouse samples (fig 5a). Immunity (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig e8a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig e8a). Nature (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend CD8 antibody (Biolegend, 100706) was used in flow cytometry on mouse samples (fig s2a). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5b). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend CD8 antibody (Biolegend, 100722) was used in flow cytometry on mouse samples (fig 3d). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3c
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s3c). J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5a
BioLegend CD8 antibody (Biolegend, 5.3?C6.7) was used in flow cytometry on mouse samples (fig s5a). Eur J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2j
BioLegend CD8 antibody (BioLegend, clone 53-6.7) was used in flow cytometry on mouse samples (fig s2j). Science (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3g
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3g). Nat Med (2018) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig s2a
BioLegend CD8 antibody (Biolegend, 53.6-7) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig s2a). Science (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s2a
BioLegend CD8 antibody (BioLegend, 53?C6.7) was used in flow cytometry on mouse samples at 1:200 (fig s2a). J Exp Med (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). Int J Cancer (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2c
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2c). Cell Rep (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s11
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s11). Oncoimmunology (2018) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5c
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in immunohistochemistry - paraffin section on mouse samples (fig 5c). PLoS ONE (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s5a). Front Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend CD8 antibody (Biolegend, 100705) was used in flow cytometry on mouse samples (fig s1a). Cell (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2f
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2f). Transgenic Res (2018) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s5c
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig s5c). J Cell Biol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s4a). J Cell Biol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2). Front Microbiol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3c). Science (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD8 antibody (BioLegend, 53.6-7) was used in flow cytometry on mouse samples (fig 3a). Oncoimmunology (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 3a
BioLegend CD8 antibody (Biolegend, 100734) was used in flow cytometry on mouse samples at 1:100 (fig 3a). Development (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b, 3e
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3b, 3e). J Virol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3f). Science (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5a). Eur J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1k
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1k). J Exp Med (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 6a). Infect Immun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4b). J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 3b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 3b). Science (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). JCI Insight (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s11
BioLegend CD8 antibody (BD, 100725) was used in flow cytometry on mouse samples (fig s11). Science (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s10e
BioLegend CD8 antibody (BioLegend, 100708) was used in flow cytometry on mouse samples (fig s10e). Nature (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 2a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 2a). Nat Commun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s4a
BioLegend CD8 antibody (BioLegend, 100721) was used in flow cytometry on mouse samples (fig s4a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1f
BioLegend CD8 antibody (Biolegend, 100712) was used in flow cytometry on mouse samples (fig 1f). Sci Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5d
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s5d). Nature (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s7c
BioLegend CD8 antibody (Biolegend, 100721) was used in flow cytometry on mouse samples at 1:200 (fig s7c). Nat Cell Biol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s1d
BioLegend CD8 antibody (BioLegend, 100725) was used in flow cytometry on mouse samples at 1:100 (fig s1d). Leukemia (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4c). Nature (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to study the role of lysine acetyltransferase GCN5 in iNKT cell development and its mechanism, BioLegend CD8 antibody (BioLegend, 100733) was used in flow cytometry on mouse samples (fig 1b). Cell Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
In order to evaluate mouse models of hepacivirus infection, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). Science (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5e
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5e). Cell Death Differ (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig s3a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig s3a). Nat Commun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
In order to investigate the effect of lymphatic endothelial S1P on mitochondrial function and naive T cell survival, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2a). Nature (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig st1
In order to investigate the effect of PD-1 expression on phagocytosis and tumour immunity, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig st1). Nature (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1d
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . Cell Mol Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
In order to investigate the role of endothelial TLR4 and the microbiome in cerebral cavernous malformations, BioLegend CD8 antibody (Biolegend, 100725) was used in flow cytometry on mouse samples (fig s2a). Nature (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig st1a
In order to investigate the similarity between interferon gamma-induced tumor ischemia and physiological blood vessel regression, BioLegend CD8 antibody (BioLegend, 100708) was used in flow cytometry on mouse samples (fig st1a). Nature (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4e
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4e). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s11b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s11b). J Clin Invest (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3b). Nat Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:250; loading ...; fig 4a
In order to generate a technique for adeno-associated virus-based passive immunization against the effects of methamphetamine, BioLegend CD8 antibody (BioLegend, 100707) was used in flow cytometry on mouse samples at 1:250 (fig 4a). Sci Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to assess the contribution of viral infection to the development of celiac disease, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . Science (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1g
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s1g). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to show that TLR4 signals through the BCR leading to activation of SYK, ERK, and AKT as well as through MYD88 leading to activation of NFkappaB, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; loading ...; fig 3e
In order to clarify the mechanisms by which miR-21 contributes to oncogenesis, BioLegend CD8 antibody (Biolegend, 100701) was used in immunohistochemistry on mouse samples (fig 3e). Oncogene (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:300; loading ...; fig 6b
In order to test if oncolytic poxvirus treatment improves anti-PD-L1 immunotherapy, BioLegend CD8 antibody (BioLegend, 100708) was used in flow cytometry on mouse samples at 1:300 (fig 6b). Nat Commun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). Front Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6e
In order to investigate the role of adiponectin in a mouse model of colitis, BioLegend CD8 antibody (BioLegend, 53-67) was used in flow cytometry on mouse samples (fig 6e). J Biol Chem (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2h
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2h). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1f
In order to demonstrate that loss of autophagy results in the accumulation of mitochondria and an activated metabolic state of hematopoietic stem cells, BioLegend CD8 antibody (BioLegend, 100908) was used in flow cytometry on mouse samples (fig s1f). Nature (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1
In order to examine the contribution of T-bet-expressing B cells to autoimmune diseases, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Clin Invest (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5c
In order to propose that type 2 immunity is induced by a unique mechanism in the genital tract, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5c). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2
In order to examine the role of herpes virus entry mediator in corneal disease during viral infection, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2). Invest Ophthalmol Vis Sci (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4b
In order to discover that SIRPalpha is highly expressed in human renal cell carcinoma and melanoma, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4b). JCI Insight (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1g
In order to characterize mitochondrial changes in T cells due to PD-1 blockade therapy, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1g). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; loading ...; fig 2c
In order to evaluate host immune-mediated cell rejection in a retinal transplantation model, BioLegend CD8 antibody (Biolegend, 100726) was used in immunohistochemistry on mouse samples (fig 2c). Cell Stem Cell (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s6a
In order to find microenvironmental regulators of metastatic colonization, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s6a). Nature (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2
In order to characterize conventional and regulatory T cells during pregnancy, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:160; loading ...; fig 5h
In order to explore the role of Axl in promoting a suppressive myeloid microenvironment in response to ionizing radiation therapy in combination with checkpoint immunotherapy, BioLegend CD8 antibody (Biolegend, 100708) was used in flow cytometry on mouse samples at 1:160 (fig 5h). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; loading ...; fig 6a
In order to discuss the contribution of astrocytic IL-15 to postischemic brain damage, BioLegend CD8 antibody (biolegend, 53-6.7) was used in blocking or activating experiments on mouse samples (fig 6a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine the effect of a high salt diet on intestinal immunity and the risk of inflammatory bowel disease, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). Oncotarget (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to show that parasite-specific CD8 positive T cell-induced fatal vascular breakdown and subsequent neuronal death in an animal model of cerebral malaria, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). PLoS Pathog (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s1b). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). J Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s2b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3c
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s3c). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1G
In order to study epigenetic heterogeneity in hematopoietic stem cells., BioLegend CD8 antibody (Biolegend, 100704) was used in flow cytometry on mouse samples (fig 1G). Cell (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2
In order to explore the role of NR4A3 in CD103+ migratory dendritic cells and CCR7-dependent cell migration, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to study the role of TMEM16F in limiting T cell responses in mice infected with virus, BioLegend CD8 antibody (BioLegend, 100705) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; loading ...; fig 4c
In order to characterize malaria-induced splenic monocyte-derived dendritic cells, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:1000 (fig 4c). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4b
In order to use MRI to track iron oxide nanoparticles in vivo, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to show that R848-mediated suppression of experimental asthma is IL-27-dependent, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . J Virol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 6). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 2a
In order to test how inhibiting autophagy impacts antitumor immune responses in immune-competent mouse models of melanoma and mammary cancer, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 2a). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...; fig 5
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on human samples (fig 5). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6f
In order to assess the effects of a genetically encoded chimeric MyD88/CD40 adjuvant, BioLegend CD8 antibody (Biolegend, 100722) was used in flow cytometry on mouse samples (fig 6f). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50; loading ...; fig s2e
In order to describe how amino acids and Lamtor1 regulate macrophage polarization, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples at 1:50 (fig s2e). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to study T cell migration in inflammatory demyelinating lesions confined to optic nerves and spinal cord, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2c). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
BioLegend CD8 antibody (BioLegend, 100725) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BioLegend CD8 antibody (BioLegend, 100722) was used in flow cytometry on mouse samples (fig 1). Cell (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s9a
In order to develop and characterize a murine model of hepatitis A virus, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s9a). Science (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5B
BioLegend CD8 antibody (Biolegend, 100747) was used in flow cytometry on mouse samples (fig 5B). Oncoimmunology (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1b
BioLegend CD8 antibody (BioLegend, 100729) was used in flow cytometry on mouse samples (fig 1b). J Exp Clin Cancer Res (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; 1:100; loading ...
In order to find that leukocyte cell-derived chemotaxin 2 promotes expansion and mobilization of hematopoietic stem cells, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on human samples at 1:100. Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 6). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
In order to demonstrate that DNMT3a directs early CD8 positive T-cell effector and memory fate decisions, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s1). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3c
In order to test if a combination of LYN and Aire defects result in organ-specific autoimmunity, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3c). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1e
In order to elucidate how Zfp36l1 and Zfp36l2 regulate the thymic beta-Selection checkpoint, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1e). J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50; fig 3
BioLegend CD8 antibody (Biolegend, 100723) was used in flow cytometry on mouse samples at 1:50 (fig 3). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 8c
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 8c). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2i
In order to use Disheveled knockout mice to study the role of Wnt signaling in gastrointestinal homeostasis, BioLegend CD8 antibody (BioLegend, 100727) was used in immunohistochemistry - frozen section on mouse samples (fig 2i). JCI Insight (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend CD8 antibody (biolegend, 100730) was used in flow cytometry on mouse samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4d
In order to report that MARCH 8 controls surface expression of major histocompatibility complex class II on thymic epithelial cells, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4d). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to explore the role of exhausted CD8 positive CXCR5 positive T cells in mice chronically infected with lymphocytic choriomeningitis virus, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:100
  • flow cytometry; mouse; 1:200; loading ...; tbl s2
In order to identify and characterize follicular cytotoxic T cells, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples at 1:100 and in flow cytometry on mouse samples at 1:200 (tbl s2). Nat Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1
In order to investigate the roles of platelets and patrolling Ly6C low monocytes in acute vascular inflammation, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s1). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4g
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4g). Am J Pathol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1e). J Leukoc Biol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6a
In order to elucidate how hematopoietic ANGPTL4 deficiency increases atherogenesis, BioLegend CD8 antibody (BioLegend, 536.7) was used in flow cytometry on mouse samples (fig 6a). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; fig 4
BioLegend CD8 antibody (BioLegend, 53.6.7) was used in flow cytometry on human samples (fig 4). J Virol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s6b
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s6b). Nat Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3
In order to study the impact of p21 signaling on monocyte reprogramming, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s3). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5c
BioLegend CD8 antibody (Biolegend, 100733) was used in flow cytometry on mouse samples (fig 5c). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to explain how glial cells impact ILC3-derived IL-22, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:300; loading ...; fig s4b
In order to investigate the stromal contribution to the microenvironment of tumor-draining lymph nodes, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples at 1:300 (fig s4b). Nat Immunol (2016) ncbi
rat monoclonal (53-6.7)
In order to develop a protocol for differentiation of retinal pigment epithelium from mouse induced pluripotent stem cells, BioLegend CD8 antibody (BioLegend, 100711) was used . PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3c
In order to assess the contribution of interferon-induced transmembrane protein 3 to West Nile virus infection, BioLegend CD8 antibody (Biolegend, 100734) was used in flow cytometry on mouse samples (fig 3c). J Virol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4b
BioLegend CD8 antibody (Biolegend, 100706) was used in flow cytometry on mouse samples (fig 4b). J Transl Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1a
In order to compare extravasation of activated CD4+ and CD8+ T cells across primary mouse brain microvascular endothelial cells, BioLegend CD8 antibody (Biolegend, 100708) was used in flow cytometry on mouse samples (fig 1a). Eur J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s1
In order to find that coagulation factor XII modulates immune responses, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig s1). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
BioLegend CD8 antibody (Biolegend, 100722) was used in flow cytometry on mouse samples (fig 3). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s5
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig s5). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1a
In order to demonstrate that Ndfip1/Ndfip2 regulate cross talk between T-cell receptor and cytokine signaling pathways, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 1a). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig st1
In order to study how bone marrow endothelial cells regulate bone marrow stem cell maintenance and leukocyte trafficking, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig st1). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . Oncoimmunology (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s2
In order to describe a role for Nbn in skin homeostasis, BioLegend CD8 antibody (Biolegend, 100744) was used in flow cytometry on mouse samples (fig s2). Oncotarget (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3a
In order to report how the parallel networks of necroptosis-induced CXCL1 and Mincle signaling promote pancreatic ductal adenocarcinoma progression, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s3a). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s1). Oncotarget (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to determine the effects of an altered intestinal microbiota and microbial metabolites on graft-versus-host disease, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). Nat Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to study the requisite for the function of regulatory T cells known as phosphatase PP2A, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 7d
In order to observe that Suppressor of Cytokine Signaling 3-deficient bone marrow-derived macrophages display enhanced and prolonged expression of pro-inflammatory M1 cytokines when exposed to glioma tumor cell conditioned medium in vitro, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 7d). Oncotarget (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3a
In order to propose that neuronal autoimmunity is a pathogenic feature of type 1 diabetes, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s3a). Diabetes (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of B cells in the initiation of central nervous system autoimmunity, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5a). Gastroenterology (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to study how a novel multi-drug metronomic chemotherapy can delay tumor growth in mice significantly, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5). J Transl Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1). Mucosal Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (53-6.7)
BioLegend CD8 antibody (Biolegend, 100711) was used . Clin Cancer Res (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s13
In order to study the response of intestinal tuft cells to parasites, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s13). Science (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5a
In order to discuss models of squamous lung tumors to test therapeutic regimens, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5a). J Thorac Oncol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to show that Bhlhe40 expression marks encephalitogenic T helper cells and that the PTX-IL-1-Bhlhe40 pathway is active in mice with experimental autoimmune encephalomyelitis, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . Dis Model Mech (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 100713) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s5
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s5). EMBO Mol Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1a
In order to study the effect of atypical protein kinase C i on asymmetric division and CD8(+) T Lymphocyte, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study dendritic cells in Sirt6 knock out mice, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . Aging (Albany NY) (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4). PLoS Pathog (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 2e
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, BioLegend CD8 antibody (BioLegend, 100722) was used in flow cytometry on mouse samples at 1:400 (fig 2e). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
BioLegend CD8 antibody (Biolegend, 100725) was used . Sci Rep (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1
In order to study the polysialylation of CCR7, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s1). Science (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of TfR1 in adaptive immunity, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . Nat Genet (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
BioLegend CD8 antibody (biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Theranostics (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
  • immunohistochemistry; mouse; fig 1
In order to research skin-resident memory T cell homeostasis and lymphoma mediated by hair follicle-derived IL-7 and IL-15, BioLegend CD8 antibody (BioLegend, 53.6.7) was used in flow cytometry on mouse samples (fig 1) and in immunohistochemistry on mouse samples (fig 1). Nat Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5). Eur J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study the life span of individual memory B cells, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on human samples . Science (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s7
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig s7). elife (2015) ncbi
rat monoclonal (53-6.7)
BioLegend CD8 antibody (BioLegend, 100731) was used . Mol Med Rep (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4). Mucosal Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; fig 4
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 4). Cancer Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). Cancer Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2d). Cancer Res (2015) ncbi
rat monoclonal (5H10-1)
  • flow cytometry; mouse; fig 1
BioLegend CD8 antibody (BioLegend, #100802) was used in flow cytometry on mouse samples (fig 1). Exp Ther Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1
In order to discuss tissue tropisms of innate lymphoid cells, BioLegend CD8 antibody (biolegend, 53?C6.7) was used in flow cytometry on mouse samples (fig s1). Immunity (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine if therapeutic antiviral T cells eliminate viral load in the brain of mice persistently infected from birth with lymphocytic choriomeningitis virus without causing blood-brain barrier breakdown or tissue damage, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 10 ug/ml; fig 7a
In order to propose that thymoproteasomes contribute to the positive selection of CD8 positive T cells by preferentially producing low-affinity T-cell receptor ligand peptides, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples at 10 ug/ml (fig 7a). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; fig 9
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 9). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl s1
In order to study the role of ICOS in group 2 innate lymphoid cell responses, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to examine the contribution of stromal cells to non-small cell lung cancer, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend CD8 antibody (BioLegend, 5.3-6.7) was used in flow cytometry on mouse samples (fig 3b). J Leukoc Biol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to determine the role of Sirt1 in regulating the expression of tissue-restricted antigens in medullary thymic epithelial cells, BioLegend CD8 antibody (BioLegend, 100707) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 7
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 7). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; fig 4
BioLegend CD8 antibody (BioLegend, 100711) was used in immunohistochemistry on mouse samples (fig 4). J Virol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study the effect of ERK1/2 and ERK5 activation on BAFF-induced B cell survival, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . J Exp Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4
In order to show that CD4 positive T cells and ILC2s together block Nippostrongylus brasiliensis development in the parenchyma, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to elucidate the role of Treg during T. gondii infection, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . Microbes Infect (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). Tuberculosis (Edinb) (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 7d
  • immunohistochemistry; mouse; fig 4c
BioLegend CD8 antibody (Biolegend, 100733) was used in flow cytometry on mouse samples (fig 7d) and in immunohistochemistry on mouse samples (fig 4c). Proc Natl Acad Sci U S A (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s4
BioLegend CD8 antibody (Biolegend, 100734) was used in flow cytometry on mouse samples (fig s4). Proc Natl Acad Sci U S A (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2a
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). Sci Transl Med (2015) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in blocking or activating experiments on mouse samples . Oncotarget (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:5000; fig 4
BioLegend CD8 antibody (BioLegend, 100705) was used in flow cytometry on mouse samples at 1:5000 (fig 4). Immun Ageing (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; rat
BioLegend CD8 antibody (BioLegend, 100701) was used in flow cytometry on rat samples . Transpl Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl s3
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (tbl s3). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 100705) was used in flow cytometry on mouse samples . Anticancer Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 4). Neuropathol Appl Neurobiol (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - paraffin section; mouse; tbl 1
In order to characterize histomorphometric tumors by induction of colorectal cancer in mice, BioLegend CD8 antibody (Biolegend, 100701) was used in immunohistochemistry - paraffin section on mouse samples (tbl 1). Methods Mol Biol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to study the contribution of SEMA4D-PLXNB1 interactions to immune-cell trafficking in the tumor microenvironment, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5). Cancer Immunol Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 8f
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 8f). J Virol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to show how early events during viral infection decide the immune response and facilitate either control, clearance, or persistence of the virus, BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2). PLoS Pathog (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3a
In order to investigate the effect of IL-7 and anti-PD-1 treatment in sepsis model followed by Candida albicans infection, BioLegend CD8 antibody (Biolegend, 100734) was used in flow cytometry on mouse samples (fig 3a). Shock (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
BioLegend CD8 antibody (Biolegend, clone 53-6.7) was used in flow cytometry on mouse samples (fig 5). Eur J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 100710) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 3). Infect Immun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . J Clin Invest (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend CD8 antibody (biolegend, 100707) was used in flow cytometry on mouse samples (fig 6a). Appl Microbiol Biotechnol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl s1
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (tbl s1). Stem Cells (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to determine the role of interferon regulatory factor 7 in Plasmodium berghei ANKA infection, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples (fig 5). Eur J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples at 1:200. PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
In order to examine the role of interleukin-4 in relation to eomesodermin within CD8+ T cells, BioLegend CD8 antibody (Biolegend, 53-6.7) was used . PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
BioLegend CD8 antibody (BioLegend, 53-6.7) was used . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
BioLegend CD8 antibody (BioLegend, 53-6.7) was used . Cell Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . Blood (2014) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; 150 ug/mice
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in blocking or activating experiments on mouse samples at 150 ug/mice. PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . Cancer Immunol Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate incomplete immunity against intracellular pathogens in neonates, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate how Fbw7-mediated GATA3 regulation and CDK2-mediated phosphorylation of Cdc4 phosphodegron regulate differentiation of T-cell lineages, BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . Mol Cell Biol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples . Infect Immun (2014) ncbi
rat monoclonal (53-6.7)
BioLegend CD8 antibody (BioLegend, 53-6.7) was used . PLoS Negl Trop Dis (2014) ncbi
rat monoclonal (53-6.7)
  • immunocytochemistry; mouse
BioLegend CD8 antibody (Biolegend, 100723) was used in immunocytochemistry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
  • immunohistochemistry; mouse; fig 2
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig 2) and in immunohistochemistry on mouse samples (fig 2). Immunol Cell Biol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2
BioLegend CD8 antibody (BioLegend, 53-6.7) was used in flow cytometry on mouse samples (fig s2). J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100
BioLegend CD8 antibody (BioLegend, 100712) was used in flow cytometry on mouse samples at 1:100. Nat Med (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
BioLegend CD8 antibody (Biolegend, 100733) was used in flow cytometry on mouse samples (fig 4). Autophagy (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BioLegend CD8 antibody (Biolegend, 53-6.7) was used in flow cytometry on mouse samples . Arch Immunol Ther Exp (Warsz) (2013) ncbi
Invitrogen
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...
Invitrogen CD8 antibody (eBioscience, 17-0081-81) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2022) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:1000; fig 3a
Invitrogen CD8 antibody (Thermo Fisher, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:1000 (fig 3a). Theranostics (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; loading ...; fig 3b, 3c
Invitrogen CD8 antibody (Invitrogen, 48-0081-80) was used in flow cytometry on mouse samples at 1:1000 (fig 3b, 3c). Theranostics (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; 1:100; fig s5a
Invitrogen CD8 antibody (Invitrogen, 25-0081-81) was used in flow cytometry on human samples at 1:100 (fig s5a). Nat Commun (2022) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:1000; fig s5b
Invitrogen CD8 antibody (Invitrogen, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:1000 (fig s5b). Sci Transl Med (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b, 2g
Invitrogen CD8 antibody (eBioscience, 56-0081-82) was used in flow cytometry on mouse samples (fig 2b, 2g). PLoS Pathog (2022) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 4a
Invitrogen CD8 antibody (e-Bioscience, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 4a). In Vivo (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 1c, s3a, s3b
Invitrogen CD8 antibody (eBioscience, 11-0081-82) was used in flow cytometry on mouse samples at 1:400 (fig 1c, s3a, s3b). Development (2022) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:2000; loading ...; fig s6a
Invitrogen CD8 antibody (eBioscience, 14-0808) was used in immunohistochemistry on mouse samples at 1:2000 (fig s6a). Nat Commun (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3, 1d
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s3, 1d). Int J Mol Sci (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2j, 5g, e5b, s1g
Invitrogen CD8 antibody (eBioscience, 45-0081-82) was used in flow cytometry on mouse samples at 1:100 (fig 2j, 5g, e5b, s1g). EMBO Mol Med (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 6f
Invitrogen CD8 antibody (Thermo Fisher, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig 6f). Sci Rep (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4b
Invitrogen CD8 antibody (Invitrogen, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4b). Nat Commun (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:5000; loading ...; fig 6b
Invitrogen CD8 antibody (Ebioscience, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:5000 (fig 6b). Cancers (Basel) (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3c
Invitrogen CD8 antibody (Invitrogen, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:200 (fig 3c). Cancers (Basel) (2021) ncbi
rat monoclonal (4SM15)
  • immunocytochemistry; mouse; 1:100; fig 3b
Invitrogen CD8 antibody (Thermo Fisher Scientific, 4?C0808) was used in immunocytochemistry on mouse samples at 1:100 (fig 3b). J Immunother Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen CD8 antibody (eBioscience, 25-0081-82) was used in flow cytometry on mouse samples (fig 3d). Cell Death Dis (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50; loading ...; fig 4d
Invitrogen CD8 antibody (eBioscience, 11-0081-85) was used in flow cytometry on mouse samples at 1:50 (fig 4d). Cells (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 7e
Invitrogen CD8 antibody (Invitrogen, 14-0808-80) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 7e). NPJ Breast Cancer (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; fig 7e
Invitrogen CD8 antibody (Thermo fisher, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 7e). Cell Rep (2021) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; 1:100; fig 2e
Invitrogen CD8 antibody (eBioscience, 14-0081-82) was used in immunohistochemistry on mouse samples at 1:100 (fig 2e). Cell Death Discov (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
Invitrogen CD8 antibody (eBioscience, 45-0081-82) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2e
Invitrogen CD8 antibody (Invitrogen, 14-0081-82) was used in immunohistochemistry - frozen section on mouse samples (fig 2e). Int J Mol Sci (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...
Invitrogen CD8 antibody (Thermo Fisher Scientific, 48-0081-82) was used in flow cytometry on mouse samples at 1:100. elife (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; 1:40; loading ...
Invitrogen CD8 antibody (ThermoFisher Scientific, 53-0081-82) was used in flow cytometry on human samples at 1:40. elife (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3f
Invitrogen CD8 antibody (Ebiosciences, 14-0808-80) was used in immunohistochemistry - paraffin section on mouse samples (fig 3f). Mol Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen CD8 antibody (eBioscience, 12-0081-81) was used in flow cytometry on mouse samples (fig 2b). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; tbl 2
Invitrogen CD8 antibody (Thermo Fisher, 47-0081-82) was used in flow cytometry on mouse samples (tbl 2). Int J Mol Sci (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 6c
Invitrogen CD8 antibody (eBioscience, 11-0081-82) was used in flow cytometry on mouse samples at 1:100 (fig 6c). Cell Prolif (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
Invitrogen CD8 antibody (eBioscience, 56-0081-82) was used in flow cytometry on mouse samples . Mucosal Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3
Invitrogen CD8 antibody (Thermo Fisher, 53-6.7) was used in flow cytometry on mouse samples (fig s3). Cell Death Dis (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3b). BMC Res Notes (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6c
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6c). Antioxidants (Basel) (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
Invitrogen CD8 antibody (Thermo-Fisher, 12-0081-82) was used in flow cytometry on mouse samples . J Exp Clin Cancer Res (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 7e
Invitrogen CD8 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 7e). Nat Commun (2021) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 2
Invitrogen CD8 antibody (Thermo Fisher Scientific, 4SM15) was used in immunohistochemistry on mouse samples at 1:50 (fig 2). NPJ Breast Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD8 antibody (ThermoFisher, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). Front Immunol (2020) ncbi
rat monoclonal (5H10)
  • flow cytometry; human; loading ...; fig 5f
Invitrogen CD8 antibody (Thermo Fisher, MCD0801) was used in flow cytometry on human samples (fig 5f). Oncogene (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; loading ...; fig 1c
Invitrogen CD8 antibody (Thermofisher, 53-6.7) was used in flow cytometry on mouse samples at 1:1000 (fig 1c). Protein Cell (2021) ncbi
rat monoclonal (4SM16)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6a
  • immunohistochemistry - paraffin section; human; loading ...; fig 7c
Invitrogen CD8 antibody (eBioscience, 14-0195-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 6a) and in immunohistochemistry - paraffin section on human samples (fig 7c). Oncogene (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s8
Invitrogen CD8 antibody (eBioscience, 12-0081-81) was used in flow cytometry on mouse samples (fig s8). Commun Biol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 7
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 7). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 10a
Invitrogen CD8 antibody (Thermo Fisher, 53-6.7) was used in flow cytometry on mouse samples (fig 10a). PLoS Pathog (2021) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 1c
Invitrogen CD8 antibody (eBioscience, 14-0081-82) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 1c). Nat Neurosci (2021) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; 1:100; loading ...; fig 1a
Invitrogen CD8 antibody (eBioscience, MCD0828) was used in flow cytometry on mouse samples at 1:100 (fig 1a). J Neuroinflammation (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; fig 6d
Invitrogen CD8 antibody (eBiosciences, 56-0081-82) was used in flow cytometry on mouse samples at 1:500 (fig 6d). Cancer Res (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig ev4d
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig ev4d). EMBO Mol Med (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
Invitrogen CD8 antibody (eBioscience, 48-0081-82) was used in flow cytometry on mouse samples . J Clin Invest (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). J Clin Invest (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s2a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s2a). Mucosal Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2b
Invitrogen CD8 antibody (eBioscience, 13-0081-82) was used in flow cytometry on mouse samples (fig s2b). Cell (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4
Invitrogen CD8 antibody (Thermo Fisher, 53-6.7) was used in flow cytometry on mouse samples (fig s4). Eur J Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4c
Invitrogen CD8 antibody (Thermo Fisher, 53-0081-82) was used in flow cytometry on mouse samples (fig 4c). Cell (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a, s1b
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1a, s1b). BMC Immunol (2020) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; fig 4a
Invitrogen CD8 antibody (eBioscience, 16-0081-81) was used in immunohistochemistry on mouse samples (fig 4a). Basic Res Cardiol (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4b
Invitrogen CD8 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 4b). Cell (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 5e
Invitrogen CD8 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:50 (fig 5e). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; 1:100; loading ...; fig 6a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on human samples at 1:100 (fig 6a). Front Immunol (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 7b
Invitrogen CD8 antibody (Invitrogen, 53-6.7) was used in flow cytometry on mouse samples (fig 7b). PLoS Pathog (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:300; loading ...; fig 4d
Invitrogen CD8 antibody (Invitrogen, 17-0081-82) was used in flow cytometry on mouse samples at 1:300 (fig 4d). Cell Res (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 3, s4
Invitrogen CD8 antibody (eBioscience, 45-0081-82) was used in flow cytometry on mouse samples at 1:100 (fig 3, s4). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2e
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2e). Nature (2020) ncbi
rat monoclonal (4SM16)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6e
Invitrogen CD8 antibody (eBioscience, 14-0195-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 6e). Sci Transl Med (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
Invitrogen CD8 antibody (eBioscience, 53.6-7) was used in flow cytometry on mouse samples . elife (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5b
Invitrogen CD8 antibody (Fisher Scientific, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples (fig 5b). Cancers (Basel) (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5b
Invitrogen CD8 antibody (eBioscience, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples (fig 5b). Acta Neuropathol (2020) ncbi
rat monoclonal (KT15)
  • flow cytometry; mouse; 1:100; loading ...; fig s15
Invitrogen CD8 antibody (ThermoFisher, MA5-16761) was used in flow cytometry on mouse samples at 1:100 (fig s15). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5b
Invitrogen CD8 antibody (eBioscience, 12-0081-82) was used in flow cytometry on mouse samples (fig 5b). Aging (Albany NY) (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50; loading ...; fig s5a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:50 (fig s5a). Mol Ther Methods Clin Dev (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:800; fig s15b
Invitrogen CD8 antibody (Thermo Fisher, 12-0081-81) was used in flow cytometry on mouse samples at 1:800 (fig s15b). Nat Commun (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - frozen section; mouse; 1:150; loading ...; fig 2a
Invitrogen CD8 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - frozen section on mouse samples at 1:150 (fig 2a). Nat Commun (2020) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s7f
Invitrogen CD8 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples (fig s7f). Nature (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d, s3a, s3b
Invitrogen CD8 antibody (ThermoFisher, 47-0081-82) was used in flow cytometry on mouse samples (fig 2d, s3a, s3b). Cell Rep (2019) ncbi
rat monoclonal (4SM16)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4f
Invitrogen CD8 antibody (Thermo Fisher, 4SM16) was used in immunohistochemistry - paraffin section on mouse samples (fig 4f). Cell Rep (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 5b
Invitrogen CD8 antibody (eBioscience, MA1-10304) was used in flow cytometry on mouse samples at 1:100 (fig 5b). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s1f
Invitrogen CD8 antibody (Invitrogen, 11-0081-85) was used in flow cytometry on mouse samples at 1:200 (fig s1f). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s4
Invitrogen CD8 antibody (eBioscience, 17-0081-82) was used in flow cytometry on mouse samples at 1:100 (fig s4). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3a, s3b
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s3a, s3b). Sci Adv (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 3s1
Invitrogen CD8 antibody (eBiosciences, 25-0081-81) was used in flow cytometry on mouse samples at 1:100 (fig 3s1). elife (2019) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; loading ...; fig s1d
Invitrogen CD8 antibody (Thermo Fisher, 5H10) was used in flow cytometry on mouse samples (fig s1d). Science (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 5a
Invitrogen CD8 antibody (eBioscience, 14-C0808) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5a). Br J Cancer (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2c
Invitrogen CD8 antibody (eBioscience, 25-0081-82) was used in flow cytometry on mouse samples (fig s2c). Cell (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:4000; loading ...; fig 5a
Invitrogen CD8 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:4000 (fig 5a). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2h, 3k, 5a
Invitrogen CD8 antibody (Ebioscience, 45-0081-82) was used in flow cytometry on mouse samples (fig 2h, 3k, 5a). Oncoimmunology (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen CD8 antibody (Thermo Fisher, 53-6.7) was used in flow cytometry on mouse samples (fig s2a). Science (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 3f
Invitrogen CD8 antibody (ebioscience, 14-0808-80) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 3f). JCI Insight (2019) ncbi
rat monoclonal (53-6.7)
  • other; mouse; loading ...; fig 2b
Invitrogen CD8 antibody (eBioscience, 13-0081-86) was used in other on mouse samples (fig 2b). Int Immunol (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig s5a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig s5a). Science (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; fig 6a
Invitrogen CD8 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 6a). Cancer Cell (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig e3b
Invitrogen CD8 antibody (Invitrogen, 47-0081-82) was used in flow cytometry on mouse samples at 1:200 (fig e3b). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:2000; loading ...; fig e5c
Invitrogen CD8 antibody (eBioscience, 17-0081-83) was used in flow cytometry on mouse samples at 1:2000 (fig e5c). Nature (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7e
Invitrogen CD8 antibody (eBioscience, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples (fig 7e). J Clin Invest (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig e3p
Invitrogen CD8 antibody (eBioscience, 56-0081-82) was used in flow cytometry on mouse samples (fig e3p). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s6a
Invitrogen CD8 antibody (eBioscience, 12-0081-82) was used in flow cytometry on mouse samples (fig s6a). Cell (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2d). J Exp Med (2019) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; loading ...; fig s7c
Invitrogen CD8 antibody (Invitrogen, MCD0830) was used in flow cytometry on mouse samples (fig s7c). Cell Metab (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen CD8 antibody (Thermo Fisher Scientific, A15386) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). Oncoimmunology (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; loading ...; fig 5a
Invitrogen CD8 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples at 1:1000 (fig 5a). Cell (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). Immune Netw (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4b
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s4b). Front Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 2d
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 2d). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5d). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen CD8 antibody (eBioscience, 56-0081-82) was used in flow cytometry on mouse samples (fig 3b). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • immunocytochemistry; mouse; loading ...; fig 1c
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in immunocytochemistry on mouse samples (fig 1c). Science (2019) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s4
Invitrogen CD8 antibody (eBioscience, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples (fig s4). JCI Insight (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s2a, s2b
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig s2a, s2b). J Pathol (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 2d
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 2d). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD8 antibody (eBioscience, 12-0081-81) was used in flow cytometry on mouse samples (fig 1a). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
Invitrogen CD8 antibody (eBioscience, 53-C6.7) was used in flow cytometry on mouse samples (fig 3b). PLoS ONE (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s3b
Invitrogen CD8 antibody (eBioscience, 25-0081-82) was used in flow cytometry on mouse samples at 1:100 (fig s3b). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1a). Blood (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig ev2c
Invitrogen CD8 antibody (eBioscience, 53?\6.7) was used in flow cytometry on mouse samples (fig ev2c). EMBO J (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4i
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4i). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Sci Rep (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s3c
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig s3c). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3b
Invitrogen CD8 antibody (eBiosciences, 53.6.7) was used in flow cytometry on mouse samples (fig s3b). Science (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen CD8 antibody (Thermo Fisher Scientific, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). Eur J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2c
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 2c). PLoS ONE (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:300; loading ...; fig 3c
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:300 (fig 3c). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 4a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 4a). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; loading ...; fig s11c
Invitrogen CD8 antibody (Thermo Fisher Scientific, 47-0081-82) was used in flow cytometry on mouse samples at 1:500 (fig s11c). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5k
  • immunohistochemistry; mouse; loading ...; fig 4d
Invitrogen CD8 antibody (eBioscience, 14-0081-82) was used in flow cytometry on mouse samples (fig 5k) and in immunohistochemistry on mouse samples (fig 4d). Cancer Res (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen CD8 antibody (eBioscience, 45-0081-82) was used in flow cytometry on mouse samples (fig 2b). Cell Rep (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig e2c
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig e2c). Nature (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1e
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s1e). Cell Stem Cell (2018) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; 1:40; loading ...; fig 5a
Invitrogen CD8 antibody (Thermo Fisher, 14-0808-82) was used in immunohistochemistry on mouse samples at 1:40 (fig 5a). J Exp Med (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4d
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4d). EMBO J (2018) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; fig 5c
Invitrogen CD8 antibody (eBioscience, 14-0808) was used in immunohistochemistry - paraffin section on mouse samples (fig 5c). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; loading ...; fig s3d
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in immunohistochemistry on mouse samples (fig s3d). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3e
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3e). J Virol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen CD8 antibody (Thermo Fisher, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). Oncogene (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2b
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s2b). Cell Metab (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1c
Invitrogen CD8 antibody (Affymetrix/eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 1c). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen CD8 antibody (Thermo Fisher Scientific, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1a). J Exp Med (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). Front Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...; fig s14a
Invitrogen CD8 antibody (eBioscience, 25-0081) was used in flow cytometry on human samples (fig s14a). Nat Med (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). Front Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; loading ...; fig s4b
Invitrogen CD8 antibody (eBiosciences, 17-0081-82) was used in flow cytometry on mouse samples at 1:500 (fig s4b). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3b
Invitrogen CD8 antibody (eBiosciences, 56-0081-82) was used in flow cytometry on mouse samples (fig 3b). Cell (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2d). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s2a). Science (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 7a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 7a). Cell (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2b
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s2b). Cancer Res (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...
Invitrogen CD8 antibody (ebioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:400. Nat Commun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
Invitrogen CD8 antibody (eBioscience, 53.6-72) was used in flow cytometry on mouse samples (fig 3a). J Clin Invest (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to study the role of lysine acetyltransferase GCN5 in iNKT cell development and its mechanism, Invitrogen CD8 antibody (eBioscience, 12-0081-83) was used in flow cytometry on mouse samples (fig 1b). Cell Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to investigate the involvement of Sec22b in antigen cross-presentation and antitumor immunity, Invitrogen CD8 antibody (eBiosciences, 45-0081-82) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5a
In order to characterize murine monocytes through transcriptome and genome analyses, Invitrogen CD8 antibody (eBioscience, 17-0081-82) was used in flow cytometry on mouse samples (fig 5a). Immunity (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1
In order to investigate the role of Egr2 and 3 in adaptive immune responses and its mechanism, Invitrogen CD8 antibody (eBiosciences, 12-0081-81) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2c
In order to investigate the function of AIM2 inflammasome in influenza-iInduced lung injury and mortality, Invitrogen CD8 antibody (Thermo, 25-0081-81) was used in flow cytometry on mouse samples (fig s2c). J Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1b
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, Invitrogen CD8 antibody (Thermo Fisher Scientific, 53?C6.7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 5e
Invitrogen CD8 antibody (eBiosciences, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 5e). JCI Insight (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...
In order to show that Eros is essential for host defense via the phagocyte NAPDH oxidase, Invitrogen CD8 antibody (eBioscience, 11-0081-82) was used in flow cytometry on mouse samples at 1:400. J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5b
In order to find that TLR3, 7 and 9 deficiencies on host cells result in complete tumor regression and induction of anti-tumor immunity, Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 5b). Nat Commun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3d
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, Invitrogen CD8 antibody (eBioscience, 48-0081-82) was used in flow cytometry on mouse samples (fig s3d). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry; mouse; loading ...; fig s7b
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, Invitrogen CD8 antibody (eBioscience, 4SM15) was used in immunohistochemistry on mouse samples (fig s7b). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c,d
In order to examine the contribution of stroma-derived osteopontin for hematopoietic stem cell aging, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1c,d). EMBO J (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to study anti-cancer immunity after Treg depletion in mice., Invitrogen CD8 antibody (ebioscience, 47?\0081?\82) was used in flow cytometry on mouse samples (fig 1b). Immun Inflamm Dis (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:300; loading ...; fig 6c
In order to examine two llama-derived single-domain respiratory syncytial virus neutralizing antibodies, Invitrogen CD8 antibody (eBioscience, 25-0081-81) was used in flow cytometry on mouse samples at 1:300 (fig 6c). Nat Commun (2017) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; loading ...; fig s6
In order to determine the contribution of B cell to obesity-induced insulin resistance, Invitrogen CD8 antibody (eBiosciences, 16-0081-85) was used in blocking or activating experiments on mouse samples (fig s6). J Clin Invest (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1d
In order to test the effect of paeoniflorin in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, Invitrogen CD8 antibody (eBioscience, 25-0081) was used in flow cytometry on mouse samples (fig 1d). Sci Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). Blood (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2c
In order to evaluate miR-29a in B cells as a potential therapeutic target in arthritis, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2c). Cell Mol Life Sci (2017) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2a
In order to test if intraperitoneal administration of adeno-associated virus produces unique patterns of tissue tropism, Invitrogen CD8 antibody (eBioscience, 14-0081-82) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2a). Sci Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2d
In order to establish a method to isolate apoptotic bodies from cultured cells to 99% purity, Invitrogen CD8 antibody (eBioscience, 12-0081-82) was used in flow cytometry on mouse samples (fig 2d). Sci Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
In order to utilize a G2-Gata4Cre;R26REYFP mouse line to track the developmental fate of the G2-Gata4 cell lineage, Invitrogen CD8 antibody (EBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1). Haematologica (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to assess the role of p38 signaling in limiting regulatory T cell induction, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Biol Chem (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to explore if the anti-diabetic sulphonylurea glibenclamide protects insulin-producing cells against conditions mimicking those expected at the onset of type 1 diabetes, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3c
In order to discuss how NLRC3 protects against colorectal cancer by modulating mTor signaling, Invitrogen CD8 antibody (Affymetrix eBioscience, 48-0081-82) was used in flow cytometry on mouse samples (fig s3c). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to study the role of T cells in the effector phase of antibody-mediated autoimmune dermatoses, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2j
In order to characterize Nlrp2-deficient mice and identify a role for this protein in fertility, Invitrogen CD8 antibody (eBioscience, 17-0081-81) was used in flow cytometry on mouse samples (fig 2j). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4b
In order to find that dendritic cells modulate thymic egress, Invitrogen CD8 antibody (ebioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4b). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:800; loading ...; fig 4d
In order to characterize malaria-induced splenic monocyte-derived dendritic cells, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:800 (fig 4d). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 2a
In order to test how inhibiting autophagy impacts antitumor immune responses in immune-competent mouse models of melanoma and mammary cancer, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 2a). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3h
In order to study the role of miR-7 in acute lung injury, Invitrogen CD8 antibody (ebioscience, 25-0081-81) was used in flow cytometry on mouse samples (fig 3h). Front Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
In order to identify and characterize a Nei endonuclease VIII-like 3 mutation in three siblings from a consanguineous family with autoimmunity, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s2a). J Clin Invest (2016) ncbi
rat monoclonal (YTS105.18)
  • blocking or activating experiments; mouse; fig 9b
In order to propose that blocking antibodies suppress autoreactive CD8 positive T-cell activation in a relatively selective manner, Invitrogen CD8 antibody (Thermo Scientific, YTS105.18) was used in blocking or activating experiments on mouse samples (fig 9b). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2B
In order to examine the thymic microenvironment using a model of paracoccidioidomycosis, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2B). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3
Invitrogen CD8 antibody (eBioscience, 11-0081-82) was used in flow cytometry on mouse samples (fig s3). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (KT15)
  • flow cytometry; mouse; loading ...; fig 8a
In order to characterize the immunological changes in tumors induced by radiation therapy, Invitrogen CD8 antibody (Thermo Fisher Scientific, KT15) was used in flow cytometry on mouse samples (fig 8a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3b
In order to develop and characterize a murine model of hepatitis A virus, Invitrogen CD8 antibody (eBiosciences, 14-0808) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3b). Science (2016) ncbi
rat monoclonal (53-6.7)
  • western blot; mouse; 1:1000; fig 4
Invitrogen CD8 antibody (eBioscience, 14-0081) was used in western blot on mouse samples at 1:1000 (fig 4). Sci Rep (2016) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3a
In order to establish and characterize a mouse model of narcolepsy, Invitrogen CD8 antibody (eBioscience, 4SM15) was used in immunohistochemistry - paraffin section on mouse samples (fig 3a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5a
Invitrogen CD8 antibody (Affymetrix eBioscience, 25-0081-82) was used in flow cytometry on mouse samples (fig 5a). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen CD8 antibody (eBioscience, 45-0081-82) was used in flow cytometry on mouse samples (fig 4). Front Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Invitrogen CD8 antibody (Ebioscience, 12-0081) was used in flow cytometry on mouse samples (fig 5). BMC Complement Altern Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1d
In order to identify Matrilin-4 (Matn4) as a negative regulator of the hematopoietic stem cell stress response, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; fig s4k
In order to investigate the effects of caloric restriction on beige fat, Invitrogen CD8 antibody (eBioscience, 12-0081) was used in flow cytometry on mouse samples at 1:200 (fig s4k). Cell Metab (2016) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3a
  • flow cytometry; mouse; fig s2
In order to measure expression of major histocompatibility complex class one and paired immunoglobulin-like receptor B in the central and peripheral nervous system after sciatic nerve injury in mice, Invitrogen CD8 antibody (eBioscience, 11-0081) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3a) and in flow cytometry on mouse samples (fig s2). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 8
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 8). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
In order to determine the contribution of lymphatic drainage to tumor inflammation and immunity, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3b). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). PLoS Pathog (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
In order to implement lck-cre transgenic mice to study the role of loxP-targeted genes in T cell development and function, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5c
In order to examine the role of BRPF1 during hematopoiesis, Invitrogen CD8 antibody (eBiosciences, 11-0081-81) was used in flow cytometry on mouse samples (fig s5c). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a
In order to demonstrate that lymphotoxin beta receptor directly controls thymic endothelial cells to guide hematopoietic progenitor cell homing, Invitrogen CD8 antibody (eBioscience, 47-0081) was used in flow cytometry on mouse samples (fig s1a). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1
In order to investigate the roles of platelets and patrolling Ly6C low monocytes in acute vascular inflammation, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6). Clin Cancer Res (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3
In order to report that vaccine-induced T regulatory cells aid to control de novo primed autoreactive effector CD8(+) T cells in a diabetes model, Invitrogen CD8 antibody (BD Biosciences, 17-0081-83) was used in flow cytometry on mouse samples (fig 3). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to investigate the role of general control non-derepressible 2 in resolving autoimmune neuroinflammation, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Neuroimmunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 11-0081) was used in flow cytometry on mouse samples . Front Cell Neurosci (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1-s1
In order to propose that the ERK-AP-1 axis is important for translating TCR signal strength into proportional activation of downstream events, Invitrogen CD8 antibody (eBiosciences, 13-0081-86) was used in flow cytometry on mouse samples (fig 1-s1). elife (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, Invitrogen CD8 antibody (eBioscience, 45-0081-8) was used in flow cytometry on mouse samples (fig 1). Nat Immunol (2016) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; 1:200; fig 1
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, Invitrogen CD8 antibody (Invitrogen, MCD0817) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; fig st1
Invitrogen CD8 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples at 1:500 (fig st1). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig st2
In order to identify the origin of vascular smooth muscle cells and macrophages within atherosclerosis lesions, Invitrogen CD8 antibody (eBioscience, 25-0081) was used in flow cytometry on mouse samples (fig st2). Atherosclerosis (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to discuss Staphylococcus aureus-derived allergens, Invitrogen CD8 antibody (eBioscience, 45-0081-80) was used in flow cytometry on mouse samples . J Allergy Clin Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1a
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). elife (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to detail how to obtain innate lymphoid cells from isolated common lymphoid progenitors, Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . Bio Protoc (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3g
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3g). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s4
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s4). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:66; loading ...; fig 2f
In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., Invitrogen CD8 antibody (eBioscience, 11-0081-82) was used in flow cytometry on mouse samples at 1:66 (fig 2f). Nat Cell Biol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2
In order to discover cell-intrinsic division and differentiation differences in neonatal CD8+ T cells, Invitrogen CD8 antibody (eBiosciences, 48-0081-82) was used in flow cytometry on mouse samples (fig 2). Immunol Cell Biol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; fig s3
In order to characterize dysregulation of neuronal network activity following a stroke due to microglia protecting against brain injury and their selective elimination, Invitrogen CD8 antibody (eBioscience, 12-0081-82) was used in flow cytometry on mouse samples at 1:400 (fig s3). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s6
In order to investigate the effects of IL-1 on hematopoietic stem cells, Invitrogen CD8 antibody (eBioscience, 16-0081-82) was used in flow cytometry on mouse samples (fig s6). Nat Cell Biol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 48-0081) was used in flow cytometry on mouse samples . Biol Open (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Invitrogen CD8 antibody (eBiosciences, 47-0081) was used in flow cytometry on mouse samples (fig 5). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4b
In order to assess whether flagellin is useful as an adjuvant for a topical therapeutic vaccine for female genital cancer, Invitrogen CD8 antibody (eBioscience, 55-3030) was used in flow cytometry on mouse samples (fig 4b). Oncoimmunology (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s4
Invitrogen CD8 antibody (eBioscience, 11-0081) was used in flow cytometry on mouse samples at 1:100 (fig s4). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen CD8 antibody (eBioscience, 53-C6.7) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
Invitrogen CD8 antibody (eBioscience, 48-0081-82) was used in flow cytometry on mouse samples (fig 2). Mucosal Immunol (2017) ncbi
rat monoclonal (2.43)
  • immunohistochemistry - paraffin section; mouse; 1:25-1:50; fig 4
In order to study how Tg6F ameliorates the increase in oxidized phosopholipids in mice jejunum that were fed unsaturated LysoPC or WD diets, Invitrogen CD8 antibody (Thermo Scientific, MA1-145) was used in immunohistochemistry - paraffin section on mouse samples at 1:25-1:50 (fig 4). J Lipid Res (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 4b
In order to show that FMNL1 regulates podosomes and normal macrophage migration, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:400 (fig 4b). Cellbio (Irvine, Calif) (2015) ncbi
rat monoclonal (4SM15)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 10
Invitrogen CD8 antibody (eBioscience, 14-0808-82) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 10). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen CD8 antibody (eBioscience, 53.6.7) was used in flow cytometry on mouse samples (fig 2). elife (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
In order to demonstrate that control of acute infection with Trypanosoma cruzi is associated with development of systemic necrotizing vasculitis, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). Infect Immun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s21
Invitrogen CD8 antibody (eBioscience, 17-0081-82) was used in flow cytometry on mouse samples (fig s21). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s6a
In order to suggest that locally synthesized C1q promotes tumor growth, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig s6a). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3). PLoS Pathog (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
In order to test if enforced virus replication occurs in the presence of virus-specific antibodies or virus-specific CD8 positive T cells, Invitrogen CD8 antibody (eBioscience, 53?C6.7) was used in flow cytometry on mouse samples (fig 3). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
In order to show that ATP11C is an aminophospholipid translocase in immune cells, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 11-0081-85) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6). PLoS Biol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2J
In order to determine that Th2 cell responses, alternative macrophage activation, and immunoglobulin class switching to IgG1, are enhanced in Batf3(-/-) mice responding to helminth parasites, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2J). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - paraffin section; mouse
Invitrogen CD8 antibody (eBioscience, 11-0081-82) was used in immunohistochemistry - paraffin section on mouse samples . Nature (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
In order to research the connection between oligodendrocyte death and immune-mediated CNS demyelination, Invitrogen CD8 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples (fig 4). Nat Neurosci (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig 3
In order to determine the affects of dendritic cell migration in vitro by loss of gadkin, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig 3). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; fig s8
In order to test if GATA5 is a regulator of blood pressure, Invitrogen CD8 antibody (eBioscience, 17-0081-81) was used in flow cytometry on mouse samples at 1:1000 (fig s8). Nat Commun (2015) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to explore the impact of chronic antigenic stimulation on CD4(+) T cell dynamics, Invitrogen CD8 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3
In order to determine how induced arthritis can be effectively treated by CTRP6, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s3). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to investigate the role of FAT10 in thymic antigen presentation, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2
In order to report a role for effector T helper type 2 cells during T cell receptor-independent innate-like immune responses, Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study PI3Kdelta in CD8+ T cells during infection with Listeria monocytogenes, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to determine the role of Syk in development of obliterative bronchiolitis, Invitrogen CD8 antibody (EBioscience, 53-6.7) was used in flow cytometry on mouse samples . Am J Transplant (2016) ncbi
rat monoclonal (YTS 169AG 101HL)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 2
In order to study transplantation of pancreatic tissue in TheraCyte encapsulation devices that is protected and prevents hyperglycemia in an mouse model of immune-mediated diabetes, Invitrogen CD8 antibody (Pierce Antibodies, MA1-70041) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2). Cell Transplant (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Science (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4b
In order to test if anti-retroviral natural killer cell functions are inhibited by T regulatory cells during an acute Friend retrovirus infection, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s4b). Retrovirology (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). Cancer Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2e
In order to assess surface expression of C-type lectin-like receptor 2 on hematopoietic cells from peripheral blood and secondary lymphoid organs, Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2e). Eur J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 46-0081-80) was used in flow cytometry on mouse samples . J Vis Exp (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to evaluate as a mucosal vaccine platform against influenza A virus, Invitrogen CD8 antibody (eBioscience, # 11-0081-82) was used in flow cytometry on mouse samples (fig 5). Front Immunol (2015) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine if therapeutic antiviral T cells eliminate viral load in the brain of mice persistently infected from birth with lymphocytic choriomeningitis virus without causing blood-brain barrier breakdown or tissue damage, Invitrogen CD8 antibody (Invitrogen, 5H-10) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to test if metformin ameliorates ionizing radiation-induced long-term bone marrow injury in a total-body irradiation mouse model, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Free Radic Biol Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). Immunity (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to optimize application routes for trifunctional bispecific antibodies against tumor-associated ganglioside GD2, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). Mol Cancer Ther (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - paraffin section; human; fig s8
In order to describe the use of CCR9 expression to create primary gastrointestinal tumors in immunodeficient mice by tail-vein injection, Invitrogen CD8 antibody (ebiosciences, 53.67) was used in immunohistochemistry - paraffin section on human samples (fig s8). Nat Biotechnol (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; fig 6
Invitrogen CD8 antibody (eBiosciences, 14008182) was used in immunohistochemistry on mouse samples (fig 6). Oncotarget (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6e
  • immunohistochemistry; mouse; loading ...; fig 4k
In order to find that lymph node-like vasculature in melanoma and lung carcinoma murine models is both a consequence of and key contributor to anti-tumor immunity, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6e) and in immunohistochemistry on mouse samples (fig 4k). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
Invitrogen CD8 antibody (eBioscience, 55-6.7) was used in flow cytometry on mouse samples (fig s1). J Immunol (2015) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to elucidate the role of Treg during T. gondii infection, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . Microbes Infect (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 25-0081-82) was used in flow cytometry on mouse samples . Cardiovasc Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; fig 2
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:1000 (fig 2). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Invitrogen CD8 antibody (eBioscience, 15-0081-82) was used in flow cytometry on mouse samples (fig 5). PLoS Negl Trop Dis (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Invitrogen CD8 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples (fig 5). EMBO Mol Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6b
  • immunohistochemistry; mouse; loading ...; fig 3a
In order to determine if specific B cell subsets or if B cell-derived interleukin-10 contributes to tolerance, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6b) and in immunohistochemistry on mouse samples (fig 3a). Transplantation (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS Pathog (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s1). PLoS Pathog (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3A
In order to report a B cell-intrinsic role for Rab7, Invitrogen CD8 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples (fig 3A). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig 2
In order to test if carbon monoxide suppresses chronic inflammation and leads to metabolic disturbances, Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig 2). Am J Physiol Endocrinol Metab (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl s3
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (tbl s3). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). PLoS Pathog (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s2
In order to elucidate the function of miR-29a in hematopoietic stem and progenitor cells, Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s2). Blood (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
In order to test if blocking several checkpoint receptors boosts anti-tumor immunity in a low-dose, lymphodepleting whole body radiation model, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). J Immunother Cancer (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
  • immunocytochemistry; mouse; fig 2
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1) and in immunocytochemistry on mouse samples (fig 2). J Exp Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Immunol Cell Biol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on human samples . J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig 3
Invitrogen CD8 antibody (eBioscience, 15-0081) was used in flow cytometry on mouse samples at 1:100 (fig 3). Biol Reprod (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to show how early events during viral infection decide the immune response and facilitate either control, clearance, or persistence of the virus, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). PLoS Pathog (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to identify Cd8 cis-regulatory elements, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
  • immunocytochemistry; mouse
Invitrogen CD8 antibody (eBioscience or BioLegend, 53-6.7) was used in flow cytometry on mouse samples and in immunocytochemistry on mouse samples . Cell Mol Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Development (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . J Am Heart Assoc (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5i
In order to investigate the application of intra-dermal mesoporous silica rods in immune modulation., Invitrogen CD8 antibody (eBioscience, 17-0081) was used in flow cytometry on mouse samples (fig 5i). Nat Biotechnol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
  • immunocytochemistry; mouse
In order to evaluate a model of cerebral malaria pathogenesis and its effect on the blood brain barrier, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples and in immunocytochemistry on mouse samples . PLoS Pathog (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3
Invitrogen CD8 antibody (ebioscience, 53.67) was used in flow cytometry on mouse samples (fig s3). J Natl Cancer Inst (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
Invitrogen CD8 antibody (eBioscience, 53-6.8) was used in flow cytometry on mouse samples (fig s1). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to examine the role of lymph node stromal cells in immune responses, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . elife (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . EMBO J (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study CD4 and CD8 responses to L. monocytogenes using GZMB-Tom knock-in mice, Invitrogen CD8 antibody (eBioscience, 53.6.7 A700) was used in flow cytometry on mouse samples . Immunology (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1b
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). Nat Immunol (2014) ncbi
rat monoclonal (KT15)
  • immunohistochemistry - paraffin section; human
In order to study the effects of IL9 in multiple models of breast and colon cancer development using IL-9 KO mice, Invitrogen CD8 antibody (Thermo Scientific, MA5-16761) was used in immunohistochemistry - paraffin section on human samples . Cancer Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig S2a
In order to investigate the role of DUSP6 in colonic CD4 positive T-cell function, differentiation, and inflammatory profile, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig S2a). Mucosal Immunol (2015) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
Invitrogen CD8 antibody (BD Biosciences, MCD0830) was used in flow cytometry on mouse samples . J Neuroimmunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). Nat Med (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:50
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples at 1:50. Mol Pharm (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3c
In order to test the efficacy of combining different monoclonal antibodies to treat cancer, Invitrogen CD8 antibody (ebioscience, 14-0081-82) was used in flow cytometry on mouse samples (fig 3c). Clin Cancer Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to investigate the use of mannosylated synthetic long peptides for vaccination, Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 5). PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to assess the contribution of Tbx1 to thymus and parathyroid development, Invitrogen CD8 antibody (eBioscience, clone 53-6.) was used in flow cytometry on mouse samples . Development (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to show that MID1 regulates cytotoxic lymphocytes responses, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s5
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s5). Mucosal Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
In order to examine the quantitative and temporal requirements of Zap70's function in thymocyte development, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). Nat Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2014) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to determine if HSPs ameliorate ischemic renal injury in vivo using HSF-1 KO mice, Invitrogen CD8 antibody (Invitrogen, MCD0830) was used in flow cytometry on mouse samples . Kidney Int (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate the role of thoracic thymus in T cell development and homeostasis, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience Inc., 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; 1:50
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in immunohistochemistry on mouse samples at 1:50. PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Bone (2014) ncbi
rat monoclonal (53-6.7)
  • immunocytochemistry; human; tbl 2
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in immunocytochemistry on human samples (tbl 2). J Clin Invest (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100
In order to study the involvement of endothelium in efficient Treg T cell recruitment in vivo, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5a
In order to investigate the effects of lymphopenia and chronic exposure to IFN on T cell homeostasis, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5a). PLoS Pathog (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
Invitrogen CD8 antibody (Ebioscience, 12-008-81) was used in flow cytometry on mouse samples (fig s1). PLoS Pathog (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to characterize the Treg populations the Friend retrovirus mouse model, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Virol Sin (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50
Invitrogen CD8 antibody (eBioscience, 45-0081-82) was used in flow cytometry on mouse samples at 1:50. Acta Neuropathol Commun (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100
Invitrogen CD8 antibody (eBioscience, 11-0081-82) was used in flow cytometry on mouse samples at 1:100. Cell Transplant (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
In order to characterize tumor-associated macrophages isolated from gastrointestinal stromal tumors, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3). J Exp Med (2013) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse
Invitrogen CD8 antibody (ebioscience, 53-6.7) was used in immunohistochemistry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
Invitrogen CD8 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to determine optimal IL-17-inducing conditions using a vaccine and Mycobacterium tuberculosis challenge strategy, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2013) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Surg Infect (Larchmt) (2014) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 3
In order to examine Treg cell control of chronic autoimmunity in a lymphoreplete host, Invitrogen CD8 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (fig 3). J Immunol (2013) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2
In order to elucidate the role of dendritic cells in cancer immunosurveillance failure, Invitrogen CD8 antibody (Caltag, CT-CD8) was used in flow cytometry on mouse samples (fig 2). Immunol Cell Biol (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to elucidate the role of CD4+ T cells in Porphyromonas gingivalis infection, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). Mol Oral Microbiol (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Stem Cells (2014) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to characterize mice deficient in podoplanin and explore the effect of podoplanin modulation on T cell populations, Invitrogen CD8 antibody (CALTAG, 5H10) was used in flow cytometry on mouse samples (fig 2). Immunol Lett (2013) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; loading ...; fig 4b
In order to assess different ways to use rotaviral V6 as a vaccine candidate, Invitrogen CD8 antibody (eBioscience, 16-0081) was used in blocking or activating experiments on mouse samples (fig 4b). Hum Vaccin Immunother (2013) ncbi
rat monoclonal (YTS 169AG 101HL)
  • flow cytometry; mouse; fig 2
In order to determine if Bok and Bax have any functional redundancy controlling apoptosis using knock out mice, Invitrogen CD8 antibody (Caltag, clone YTS169) was used in flow cytometry on mouse samples (fig 2). Cell Death Dis (2013) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 2
In order to determine if Bok and Bax have any functional redundancy controlling apoptosis using knock out mice, Invitrogen CD8 antibody (Caltag, clone YTS169) was used in flow cytometry on mouse samples (fig 2). Cell Death Dis (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 5b
In order to report the development of dendritic cells and other lineages in Bcl11a knockout mice, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 5b). PLoS ONE (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to test if a differential composition of immune cells within the central nervous system modulates the age-associated susceptibility to autoimmune disease, Invitrogen CD8 antibody (Invitrogen, MCD0830) was used in flow cytometry on mouse samples (fig 1). J Neuroinflammation (2013) ncbi
rat monoclonal (YTS 169AG 101HL)
  • immunohistochemistry - paraffin section; mouse; 1:50
  • immunohistochemistry; mouse; 1:50
In order to study the ability of adenosine A2A receptor activation to inhibit epithelial-mesenchymal transition and the development of renal interstitial fibrosis in a murine model, Invitrogen CD8 antibody (Pierce, MA1-70041) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 and in immunohistochemistry on mouse samples at 1:50. PLoS ONE (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to report that interferon gamma is essential for effective ionizing radiation therapy, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Am J Pathol (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to review the role of S1P lyase in T cell-mediated disease, Invitrogen CD8 antibody (ebioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to study immune exhaustion, Invitrogen CD8 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (fig 2). J Exp Med (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl 1
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (tbl 1). PLoS ONE (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBiosciences, 17-0081) was used in flow cytometry on mouse samples . PLoS Genet (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to study heterogeneous clonal T cell responses, Invitrogen CD8 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples . J Immunol (2013) ncbi
rat monoclonal (53-6.7)
  • other; mouse; fig 5
  • flow cytometry; mouse; fig 5
In order to study the impact of mesenchymal stem cells to experimental allergic encephalomyelitis, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in other on mouse samples (fig 5) and in flow cytometry on mouse samples (fig 5). Front Immunol (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . FASEB J (2013) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 4
In order to discuss the use of synthetic vaccines employing synthetic mRNA to treat cancer, Invitrogen CD8 antibody (Invitrogen, MCD0801) was used in flow cytometry on mouse samples (fig 4). Methods Mol Biol (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Exp Med (2013) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 5a
In order to report that CD81 interacts with the T cell receptor to suppress signaling, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 5a). PLoS ONE (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1b
In order to quantify the CD8 T cells needed to cause type 1 diabetes and observe the anatomy of the CD8 T cell/beta cell interaction at the immunologic synapse, Invitrogen CD8 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). PLoS Pathog (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to report that ABCG1 regulates iNKT cell development in a cell-intrinsic manner, Invitrogen CD8 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (fig 2). J Immunol (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate the role of BTB-ZF factors in lymphoid effector programs, Invitrogen CD8 antibody (e-Bioscience, 53-6.7) was used in flow cytometry on mouse samples . Nature (2012) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study the kinetics of iNKT cell precursors, Invitrogen CD8 antibody (Caltag Laboratories, CT-CD8alpha) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to investigate which portions of CD28 are needed for T cells, Invitrogen CD8 antibody (Invitrogen, clone 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to elucidate how TGF-beta signaling regulates the self-reactivity of peripheral T cells, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Nat Immunol (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 13-0081-82) was used in flow cytometry on mouse samples . Exp Hematol (2012) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse
In order to suggest that CD80 and CD86 contribute to polyclonal B cell activation mediated by Lat(Y136F) CD4 positive T cells, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples . Front Immunol (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to study splenic natural killer T cells, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . EMBO J (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to elucidate age-specific tumor-associated immune dysfunction, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 5
In order to optimize a P. vivax vaccine, Invitrogen CD8 antibody (Zymed/Invitrogen, clone 5H10) was used in flow cytometry on mouse samples (fig 5). Vaccine (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study the contribution of IL-10 in mice infected with respiratory syncytial virus, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to investigate the effects of age on immune regulation and auto-aggressive T cells, Invitrogen CD8 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . Aging Cell (2012) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to study the mechanisms by which the kinin receptor regulates multiple sclerosis development, Invitrogen CD8 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to determine the role of granzyme B in immune regulation during viral infections, Invitrogen CD8 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (fig 2). J Immunol (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; dogs
Invitrogen CD8 antibody (eBiosciences, 11-0081-85) was used in flow cytometry on dogs samples . J Biol Chem (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 25-0081-81) was used in flow cytometry on mouse samples . J Immunol (2011) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to report coreceptor gene imprinting as a critical determinant of lineage fate determination in the thymus, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . EMBO J (2012) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to determine the importance of ligand-activated N3 in promoting beta-selection and N1 intracellular domain-induced T cell leukemogenesis, Invitrogen CD8 antibody (eBioScience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5). Mol Biol Cell (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3). Nat Immunol (2011) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to report how Tregs suppress early immune responses after vaccination, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2011) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig s1
In order to study the contribution of cathepsin K to human abdominal aortic aneurysm lesions, Invitrogen CD8 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (fig s1). Arterioscler Thromb Vasc Biol (2012) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2
In order to test if anti-CD8 Abs induce effector function, Invitrogen CD8 antibody (Caltag, clone CT-CD8a) was used in flow cytometry on mouse samples (fig 2). J Immunol (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to examine how IL-27 influences Tregs in vivo, Invitrogen CD8 antibody (Invitrogen, 53?C6.7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
In order to identify signaling pathways that regulate thymic selection of un-manipulated polyclonal natural CD25(+)foxp3(+) regulatory T cells, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2011) ncbi
rat monoclonal (5H10)
  • immunohistochemistry - frozen section; mouse; 1:50; fig 4
In order to discuss the contribution of T cells to euglycemia, Invitrogen CD8 antibody (Molecular Probes, MCD0801) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 4). J Surg Res (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6, 7
In order to use the Friend retrovirus mouse model to elucidate the mode of action of poly(I:C) in antiretroviral immunotherapy, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 6, 7). J Immunol (2010) ncbi
rat monoclonal (5H10)
  • immunocytochemistry; mouse; fig s3
In order to investigate factors that mediate memory B cells activation, Invitrogen CD8 antibody (Caltag Laboratories, clone 5H10) was used in immunocytochemistry on mouse samples (fig s3). J Immunol (2010) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). J Immunol (2010) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 3
In order to test if upregulation of major histocompatibility complex class II and costimulatory molecules in the retina contributes to the regulation of CD4 T cells, Invitrogen CD8 antibody (Invitrogen, CT-CD8alpha) was used in flow cytometry on mouse samples (fig 3). Infect Immun (2010) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 3
In order to characterize a spread-deficient murine cytomegalovirus as a novel approach for betaherpesvirus vaccination, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 3). J Virol (2010) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1, 2, 3
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1, 2, 3). Blood (2010) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; tbl 1
In order to report that a non-peptidyl mimetic of MnSOD reduces total body irradiation-induced tissue damage, Invitrogen CD8 antibody (Caltag, RM2204) was used in flow cytometry on mouse samples (tbl 1). Free Radic Res (2010) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; tbl 1
In order to develop and characterize a novel model of heterologous pulmonary infection using Bordetella parapertussis and influenza virus, Invitrogen CD8 antibody (Invitrogen, 5H10) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2010) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
In order to determine the roles of c-Myb during lymphocyte development, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 3). J Immunol (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study the role of bone marrow-derived cells in lymphangiogenesis, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2009) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4
In order to test if deficiency of p19 in the allogeneic donor transplant reduces the inflammation caused by acute GVHD, Invitrogen CD8 antibody (Caltag, RM2204) was used in flow cytometry on mouse samples (fig 4). Bone Marrow Transplant (2010) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . Nat Med (2009) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the kinetics and functions of hematopoietic stem and progenitor cells in mice with Notch1-induced leukemia, Invitrogen CD8 antibody (Caltag Laboratories, RM2215-3) was used in flow cytometry on mouse samples . Blood (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to investigate immune responses to antigen in skin, Invitrogen CD8 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to evaluate immunotherapeutic regimens in mice chronically infected with lymphocytic choriomeningitis virus, Invitrogen CD8 antibody (Caltag, 53.6.7) was used in flow cytometry on mouse samples (fig 1). J Virol (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 5
In order to report that estradiol prevents antigen loading of vaginal antigen presenting cells after intravaginal immunization, Invitrogen CD8 antibody (CalTag, clone 5H10) was used in flow cytometry on mouse samples (fig 5). Vaccine (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study interactions between CD8 T cells, Toxoplasma gondii, and APCs in the brain, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to study interactions between CD8 T cells, Toxoplasma gondii, and APCs in the brain, Invitrogen CD8 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to track populations of T cells specific for a given peptide-major histocompatibility complex epitope, Invitrogen CD8 antibody (Caltag-Invitrogen, MCD0830) was used in flow cytometry on mouse samples . Nat Protoc (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to assess the effects of early termination of infection on primary T cell expansion, subsequent memory cell development, and protective immunity, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to determine the contribution of CD4+ T cells in the generation of CD8+-T-cell responses following acute infection with HSV-1, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Virol (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to determine the contribution of CD4+ T cells in the generation of CD8+-T-cell responses following acute infection with HSV-1, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . J Virol (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1c
In order to elucidate the role of IL-17 in influenza A infection, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2009) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2, 4
In order to describe a role for Marco in the development of disease in BXSB mice, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 2, 4). J Immunol (2009) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to report that Ly49D engagement on T cells leads to T cell activation and TCR-independent effector functions of CD8 T cells, Invitrogen CD8 antibody (eBioscience, 53.6.7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2009) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to investigate the role of the PD-1 pathway in the maintenance of graft survival, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). J Immunol (2008) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to identify key signals required for the exponential expansion of specific CD8 positive mouse T cells in vivo, Invitrogen CD8 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples . J Immunol (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to examine the role of IL-6 in the development of Th17 cells in experimental autoimmune encephalomyelitis, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Proc Natl Acad Sci U S A (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s4
In order to assess the effects of Flt3 signaling on macrophage dendritic cell progenitors and on peripheral dendritic cells, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s4). Nat Immunol (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Cancer Res (2008) ncbi
rat monoclonal (53-6.7)
  • other; mouse; 5 mg/kg
Invitrogen CD8 antibody (eBioscience, 53-6.72) was used in other on mouse samples at 5 mg/kg. Invest Ophthalmol Vis Sci (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to analyze protection against Plasmodium berghei by a single-dose simian adenovirus vector using a human cytomegalovirus promoter containing intron A, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Virol (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to study how multifactorial adjuvants show reduced toxicity and enhanced efficacy compared to unitary adjuvants as cancer vaccines, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Blood (2008) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to compare the requirements for positive selection and T(reg) development, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2007) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to provide evidence that lymphotoxin pathway signals regulate development of the composition and organization of the thymus, specifically the medullary epithelial compartment, Invitrogen CD8 antibody (Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . J Immunol (2007) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to report murine CD4(+) and CD8(+) T cell responses to male-specific minor histocompatibility antigens, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2007) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate whether hematopoietic cells transduce canonical Wnt signals in the absence of beta- and gamma-catenin, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Blood (2008) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to indicate that defective DRF1 expression or mammalian diaphanous 1 function contributes to myeloid malignancies and suggest mammalian diaphanous 1 as an attractive therapeutic target in human myeloproliferative syndrome and myelodysplastic syndrome, Invitrogen CD8 antibody (Invitrogen/Caltag Laboratories, 5H10) was used in flow cytometry on mouse samples . Cancer Res (2007) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study autoimmune-mediated pathology in chronic graft-versus-host disease due to the absence of regulatory T-cell control of TH1 and TH17 cells, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2007) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to assess the effects of C5a on IL-12p70 secretion by murine dendritic cells and Th1 immunity, Invitrogen CD8 antibody (Caltag Laboratories, RM2201-3) was used in flow cytometry on mouse samples . J Leukoc Biol (2007) ncbi
rat monoclonal (CT-CD8a)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse
In order to demonstrate that cerebral malaria development is independent of TLR2, 4 and 9, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples . Med Microbiol Immunol (2008) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to assess the role and mechanism of Bifidobacterium longum BB536 probiotic in suppressing antigen-induced Th2 immune response in vitro, Invitrogen CD8 antibody (e-bioscience, 53-6.7) was used in flow cytometry on mouse samples . Microbiol Immunol (2007) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to develop a system for the decoration of enveloped viruses with functionally active cytokines, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . J Virol (2007) ncbi
rat monoclonal (CT-CD8a)
  • immunohistochemistry - paraffin section; fruit fly ; 1:100
In order to describe a basic method for dissection and immunofluorescence staining of the Drosophila brain at various developmental stages, Invitrogen CD8 antibody (Invitrogen, RM2200) was used in immunohistochemistry - paraffin section on fruit fly samples at 1:100. Nat Protoc (2006) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to identify targets of HDAC7 in T cells, Invitrogen CD8 antibody (Caltag Laboratories, MCD0805) was used in flow cytometry on mouse samples . Mol Cell Biol (2007) ncbi
rat monoclonal (CT-CD8a)
  • immunocytochemistry; fruit fly ; 1:100
In order to discuss the uses of mosaic analysis with a repressible cell marker (MARCM), Invitrogen CD8 antibody (CALTAG, RM2200) was used in immunocytochemistry on fruit fly samples at 1:100. Nat Protoc (2006) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to study a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo known as immunostimulatory RNA, Invitrogen CD8 antibody (Caltag, CD8alpha) was used in flow cytometry on mouse samples (fig 1). Int Immunol (2007) ncbi
rat monoclonal (CT-CD8a)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse
In order to characterize "class I APC-bald" mice and see if they develop diabetes, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2007) ncbi
rat monoclonal (5H10)
  • immunohistochemistry - frozen section; mouse
In order to characterize "class I APC-bald" mice and see if they develop diabetes, Invitrogen CD8 antibody (Caltag, 5H10) was used in immunohistochemistry - frozen section on mouse samples . Proc Natl Acad Sci U S A (2007) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to assess how FTY720-treatment affects T cell populations, Invitrogen CD8 antibody (ebiosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 1). Int Immunopharmacol (2006) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to report that dectin-1 deficiency renders mice susceptible to infection with Candida albicans, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . Nat Immunol (2007) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to identify the cells that are producing gamma interferon during infection with Listeria monocytogenes, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). Infect Immun (2007) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 4). Circulation (2006) ncbi
rat monoclonal (5H10)
  • immunohistochemistry - paraffin section; mouse
In order to report a role for CD4 positive alphabeta T cells in S. aureus infections, Invitrogen CD8 antibody (Caltag, MCD0820) was used in immunohistochemistry - paraffin section on mouse samples . Proc Natl Acad Sci U S A (2006) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to explore how Melan-A expression in dendritic cells fails to elicit T-cell responses, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . Cancer Res (2006) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to demonstrate that software designed for transcriptomics applications can be used in multiparameter flow cytometry, Invitrogen CD8 antibody (ebiosciences, 53-6.7) was used in flow cytometry on mouse samples . Cytometry A (2006) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Exp Med (2006) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to study the use of a recombinant lentivector to immunize against the melanoma-associated antigen, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2006) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to study the use of a recombinant lentivector to immunize against the melanoma-associated antigen, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2006) ncbi
rat monoclonal (KT15)
  • immunohistochemistry; mouse; fig 5
In order to show that EtxB can block diabetes, Invitrogen CD8 antibody (Biosource, KT15) was used in immunohistochemistry on mouse samples (fig 5). Immunology (2006) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to clone and characterize Siglec-H, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). Blood (2006) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 7
In order to study the in vivo role of cytokine- and antigen-mediated T cell activation in the resistance to Burkholderia pseudomallei, Invitrogen CD8 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 7). J Infect Dis (2006) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine the influence of gut ischemia/reperfusion on gut-associated lymphoid tissue mass and function, Invitrogen CD8 antibody (Caltag, CTCD8a) was used in flow cytometry on mouse samples . Crit Care Med (2006) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to characterize T cells from mice infected with Theiler's murine encephalomyelitis virus, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 1). J Virol (2005) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2005) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1
In order to study T cell progenitors in the adult thymus, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (fig 1). J Immunol (2005) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to conclude that bone marrow committed T cell progenitors can generate functional T cells via an extrathymic pathway, Invitrogen CD8 antibody (Caltag, CT-CD8) was used in flow cytometry on mouse samples . J Immunol (2005) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to evaluate the tuberculosis vaccine candidate Mtb72F, Invitrogen CD8 antibody (eBiosciences, 53-6.7) was used in flow cytometry on mouse samples . Infect Immun (2005) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to characterize dendritic cells in mice infected with Trichuris muris, Invitrogen CD8 antibody (Caltag, CTCD8a) was used in flow cytometry on mouse samples . Parasitol Res (2005) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 5
In order to optimize the targeted delivery of the ErbB2 tumor antigen to antigen presenting cells in vivo, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 5). J Immunol (2005) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine graft-versus-host disease and emergent autoimmunity, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2005) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to use infection of the respiratory tract with paramyxovirus simian virus 5 to study lung CD8+ T cell responses, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Virol (2005) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to report that Runx3 drives thymocytes to select the CD4-8+ lineage, Invitrogen CD8 antibody (Invitrogen Life Technologies, 53-6.7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2005) ncbi
rat monoclonal (5H10)
  • other; mouse
  • flow cytometry; mouse
In order to elucidate the lack of cytolysis of CD8+ tumor-infiltrating lymphocytes, Invitrogen CD8 antibody (Caltag, 5H10) was used in other on mouse samples and in flow cytometry on mouse samples . J Immunol (2005) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2005) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study mycobacterial dissemination and immune-cell trafficking in tuberculosis, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Infect Dis (2004) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 2
In order to study the effects of stimulating CD137 in vivo after tumor lysate-pulsed dendritic cell vaccination, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 2). Cancer Res (2004) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to investigate the differentiation of CD4+CD25+ regulatory T cells, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . J Exp Med (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the differentiation of CD4+CD25+ regulatory T cells, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Exp Med (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to identify a role for TRAIL in apoptosis during listeriosis, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Immunol (2004) ncbi
rat monoclonal (CT-CD8a)
  • immunocytochemistry; mouse; fig 5
In order to study the essential role for the binding to and killing of activated macrophages by gamma delta T cells by Fas-Fas ligand interactions, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in immunocytochemistry on mouse samples (fig 5). J Immunol (2004) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to investigate mechanisms that regulate thymus size, Invitrogen CD8 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 5). J Immunol (2004) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to investigate the contribution of GRAIL and GRAIL-interacting proteins to CD4 T cell anergy, Invitrogen CD8 antibody (eBioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4
In order to determine the contribution of IFN during infection with Leishmania major, Invitrogen CD8 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples (fig 4). J Immunol (2004) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate the use of three-domain single-chain T-cell receptors, Invitrogen CD8 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples . Cancer Gene Ther (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to test if CD4 regulatory cells prevent autologous graft-vs.-host disease, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Am J Transplant (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4
In order to demonstrate that deletion p18(INK4C) results in improved long-term engraftment, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 4). Nat Cell Biol (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine the fate of autoreactive CD4+T cells in HNT-TCR x GFAP-HA double transgenic mice, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Autoimmun (2004) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to determine the fate of autoreactive CD4+T cells in HNT-TCR x GFAP-HA double transgenic mice, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . J Autoimmun (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; tbl 1
In order to analyze NOD mice after irradiation and bone marrow transplantation and the persistence of recipient lymphocytes, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (tbl 1). J Autoimmun (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 6
In order to characterize a new mouse model of rheumatoid arthritis, Invitrogen CD8 antibody (Caltag, CTCD8) was used in flow cytometry on mouse samples (fig 6). Int Immunol (2004) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to test if higher numbers of hematopoietic stem cells correlate with the speed of immune reconstitution in a congenic transplantation mouse model, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). Blood (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to test if higher numbers of hematopoietic stem cells correlate with the speed of immune reconstitution in a congenic transplantation mouse model, Invitrogen CD8 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples (fig 1). Blood (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 6
In order to test if Tyk2 kinase is required for protection against Leishmania major, Invitrogen CD8 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples (fig 6). Eur J Immunol (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to identify cellular mechanisms that contribute to susceptibility/resistance to tuberculosis, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Clin Exp Immunol (2004) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to assess the contribution of DC function in non-obese diabetic mice, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Clin Exp Immunol (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study the initiation of insulitis, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Exp Med (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to test if tetramers distinguish between high and low avidity T cell clones, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 1). J Immunol (2003) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to test if tetramers distinguish between high and low avidity T cell clones, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; tbl 1
In order to test if recombinant human growth hormone promotes immune recovery after allogeneic T-cell-depleted bone marrow transplantation, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (tbl 1). Exp Hematol (2003) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to study CCR6 expression by T lymphocyte precursors undergoing extrathymic differentiation in intestinal cryptopatches, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2003) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to determine the influence of in vivo-mobilized immature donor DC plus anti-CD40L mAb on vascular sclerosis in functional murine aortic allografts, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). Transplantation (2003) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1
In order to investigate factors that mediate induction and maintenance of the 3D configuration of the epithelial network in fetal thymic lobes in vitro, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (fig 1). J Histochem Cytochem (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the role of granulocyte colony-stimulating factor on hematopoietic progenitors in vivo, Invitrogen CD8 antibody (Zymed, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to examine early T cell progenitor development in the nu/nu bone marrow, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 1). J Immunol (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4
In order to investigate the relationship between progenitors and TCRbeta transcription, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 4). Cell Immunol (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 6, 7
In order to report that iNOS and phox are both required for the control of L. major in different tissues and at different stages, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 6, 7). Eur J Immunol (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to test if NKT cells produce IL-4 in response to T. muris infection and induce an Th2 response, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Parasite Immunol (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to examine the role of SOCS-1 in regulating inflammatory and immune responses in acute inflammatory arthritis, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Clin Invest (2003) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; tbl 1
In order to assess the proliferative potential of thymic progenitors that are T cell lineage restricted, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (tbl 1). Eur J Immunol (2003) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 4
In order to report that polarized type-2 immune responses are initiated independently of adaptive immunity, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 4). Nature (2002) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to examine the T cell responses in cyclophosphamide-treated mice after systemic infection with Candida albicans, Invitrogen CD8 antibody (Caltag, YTS 169.4) was used in flow cytometry on mouse samples . Cell Immunol (2002) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse
In order to study the effect of infection age using severe respiratory syncytial virus, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples . J Exp Med (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to suggest that p38 is involved in positive selection of T cells, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2003) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2
In order to investigate the control of functional avidity in response to viral infection, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 2). J Immunol (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to investigate graft-versus-leukemia, Invitrogen CD8 antibody (Caltag Laboratories, clone CT-CD8a) was used in flow cytometry on mouse samples (fig 1). Blood (2002) ncbi
rat monoclonal (CT-CD8a)
  • immunohistochemistry; mouse; fig 1
In order to study the cellular infiltrate during central nervous system inflammation, Invitrogen CD8 antibody (Caltag, clone CT-CD8a) was used in immunohistochemistry on mouse samples (fig 1). J Neuroimmunol (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to test if T-cell-specific expression of p300 alters GR-TCR cross talk between thymocytes, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Mol Cell Biol (2002) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to characterize the differences in dendritic cell generation in vivo caused by non-MHC NOD genes, Invitrogen CD8 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Int Immunol (2002) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate the role of VCAM-1 in collagen-induced arthritis, Invitrogen CD8 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples . Clin Exp Immunol (2002) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to characterize two subsets of mouse CD8 T cells, Invitrogen CD8 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Immunol (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the origin and involvement of CD8alpha(-) and CD8alpha(+) DCs in antiviral immune responses in vivo, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the origins of CD8alpha+ and CD8alpha- dendritic cells, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2002) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6
In order to elucidate the role of beta2 integrins in T cell-mediated immune responses, Invitrogen CD8 antibody (noco, 53-6.7) was used in flow cytometry on mouse samples (fig 6). J Clin Invest (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4, 5
In order to study loss of CD8+ cells in IL-15Ralpha(-/-) mice, Invitrogen CD8 antibody (CALTAG, CT-CD8alpha) was used in flow cytometry on mouse samples (fig 4, 5). J Immunol (2002) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to compare myeloid and lymphoid recovery using bone marrow and cord blood as sources of stem cells, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2002) ncbi
rat monoclonal (5H10)
  • flow cytometry; mouse; fig 1
In order to determine the role of CD8alpha-(myeloid) DCs in organ transplantation, Invitrogen CD8 antibody (Caltag, 5H10) was used in flow cytometry on mouse samples (fig 1). J Immunol (2002) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to identify the source of the early IFN-gamma after injection with anti-CD3, Invitrogen CD8 antibody (Life Technologies, 53-6.7) was used in flow cytometry on mouse samples (fig 2). J Immunol (2001) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2
In order to elucidate the role of IL-10 in mycobacterial infections, Invitrogen CD8 antibody (Caltag, clone CT-CD8) was used in flow cytometry on mouse samples (fig 2). Scand J Immunol (2001) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study the cell cycle using FADD(-/-) peripheral T cells, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Biol Chem (2001) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to test if specific subsets of cells in allogeneic bone marrow transplants can treat the BCL(1) B-cell lymphoma without inducing graft verses host disease, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2001) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1
In order to examine multipotent progenitors from early fetuses, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (fig 1). J Immunol (2001) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 3, 4
In order to investigate the effect of IL-18 on NKT cells, Invitrogen CD8 antibody (Caltag, YTS 169.4) was used in flow cytometry on mouse samples (fig 3, 4). J Immunol (2001) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to study regulation of the lck in T cell lineage commitment, Invitrogen CD8 antibody (Caltag, CT-CD8alpha-APC) was used in flow cytometry on mouse samples (fig 1). Int Immunol (2001) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 3
In order to assess the effects of folate analogues on superantigen-reactive peripheral T cells in vivo, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 3). Int Immunol (2001) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
In order to investigate the role of AML1 in T cell development, Invitrogen CD8 antibody (Life Technologies, 53-6.7) was used in flow cytometry on mouse samples (fig 3). J Immunol (2000) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to investigate the origin of CD8alpha(+) and CD8alpha(-) DCs, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (2000) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 2
In order to examine the contribution of different DC subsets during infection with Cryptococcus neoformans, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 2). J Immunol (2000) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine the expression of endothelial addressins and integrins on T cells during infection with Mycobacterium tuberculosis, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Immunol (2000) ncbi
rat monoclonal (CT-CD8a)
  • immunohistochemistry - frozen section; mouse
In order to determine the role of polymorphonuclear neutrophils in Chlamydophila abortus-infected mice, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in immunohistochemistry - frozen section on mouse samples . Infect Immun (2000) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 1
In order to determine the phenotype and function of T cells that prevent diabetes, Invitrogen CD8 antibody (Caltag, CT-CD8) was used in flow cytometry on mouse samples (fig 1). J Immunol (2000) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to identify a rare population of cells in the adult mouse bone marrow that generates CD4(+) and CD8(+) TCRalphabeta(+) T cells, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to describe a clonal system that supports the development of T and natural killer cells evenly, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Exp Med (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to investigate the aorta-gonad-mesonephros region as a source of hemopoietic progenitors, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to determine the role of IL-7R signaling in gamma/delta T cell development, Invitrogen CD8 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples . J Exp Med (1999) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine the importance of T cells in Chlamydia pneumoniae infection, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Immunology (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to study Fas-mediated activation-induced cell death in naive and primed T cells, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to study activation-induced nonresponsiveness of T cells, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to investigate hyper responsive CD8 T cells, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . Int Immunol (1999) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to characterize in vitro-generated dendritic cells, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Immunology (1999) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to determine the contribution of NK1.1(-) and NK1.1(+) T cell subsets to GVHD, Invitrogen CD8 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples . J Exp Med (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to assess if progenitors colonizing the thymus are T cell lineage restricted, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1, 2
In order to examine the effect of dietary docosahexaenoic acid on the surface molecules involved in T cell proliferation, Invitrogen CD8 antibody (Caltag, YTS-169.4) was used in flow cytometry on mouse samples (fig 1, 2). Biochim Biophys Acta (1999) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study FasL expression on thyrocytes, Invitrogen CD8 antibody (Caltag, 53?C6.72) was used in flow cytometry on mouse samples . J Immunol (1999) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse; fig 4
In order to assess experimental autoimmune encephalomyelitis in mice deficient in IL-6, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples (fig 4). J Immunol (1998) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to use T cells from BALB mice and study IL-4 production, Invitrogen CD8 antibody (Caltag, CT-CD8alpha) was used in flow cytometry on mouse samples . J Exp Med (1998) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to compare gut and peripheral T cell responses after staphylococcal enterotoxin treatment, Invitrogen CD8 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (1998) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to analyze the cell activation and proliferation requirements for the deletion of viral superantigen-reactive Vbeta8.1 T-cell receptor transgenic thymocytes, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Blood (1998) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to develop a mouse model to study the ability of a glycoprotein conjugate vaccine to induce immunologic memory for the polysaccharide moiety, Invitrogen CD8 antibody (Caltag, CT-CD8a) was used in flow cytometry on mouse samples . Infect Immun (1998) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
In order to determine if the microbiota contributes to autoimmunity in IL-2 deficient mice, Invitrogen CD8 antibody (Life Technologies, 53-6.7) was used in flow cytometry on mouse samples (fig 4). J Immunol (1998) ncbi
rat monoclonal (CT-CD8a)
  • flow cytometry; mouse
In order to characterize different populations of mouse lymph node dendritic cells, Invitrogen CD8 antibody (Caltag, T-CD8a) was used in flow cytometry on mouse samples . J Immunol (1998) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to elucidate the role of B7 in thymic selection, Invitrogen CD8 antibody (Caltag, clone 53.6.7) was used in flow cytometry on mouse samples (fig 1). Int Immunol (1997) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 2
In order to elucidate the pathway and cytokine regulation of NK cell development in vitro, Invitrogen CD8 antibody (Caltag Laboratories, YTS 169.4) was used in flow cytometry on mouse samples (fig 2). Blood (1997) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
In order to report that bGH stimulates the proliferation of activated murine T cells, Invitrogen CD8 antibody (Caltag, 53-6.7) was used in flow cytometry on mouse samples (fig 3). Endocrinology (1997) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to test if pregnancies and gender influence the cellar changes observed during ageing in mice, Invitrogen CD8 antibody (Caltag, YTS169-4) was used in flow cytometry on mouse samples . Clin Exp Immunol (1997) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to test if different activation thresholds distinguish naive from memory CD8+ T cell populations, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Exp Med (1996) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to report that FcR is a useful marker to isolate the most immature population of murine fetal thymic cells, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Exp Med (1996) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to study the long-term role of L-selectin-mediated migration in the maintenance of leukocyte subpopulations, Invitrogen CD8 antibody (Life Technologies, 53-6.7) was used in flow cytometry on mouse samples (fig 5). J Immunol (1996) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1
In order to develop and characterize a MV1-induced vasculitis model, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (fig 1). Clin Exp Immunol (1996) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse
In order to report that TAN1 is an oncoprotein, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples . J Exp Med (1996) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; tbl 1
In order to suggest that T lymphocyte lineage commitment and peripheral function does not depend on functional CD4, Invitrogen CD8 antibody (CalTag, YTS 169.4) was used in flow cytometry on mouse samples (tbl 1). Science (1993) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 3
In order to test the requirement for CD8 to interact with class I MHC molecules to promote CD4-CD8- T cells in lpr/lpr mice, Invitrogen CD8 antibody (Caltag, YTS 169.4) was used in flow cytometry on mouse samples (fig 3). J Immunol (1995) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 1
In order to use an in vivo transfer system to analyze the progeny of CD4+ T cells from B6-lpr/lpr mice, Invitrogen CD8 antibody (Caltag, YTS-169.4) was used in flow cytometry on mouse samples (fig 1). J Immunol (1994) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl 1
In order to report expression of Lyt-1, Lyt-2, and Lyt-3 on T cell subpopulations, Invitrogen CD8 antibody (noco, 53-6.7) was used in flow cytometry on mouse samples (tbl 1). J Exp Med (1980) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; tbl 1
  • ELISA; mouse; tbl 1
In order to compare the domains needed for LFA-1 and Mac-1 to bind ICAM-1, Invitrogen CD8 antibody (CalTag, YTS 169.4) was used in flow cytometry on mouse samples (tbl 1) and in ELISA on mouse samples (tbl 1). Cell (1991) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; fig 5
In order to develop a new method to isolate dendritic cells and characterize splenic and thymic dendritic cells, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (fig 5). J Exp Med (1992) ncbi
rat monoclonal (53-6.7)
  • other; mouse; fig 2
In order to assess T-cell surface molecules regulating T-cell interleukin 2 responses, Invitrogen CD8 antibody (noco, 53-6.72) was used in other on mouse samples (fig 2). Proc Natl Acad Sci U S A (1992) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; tbl 2
In order to describe the cells that transfer adoptive murine experimental hypersensitivity pneumonitis, Invitrogen CD8 antibody (Caltag, YTS169.4) was used in flow cytometry on mouse samples (tbl 2). Am Rev Respir Dis (1992) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1C
  • immunoprecipitation; mouse; fig 3F
In order to test the effects of xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens, Invitrogen CD8 antibody (noco, 53-6.7) was used in flow cytometry on mouse samples (fig 1C) and in immunoprecipitation on mouse samples (fig 3F). Immunol Rev (1979) ncbi
Abcam
domestic rabbit monoclonal (EPR21769)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 1d
Abcam CD8 antibody (Abcam, ab217344) was used in immunohistochemistry on mouse samples at 1:50 (fig 1d). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; fig 7a
Abcam CD8 antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples (fig 7a). J Int Med Res (2022) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry; mouse; 1:1000; fig 2h
Abcam CD8 antibody (ABCAM, ab209775) was used in immunohistochemistry on mouse samples at 1:1000 (fig 2h). J Immunol Res (2022) ncbi
domestic rabbit monoclonal (EPR21769)
  • immunohistochemistry - paraffin section; mouse; 1:2000; fig s8a
Abcam CD8 antibody (Abcam, ab217344) was used in immunohistochemistry - paraffin section on mouse samples at 1:2000 (fig s8a). Theranostics (2022) ncbi
domestic rabbit monoclonal (EPR21769)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5g, s5b
Abcam CD8 antibody (Abcam, 217344) was used in immunohistochemistry - paraffin section on mouse samples (fig 5g, s5b). J Immunother Cancer (2022) ncbi
mouse monoclonal (OX-8)
  • immunohistochemistry - frozen section; rat; 1:100; loading ...; fig 4d
Abcam CD8 antibody (Abcam, ab33786) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 4d). Sci Rep (2022) ncbi
domestic rabbit monoclonal (EPR21769)
  • immunohistochemistry - paraffin section; mouse; 1:2000; loading ...; fig 5a
Abcam CD8 antibody (Abcam, 217344) was used in immunohistochemistry - paraffin section on mouse samples at 1:2000 (fig 5a). Front Pharmacol (2022) ncbi
domestic rabbit monoclonal (EPR21769)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 4c
Abcam CD8 antibody (Abcam, ab217344) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 4c). Oncol Rep (2022) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig s2
Abcam CD8 antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig s2). Development (2022) ncbi
rat monoclonal (YTS169.4)
  • immunohistochemistry; mouse; fig 4g
Abcam CD8 antibody (Abcam, ab22378) was used in immunohistochemistry on mouse samples (fig 4g). J Exp Clin Cancer Res (2022) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 3b
Abcam CD8 antibody (Abcam, EPR20305) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3b). Med Oncol (2022) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; fig 4b
Abcam CD8 antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples (fig 4b). Gastric Cancer (2022) ncbi
rat monoclonal (YTS169.4)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig s6g
Abcam CD8 antibody (Abcam, ab22378) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig s6g). Theranostics (2021) ncbi
rat monoclonal (YTS169.4)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 5a
Abcam CD8 antibody (Abcam, ab22378) was used in immunohistochemistry on mouse samples at 1:50 (fig 5a). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (EPR21769)
  • western blot; human; loading ...; fig 6h
  • immunohistochemistry - paraffin section; mouse; fig 4n
  • flow cytometry; mouse; fig 4o
Abcam CD8 antibody (Abcam, ab217344) was used in western blot on human samples (fig 6h), in immunohistochemistry - paraffin section on mouse samples (fig 4n) and in flow cytometry on mouse samples (fig 4o). Mol Cancer (2021) ncbi
domestic rabbit monoclonal (EPR21769)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4b
Abcam CD8 antibody (Abcam, ab217344) was used in immunohistochemistry on mouse samples at 1:100 (fig 4b). Am J Cancer Res (2021) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1h
Abcam CD8 antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples (fig 1h). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (YTS169.4)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 5c
Abcam CD8 antibody (Abcam, ab22378) was used in immunohistochemistry on mouse samples at 1:200 (fig 5c). J Oncol (2021) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry; mouse; loading ...; fig 8c
Abcam CD8 antibody (Abcam, ab209775) was used in immunohistochemistry on mouse samples (fig 8c). Neoplasia (2021) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6f
Abcam CD8 antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples (fig 6f). Sci Adv (2021) ncbi
domestic rabbit monoclonal (EPR21769)
  • immunohistochemistry - paraffin section; mouse; fig 5e
Abcam CD8 antibody (Abcam, ab217344) was used in immunohistochemistry - paraffin section on mouse samples (fig 5e). BMC Cancer (2021) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - frozen section; mouse; fig 5c
Abcam CD8 antibody (Abcam, EPR20305) was used in immunohistochemistry - frozen section on mouse samples (fig 5c). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; 1:2000; loading ...; fig 4a
Abcam CD8 antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples at 1:2000 (fig 4a). BMC Cancer (2020) ncbi
mouse monoclonal (OX-8)
  • immunohistochemistry; rat; 1:500; loading ...
Abcam CD8 antibody (Abcam, ab33786) was used in immunohistochemistry on rat samples at 1:500. Biol Proced Online (2020) ncbi
rat monoclonal (YTS169.4)
  • immunohistochemistry; mouse; loading ...; fig 2e
Abcam CD8 antibody (Abcam, ab22378) was used in immunohistochemistry on mouse samples (fig 2e). Sci Rep (2020) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6
Abcam CD8 antibody (Abcam, ab209775) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Oncoimmunology (2020) ncbi
rat monoclonal (YTS169.4)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5d
Abcam CD8 antibody (Abcam, ab22378) was used in immunohistochemistry - paraffin section on human samples (fig 5d). Oncoimmunology (2020) ncbi
rat monoclonal (YTS169.4)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1d
Abcam CD8 antibody (Abcam, ab22378) was used in immunohistochemistry - frozen section on mouse samples (fig 1d). Cell (2019) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 8c
Abcam CD8 antibody (Abcam, EPR20305) was used in immunohistochemistry - paraffin section on mouse samples (fig 8c). J Exp Med (2019) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry; human; 1:100; loading ...
Abcam CD8 antibody (Abcam, EPR20305) was used in immunohistochemistry on human samples at 1:100. Nature (2019) ncbi
domestic rabbit monoclonal (EPR20305)
  • immunohistochemistry; mouse; 1:750; loading ...; fig s4b
Abcam CD8 antibody (Abcam, ab209775) was used in immunohistochemistry on mouse samples at 1:750 (fig s4b). Breast Cancer Res (2018) ncbi
mouse monoclonal (OX-8)
  • immunohistochemistry; rat; 1:200; loading ...; fig 7a
In order to develop and characterize a rat model of glioma, Abcam CD8 antibody (Abcam, ab33786) was used in immunohistochemistry on rat samples at 1:200 (fig 7a). PLoS ONE (2017) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 3a
In order to demonstrate that control of acute infection with Trypanosoma cruzi is associated with development of systemic necrotizing vasculitis, Abcam CD8 antibody (Abcam, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 3a). Infect Immun (2016) ncbi
rat monoclonal (YTS169.4)
  • immunohistochemistry - frozen section; mouse; 1:100
Abcam CD8 antibody (abcam, 22378) was used in immunohistochemistry - frozen section on mouse samples at 1:100. J Transl Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
Abcam CD8 antibody (Abcam, clone 53-6.7) was used in flow cytometry on mouse samples (fig 5). Vaccine (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse
Abcam CD8 antibody (Abcam, Ab25478) was used in immunohistochemistry - frozen section on mouse samples . Transplant Res (2013) ncbi
Bio X Cell
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; ; fig 2d
Bio X Cell CD8 antibody (Bio X Cell, 2.43) was used in blocking or activating experiments on mouse samples at (fig 2d). J Immunother Cancer (2022) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; ; fig 3a
Bio X Cell CD8 antibody (BioXCell, 53-6.7) was used in blocking or activating experiments on mouse samples at (fig 3a). PLoS Pathog (2022) ncbi
rat monoclonal (YTS169.4)
  • blocking or activating experiments; mouse; fig s5d
Bio X Cell CD8 antibody (BioXcell, BE0117) was used in blocking or activating experiments on mouse samples (fig s5d). Nat Commun (2021) ncbi
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; fig s3k
Bio X Cell CD8 antibody (BioXCell, 2.43) was used in blocking or activating experiments on mouse samples (fig s3k). J Immunother Cancer (2021) ncbi
rat monoclonal (YTS169.4)
  • blocking or activating experiments; mouse; ; fig 2g
Bio X Cell CD8 antibody (Bio X Cell, YTS 169.4) was used in blocking or activating experiments on mouse samples at (fig 2g). Nat Commun (2021) ncbi
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; fig 10d
Bio X Cell CD8 antibody (BioXCell, 2.43) was used in blocking or activating experiments on mouse samples (fig 10d). PLoS Pathog (2021) ncbi
rat monoclonal (YTS169.4)
  • blocking or activating experiments; mouse; fig 4c
Bio X Cell CD8 antibody (BioXCell, YTS 169.4) was used in blocking or activating experiments on mouse samples (fig 4c). elife (2020) ncbi
rat monoclonal (2.43)
  • flow cytometry; mouse; loading ...; fig s2c
Bio X Cell CD8 antibody (Bio X cell, 2.43) was used in flow cytometry on mouse samples (fig s2c). Nature (2020) ncbi
rat monoclonal (YTS169.4)
  • blocking or activating experiments; mouse; fig 5h
Bio X Cell CD8 antibody (BioXcell, YTS 169.4) was used in blocking or activating experiments on mouse samples (fig 5h). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; fig 4g
  • flow cytometry; mouse; loading ...; fig 1a
Bio X Cell CD8 antibody (Bio X Cell, 53-6.7) was used in blocking or activating experiments on mouse samples (fig 4g) and in flow cytometry on mouse samples (fig 1a). Sci Adv (2020) ncbi
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; fig 7f
Bio X Cell CD8 antibody (BioXCell, BE0061) was used in blocking or activating experiments on mouse samples (fig 7f). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; 150 ug/mouse; fig 1h
Bio X Cell CD8 antibody (BioXcell, 53-6.7) was used in blocking or activating experiments on mouse samples at 150 ug/mouse (fig 1h). elife (2020) ncbi
rat monoclonal (YTS169.4)
  • blocking or activating experiments; mouse; fig e5g
Bio X Cell CD8 antibody (BioXCell, YTS 169.4) was used in blocking or activating experiments on mouse samples (fig e5g). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; ; fig 1g
Bio X Cell CD8 antibody (BioXcell, BE0004-1) was used in blocking or activating experiments on mouse samples at (fig 1g). J Exp Med (2020) ncbi
rat monoclonal (2.43)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1c
Bio X Cell CD8 antibody (Bio-X-Cel, BE0061) was used in immunohistochemistry - frozen section on mouse samples (fig 1c). Cell (2019) ncbi
rat monoclonal (2.43)
  • other; mouse
Bio X Cell CD8 antibody (BioXCell, 2.43) was used in other on mouse samples . Nature (2019) ncbi
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; loading ...; fig s8
Bio X Cell CD8 antibody (BioXcel, 2.43) was used in blocking or activating experiments on mouse samples (fig s8). Science (2018) ncbi
rat monoclonal (YTS169.4)
  • blocking or activating experiments; mouse; fig 1e
Bio X Cell CD8 antibody (BioXcell, BE0117) was used in blocking or activating experiments on mouse samples (fig 1e). Cell Rep (2018) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; loading ...; fig s3a
Bio X Cell CD8 antibody (Bio X Cell, 53-6.72) was used in blocking or activating experiments on mouse samples (fig s3a). J Clin Invest (2019) ncbi
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; loading ...; fig 5b
Bio X Cell CD8 antibody (BioXcell, BE0061) was used in blocking or activating experiments on mouse samples (fig 5b). Nature (2018) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; 100 ug/mouse; loading ...; fig 5a
Bio X Cell CD8 antibody (Bioxcell, BE0004-1) was used in blocking or activating experiments on mouse samples at 100 ug/mouse (fig 5a). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; loading ...; fig 5a
Bio X Cell CD8 antibody (BioXCell, 53.6.72) was used in immunohistochemistry on mouse samples (fig 5a). PLoS ONE (2018) ncbi
rat monoclonal (2.43)
  • flow cytometry; mouse; loading ...; fig 7a
Bio X Cell CD8 antibody (BioXcell, 2.43) was used in flow cytometry on mouse samples (fig 7a). Cell (2017) ncbi
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; loading ...; fig 3a
Bio X Cell CD8 antibody (BioXcell, 2.43) was used in blocking or activating experiments on mouse samples (fig 3a). Nat Commun (2017) ncbi
rat monoclonal (YTS169.4)
  • blocking or activating experiments; mouse; loading ...; fig 10
Bio X Cell CD8 antibody (BioXcell, YTS 169.4) was used in blocking or activating experiments on mouse samples (fig 10). J Virol (2017) ncbi
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; loading ...; fig s6a
In order to evaluate mouse models of hepacivirus infection, Bio X Cell CD8 antibody (Bioxcell, 2.43) was used in blocking or activating experiments on mouse samples (fig s6a). Science (2017) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; loading ...; fig 6
Bio X Cell CD8 antibody (BioXCell, 53-6.72) was used in blocking or activating experiments on mouse samples (fig 6). J Transl Med (2017) ncbi
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; loading ...; fig 6a
Bio X Cell CD8 antibody (BioXcell, 2.43) was used in blocking or activating experiments on mouse samples (fig 6a). J Exp Med (2017) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; loading ...; fig 7h
Bio X Cell CD8 antibody (BioXcell, 53-6.72) was used in blocking or activating experiments on mouse samples (fig 7h). J Exp Med (2017) ncbi
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; loading ...; fig 6a
In order to find that TLR3, 7 and 9 deficiencies on host cells result in complete tumor regression and induction of anti-tumor immunity, Bio X Cell CD8 antibody (BioXCell, 2.43) was used in blocking or activating experiments on mouse samples (fig 6a). Nat Commun (2017) ncbi
rat monoclonal (YTS169.4)
  • blocking or activating experiments; mouse; loading ...; fig 4d
In order to find microenvironmental regulators of metastatic colonization, Bio X Cell CD8 antibody (BioXCell, YTS169.4) was used in blocking or activating experiments on mouse samples (fig 4d). Nature (2017) ncbi
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; loading ...
In order to explore the role of Axl in promoting a suppressive myeloid microenvironment in response to ionizing radiation therapy in combination with checkpoint immunotherapy, Bio X Cell CD8 antibody (Bio-X-Cell, 2.43) was used in blocking or activating experiments on mouse samples . Nat Commun (2016) ncbi
rat monoclonal (YTS169.4)
  • blocking or activating experiments; mouse; loading ...; fig 3a
In order to show that parasite-specific CD8 positive T cell-induced fatal vascular breakdown and subsequent neuronal death in an animal model of cerebral malaria, Bio X Cell CD8 antibody (BioXcell, YTS 169.4) was used in blocking or activating experiments on mouse samples (fig 3a). PLoS Pathog (2016) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; loading ...; fig 7b
In order to characterize the immunological changes in tumors induced by radiation therapy, Bio X Cell CD8 antibody (BioXcell, 53-6.7) was used in blocking or activating experiments on mouse samples (fig 7b). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (2.43)
  • blocking or activating experiments; mouse; loading ...; fig s8
Bio X Cell CD8 antibody (BioXcell, 2.43) was used in blocking or activating experiments on mouse samples (fig s8). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
In order to investigate the effect of ADAM17 on CSF1R protein expression on hematopoietic progenitors, Bio X Cell CD8 antibody (Bio X-Cell/Bhattacharya, 53-6.72) was used in flow cytometry on mouse samples (fig s1). Exp Hematol (2015) ncbi
Bio-Rad
rat monoclonal (KT15)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 2a
Bio-Rad CD8 antibody (Bio-Rad AbD Serotec, MCA609G) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 2a). Brain Commun (2021) ncbi
rat monoclonal (YTS169.4)
  • flow cytometry; mouse; loading ...; fig 3a
Bio-Rad CD8 antibody (Bio-Rad, YTS169.4) was used in flow cytometry on mouse samples (fig 3a). Clin Transl Med (2021) ncbi
rat monoclonal (KT15)
  • flow cytometry; human; 0.125 ug/ml; loading ...; fig 6d
Bio-Rad CD8 antibody (BioRad, KT15) was used in flow cytometry on human samples at 0.125 ug/ml (fig 6d). Cell Host Microbe (2019) ncbi
rat monoclonal (KT15)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 1e
Bio-Rad CD8 antibody (BioRad, MCA609G) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1e). Mol Cell (2018) ncbi
rat monoclonal (KT15)
  • immunohistochemistry - frozen section; mouse; 1:500; fig 4b
In order to find that TLR3, 7 and 9 deficiencies on host cells result in complete tumor regression and induction of anti-tumor immunity, Bio-Rad CD8 antibody (AbD Serotec/Bio-Rad, KT15) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 4b). Nat Commun (2017) ncbi
rat monoclonal (KT15)
  • immunohistochemistry - free floating section; mouse; 1:100; loading ...; fig 3a
In order to explore the role of hippocampal T cell infiltration in tau-driven pathophysiology and cognitive impairments, Bio-Rad CD8 antibody (AbD Serotec, KT15) was used in immunohistochemistry - free floating section on mouse samples at 1:100 (fig 3a). Brain (2017) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; loading ...; fig 2d
In order to report that vaccine-induced T regulatory cells aid to control de novo primed autoreactive effector CD8(+) T cells in a diabetes model, Bio-Rad CD8 antibody (AbD Serotec, MCA2694) was used in immunohistochemistry on mouse samples (fig 2d). Sci Rep (2016) ncbi
rat monoclonal (YTS105.18)
  • immunohistochemistry - frozen section; mouse; 7 ug/ml
Bio-Rad CD8 antibody (AbD, MCA1108GT) was used in immunohistochemistry - frozen section on mouse samples at 7 ug/ml. J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; 1:100
In order to examine the role of perforin and CD8 T cells in immune-mediated blood-brain barrier disruption, Bio-Rad CD8 antibody (AbD Serotec, MCA2694) was used in immunohistochemistry on mouse samples at 1:100. PLoS ONE (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (32-M4)
  • immunohistochemistry; human; loading ...; fig 1a
Santa Cruz Biotechnology CD8 antibody (Santa Cruz, SC-1177) was used in immunohistochemistry on human samples (fig 1a). J Immunother Cancer (2022) ncbi
mouse monoclonal (32-M4)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 9d
Santa Cruz Biotechnology CD8 antibody (Santa Cruz, sc-1177) was used in immunohistochemistry on mouse samples at 1:50 (fig 9d). J Neuroinflammation (2020) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; fig 3
Santa Cruz Biotechnology CD8 antibody (Santa Cruz Biotechnology, sc-18913) was used in immunohistochemistry on mouse samples (fig 3). Int J Mol Med (2016) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; fig 2
Santa Cruz Biotechnology CD8 antibody (Santa Cruz Biotechnology, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 2). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; rat; 1:1000
Santa Cruz Biotechnology CD8 antibody (Santa Cruz Biotechnology, sc-18913) was used in flow cytometry on rat samples at 1:1000. Mol Med Rep (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; fig 5
Santa Cruz Biotechnology CD8 antibody (Santa Cruz, sc18913) was used in immunohistochemistry on mouse samples (fig 5). PLoS ONE (2015) ncbi
Novus Biologicals
rat monoclonal (YTS105.18)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 5c
Novus Biologicals CD8 antibody (Novus, NB200-578) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 5c). Sci Transl Med (2022) ncbi
domestic rabbit polyclonal (A103)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6q
Novus Biologicals CD8 antibody (Novus, NBP2-29475) was used in immunohistochemistry - paraffin section on mouse samples (fig 6q). Signal Transduct Target Ther (2021) ncbi
domestic rabbit polyclonal (A103)
  • immunohistochemistry; human; 1:100; loading ...; fig 4i
Novus Biologicals CD8 antibody (Novus Biologicals, NBP2-29475) was used in immunohistochemistry on human samples at 1:100 (fig 4i). Adv Sci (Weinh) (2021) ncbi
Dianova
rat monoclonal (GHH8)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 1f
Dianova CD8 antibody (Dianova, DIA-808) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1f). Br J Cancer (2022) ncbi
rat monoclonal (GHH8)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3
Dianova CD8 antibody (Dianova, DIA-808) was used in immunohistochemistry on mouse samples at 1:200 (fig 3). Sci Rep (2020) ncbi
Miltenyi Biotec
human monoclonal (REA601)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s6
Miltenyi Biotec CD8 antibody (Miltenyi Biotec, 130-123-781) was used in immunohistochemistry - frozen section on mouse samples (fig s6). Sci Rep (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1
Miltenyi Biotec CD8 antibody (Miltenyi Biotec, 130-102-595) was used in flow cytometry on mouse samples (fig s1). J Cell Mol Med (2018) ncbi
R&D Systems
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 2 ug/ml; loading ...; fig 3e
R&D Systems CD8 antibody (RD Systems, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples at 2 ug/ml (fig 3e). Science (2021) ncbi
Synaptic Systems
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:250; fig 3f
Synaptic Systems CD8 antibody (Synaptic Systems, HS-361 003) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 3f). Cell Rep (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; loading ...; fig 8a
Synaptic Systems CD8 antibody (Synaptic Systems, 361003) was used in immunohistochemistry - frozen section on mouse samples (fig 8a). Front Oncol (2021) ncbi
Cell Signaling Technology
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 6k
Cell Signaling Technology CD8 antibody (CST, 98941S) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 6k). J Immunother Cancer (2022) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; fig 2d
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry on mouse samples (fig 2d). Cancer Commun (Lond) (2022) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; fig 6f
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941s) was used in immunohistochemistry - paraffin section on mouse samples (fig 6f). Invest Ophthalmol Vis Sci (2022) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; 1:2000; fig 1f
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry - paraffin section on mouse samples at 1:2000 (fig 1f). Cell Rep Med (2022) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s1a
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry - paraffin section on mouse samples (fig s1a). J Immunother Cancer (2022) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; fig 6d
Cell Signaling Technology CD8 antibody (Cell Signaling, D4W2Z) was used in immunohistochemistry - paraffin section on mouse samples (fig 6d). Cancers (Basel) (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; 1:50; loading ...; fig 6
Cell Signaling Technology CD8 antibody (Cell Signaling Technology, 98941) was used in immunohistochemistry on mouse samples at 1:50 (fig 6). Front Cell Infect Microbiol (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; 1:400; fig 2c, 2f
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry on mouse samples at 1:400 (fig 2c, 2f). J Immunother Cancer (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; loading ...; fig s4a
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry on mouse samples (fig s4a). Cells (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; 1:200; loading ...; fig s15d
Cell Signaling Technology CD8 antibody (Cell Signaling Technology, D4W2Z) was used in immunohistochemistry on mouse samples at 1:200 (fig s15d). Nat Commun (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; fig 6
Cell Signaling Technology CD8 antibody (CST, 98941) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Front Cell Dev Biol (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; 1:400; fig 4d
Cell Signaling Technology CD8 antibody (CST, 98941) was used in immunohistochemistry on mouse samples at 1:400 (fig 4d). Cancer Res (2021) ncbi
monoclonal (D4W2Z)
  • immunocytochemistry; human; 1:100; loading ...; fig 6a
Cell Signaling Technology CD8 antibody (Cell Signaling Technology, D4W2Z) was used in immunocytochemistry on human samples at 1:100 (fig 6a). Nat Cancer (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; loading ...; fig 5b
Cell Signaling Technology CD8 antibody (Cell Signaling Technology, 98941S) was used in immunohistochemistry on mouse samples (fig 5b). Br J Cancer (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig s6g
Cell Signaling Technology CD8 antibody (CST, 98941) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6g). Nat Commun (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; loading ...; fig 3
Cell Signaling Technology CD8 antibody (Cell Signaling Technology, D4W2Z) was used in immunohistochemistry on mouse samples (fig 3). PLoS ONE (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 5d
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5d). Clin Cancer Res (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; 1:1000; fig 6g
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry on mouse samples at 1:1000 (fig 6g). Sci Rep (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 5e
Cell Signaling Technology CD8 antibody (Cell Signaling Technology, 98941S) was used in immunohistochemistry on mouse samples at 1:400 (fig 5e). Cancer Res (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; loading ...; fig 5f
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry on mouse samples (fig 5f). Front Immunol (2020) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; fig s5
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry - paraffin section on mouse samples (fig s5). Cancer Sci (2021) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 6d
Cell Signaling Technology CD8 antibody (Cell Signaling Technology, 98941S) was used in immunohistochemistry on mouse samples at 1:500 (fig 6d). JCI Insight (2020) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 4e
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 4e). EMBO Mol Med (2020) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; fig 3e
Cell Signaling Technology CD8 antibody (Cell Signaling Technology, D4W22) was used in immunohistochemistry on mouse samples (fig 3e). Nat Commun (2020) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 8a
Cell Signaling Technology CD8 antibody (Cell Signalling, D4W2Z) was used in immunohistochemistry - paraffin section on mouse samples (fig 8a). Sci Rep (2020) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 5c
Cell Signaling Technology CD8 antibody (Cell Signaling Technology, 98941) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 5c). Nature (2019) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig e8d
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry - paraffin section on mouse samples (fig e8d). Nature (2019) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; fig 3g
Cell Signaling Technology CD8 antibody (Cell Signaling Technology, 98941) was used in immunohistochemistry - paraffin section on mouse samples (fig 3g). J Clin Invest (2019) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig e5c
  • flow cytometry; mouse; loading ...; fig e5b
Cell Signaling Technology CD8 antibody (Cell Signaling, 98941) was used in immunohistochemistry - paraffin section on mouse samples (fig e5c) and in flow cytometry on mouse samples (fig e5b). Nature (2019) ncbi
monoclonal (D4W2Z)
  • immunohistochemistry; mouse; loading ...; fig 4a, 4b
Cell Signaling Technology CD8 antibody (Cell Signaling, D4W2Z) was used in immunohistochemistry on mouse samples (fig 4a, 4b). J Immunol (2019) ncbi
Tonbo Biosciences
monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 3s1a
Tonbo Biosciences CD8 antibody (Tonbo, 35-0081 U500) was used in flow cytometry on mouse samples at 1:400 (fig 3s1a). elife (2021) ncbi
monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
Tonbo Biosciences CD8 antibody (Tonbo, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). Nutrients (2018) ncbi
monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
Tonbo Biosciences CD8 antibody (Tonbo, 65-0081) was used in flow cytometry on mouse samples (fig 2a). PLoS Pathog (2018) ncbi
monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2a
Tonbo Biosciences CD8 antibody (Tonbo, 53-67) was used in flow cytometry on mouse samples (fig s2a). J Immunol (2018) ncbi
monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
Tonbo Biosciences CD8 antibody (Tonbo, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2017) ncbi
BD Biosciences
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50; fig 4b
BD Biosciences CD8 antibody (BD, 551162) was used in flow cytometry on mouse samples at 1:50 (fig 4b). Nat Commun (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2f
BD Biosciences CD8 antibody (BD, 553035) was used in flow cytometry on mouse samples (fig 2f). Nat Commun (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BD Biosciences CD8 antibody (BD Pharmingen, 561109) was used in flow cytometry on mouse samples . Front Oncol (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5c, s5d
BD Biosciences CD8 antibody (BD Biosciences, 553035) was used in flow cytometry on mouse samples (fig 5c, s5d). J Immunother Cancer (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1e, s2a, s4f
BD Biosciences CD8 antibody (BD Biosciences, 563786) was used in flow cytometry on mouse samples (fig s1e, s2a, s4f). Sci Adv (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig e5f
BD Biosciences CD8 antibody (BD Horizon, 53-6.7) was used in flow cytometry on mouse samples (fig e5f). Nature (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:400; loading ...; fig 1c, s3a, s3b
BD Biosciences CD8 antibody (BD Biosciences, 563332) was used in flow cytometry on mouse samples at 1:400 (fig 1c, s3a, s3b). Development (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6i
BD Biosciences CD8 antibody (BD Biosciences, 552877) was used in flow cytometry on mouse samples (fig 6i). Mol Ther Oncolytics (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 2, s1
BD Biosciences CD8 antibody (BD Bioscience, 563046) was used in flow cytometry on mouse samples at 1:100 (fig 2, s1). Front Immunol (2022) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s2f
BD Biosciences CD8 antibody (BD Pharmingen, 553849) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s2f). J Cell Sci (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1l
BD Biosciences CD8 antibody (BD Biosciences, 561097) was used in flow cytometry on mouse samples (fig 1l). J Immunother Cancer (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...; fig s7j
BD Biosciences CD8 antibody (BD Biosciences, 553032) was used in flow cytometry on human samples (fig s7j). J Clin Invest (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 5n
BD Biosciences CD8 antibody (BD Biosciences, 563786) was used in flow cytometry on mouse samples at 1:100 (fig 5n). Nat Commun (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1f
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig s1f). J Exp Med (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2c
BD Biosciences CD8 antibody (BD Biosciences, 558106) was used in flow cytometry on mouse samples (fig s2c). Signal Transduct Target Ther (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
BD Biosciences CD8 antibody (BD Biosciences, 553032) was used in flow cytometry on mouse samples (fig 1c). EMBO J (2022) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2i, 5g, 5i
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 2i, 5g, 5i). Front Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 6f
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 6f). Sci Rep (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). J Immunother Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...; fig s2b
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on human samples (fig s2b). Front Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; loading ...; fig 3a
BD Biosciences CD8 antibody (BD Biosciences, 563786) was used in immunohistochemistry on mouse samples (fig 3a). Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100
BD Biosciences CD8 antibody (BD Pharmingen, 553032) was used in flow cytometry on mouse samples at 1:100. Hypertension (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3a
BD Biosciences CD8 antibody (BD, 562283) was used in flow cytometry on mouse samples (fig 3a). Theranostics (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
BD Biosciences CD8 antibody (BD Pharmingen, 551162) was used in flow cytometry on mouse samples (fig 2b). Signal Transduct Target Ther (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4b, 6a
BD Biosciences CD8 antibody (BD Biosciences, 53?C6.7) was used in flow cytometry on mouse samples (fig 4b, 6a). Sci Rep (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:300; loading ...; fig s2b
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples at 1:300 (fig s2b). Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 7e
BD Biosciences CD8 antibody (BD Pharmingen, 553033) was used in flow cytometry on mouse samples (fig 7e). Signal Transduct Target Ther (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 4d
BD Biosciences CD8 antibody (BD Horizon, 560776) was used in flow cytometry on mouse samples at 1:200 (fig 4d). Cells (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 6e, s3l
BD Biosciences CD8 antibody (BD Biosciences, 564422) was used in flow cytometry on mouse samples at 1:200 (fig 6e, s3l). J Immunother Cancer (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 2j
BD Biosciences CD8 antibody (BD Bioscience, 561109) was used in flow cytometry on mouse samples at 1:200 (fig 2j). Proc Natl Acad Sci U S A (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BD Biosciences CD8 antibody (BD Biosciences, 562283) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s13
BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s13). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2c
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 2c). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 5d
BD Biosciences CD8 antibody (BD, 552877) was used in flow cytometry on mouse samples at 1:100 (fig 5d). iScience (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s3a, s3b
BD Biosciences CD8 antibody (BD Biosciences, 563068) was used in flow cytometry on mouse samples at 1:200 (fig s3a, s3b). Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3
BD Biosciences CD8 antibody (BD Biosciences, 553032) was used in flow cytometry on mouse samples (fig s3). Cell Death Dis (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2i
BD Biosciences CD8 antibody (BD, 560776) was used in flow cytometry on mouse samples (fig s2i). Front Cell Dev Biol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s3b
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig s3b). Cancer Res (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). Sci Adv (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4e
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 4e). Acta Naturae (2021) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; loading ...; fig 2g
BD Biosciences CD8 antibody (BD, 550281) was used in immunohistochemistry on mouse samples (fig 2g). Front Cell Dev Biol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 3b). Front Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples at 1:200. Front Immunol (2021) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s3a
BD Biosciences CD8 antibody (BD, 550281) was used in immunohistochemistry - frozen section on mouse samples (fig s3a). Aging (Albany NY) (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200
BD Biosciences CD8 antibody (BD Biosciences, 557654) was used in flow cytometry on mouse samples at 1:200. Commun Biol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6k
BD Biosciences CD8 antibody (BD Pharmingen, 551162) was used in flow cytometry on mouse samples (fig 6k). Signal Transduct Target Ther (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4a
BD Biosciences CD8 antibody (BD Biosciences, 561095) was used in flow cytometry on mouse samples (fig s4a). JCI Insight (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a, 2b, s5, s7b
BD Biosciences CD8 antibody (BD Biosciences, 553035) was used in flow cytometry on mouse samples (fig 2a, 2b, s5, s7b). Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s6d, s4e
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig s6d, s4e). Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 12i
BD Biosciences CD8 antibody (BD Pharmingen, 551162) was used in flow cytometry on mouse samples (fig 12i). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s8
BD Biosciences CD8 antibody (BD Pharmingen, 557654) was used in flow cytometry on mouse samples at 1:200 (fig s8). Nat Commun (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; fig 6d
BD Biosciences CD8 antibody (BD Biosciences, 558106) was used in flow cytometry on mouse samples at 1:200 (fig 6d). Cancer Res (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:300; loading ...; fig e10e
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples at 1:300 (fig e10e). Nat Neurosci (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BD Biosciences CD8 antibody (BD Biosciences, 53-C6.7) was used in flow cytometry on mouse samples . elife (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 8a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 8a). Front Immunol (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...; fig s3c
BD Biosciences CD8 antibody (BD, 553030) was used in flow cytometry on human samples (fig s3c). Cell (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). J Clin Invest (2021) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5d
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 5d). Front Immunol (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1f
BD Biosciences CD8 antibody (BD Biosciences, 53-C6.7) was used in flow cytometry on mouse samples at 1:200 (fig 1f). elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s6-1b
BD Biosciences CD8 antibody (BD Biosciences, 53-C6.7) was used in flow cytometry on mouse samples at 1:200 (fig s6-1b). elife (2020) ncbi
rat monoclonal (53-6.7)
BD Biosciences CD8 antibody (BD, 563786) was used . Aging Cell (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5
BD Biosciences CD8 antibody (BD Pharmingen, 553031) was used in flow cytometry on mouse samples (fig s5). Vaccines (Basel) (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5s1a
BD Biosciences CD8 antibody (BD Biosciences, 561093) was used in flow cytometry on mouse samples (fig 5s1a). elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; fig 1j
BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on mouse samples at 1:500 (fig 1j). J Allergy Clin Immunol (2021) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 5b, 5g
BD Biosciences CD8 antibody (BD Biosciences, 553849) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 5b, 5g). Angiogenesis (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4d
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 4d). elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 4h
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 4h). elife (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
BD Biosciences CD8 antibody (BD Bioscience, 553033) was used in flow cytometry on mouse samples (fig 3b). Sci Rep (2020) ncbi
rat monoclonal (MECA-32)
  • blocking or activating experiments; mouse; fig 5c
BD Biosciences CD8 antibody (BD, 550563) was used in blocking or activating experiments on mouse samples (fig 5c). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3j
BD Biosciences CD8 antibody (BD, 563068) was used in flow cytometry on mouse samples (fig 3j). J Clin Invest (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1m
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 1m). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2a
BD Biosciences CD8 antibody (BD Biosciences, 553035) was used in flow cytometry on mouse samples (fig 2a). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4f, s6b
BD Biosciences CD8 antibody (BD, 560182) was used in flow cytometry on mouse samples (fig s4f, s6b). Nat Commun (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6c
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 6c). elife (2020) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1.25 ug/ml; loading ...; fig 4a
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples at 1.25 ug/ml (fig 4a). BMC Cancer (2020) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2e
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2e). Sci Adv (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig s4a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig s4a). Cell Rep (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). BMC Infect Dis (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s2
BD Biosciences CD8 antibody (BD Biosciences, 563898) was used in flow cytometry on mouse samples at 1:100 (fig s2). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3a
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig s3a). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:500; loading ...; fig s1h
BD Biosciences CD8 antibody (BD Pharmingen, 553032) was used in flow cytometry on mouse samples at 1:500 (fig s1h). Nat Metab (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b, 4b
BD Biosciences CD8 antibody (BD, 53-67) was used in flow cytometry on mouse samples (fig 3b, 4b). Biomolecules (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2h, 3k, 5a
BD Biosciences CD8 antibody (BD Biosciences, 563234) was used in flow cytometry on mouse samples (fig 2h, 3k, 5a). Oncoimmunology (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig s5
BD Biosciences CD8 antibody (BD Bioscience, 563046) was used in flow cytometry on mouse samples at 1:100 (fig s5). Science (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 1h, 3c
BD Biosciences CD8 antibody (BD Biosciences, 557959) was used in flow cytometry on mouse samples at 1:200 (fig 1h, 3c). Nat Immunol (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:40; loading ...; fig s3a
BD Biosciences CD8 antibody (BD, 557654) was used in flow cytometry on mouse samples at 1:40 (fig s3a). Nat Commun (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3b
BD Biosciences CD8 antibody (BD Biosciences, 553036) was used in flow cytometry on mouse samples (fig s3b). Cell Rep (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1
BD Biosciences CD8 antibody (BD Bioscience, 552877) was used in flow cytometry on mouse samples (fig s1). Oncoimmunology (2019) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry; mouse; 1:400; loading ...; fig 1a
BD Biosciences CD8 antibody (BD Biosciences, 553849) was used in immunohistochemistry on mouse samples at 1:400 (fig 1a). elife (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3f
BD Biosciences CD8 antibody (BD Pharmigen, 553029) was used in flow cytometry on mouse samples (fig 3f). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a
BD Biosciences CD8 antibody (BD Biosciences, 553030) was used in flow cytometry on mouse samples (fig s1a). Sci Rep (2019) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3b
BD Biosciences CD8 antibody (BD Pharmingen, 553849) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3b). elife (2019) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry; mouse; loading ...; fig 1b
BD Biosciences CD8 antibody (BD Biosciences, 553849) was used in immunohistochemistry on mouse samples (fig 1b). elife (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig ex4a
BD Biosciences CD8 antibody (BD Biosciences, 563786) was used in flow cytometry on mouse samples (fig ex4a). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 3e
  • flow cytometry; mouse; loading ...; fig s6d
BD Biosciences CD8 antibody (BD, 563786) was used in immunohistochemistry - frozen section on mouse samples (fig 3e) and in flow cytometry on mouse samples (fig s6d). Cell (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3d
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3d). J Clin Invest (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). Nature (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1
BD Biosciences CD8 antibody (BD Biosciences, 557959) was used in flow cytometry on mouse samples (fig s1). J Clin Invest (2019) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; loading ...; fig 4d
BD Biosciences CD8 antibody (BD PharMingen, 53-6.7) was used in immunohistochemistry on mouse samples (fig 4d). J Exp Med (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
BD Biosciences CD8 antibody (BD, 558106) was used in flow cytometry on mouse samples (fig 3a). Oncoimmunology (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5b
BD Biosciences CD8 antibody (BD, 551162) was used in flow cytometry on mouse samples (fig s5b). Cell Rep (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
BD Biosciences CD8 antibody (BD, 560776) was used in flow cytometry on mouse samples (fig 2a). Cell (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s3a). J Clin Invest (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2f
BD Biosciences CD8 antibody (BD, 553035) was used in flow cytometry on mouse samples (fig 2f). Cell (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4
BD Biosciences CD8 antibody (BD Pharminger, 53-6.7) was used in flow cytometry on mouse samples (fig 4). J Diabetes Res (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s1a). J Clin Invest (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5
BD Biosciences CD8 antibody (BD Biosciences, 53-C6.7) was used in flow cytometry on mouse samples (fig 5). Virology (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6b
BD Biosciences CD8 antibody (BD Biosciences, 558106) was used in flow cytometry on mouse samples (fig 6b). Cell Stem Cell (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s7a
BD Biosciences CD8 antibody (BD, 551162) was used in flow cytometry on mouse samples (fig s7a). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5e
BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 5e). Front Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 3b). Sci Rep (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4a, s4b
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s4a, s4b). Oncogene (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1d
BD Biosciences CD8 antibody (BD Biosciences, 553033) was used in flow cytometry on mouse samples (fig s1d). Cell (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1a
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). Cancer Immunol Immunother (2019) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2c
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2c). Oncotarget (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5b
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 5b). J Biol Chem (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD8 antibody (BD Bioscience, 562283) was used in flow cytometry on human samples (fig s1a). Immunity (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s17a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s17a). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 3b). Cell Death Dis (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2c
BD Biosciences CD8 antibody (BD Biosciences, 562283) was used in flow cytometry on mouse samples (fig 2c). Mol Cell (2018) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; loading ...; fig 2d
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in immunohistochemistry on mouse samples (fig 2d). Int J Cancer (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3c
BD Biosciences CD8 antibody (BD Biosciences, 551162) was used in flow cytometry on mouse samples (fig 3c). Nat Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
BD Biosciences CD8 antibody (BD Pharmingen, 561967) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3e
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 3e). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:250; loading ...; fig s6a
BD Biosciences CD8 antibody (BD Biosciences, 553033) was used in flow cytometry on mouse samples at 1:250 (fig s6a). Nat Commun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:1000; fig s7
BD Biosciences CD8 antibody (BioLegend, 553031) was used in flow cytometry on mouse samples at 1:1000 (fig s7). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s7c
BD Biosciences CD8 antibody (BD Biosciences, 553033) was used in flow cytometry on mouse samples (fig s7c). Cell (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s4a). PLoS ONE (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4c
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 4c). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 9a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 9a). J Exp Med (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5d
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 5d). J Exp Med (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2a
BD Biosciences CD8 antibody (BD Biosciences, 553031) was used in flow cytometry on mouse samples (fig 2a). Cell (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4
BD Biosciences CD8 antibody (BD Pharmingen, 558106) was used in flow cytometry on mouse samples (fig s4). J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 8d
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 8d). J Clin Invest (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
BD Biosciences CD8 antibody (BD Biosciences, 562283) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1d
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 1d). Cell (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3b, 4d
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 3b, 4d). Nature (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1c
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 1c). Sci Rep (2018) ncbi
rat monoclonal (53-6.7)
BD Biosciences CD8 antibody (BD, 53-6.7) was used . Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 2b
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples at 1:200 (fig 2b). Infect Immun (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3d
BD Biosciences CD8 antibody (BD Bioscience, 560469) was used in flow cytometry on mouse samples (fig 3d). J Immunol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to study the role of hypercholesterolemia in T cell receptor signaling and regulatory T cell population, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Sci Rep (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). J Virol (2018) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3f
BD Biosciences CD8 antibody (BD Biosciences, 553032) was used in flow cytometry on mouse samples (fig 3f). Cancer Cell (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3c
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3c). J Cell Biol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6a
In order to investigate the role of protease-activated receptor 2 in lymphocyte development, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 6a). Int J Biochem Cell Biol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4a
BD Biosciences CD8 antibody (Becton Dickinson, 53?C6.7) was used in flow cytometry on mouse samples (fig 4a). PLoS ONE (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s6b
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s6b). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry; mouse; loading ...; fig 3h
BD Biosciences CD8 antibody (BD Biosciences, 553849) was used in immunohistochemistry on mouse samples (fig 3h). J Clin Invest (2017) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry; mouse; loading ...; fig 2b
BD Biosciences CD8 antibody (BD Biosciences, 553849) was used in immunohistochemistry on mouse samples (fig 2b). Neuron (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1c
BD Biosciences CD8 antibody (BD, 53 6.7) was used in flow cytometry on mouse samples (fig s1c). Science (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
In order to investigate the role of the E-Id protein axis in the innate and adaptive lymphoid development, BD Biosciences CD8 antibody (BD Biosciences, 553033) was used in flow cytometry on mouse samples (fig 2b). Immunity (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2
In order to investigate the regulated egress of T-cell subsets from tumors, BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 4b
In order to study the role of APBA3/Mint3 in metastatic niche formation, BD Biosciences CD8 antibody (BD Pharmingen, 553027) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 4b). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; tbl s1
In order to elucidate the effect of S100 calcium-binding proteins A8/A9 on thrombocytosis and atherogenesis in diabetes, BD Biosciences CD8 antibody (BD Bioscience, 553030) was used in flow cytometry on mouse samples (tbl s1). J Clin Invest (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4c
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s4c). J Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1f
In order to study the effects of IL-10R signaling during Plasmodium berghei ANKA-induced experimental cerebral malaria, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s1f). Infect Immun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; tbl 1
In order to identify pleiotropic functions for RIPK3 using a mouse model of West Nile virus encephalitis, BD Biosciences CD8 antibody (BD Biosciences, 563786) was used in flow cytometry on mouse samples (tbl 1). Cell (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5c
In order to find that TLR3, 7 and 9 deficiencies on host cells result in complete tumor regression and induction of anti-tumor immunity, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 5c). Nat Commun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). Immunology (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s2b
In order to study the role of moesin during the generation of TGF-beta-induced T regulatory cells, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig s2b). J Clin Invest (2017) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s3c
BD Biosciences CD8 antibody (BD Biosciences, 550281) was used in immunohistochemistry - paraffin section on mouse samples (fig s3c). PLoS ONE (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1a
BD Biosciences CD8 antibody (Pharmingen, 553029) was used in flow cytometry on mouse samples (fig 1a). Redox Biol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; loading ...; fig 3
In order to examine B cell homeostasis modifications in an experimental model of systemic sclerosis, BD Biosciences CD8 antibody (BD Bioscience, 558106) was used in flow cytometry on mouse samples at 1:100 (fig 3). Front Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6l
In order to investigate the mechanisms by which eomesodermin regulates memory fitness in T cells, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 6l). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:50
  • immunohistochemistry; mouse; loading ...; fig 48
In order to outline the protocols for antibodies used for immunohistochemical studies, BD Biosciences CD8 antibody (BD Biosciences, 550281) was used in immunohistochemistry - frozen section on mouse samples at 1:50 and in immunohistochemistry on mouse samples (fig 48). J Toxicol Pathol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to characterize the importance of glycolysis transcriptional regulator Nur77 during muscle growth, BD Biosciences CD8 antibody (BD Biosciences, 557654) was used in flow cytometry on mouse samples . PLoS ONE (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 3). Eur J Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1c
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig s1c). Nat Commun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human
In order to show that QS-21 directly activated human monocyte-derived dendritic cells and promoted a pro-inflammatory transcriptional program, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on human samples . Front Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s11
In order to discover that SIRPalpha is highly expressed in human renal cell carcinoma and melanoma, BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s11). JCI Insight (2017) ncbi
rat monoclonal (53-6.7)
  • other; mouse; loading ...
BD Biosciences CD8 antibody (BD PharMingen, 5532029) was used in other on mouse samples . PLoS ONE (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1 ug/ml; loading ...; fig 1a
In order to find that CD4+ T cells from DOCK8-deficient mice produce large amounts of IL-31, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples at 1 ug/ml (fig 1a). Nat Commun (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5c
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 5c). J Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s6a
In order to find microenvironmental regulators of metastatic colonization, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s6a). Nature (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; loading ...; fig 4a
In order to study the role of oxidative stress in optic neuritis, BD Biosciences CD8 antibody (Becton - Dickinson, 53-67) was used in flow cytometry on mouse samples at 1:200 (fig 4a). Mol Vis (2016) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - paraffin section; mouse; 1:250; loading ...; fig 1c
In order to explore the role of Axl in promoting a suppressive myeloid microenvironment in response to ionizing radiation therapy in combination with checkpoint immunotherapy, BD Biosciences CD8 antibody (BD Biosciences, 550563) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 1c). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4d
In order to discuss the contribution of astrocytic IL-15 to postischemic brain damage, BD Biosciences CD8 antibody (bd, 53-6.7) was used in flow cytometry on mouse samples (fig 4d). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to determine the effect of a high salt diet on intestinal immunity and the risk of inflammatory bowel disease, BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). Oncotarget (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to research the transition of T cells to B cells, BD Biosciences CD8 antibody (BD Bioscience, 553031) was used in flow cytometry on mouse samples (fig 2). Genes Dev (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 5a). Cell (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5f
In order to implicate epigenetic modifications in defining microbial community-affiliated functional features of host immune cell lineages, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig s5f). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s3a). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to find a role for RAB43 in cross-presentation by classical dendritic cells, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
BD Biosciences CD8 antibody (BD PharMingen, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1h
In order to use knockout mice to determine if GRK6 contributes to hematopoiesis, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 1h). Cell Death Dis (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s10a
In order to show that DNA hypermethylation at the PPARgamma1 promoter is induced by obesity-related factors, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig s10a). JCI Insight (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3d
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 3d). Cancer Res (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; loading ...; fig 4c
In order to functionally characterize herpes simplex virus-specific CD8 positive T cells, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on human samples (fig 4c). J Virol (2017) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry; mouse; 1:100; loading ...; tbl 1
In order to report the relationship between pre-tumor cells and their surrounding stroma in cerebellar tumor medulloblastoma, BD Biosciences CD8 antibody (BD Biosciences, 553849) was used in immunohistochemistry on mouse samples at 1:100 (tbl 1). elife (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s4a
In order to explore the role of hippocampal T cell infiltration in tau-driven pathophysiology and cognitive impairments, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s4a). Brain (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1b
In order to study the role of TMEM16F in limiting T cell responses in mice infected with virus, BD Biosciences CD8 antibody (BD, 553035) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • blocking or activating experiments; mouse; loading ...; fig 6c
  • flow cytometry; mouse; loading ...; fig 5a
In order to use a humanized mouse model to study Middle East respiratory syndrome coronavirus, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in blocking or activating experiments on mouse samples (fig 6c) and in flow cytometry on mouse samples (fig 5a). J Virol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 0.2-0.8 ug/ml; loading ...
BD Biosciences CD8 antibody (BD Biosciences, BD553028) was used in flow cytometry on mouse samples at 0.2-0.8 ug/ml. Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 3a
In order to report a role for plasmalemma vesicle-associated protein in hematopoiesis, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 3a). J Immunol (2016) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - frozen section; mouse; loading ...; fig st2
In order to demonstrate that plasmalemma vesicle-associated protein governs the seeding of fetal monocyte-derived macrophages in the tissues of mice, BD Biosciences CD8 antibody (BD, 550563) was used in immunohistochemistry - frozen section on mouse samples (fig st2). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig st2
In order to demonstrate that plasmalemma vesicle-associated protein governs the seeding of fetal monocyte-derived macrophages in the tissues of mice, BD Biosciences CD8 antibody (BD, 553032) was used in flow cytometry on mouse samples (fig st2). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4b
In order to assess the role of cathepsin L during infection with orthomyxovirus influenza A, BD Biosciences CD8 antibody (BD Pharmingen, 552877) was used in flow cytometry on mouse samples (fig 4b). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1b
In order to examine the contribution of T cells to the pathogenesis of age-related ocular surface disease, BD Biosciences CD8 antibody (BD Pharmingen, 552877) was used in flow cytometry on mouse samples (fig s1b). Mucosal Immunol (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4D
BD Biosciences CD8 antibody (BD, 563068) was used in flow cytometry on mouse samples (fig 4D). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5
In order to describe the microRNA regulatory network that is activated in macrophages during infection with Mycobacterium tuberculosis, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig s5). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig 10
BD Biosciences CD8 antibody (BD PharMingen, (53-6.7) was used in flow cytometry on mouse samples at 1:100 (fig 10). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig 3
BD Biosciences CD8 antibody (Cell signaling, 553033) was used in flow cytometry on mouse samples at 1:100 (fig 3). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
BD Biosciences CD8 antibody (BD, 553033) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a, 1b
In order to explore signaling pathways regulated by RLTPR in T and B cells, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 1a, 1b). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig s7g
  • flow cytometry; mouse; loading ...; fig 3f
In order to investigate how PI3Kgamma regulates macrophage polarization, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig s7g) and in flow cytometry on mouse samples (fig 3f). Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BD Biosciences CD8 antibody (BD, 557959) was used in flow cytometry on mouse samples . Cell (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to establish and characterize a mouse model of narcolepsy, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; fig 5d
BD Biosciences CD8 antibody (BD, 553027) was used in immunohistochemistry - frozen section on mouse samples (fig 5d). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2c
In order to characterize side population T cells, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2c). J Clin Invest (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
In order to investigate if CRISPR-Cas9 delivery by adeno-associated virus induces an immune response, BD Biosciences CD8 antibody (BD, 553031) was used in flow cytometry on mouse samples (fig 2b). Nat Methods (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to investigate the hierarchical genomic and regulatory states that lead to neutrophil or macrophage specification, BD Biosciences CD8 antibody (Becton, 53-6.7) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; fig 3
BD Biosciences CD8 antibody (BD Horizon, 563332) was used in flow cytometry on mouse samples at 1:200 (fig 3). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 561093) was used in flow cytometry on mouse samples . Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 8c
In order to explore the relationships among beta8 integrin, TGF-beta, and intestinal dendritic cells, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 8c). J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3a
In order to characterize a mouse model of MICU1 deficiency, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig s3a). Cell Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4a
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 4a). J Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to study prevention of allergic skin disease by epidermal RAF, BD Biosciences CD8 antibody (BD Bioscience, 553032) was used in flow cytometry on mouse samples (fig 2). elife (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; fig 3
BD Biosciences CD8 antibody (BD Biosciences, 557682) was used in flow cytometry on mouse samples at 1:200 (fig 3). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s3
  • western blot; human; 1:1000; fig 5g
In order to discuss the role of myeloid cells in pancreatic cancer pathogenesis, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig s3) and in western blot on human samples at 1:1000 (fig 5g). Gut (2017) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2a
In order to determine the role of CD6 in T cells using knock out mice, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2016) ncbi
rat monoclonal (53-6.7)
  • immunocytochemistry; mouse; fig 4a
BD Biosciences CD8 antibody (BD Pharmingen, 550281) was used in immunocytochemistry on mouse samples (fig 4a). J Transl Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s1b
In order to discuss the environmental and cellular factors that contribute to allergic responses, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s1b). J Allergy Clin Immunol (2017) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - paraffin section; human; loading ...; fig 9c
In order to determine how C3G controls tumorigenesis, BD Biosciences CD8 antibody (BD Pharmigen, 550563) was used in immunohistochemistry - paraffin section on human samples (fig 9c). Oncotarget (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
BD Biosciences CD8 antibody (Becton Dickinson, 553029) was used in flow cytometry on mouse samples (fig 4). Blood (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3
In order to characterize the cellular basis and dynamics of the inflammatory microenvironment present in glioblastomas multiforme, BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on mouse samples (fig s3). Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50; fig 4
BD Biosciences CD8 antibody (BD, 560776) was used in flow cytometry on mouse samples at 1:50 (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4c
In order to elucidate the role of AMP-activated protein kinase in regulating T cell survival and function, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 4c). Oncotarget (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
BD Biosciences CD8 antibody (Becton Dickinson, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). Vaccines (Basel) (2016) ncbi
rat monoclonal (53-6.7)
  • other; mouse; loading ...
In order to examine the effects of mesenchymal stromal cell-derived extracellular vesicles on bone marrow radiation damage, BD Biosciences CD8 antibody (BD Bioscience, 553026) was used in other on mouse samples . Leukemia (2016) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry; human; 1:100; fig 3b
BD Biosciences CD8 antibody (BD Pharmingen, 550563) was used in immunohistochemistry on human samples at 1:100 (fig 3b). J Transl Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s8
In order to investigate how spinal cord injury above thoracic level 5 causes systemic immune suppression, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s8). Nat Neurosci (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...
In order to explore the role of the JAK/STAT pathway in controlling Foxp3 in regulatory T cells, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig 6
BD Biosciences CD8 antibody (BD Biosciences, 553032) was used in flow cytometry on mouse samples at 1:100 (fig 6). Nat Commun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3e
In order to compare methods of generating tumor lysates/cells used for pulsing dendritic cell vaccines, BD Biosciences CD8 antibody (BD, 563898) was used in flow cytometry on mouse samples (fig 3e). Oncoimmunology (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s1
BD Biosciences CD8 antibody (BD-Biosciences, 553030) was used in flow cytometry on mouse samples (fig s1). Oncoimmunology (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
In order to analyze induction of efficient anti-tumor immunity by vaccination with necroptotic cancer cells, BD Biosciences CD8 antibody (BD Pharmingen, 553036) was used in flow cytometry on mouse samples (fig 3). Cell Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5a
In order to research the role of C9orf72 in macrophage and microglial function, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s5a). Science (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig s5b
In order to report that the maternal microbiota shapes the offspring's immune system, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig s5b). Science (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:600; fig 2
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples at 1:600 (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to learn the enhancement of T-cell chemokine expression and augment response to PD-1 immunotherapy in lung adenocarcinoma by HDAC inhibitors, BD Biosciences CD8 antibody (BD Biosciences, 551162) was used in flow cytometry on mouse samples (fig 2). Clin Cancer Res (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; rat; fig 2d
In order to report bifurcation in hematopoietic stem cell types at early embryonic stages in the aorta-gonad-mesonephros, BD Biosciences CD8 antibody (BD, 553032) was used in flow cytometry on rat samples (fig 2d). Stem Cell Reports (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to characterize a nanoparticle vaccine that is therapeutic against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease, BD Biosciences CD8 antibody (BD Biosciences, 560776) was used in flow cytometry on mouse samples (fig 5). Hum Vaccin Immunother (2016) ncbi
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 557766) was used in flow cytometry on mouse samples . Sci Rep (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 2). EMBO Mol Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 6a
In order to study the role of sprouty-related ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein-2 in influenza a virus-induced pneumonia, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 6a). Crit Care Med (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
BD Biosciences CD8 antibody (BD Biosciences, 553035) was used in flow cytometry on mouse samples (fig 2). Nat Immunol (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2f
In order to study the interactions between hepatoma cells and anti-hepatocellular carcinoma T-cells, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2f). Immunol Cell Biol (2016) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry; mouse; fig s5
In order to determine the roles of Sox7, Sox17, and Sox18 in the developing and mature mouse vasculature, BD Biosciences CD8 antibody (BD Biosciences, 553849) was used in immunohistochemistry on mouse samples (fig s5). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; 1:200
In order to elucidate the relationship between MITF and c-Jun in melanoma, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on human samples at 1:200. Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
In order to study the contribution of IL-7 to pneumocystis pneumonia, BD Biosciences CD8 antibody (BD Pharmingen, 553036) was used in flow cytometry on mouse samples (fig 4). Infect Immun (2016) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s2d
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s2d). Nat Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl 1
In order to study apolipoprotein-1 during normocholesterolemic conditions, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 6
In order to study B cells migration in vivo, BD Biosciences CD8 antibody (BD Biosciences, 551162) was used in flow cytometry on mouse samples (fig 6). Oncoimmunology (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2b
In order to determine the mechanism by which BCR-ABL positive leukemia escapes immune surveillance, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to compare the immunometabolic phenotype of C57Bl/6 and BALB/c mice fed chow or high-fat diets, BD Biosciences CD8 antibody (BD Biosciences, 553035) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 1a
BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 1a). J Virol (2015) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 1j
BD Biosciences CD8 antibody (BD Biosciences, 550563) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 1j). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2e
In order to assess surface expression of C-type lectin-like receptor 2 on hematopoietic cells from peripheral blood and secondary lymphoid organs, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2e). Eur J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study the contribution of IL-10 to virus-induced demyelination, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Glia (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study mediation of TLR7-dependent inflammation and autoimmunity by B cell autophagy, BD Biosciences CD8 antibody (BD Biosciences, 550281) was used in flow cytometry on mouse samples . Autophagy (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100; fig s1
BD Biosciences CD8 antibody (BD Biosciences, 553036) was used in flow cytometry on mouse samples at 1:100 (fig s1). Nat Commun (2015) ncbi
rat monoclonal (U5A2-13)
  • flow cytometry; mouse; loading ...; fig 7
BD Biosciences CD8 antibody (BD Pharmingen, 550082) was used in flow cytometry on mouse samples (fig 7). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (Pharmingen, 53-6.7) was used in flow cytometry on mouse samples . Nat Med (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; 1:25
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in immunohistochemistry on mouse samples at 1:25. Cancer Immunol Immunother (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
  • flow cytometry; human
BD Biosciences CD8 antibody (BD Pharmingen, 53- 6.7) was used in flow cytometry on mouse samples and in flow cytometry on human samples . Cancer Immunol Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
BD Biosciences CD8 antibody (BD Pharmingen, 561094) was used in flow cytometry on mouse samples (fig 5). Int J Obes (Lond) (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:50; fig 3
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples at 1:50 (fig 3). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to assess the role of GPA33 in intestinal barrier function using KO mice, BD Biosciences CD8 antibody (BD Pharmingen, 552877) was used in flow cytometry on mouse samples . Dis Model Mech (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD, 563068) was used in flow cytometry on mouse samples . Biochim Biophys Acta (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 10-20 ug/ml
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples at 10-20 ug/ml. Immunology (2015) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry; mouse; loading ...; fig 3a
BD Biosciences CD8 antibody (BD Pharmingen, 550563) was used in immunohistochemistry on mouse samples (fig 3a). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 2a
In order to assess the capacity of dried microneedle array vaccination on effector/memory CD8 positive T cell subsets, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 2a). Vaccine (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; loading ...; fig ED3d
In order to use personalized immunotherapy to target individual tumor-specific mutations in patients, BD Biosciences CD8 antibody (BD, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig ED3d). Nature (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; fig 2
BD Biosciences CD8 antibody (BD Pharmingen, 53e6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 2). Arthritis Res Ther (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 8
In order to characterize dendritic cell lipid content, function and phenotype due to mesothelioma tumor cell modulation, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 8). PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100
BD Biosciences CD8 antibody (BD Pharmingen, 553029) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s3b, 5g
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig s3b, 5g). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
  • immunocytochemistry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples and in immunocytochemistry on mouse samples . Immun Inflamm Dis (2014) ncbi
rat monoclonal (53-6.7)
  • immunocytochemistry; mouse; 1:200
In order to study the role of astroglial cx43 in immune quiescence of the brain, BD Biosciences CD8 antibody (BD Biosciences, clone 53-6.7) was used in immunocytochemistry on mouse samples at 1:200. J Neurosci (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 4
In order to study the role of melanoma cell surface-associated calreticulin in melphalan-induced antitumor immunity, BD Biosciences CD8 antibody (BD, 553031) was used in flow cytometry on mouse samples (fig 4). Cancer Res (2015) ncbi
rat monoclonal (MECA-32)
  • immunocytochemistry; mouse; 1:100; fig 2d
BD Biosciences CD8 antibody (BD Pharmingen, 550563) was used in immunocytochemistry on mouse samples at 1:100 (fig 2d). Sci Rep (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53?C6.7) was used in flow cytometry on mouse samples . PLoS ONE (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200; fig 3
BD Biosciences CD8 antibody (BD, 553035) was used in flow cytometry on mouse samples at 1:200 (fig 3). Nagoya J Med Sci (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; 1:400
BD Biosciences CD8 antibody (BD, BD-553027) was used in immunohistochemistry - frozen section on mouse samples at 1:400. J Control Release (2015) ncbi
rat monoclonal (53-6.7)
  • other; mouse; fig 2
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in other on mouse samples (fig 2). Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 1
In order to elucidate the mechanisms by which RANKL promotes bone formation and erosion, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 1). J Bone Miner Res (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 3
BD Biosciences CD8 antibody (BD Pharmingen, 553030) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 2
BD Biosciences CD8 antibody (BD Pharmingen, 550563) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2). Methods Mol Biol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:200
In order to report that autophaghy regulates NFkapaB activity through A20 sequestration, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 7
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 7). J Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples . Sci Rep (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Vaccines (Basel) (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig s2
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig s2). Brain (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to identify DUBA as a suppressor of IL-17 production in T cells, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples . Nature (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 7a
BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on mouse samples (fig 7a). Int Immunopharmacol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
BD Biosciences CD8 antibody (BD, 553035) was used in flow cytometry on mouse samples (fig 4). EMBO Mol Med (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 4
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig 4). Clin Exp Immunol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 2). Gut (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human; fig 2
BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in flow cytometry on human samples (fig 2). Clin Cancer Res (2015) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry; mouse
In order to investigate the relationship between hypoxia response and Norrin/Frizzled4 signaling during retinal vascular development, BD Biosciences CD8 antibody (BD Pharmingen, 553849) was used in immunohistochemistry on mouse samples . Invest Ophthalmol Vis Sci (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig e4
BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples (fig e4). Nature (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; fig 1
In order to analyze induction of murine cardiac allograft survival and regulatory T cells from treadmill exercise, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 1). Transpl Int (2015) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; fig 1
BD Biosciences CD8 antibody (BD PharMingen, 53-6.7) was used in immunohistochemistry on mouse samples (fig 1). Arthritis Rheumatol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to examine the role of perforin and CD8 T cells in immune-mediated blood-brain barrier disruption, BD Biosciences CD8 antibody (BD Biosciences, 552877) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; loading ...; fig 5
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples (fig 5). Infect Immun (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl s1
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (tbl s1). Stem Cells (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Pharmingen, 553036) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to identify the role of bone morphogenetic protein in tumor cells and inflammation, BD Biosciences CD8 antibody (BD, 550563) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Mol Oncol (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to analyze deubiquitinization Usp9X and its regulation of proximal T cell receptor signaling and tolerance induction, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples (fig 5). J Exp Med (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; fig 3
  • flow cytometry; mouse; fig 6
BD Biosciences CD8 antibody (BD, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 3) and in flow cytometry on mouse samples (fig 6). Am J Pathol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study the mechanism for the effect of HMGB1 on myeloid-derived suppressor cells, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate the role of T reg cells in exhaustion of lymphocytic choriomeningitis virus-specific CD8 T cells, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse; fig 2
BD Biosciences CD8 antibody (BD Bioscience, 53-6.7) was used in immunohistochemistry - frozen section on mouse samples (fig 2). PLoS ONE (2014) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry; mouse; fig 3
In order to elucidate the contribution of canonical Wnt pathway members to the vascular development of the central nervous system and in the specification of the blood-brain barrier and blood-retina barrier, BD Biosciences CD8 antibody (BD Biosciences, 553849) was used in immunohistochemistry on mouse samples (fig 3). J Clin Invest (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 2
In order to show that MID1 regulates cytotoxic lymphocytes responses, BD Biosciences CD8 antibody (BD Biosciences, 53?C6.7) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences Pharmingen, 53-6.7) was used in flow cytometry on mouse samples . Nanomedicine (2014) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - paraffin section; human; 1:200
In order to study the role of BMP in mammary cancer, BD Biosciences CD8 antibody (BD, 550563) was used in immunohistochemistry - paraffin section on human samples at 1:200. Oncogene (2015) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to investigate the effect of IgM-Fc receptor-ablation on autoimmunity, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Int Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Int J Cancer (2015) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - frozen section; mouse
BD Biosciences CD8 antibody (BD Pharmingen, 550563) was used in immunohistochemistry - frozen section on mouse samples . Bone (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study the role of human endogenous retrovirus (HERV) envelope proteins in the uptake of exosomes, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples . FASEB J (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100
BD Biosciences CD8 antibody (BD, 553035) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to determine the role of CD4+ T cells during mutant Kras-driven pancreatic carcinogenesis, BD Biosciences CD8 antibody (BD Pharmingen, 53-6.7) was used in flow cytometry on mouse samples . Cancer Immunol Res (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to demonstrate that CTLA-4 promotes Tc17 differentiation and robust Tc17 responses, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study the effect of FTY720 treatment on CD8 T-cells, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . J Neuroimmunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (PharMingen, 53-6.7) was used in flow cytometry on mouse samples . Vaccine (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 8
In order to study optimization of a universal flu vaccine, BD Biosciences CD8 antibody (BD, 560776) was used in flow cytometry on mouse samples (fig 8). Hum Vaccin Immunother (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.72) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 6
In order to present a mechanism for the N-myc downstream-regulated gene 2-dependent regulation of PTEN phosphatase activity via the dephosphorylation of PTEN, BD Biosciences CD8 antibody (BD, 53-6.7) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6). Nat Commun (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to study the role of CD4 T cells during mixed antibody-mediated rejection of renal allografts, BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Am J Transplant (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse; 1:2000
BD Biosciences CD8 antibody (BD pharmingen, 550281) was used in immunohistochemistry on mouse samples at 1:2000. Acta Neuropathol Commun (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
In order to demonstrate that regulation of encephalitogenic T-cell responses and EAE susceptibility by H2R signaling in CD4(+) T cells is dependent on genetic and environmental interactions, BD Biosciences CD8 antibody (BD, 53-6.7) was used in flow cytometry on mouse samples . FASEB J (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Diabetes (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Br J Cancer (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Pharmingen, 553036) was used in flow cytometry on mouse samples . PLoS ONE (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Int Immunol (2014) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry; mouse
BD Biosciences CD8 antibody (BD Biosciences Pharmingen, 53-6.7) was used in immunohistochemistry on mouse samples . Mol Ther (2014) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; 1:100
BD Biosciences CD8 antibody (BD Biosciences, 553033) was used in flow cytometry on mouse samples at 1:100. Nat Med (2013) ncbi
rat monoclonal (MECA-32)
  • immunohistochemistry - frozen section; mouse
In order to identify the role of macrophages in wound healing and fibrovascular scar production, BD Biosciences CD8 antibody (BD Pharmingen, 550563) was used in immunohistochemistry - frozen section on mouse samples . Am J Pathol (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; tbl 1
BD Biosciences CD8 antibody (BD, 553030) was used in flow cytometry on mouse samples (tbl 1). PLoS ONE (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . J Immunol (2013) ncbi
rat monoclonal (53-6.7)
  • immunohistochemistry - frozen section; mouse
BD Biosciences CD8 antibody (BD Pharmingen, 553027) was used in immunohistochemistry - frozen section on mouse samples . Circulation (2013) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD Biosciences, 53-6.7) was used in flow cytometry on mouse samples . Infect Immun (2011) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; human
BD Biosciences CD8 antibody (BD Biosciences, 553033) was used in flow cytometry on human samples . J Immunol (2010) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse
BD Biosciences CD8 antibody (BD PharMingen, 53-6.7) was used in flow cytometry on mouse samples . Nat Immunol (2006) ncbi
rat monoclonal (53-6.7)
  • flow cytometry; mouse; fig 5
In order to propose a revised model of early T cell development, BD Biosciences CD8 antibody (Becton Dickinson, 53-6.7) was used in flow cytometry on mouse samples (fig 5). J Immunol (1994) ncbi
MBL International
rat monoclonal (KT15)
  • flow cytometry; mouse; loading ...; fig s3a
MBL International CD8 antibody (MBL International, D271-4) was used in flow cytometry on mouse samples (fig s3a). Cell (2019) ncbi
Articles Reviewed
  1. Ravindranathan S, Passang T, Li J, Wang S, Dhamsania R, Ware M, et al. Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. Nat Commun. 2022;13:6418 pubmed publisher
  2. Zhang Q, Xiu B, Zhang L, Chen M, Chi W, Li L, et al. Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization. J Immunother Cancer. 2022;10: pubmed publisher
  3. Yang P, Qin H, Li Y, Xiao A, Zheng E, Zeng H, et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat Commun. 2022;13:5782 pubmed publisher
  4. Chen Y, Lian N, Chen S, Xiao T, Ke Y, Zhang Y, et al. GSDME deficiency leads to the aggravation of UVB-induced skin inflammation through enhancing recruitment and activation of neutrophils. Cell Death Dis. 2022;13:841 pubmed publisher
  5. Gawish R, Maier B, Obermayer G, Watzenboeck M, Gorki A, Quattrone F, et al. A neutrophil-B-cell axis impacts tissue damage control in a mouse model of intraabdominal bacterial infection via Cxcr4. elife. 2022;11: pubmed publisher
  6. Feng K, Meng P, Zhang M, Zou X, Li S, Huang C, et al. IL-24 Contributes to Neutrophilic Asthma in an IL-17A-Dependent Manner and Is Suppressed by IL-37. Allergy Asthma Immunol Res. 2022;14:505-527 pubmed publisher
  7. Huang J, Huang Q, Xue J, Liu H, Guo Y, Chen H, et al. Fibrinogen like protein-1 knockdown suppresses the proliferation and metastasis of TU-686 cells and sensitizes laryngeal cancer to LAG-3 blockade. J Int Med Res. 2022;50:3000605221126874 pubmed publisher
  8. Ni H, Zhang H, Li L, Huang H, Guo H, Zhang L, et al. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer. 2022;10: pubmed publisher
  9. Amaral E, Foreman T, Namasivayam S, Hilligan K, Kauffman K, Barbosa Bomfim C, et al. GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection. J Exp Med. 2022;219: pubmed publisher
  10. Hemmi T, Ainai A, Hashiguchi T, Tobiume M, Kanno T, Iwata Yoshikawa N, et al. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology. Vaccine. 2022;40:5892-5903 pubmed publisher
  11. Hou X, Shi Y, Kang X, Rousu Z, Li D, Wang M, et al. Echinococcus granulosus: The establishment of the metacestode in the liver is associated with control of the CD4+ T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model. Front Cell Infect Microbiol. 2022;12:983119 pubmed publisher
  12. Lee A, Pingali S, Pinilla Ibarz J, Atchison M, Koumenis C, Argon Y, et al. Loss of AID exacerbates the malignant progression of CLL. Leukemia. 2022;36:2430-2442 pubmed publisher
  13. Zhan Z, Liu L, Cheng M, Gao Y, Zhou W. The Effects of 6 Common Antidiabetic Drugs on Anti-PD1 Immune Checkpoint Inhibitor in Tumor Treatment. J Immunol Res. 2022;2022:2651790 pubmed publisher
  14. Smith K, Minns D, McHugh B, Holloway R, O CONNOR R, Williams A, et al. The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation. PLoS Biol. 2022;20:e3001554 pubmed publisher
  15. Piliponsky A, Sharma K, Quach P, Brokaw A, Nguyen S, Orvis A, et al. Mast cell-derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections. J Clin Invest. 2022;132: pubmed publisher
  16. Cao S, Hung Y, Wang Y, Chung Y, Qi Y, Ouyang C, et al. Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors. Theranostics. 2022;12:6038-6056 pubmed publisher
  17. Costain A, Phythian Adams A, Colombo S, Marley A, Owusu C, Cook P, et al. Dynamics of Host Immune Response Development During Schistosoma mansoni Infection. Front Immunol. 2022;13:906338 pubmed publisher
  18. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed publisher
  19. Xie F, Zhou X, Su P, Li H, Tu Y, Du J, et al. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nat Commun. 2022;13:4461 pubmed publisher
  20. Xu D, Ma R, Ju Y, Song X, Niu B, Hong W, et al. Cholesterol sulfate alleviates ulcerative colitis by promoting cholesterol biosynthesis in colonic epithelial cells. Nat Commun. 2022;13:4428 pubmed publisher
  21. Dinnon K, Leist S, Okuda K, Dang H, Fritch E, Gully K, et al. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice. Sci Transl Med. 2022;14:eabo5070 pubmed publisher
  22. Zhao X, Hu S, Zeng L, Liu X, Song Y, Zhang Y, et al. Irradiation combined with PD-L1-/- and autophagy inhibition enhances the antitumor effect of lung cancer via cGAS-STING-mediated T cell activation. iScience. 2022;25:104690 pubmed publisher
  23. Ma Z, Zhang W, Dong B, Xin Z, Ji Y, Su R, et al. Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Theranostics. 2022;12:4965-4979 pubmed publisher
  24. Wu B, Song M, Dong Q, Xiang G, Li J, Ma X, et al. UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced PDL1 transcription in triple negative breast cancer. Theranostics. 2022;12:5086-5102 pubmed publisher
  25. Liu C, Zheng S, Wang Z, Wang S, Wang X, Yang L, et al. KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer. Cancer Commun (Lond). 2022;42:828-847 pubmed publisher
  26. Lei X, Lin H, Wang J, Ou Z, Ruan Y, Sadagopan A, et al. Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression. Nat Commun. 2022;13:3882 pubmed publisher
  27. Chi R, Yao C, Chen S, Liu Y, He Y, Zhang J, et al. Elevated BCAA Suppresses the Development and Metastasis of Breast Cancer. Front Oncol. 2022;12:887257 pubmed publisher
  28. Pi xf1 eros A, Kulkarni A, Gao H, Orr K, Glenn L, Huang F, et al. Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes. Cell Rep. 2022;39:111011 pubmed publisher
  29. Laffey K, Stiles R, Ludescher M, Davis T, Khwaja S, Bram R, et al. Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations. Proc Natl Acad Sci U S A. 2022;119:e2118529119 pubmed publisher
  30. Huang S, Si H, Liu J, Qi D, Pei X, Lu D, et al. Sleep Loss Causes Dysfunction in Murine Extraorbital Lacrimal Glands. Invest Ophthalmol Vis Sci. 2022;63:19 pubmed publisher
  31. Huang J, Wang X, Li B, Shen S, Wang R, Tao H, et al. L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression. J Immunother Cancer. 2022;10: pubmed publisher
  32. Garnier L, Pick R, Montorfani J, Sun M, Brighouse D, Liaudet N, et al. IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis. Sci Adv. 2022;8:eabl5162 pubmed publisher
  33. Lu L, Li T, Feng X, Liu Z, Liu Y, Chao T, et al. Excessive immunosuppression by regulatory T cells antagonizes T cell response to schistosome infection in PD-1-deficient mice. PLoS Pathog. 2022;18:e1010596 pubmed publisher
  34. Wang Q, Bergholz J, Ding L, Lin Z, Kabraji S, Hughes M, et al. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer. Nat Commun. 2022;13:3022 pubmed publisher
  35. Deal B, Reynolds L, PATTERSON C, Janjic J, Pollock J. Behavioral and inflammatory sex differences revealed by celecoxib nanotherapeutic treatment of peripheral neuroinflammation. Sci Rep. 2022;12:8472 pubmed publisher
  36. Koutn xed k J, Klepsch V, Pommermayr M, Thuille N, Baier G, Siegmund K. A MLR-Based Approach to Analyze Regulators of T Lymphocyte Activation In Vivo. Int J Mol Sci. 2022;23: pubmed publisher
  37. Aiken T, Erbe A, Zebertavage L, Komjathy D, Feils A, Rodriguez M, et al. Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma. J Immunother Cancer. 2022;10: pubmed publisher
  38. Maruyama J, Reyna R, Kishimoto Urata M, Urata S, Manning J, Harsell N, et al. CD4 T-cell depletion prevents Lassa fever associated hearing loss in the mouse model. PLoS Pathog. 2022;18:e1010557 pubmed publisher
  39. Taniguchi H, Caeser R, Chavan S, Zhan Y, Chow A, Manoj P, et al. WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC. Cell Rep. 2022;39:110814 pubmed publisher
  40. Zhang R, Wang Y, Liu D, Luo Q, Du P, Zhang H, et al. Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice. Front Pharmacol. 2022;13:870848 pubmed publisher
  41. Pan C, Wu Q, Wang S, Mei Z, Zhang L, Gao X, et al. Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma. Oncoimmunology. 2022;11:2073010 pubmed publisher
  42. Khan M, Engstr xf6 m C, Fagman J, Smedh U, Lundholm K, Iresj xf6 B. Reduced tumor growth in EP2 knockout mice is related to signaling pathways favoring an increased local anti‑tumor immunity in the tumor stroma. Oncol Rep. 2022;47: pubmed publisher
  43. Li H, Liu Z, Liu L, Zhang H, Han C, Girard L, et al. AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells. Cell Rep Med. 2022;3:100554 pubmed publisher
  44. Melese E, Franks E, Cederberg R, Harbourne B, Shi R, Wadsworth B, et al. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. Oncoimmunology. 2022;11:2010905 pubmed publisher
  45. Kumagai Y, Futoh Y, Miyato H, Ohzawa H, Yamaguchi H, Saito S, et al. Effect of Systemic or Intraperitoneal Administration of Anti-PD-1 Antibody for Peritoneal Metastases from Gastric Cancer. In Vivo. 2022;36:1126-1135 pubmed publisher
  46. Brown G, Ca xf1 ete P, Wang H, Medhavy A, Bones J, Roco J, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605:349-356 pubmed publisher
  47. Piao W, Li L, Saxena V, Iyyathurai J, Lakhan R, Zhang Y, et al. PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration. Nat Commun. 2022;13:2176 pubmed publisher
  48. Meléndez E, Chondronasiou D, Mosteiro L, Mart xed nez de Villarreal J, Fern xe1 ndez Alfara M, Lynch C, et al. Natural killer cells act as an extrinsic barrier for in vivo reprogramming. Development. 2022;149: pubmed publisher
  49. El Sayes N, Walsh S, Vito A, Reihani A, Ask K, Wan Y, et al. IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity. Mol Ther Oncolytics. 2022;25:16-30 pubmed publisher
  50. Wedge M, Jennings V, Crupi M, Poutou J, Jamieson T, Pelin A, et al. Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy. Nat Commun. 2022;13:1898 pubmed publisher
  51. Xiong W, Gao X, Zhang T, Jiang B, Hu M, Bu X, et al. USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy. Nat Commun. 2022;13:1700 pubmed publisher
  52. Zhang Y, Huo F, Cao Q, Jia R, Huang Q, Wang Z, et al. FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer. J Immunother Cancer. 2022;10: pubmed publisher
  53. Seung H, Wröbel J, Wadle C, B xfc hler T, Chiang D, Rettkowski J, et al. P2Y12-dependent activation of hematopoietic stem and progenitor cells promotes emergency hematopoiesis after myocardial infarction. Basic Res Cardiol. 2022;117:16 pubmed publisher
  54. Wemlinger S, Parker Harp C, Yu B, Hardy I, Seefeldt M, Matsuda J, et al. Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model. J Immunol. 2022;208:1566-1584 pubmed publisher
  55. Seitz S, Dreyer T, Stange C, Steiger K, Bräuer R, Scheutz L, et al. CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer. Br J Cancer. 2022;126:1470-1480 pubmed publisher
  56. Abbas Z, GEORGE C, Ancliffe M, Howlett M, Jones A, Kuchibhotla M, et al. Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets. Front Immunol. 2022;13:837013 pubmed publisher
  57. van Vloten J, Matuszewska K, Minow M, Minott J, Santry L, Pereira M, et al. Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer. J Immunother Cancer. 2022;10: pubmed publisher
  58. Wennerberg E, Mukherjee S, Spada S, Hung C, Agrusa C, Chen C, et al. Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Sci Transl Med. 2022;14:eabe8195 pubmed publisher
  59. Pantasis S, Friemel J, Brütsch S, Hu Z, Krautbauer S, Liebisch G, et al. Vertebrate lonesome kinase modulates the hepatocyte secretome to prevent perivascular liver fibrosis and inflammation. J Cell Sci. 2022;135: pubmed publisher
  60. Tang T, Huang X, Zhang G, Lu M, Hong Z, Wang M, et al. Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis. J Immunother Cancer. 2022;10: pubmed publisher
  61. Cha J, Chan L, Wang Y, Chu Y, Wang C, Lee H, et al. Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer. J Biol Chem. 2022;298:101817 pubmed publisher
  62. Salaroglio I, Belisario D, Bironzo P, Ananthanarayanan P, Ricci L, Digiovanni S, et al. SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma. J Exp Clin Cancer Res. 2022;41:75 pubmed publisher
  63. Yokomizo K, Waki K, Ozawa M, Yamamoto K, Ogasawara S, Yano H, et al. Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth. Med Oncol. 2022;39:58 pubmed publisher
  64. Yang B, Zhang Z, Chen X, Wang X, Qin S, Du L, et al. An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment. J Clin Invest. 2022;132: pubmed publisher
  65. Thakkar D, Paliwal S, Dharmadhikari B, Guan S, Liu L, Kar S, et al. Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner. J Immunother Cancer. 2022;10: pubmed publisher
  66. Kinkhabwala A, Herbel C, Pankratz J, Yushchenko D, R xfc berg S, Praveen P, et al. MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors. Sci Rep. 2022;12:1911 pubmed publisher
  67. D Addio F, Maestroni A, Assi E, Ben Nasr M, Amabile G, Usuelli V, et al. The IGFBP3/TMEM219 pathway regulates beta cell homeostasis. Nat Commun. 2022;13:684 pubmed publisher
  68. Quách T, Huang W, Sahu R, Diadhiou C, Raparia C, Johnson R, et al. Context-dependent induction of autoimmunity by TNF signaling deficiency. JCI Insight. 2022;7: pubmed publisher
  69. Gopal A, Ibrahim R, Fuller M, Umlandt P, Parker J, Tran J, et al. TIRAP drives myelosuppression through an Ifnγ-Hmgb1 axis that disrupts the endothelial niche in mice. J Exp Med. 2022;219: pubmed publisher
  70. Feng L, Li C, Zeng L, Gao D, Sun Y, Zhong L, et al. MARCH3 negatively regulates IL-3-triggered inflammatory response by mediating K48-linked polyubiquitination and degradation of IL-3Rα. Signal Transduct Target Ther. 2022;7:21 pubmed publisher
  71. Keller E, Dvorina N, Jørgensen T. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent. Int J Mol Sci. 2022;23: pubmed publisher
  72. Yang K, Han J, Asada M, Gill J, Park J, Sathe M, et al. Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease. J Clin Invest. 2022;132: pubmed publisher
  73. Jiang Z, Li H, Schroer S, Voisin V, Ju Y, Pacal M, et al. Hypophosphorylated pRb knock-in mice exhibit hallmarks of aging and vitamin C-preventable diabetes. EMBO J. 2022;41:e106825 pubmed publisher
  74. Du Y, Peng Q, Cheng D, Pan T, Sun W, Wang H, et al. Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing γδ T cells. Nat Commun. 2022;13:231 pubmed publisher
  75. Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, et al. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. Oncoimmunology. 2022;11:2021619 pubmed publisher
  76. Nakamura Y, Kinoshita J, Yamaguchi T, Aoki T, Saito H, Hamabe Horiike T, et al. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast. Gastric Cancer. 2022;25:515-526 pubmed publisher
  77. Lin J, Chen Y, Zhu H, Cheng K, Wang H, Yu X, et al. Lymphatic Reconstruction in Kidney Allograft Aggravates Chronic Rejection by Promoting Alloantigen Presentation. Front Immunol. 2021;12:796260 pubmed publisher
  78. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  79. Bristow C, Reeves M, Winston R. Alphataxin, a Small-Molecule Drug That Elevates Tumor-Infiltrating CD4+ T Cells, in Combination With Anti-PD-1 Therapy, Suppresses Murine Renal Cancer and Metastasis. Front Oncol. 2021;11:739080 pubmed publisher
  80. Zhou Q, Liang J, Yang T, Liu J, Li B, Li Y, et al. Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer. EMBO Mol Med. 2022;14:e14502 pubmed publisher
  81. Stoff M, Ebbecke T, Ciurkiewicz M, Pavasutthipaisit S, Mayer Lambertz S, St xf6 rk T, et al. C-type lectin receptor DCIR contributes to hippocampal injury in acute neurotropic virus infection. Sci Rep. 2021;11:23819 pubmed publisher
  82. Tatsumi N, Codrington A, El Fenej J, Phondge V, Kumamoto Y. Effective CD4 T cell priming requires repertoire scanning by CD301b+ migratory cDC2 cells upon lymph node entry. Sci Immunol. 2021;6:eabg0336 pubmed publisher
  83. Arinrad S, Wilke J, Seelbach A, Doeren J, Hindermann M, Butt U, et al. NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance. Mol Psychiatry. 2021;: pubmed publisher
  84. Kettwig M, Ternka K, Wendland K, Krüger D, Zampar S, Schob C, et al. Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy. Nat Commun. 2021;12:6530 pubmed publisher
  85. Zhu Y, Elsheikha H, Wang J, Fang S, He J, Zhu X, et al. Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors. J Immunother Cancer. 2021;9: pubmed publisher
  86. Fahy N, Palomares Cabeza V, Lolli A, Witte Bouma J, Merino A, Ridwan Y, et al. Chondrogenically Primed Human Mesenchymal Stem Cells Persist and Undergo Early Stages of Endochondral Ossification in an Immunocompetent Xenogeneic Model. Front Immunol. 2021;12:715267 pubmed publisher
  87. Fearon A, Slabber C, Kuklin A, Bachofner M, Tortola L, Pohlmeier L, et al. Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosis. iScience. 2021;24:103143 pubmed publisher
  88. Ni Y, Hu B, Wu G, Shao Z, Zheng Y, Zhang R, et al. Interruption of neutrophil extracellular traps formation dictates host defense and tubular HOXA5 stability to augment efficacy of anti-Fn14 therapy against septic AKI. Theranostics. 2021;11:9431-9451 pubmed publisher
  89. Choe D, Lee E, Beeghly Fadiel A, Wilson A, Whalen M, Adunyah S, et al. High-Fat Diet-Induced Obese Effects of Adipocyte-Specific CXCR2 Conditional Knockout in the Peritoneal Tumor Microenvironment of Ovarian Cancer. Cancers (Basel). 2021;13: pubmed publisher
  90. Correia de Sousa M, Calo N, Sobolewski C, Gjorgjieva M, Clement S, Maeder C, et al. Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers (Basel). 2021;13: pubmed publisher
  91. Hoefflin R, Harlander S, Abhari B, Peighambari A, Adlesic M, Seidel P, et al. Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2021;13: pubmed publisher
  92. Van Maldegem F, Valand K, Cole M, Patel H, Angelova M, Rana S, et al. Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry. Nat Commun. 2021;12:5906 pubmed publisher
  93. Horiuchi S, Wu H, Liu W, Schmitt N, Provot J, Liu Y, et al. Tox2 is required for the maintenance of GC TFH cells and the generation of memory TFH cells. Sci Adv. 2021;7:eabj1249 pubmed publisher
  94. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  95. Susukida T, Kuwahara S, Song B, Kazaoka A, Aoki S, Ito K. Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity. Commun Biol. 2021;4:1137 pubmed publisher
  96. Tanaka Y, Onozato M, Mikami T, Kohwi Shigematsu T, Fukushima T, Kondo M. Increased Indoleamine 2,3-Dioxygenase Levels at the Onset of Sjögren's Syndrome in SATB1-Conditional Knockout Mice. Int J Mol Sci. 2021;22: pubmed publisher
  97. Carnevale D, Carnevale L, Perrotta S, Pallante F, Migliaccio A, Iodice D, et al. Chronic 3D Vascular-Immune Interface Established by Coculturing Pressurized Resistance Arteries and Immune Cells. Hypertension. 2021;78:1648-1661 pubmed publisher
  98. Tian N, Hu L, Lu Y, Tong L, Feng M, Liu Q, et al. TKT maintains intestinal ATP production and inhibits apoptosis-induced colitis. Cell Death Dis. 2021;12:853 pubmed publisher
  99. Jiang Y, Yuan Y, Chen M, Li S, Bai J, Zhang Y, et al. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression. Theranostics. 2021;11:9162-9176 pubmed publisher
  100. Yang M, Long D, Hu L, Zhao Z, Li Q, Guo Y, et al. AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation. Signal Transduct Target Ther. 2021;6:341 pubmed publisher
  101. Rizvi Z, Dalal R, Sadhu S, Kumar Y, Kumar S, Gupta S, et al. High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity. Sci Adv. 2021;7:eabg5016 pubmed publisher
  102. Onodera T, Kita S, Adachi Y, Moriyama S, Sato A, Nomura T, et al. A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site. Immunity. 2021;54:2385-2398.e10 pubmed publisher
  103. Droho S, Cuda C, Perlman H, Lavine J. Macrophage-derived interleukin-6 is necessary and sufficient for choroidal angiogenesis. Sci Rep. 2021;11:18084 pubmed publisher
  104. Hoffman K, Villar M, Poveda C, Bottazzi M, Hotez P, Tweardy D, et al. Signal Transducer and Activator of Transcription-3 Modulation of Cardiac Pathology in Chronic Chagasic Cardiomyopathy. Front Cell Infect Microbiol. 2021;11:708325 pubmed publisher
  105. Lin J, Liu H, Fukumoto T, Zundell J, Yan Q, Tang C, et al. Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer. Nat Commun. 2021;12:5321 pubmed publisher
  106. Wang Z, He L, Li W, Xu C, Zhang J, Wang D, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021;9: pubmed publisher
  107. Neumann S, Campbell K, Woodall M, Evans M, Clarkson A, Young S. Obesity Has a Systemic Effect on Immune Cells in Naïve and Cancer-Bearing Mice. Int J Mol Sci. 2021;22: pubmed publisher
  108. Drzyzga A, Cichon T, Czapla J, Jarosz Biej M, Pilny E, Matuszczak S, et al. The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent-DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors. Cancers (Basel). 2021;13: pubmed publisher
  109. Liu Z, Wang T, She Y, Wu K, Gu S, Li L, et al. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20:105 pubmed publisher
  110. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
  111. Zhu Q, Ma Y, Liang J, Wei Z, Li M, Zhang Y, et al. AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma. Signal Transduct Target Ther. 2021;6:299 pubmed publisher
  112. Xu P, Xiong W, Lin Y, Fan L, Pan H, Li Y. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression. Cell Death Dis. 2021;12:779 pubmed publisher
  113. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed publisher
  114. Tillie R, Theelen T, van Kuijk K, Temmerman L, de Bruijn J, Gijbels M, et al. A Switch from Cell-Associated to Soluble PDGF-B Protects against Atherosclerosis, despite Driving Extramedullary Hematopoiesis. Cells. 2021;10: pubmed publisher
  115. Winn N, Wolf E, Cottam M, Bhanot M, Hasty A. Myeloid-specific deletion of ferroportin impairs macrophage bioenergetics but is disconnected from systemic insulin action in adult mice. Am J Physiol Endocrinol Metab. 2021;321:E376-E391 pubmed publisher
  116. Forman R, Logunova L, Smith H, Wemyss K, Mair I, Boon L, et al. Trichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages. PLoS Pathog. 2021;17:e1009768 pubmed publisher
  117. Funk K, Arutyunov A, Desai P, White J, Soung A, Rosen S, et al. Decreased antiviral immune response within the central nervous system of aged mice is associated with increased lethality of West Nile virus encephalitis. Aging Cell. 2021;20:e13412 pubmed publisher
  118. Patial S, Lewis B, Vo T, Choudhary I, Paudel K, Mao Y, et al. Myeloid-IL4Rα is an indispensable link in IL-33-ILCs-IL-13-IL4Rα axis of eosinophil recruitment in murine lungs. Sci Rep. 2021;11:15465 pubmed publisher
  119. Lu C, Liu Z, Klement J, Yang D, Merting A, Poschel D, et al. WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape. J Immunother Cancer. 2021;9: pubmed publisher
  120. Wu S, Xiao Y, Wei J, Xu X, Jin X, Hu X, et al. MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer. J Immunother Cancer. 2021;9: pubmed publisher
  121. Van De Velde L, Allen E, Crawford J, Wilson T, Guy C, Russier M, et al. Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells. Cancer Res. 2021;81:5047-5059 pubmed publisher
  122. Tulotta C, Lefley D, Moore C, Amariutei A, Spicer Hadlington A, Quayle L, et al. IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer. NPJ Breast Cancer. 2021;7:95 pubmed publisher
  123. Bruand M, Barras D, Mina M, Ghisoni E, Morotti M, Lanitis E, et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021;36:109412 pubmed publisher
  124. Wutschka J, Kast B, Sator Schmitt M, Appak Baskoy S, Hess J, Sinn H, et al. JUNB suppresses distant metastasis by influencing the initial metastatic stage. Clin Exp Metastasis. 2021;38:411-423 pubmed publisher
  125. Goyette M, Elkholi I, Apcher C, Kuasne H, Rothlin C, Muller W, et al. Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  126. James O, Vandereyken M, Marchingo J, Singh F, Bray S, Wilson J, et al. IL-15 and PIM kinases direct the metabolic programming of intestinal intraepithelial lymphocytes. Nat Commun. 2021;12:4290 pubmed publisher
  127. Lu J, Wang W, Li P, Wang X, Gao C, Zhang B, et al. MiR-146a regulates regulatory T cells to suppress heart transplant rejection in mice. Cell Death Discov. 2021;7:165 pubmed publisher
  128. Wilke J, Hindermann M, Moussavi A, Butt U, Dadarwal R, Berghoff S, et al. Inducing sterile pyramidal neuronal death in mice to model distinct aspects of gray matter encephalitis. Acta Neuropathol Commun. 2021;9:121 pubmed publisher
  129. Gvozdeva O, Achasova K, Litvinova N, Kozhevnikova E, Litvinova E. Female Scent Activated Expression of Arginase1 and Inducible NO-Synthetase in Lung of BALB/c Male Mice. Animals (Basel). 2021;11: pubmed publisher
  130. Maier J, Rogg M, Helmstädter M, Sammarco A, Walz G, Werner M, et al. A Novel Model for Nephrotic Syndrome Reveals Associated Dysbiosis of the Gut Microbiome and Extramedullary Hematopoiesis. Cells. 2021;10: pubmed publisher
  131. Hering L, Katkeviciute E, Schwarzfischer M, Niechcial A, Riggs J, Wawrzyniak M, et al. Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis. Int J Mol Sci. 2021;22: pubmed publisher
  132. Gehlsen U, Stary D, Maass M, Riesner K, Musial G, Stern M, et al. Ocular Graft-versus-Host Disease in a Chemotherapy-Based Minor-Mismatch Mouse Model Features Corneal (Lymph-) Angiogenesis. Int J Mol Sci. 2021;22: pubmed publisher
  133. Mai J, Li Z, Xia X, Zhang J, Li J, Liu H, et al. Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine. Adv Sci (Weinh). 2021;8:2100166 pubmed publisher
  134. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  135. Innamarato P, Morse J, Mackay A, Asby S, Beatty M, Blauvelt J, et al. Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors. BMC Cancer. 2021;21:756 pubmed publisher
  136. Khan I, Del Guzzo C, Shao A, Cho J, Du R, Cohen A, et al. The CD200-CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K. Cancer Res. 2021;81:5021-5032 pubmed publisher
  137. Ryu S, Shchukina I, Youm Y, Qing H, Hilliard B, Dlugos T, et al. Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice. elife. 2021;10: pubmed publisher
  138. Souza C, Ketelut Carneiro N, Milanezi C, Faccioli L, Gardinassi L, Silva J. NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8+ T cell responses. iScience. 2021;24:102548 pubmed publisher
  139. Ho D, Tsui Y, Chan L, Sze K, Zhang X, Cheu J, et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat Commun. 2021;12:3684 pubmed publisher
  140. Uyanik B, Goloudina A, Akbarali A, Grigorash B, Petukhov A, Singhal S, et al. Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses. Nat Commun. 2021;12:3622 pubmed publisher
  141. Ramos M, Tian L, de Ruiter E, Song C, Paucarmayta A, Singh A, et al. Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction. elife. 2021;10: pubmed publisher
  142. Zhang J, Qi J, Wei H, Lei Y, Yu H, Liu N, et al. TGFβ1 in Cancer-Associated Fibroblasts Is Associated With Progression and Radiosensitivity in Small-Cell Lung Cancer. Front Cell Dev Biol. 2021;9:667645 pubmed publisher
  143. Wang J, Zhang Y, Xiao Y, Yuan X, Li P, Wang X, et al. Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancer. Am J Cancer Res. 2021;11:2005-2024 pubmed
  144. Okunuki Y, Tabor S, Lee M, Connor K. CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation. Front Immunol. 2021;12:680568 pubmed publisher
  145. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed publisher
  146. Pereira J, Cavaco P, da Silva R, Pacheco Leyva I, Mereiter S, Pinto R, et al. P-selectin glycoprotein ligand 1 promotes T cell lymphoma development and dissemination. Transl Oncol. 2021;14:101125 pubmed publisher
  147. Zhang X, Liu X, Zhou W, Du Q, Yang M, Ding Y, et al. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance. Cell Mol Gastroenterol Hepatol. 2021;12:1179-1199 pubmed publisher
  148. Wu S, Fukumoto T, Lin J, Nacarelli T, Wang Y, Ong D, et al. Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. Nat Cancer. 2021;2:189-200 pubmed publisher
  149. West J, Austin E, Rizzi E, Yan L, Tanjore H, Crabtree A, et al. KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models. Int J Mol Sci. 2021;22: pubmed publisher
  150. Kim C, Jin J, Ye Z, Jadhav R, Gustafson C, Hu B, et al. Histone deficiency and accelerated replication stress in T cell aging. J Clin Invest. 2021;131: pubmed publisher
  151. Barker K, Etesami N, Shenoy A, Arafa E, Lyon de Ana C, Smith N, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131: pubmed publisher
  152. Chen S, Liu H, Li Z, Tang J, Huang B, Zhi F, et al. Epithelial PBLD attenuates intestinal inflammatory response and improves intestinal barrier function by inhibiting NF-κB signaling. Cell Death Dis. 2021;12:563 pubmed publisher
  153. Demandt J, van Kuijk K, Theelen T, Marsch E, Heffron S, Fisher E, et al. Whole-Body Prolyl Hydroxylase Domain (PHD) 3 Deficiency Increased Plasma Lipids and Hematocrit Without Impacting Plaque Size in Low-Density Lipoprotein Receptor Knockout Mice. Front Cell Dev Biol. 2021;9:664258 pubmed publisher
  154. Kemp S, Carpenter E, Steele N, Donahue K, Nwosu Z, Pacheco A, et al. Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB-Mediated Production of CXCL1. Cancer Res. 2021;81:4305-4318 pubmed publisher
  155. Lebratti T, Lim Y, Cofie A, Andhey P, Jiang X, Scott J, et al. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection. elife. 2021;10: pubmed publisher
  156. Zhang H, Xia Y, Wang F, Luo M, Yang K, Liang S, et al. Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced Colorectal Cancer Immune Escape through Stabilizing PD-L1 Expression. Adv Sci (Weinh). 2021;8:2003404 pubmed publisher
  157. Clemen R, Freund E, Mrochen D, Miebach L, Schmidt A, Rauch B, et al. Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT-II T Cell Activation Conferring Tumor Protection in Mice. Adv Sci (Weinh). 2021;8:2003395 pubmed publisher
  158. Liu K, Jing N, Wang D, Xu P, Wang J, Chen X, et al. A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication. Cell Prolif. 2021;54:e13056 pubmed publisher
  159. Wu K, Zheng X, Yao Z, Zheng Z, Huang W, Mu X, et al. Accumulation of CD45RO+CD8+ T cells is a diagnostic and prognostic biomarker for clear cell renal cell carcinoma. Aging (Albany NY). 2021;13:14304-14321 pubmed publisher
  160. Li K, Yuan Z, Lyu J, Ahn E, Davis S, Ahmed R, et al. PD-1 suppresses TCR-CD8 cooperativity during T-cell antigen recognition. Nat Commun. 2021;12:2746 pubmed publisher
  161. Groh J, Berve K, Martini R. Immune modulation attenuates infantile neuronal ceroid lipofuscinosis in mice before and after disease onset. Brain Commun. 2021;3:fcab047 pubmed publisher
  162. Borkner L, Curham L, Wilk M, Moran B, Mills K. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils. Mucosal Immunol. 2021;14:1183-1202 pubmed publisher
  163. Amoozgar Z, Kloepper J, Ren J, Tay R, Kazer S, Kiner E, et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun. 2021;12:2582 pubmed publisher
  164. Kerselidou D, Dohai B, Nelson D, Daakour S, De Cock N, Hassoun Z, et al. Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells. Sci Adv. 2021;7: pubmed publisher
  165. Kalinina A, Khromykh L, Kazansky D, Deykin A, Silaeva Y. Suppression of the Immune Response by Syngeneic Splenocytes Adoptively Transferred to Sublethally Irradiated Mice. Acta Naturae. 2021;13:116-126 pubmed publisher
  166. Phong B, D Souza S, Baudier R, Wu E, Immethun V, Bauer D, et al. IgE-activated mast cells enhance TLR4-mediated antigen-specific CD4+ T cell responses. Sci Rep. 2021;11:9686 pubmed publisher
  167. Chen S, Han C, Bian S, Chen J, Feng X, Li G, et al. Chemerin-9 Attenuates Experimental Abdominal Aortic Aneurysm Formation in ApoE-/- Mice. J Oncol. 2021;2021:6629204 pubmed publisher
  168. Flamini S, Sergeev P, Viana de Barros Z, Mello T, Biagioli M, Paglialunga M, et al. Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment. Cell Death Dis. 2021;12:421 pubmed publisher
  169. Morel K, Sheahan A, Burkhart D, Baca S, Boufaied N, Liu Y, et al. EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer. Nat Cancer. 2021;2:444-456 pubmed publisher
  170. Liu Y, Li Y, Loh Y, Singer J, Zhu W, Macia L, et al. Fiber Derived Microbial Metabolites Prevent Acute Kidney Injury Through G-Protein Coupled Receptors and HDAC Inhibition. Front Cell Dev Biol. 2021;9:648639 pubmed publisher
  171. Go D, Lee S, Lee S, Woo S, Kim K, Kim K, et al. Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis. Cell Mol Gastroenterol Hepatol. 2021;12:715-739 pubmed publisher
  172. Zhou J, Pei X, Yang Y, Wang Z, Gao W, Ye R, et al. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma. J Immunother Cancer. 2021;9: pubmed publisher
  173. Yang C, Kwon D, Kim M, Im S, Lee Y. Commensal Microbiome Expands Tγδ17 Cells in the Lung and Promotes Particulate Matter-Induced Acute Neutrophilia. Front Immunol. 2021;12:645741 pubmed publisher
  174. Datta M, Staszewski O. Hdac1 and Hdac2 are essential for physiological maturation of a Cx3cr1 expressing subset of T-lymphocytes. BMC Res Notes. 2021;14:135 pubmed publisher
  175. Borges P, Waclawiak I, Georgii J, Fraga Junior V, Barros J, Lemos F, et al. Adenosine Diphosphate Improves Wound Healing in Diabetic Mice Through P2Y12 Receptor Activation. Front Immunol. 2021;12:651740 pubmed publisher
  176. Roux C, Mucciolo G, Kopecka J, Novelli F, Riganti C, Cappello P. IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine. Antioxidants (Basel). 2021;10: pubmed publisher
  177. Joseph R, Soundararajan R, Vasaikar S, Yang F, Allton K, Tian L, et al. CD8+ T cells inhibit metastasis and CXCL4 regulates its function. Br J Cancer. 2021;125:176-189 pubmed publisher
  178. Xia X, Li R, Zhou P, Xing Z, Lu C, Long Z, et al. Decreased NSG3 enhances PD-L1 expression by Erk1/2 pathway to promote pancreatic cancer progress. Am J Cancer Res. 2021;11:916-929 pubmed
  179. Sánchez del Campo L, Martí Díaz R, Montenegro M, González Guerrero R, Hernández Caselles T, Martínez Barba E, et al. MITF induces escape from innate immunity in melanoma. J Exp Clin Cancer Res. 2021;40:117 pubmed publisher
  180. Shang M, Yang H, Yang R, Chen T, Fu Y, Li Y, et al. The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation. Nat Commun. 2021;12:1940 pubmed publisher
  181. Brea R, Valdecantos P, Rada P, Alen R, García Monzón C, Bosca L, et al. Chronic treatment with acetaminophen protects against liver aging by targeting inflammation and oxidative stress. Aging (Albany NY). 2021;13:7800-7827 pubmed publisher
  182. Voisin M, Shrestha E, Rollet C, Nikain C, Josefs T, Mahe M, et al. Inhibiting LXRα phosphorylation in hematopoietic cells reduces inflammation and attenuates atherosclerosis and obesity in mice. Commun Biol. 2021;4:420 pubmed publisher
  183. Sugita J, Fujiu K, Nakayama Y, Matsubara T, Matsuda J, Oshima T, et al. Cardiac macrophages prevent sudden death during heart stress. Nat Commun. 2021;12:1910 pubmed publisher
  184. Petty A, Dai R, Lapalombella R, Baiocchi R, Benson D, Li Z, et al. Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function. JCI Insight. 2021;6: pubmed publisher
  185. Nakajima S, Tanaka R, Yamashiro K, Chiba A, Noto D, Inaba T, et al. Mucosal-Associated Invariant T Cells Are Involved in Acute Ischemic Stroke by Regulating Neuroinflammation. J Am Heart Assoc. 2021;10:e018803 pubmed publisher
  186. Steenbrugge J, Vander Elst N, Demeyere K, De Wever O, Sanders N, van den Broeck W, et al. OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer. NPJ Breast Cancer. 2021;7:27 pubmed publisher
  187. Shen T, Liu J, Wang C, Rixiati Y, Li S, Cai L, et al. Targeting Erbin in B cells for therapy of lung metastasis of colorectal cancer. Signal Transduct Target Ther. 2021;6:115 pubmed publisher
  188. Celorrio M, Abellanas M, Rhodes J, Goodwin V, Moritz J, Vadivelu S, et al. Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis. Acta Neuropathol Commun. 2021;9:40 pubmed publisher
  189. Xiao Y, Shu L, Wu X, Liu Y, Cheong L, Liao B, et al. Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages. JCI Insight. 2021;6: pubmed publisher
  190. Sripada A, Sirohi K, Michalec L, Guo L, McKay J, Yadav S, et al. Sprouty2 positively regulates T cell function and airway inflammation through regulation of CSK and LCK kinases. PLoS Biol. 2021;19:e3001063 pubmed publisher
  191. Uhl B, Braun C, Dominik J, Luft J, Canis M, Reichel C. A Novel Experimental Approach for In Vivo Analyses of the Salivary Gland Microvasculature. Front Immunol. 2020;11:604470 pubmed publisher
  192. Santos Zas I, Lemari xe9 J, Zlatanova I, Cachanado M, Seghezzi J, Benamer H, et al. Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nat Commun. 2021;12:1483 pubmed publisher
  193. Yin H, Zhang X, Yang P, Zhang X, Peng Y, Li D, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394 pubmed publisher
  194. Liu J, Wang C, Cheng T, Rixiati Y, Ji C, Deng M, et al. Circadian Clock Disruption Suppresses PDL1+ Intraepithelial B Cells in Experimental Colitis and Colitis-Associated Colorectal Cancer. Cell Mol Gastroenterol Hepatol. 2021;12:251-276 pubmed publisher
  195. Liu Y, Li X, Zhang H, Zhang M, Wei Y. HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer. Oncogene. 2021;40:2230-2242 pubmed publisher
  196. Zheng H, Zhang Y, Li L, Zhang R, Luo Z, Yang Z, et al. Depletion of Toll-Like Receptor-9 Attenuates Renal Tubulointerstitial Fibrosis After Ischemia-Reperfusion Injury. Front Cell Dev Biol. 2021;9:641527 pubmed publisher
  197. Choi Y, Kim Y, Oh S, Suh K, Kim Y, Lee G, et al. Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer. Adv Sci (Weinh). 2021;8:2002497 pubmed publisher
  198. Can xe8 S, Van Snick J, Uyttenhove C, Pilotte L, van den Eynde B. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism. J Immunother Cancer. 2021;9: pubmed publisher
  199. Sorrentino C, Ciummo S, D Antonio L, Lanuti P, Abrams S, Yin Z, et al. Hindering triple negative breast cancer progression by targeting endogenous interleukin-30 requires IFNγ signaling. Clin Transl Med. 2021;11:e278 pubmed publisher
  200. Guo S, Smeltz R, Nanajian A, Heller R. IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models. Front Immunol. 2020;11:614667 pubmed publisher
  201. Yuan J, Cai T, Zheng X, Ren Y, Qi J, Lu X, et al. Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Protein Cell. 2021;12:240-260 pubmed publisher
  202. Fletcher R, Tong J, Risnik D, Leibowitz B, Wang Y, Concha Benavente F, et al. Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis. Oncogene. 2021;40:2035-2050 pubmed publisher
  203. Song L, Chang R, Sun X, Lu L, Gao H, Lu H, et al. Macrophage-derived EDA-A2 inhibits intestinal stem cells by targeting miR-494/EDA2R/β-catenin signaling in mice. Commun Biol. 2021;4:213 pubmed publisher
  204. Page N, Lemeille S, Vincenti I, Klimek B, Mariotte A, Wagner I, et al. Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling. Nat Commun. 2021;12:1009 pubmed publisher
  205. Yao C, Lou G, Sun H, Zhu Z, Sun Y, Chen Z, et al. BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells. Nat Immunol. 2021;22:370-380 pubmed publisher
  206. Adam K, Iuga A, Tocheva A, Mor A. A novel mouse model for checkpoint inhibitor-induced adverse events. PLoS ONE. 2021;16:e0246168 pubmed publisher
  207. Li Y, Sun Y, Kulke M, Hechler T, Van der Jeught K, Dong T, et al. Targeted immunotherapy for HER2-low breast cancer with 17p loss. Sci Transl Med. 2021;13: pubmed publisher
  208. Mpekris F, Panagi M, Voutouri C, Martin J, Samuel R, Takahashi S, et al. Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano-immunotherapy in Breast Cancer Lung Metastasis. Adv Sci (Weinh). 2021;8:2001917 pubmed publisher
  209. Ali S, Borin T, Piranlioglu R, Ara R, Lebedyeva I, Angara K, et al. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study. PLoS ONE. 2021;16:e0246646 pubmed publisher
  210. Greferath U, Huynh M, Jobling A, Vessey K, Venables G, Surrao D, et al. Dorsal-Ventral Differences in Retinal Structure in the Pigmented Royal College of Surgeons Model of Retinal Degeneration. Front Cell Neurosci. 2020;14:553708 pubmed publisher
  211. Bielecki P, Riesenfeld S, Hütter J, Torlai Triglia E, Kowalczyk M, Ricardo Gonzalez R, et al. Skin-resident innate lymphoid cells converge on a pathogenic effector state. Nature. 2021;592:128-132 pubmed publisher
  212. Chen J, Sivan U, Tan S, Lippo L, De Angelis J, Labella R, et al. High-resolution 3D imaging uncovers organ-specific vascular control of tissue aging. Sci Adv. 2021;7: pubmed publisher
  213. Yoshikawa T, Taniguchi S, Kato H, Iwata Yoshikawa N, Tani H, Kurosu T, et al. A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome. PLoS Pathog. 2021;17:e1008859 pubmed publisher
  214. Wang F, Ye W, Wang S, He Y, Zhong H, Wang Y, et al. Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy. Neoplasia. 2021;23:281-293 pubmed publisher
  215. Dorrier C, Aran D, Haenelt E, Sheehy R, Hoi K, Pintarić L, et al. CNS fibroblasts form a fibrotic scar in response to immune cell infiltration. Nat Neurosci. 2021;24:234-244 pubmed publisher
  216. Ziegler D, Vindrieux D, Goehrig D, Jaber S, Collin G, Griveau A, et al. Calcium channel ITPR2 and mitochondria-ER contacts promote cellular senescence and aging. Nat Commun. 2021;12:720 pubmed publisher
  217. You G, Lee Y, Kang Y, Park H, Park K, Kim H, et al. B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes. Sci Adv. 2021;7: pubmed publisher
  218. Malone K, Diaz Diaz A, Shearer J, Moore A, Waeber C. The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia. J Neuroinflammation. 2021;18:37 pubmed publisher
  219. Phan T, Schink L, Mann J, Merk V, Zwicky P, Mundt S, et al. Keratinocytes control skin immune homeostasis through de novo-synthesized glucocorticoids. Sci Adv. 2021;7: pubmed publisher
  220. Steele N, Biffi G, Kemp S, Zhang Y, Drouillard D, Syu L, et al. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer. Clin Cancer Res. 2021;: pubmed publisher
  221. Kharkwal S, Johndrow C, Veerapen N, Kharkwal H, Saavedra Avila N, Carreño L, et al. Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy. Cancer Res. 2021;81:1788-1801 pubmed publisher
  222. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed publisher
  223. Brownlie D, Doughty Shenton D, Yh Soong D, Nixon C, O Carragher N, M Carlin L, et al. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β. J Immunother Cancer. 2021;9: pubmed publisher
  224. Devilbiss A, Zhao Z, Martin Sandoval M, Ubellacker J, Tasdogan A, Agathocleous M, et al. Metabolomic profiling of rare cell populations isolated by flow cytometry from tissues. elife. 2021;10: pubmed publisher
  225. Mastorakos P, Mihelson N, Luby M, Burks S, Johnson K, Hsia A, et al. Temporally distinct myeloid cell responses mediate damage and repair after cerebrovascular injury. Nat Neurosci. 2021;24:245-258 pubmed publisher
  226. Chen W, Wu Y, Tsai T, Li R, Lai A, Li L, et al. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis. Theranostics. 2021;11:2594-2611 pubmed publisher
  227. Wang Y, Mohseni M, Grauel A, Diez J, Guan W, Liang S, et al. SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms. Sci Rep. 2021;11:1399 pubmed publisher
  228. Break T, Oikonomou V, Dutzan N, Desai J, Swidergall M, Freiwald T, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371: pubmed publisher
  229. Yoneyama T, Hatakeyama S, Sutoh Yoneyama M, Yoshiya T, Uemura T, Ishizu T, et al. Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy. BMC Cancer. 2021;21:72 pubmed publisher
  230. Costa B, Fletcher M, Boskovic P, Ivanova E, Eisemann T, Lohr S, et al. A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors. Cancers (Basel). 2021;13: pubmed publisher
  231. Tyagi A, Darby T, Hsu E, Yu M, Pal S, Dar H, et al. The gut microbiota is a transmissible determinant of skeletal maturation. elife. 2021;10: pubmed publisher
  232. Hou P, Jia P, Yang K, Li Z, Tian T, Lin Y, et al. An unconventional role of an ASB family protein in NF-κB activation and inflammatory response during microbial infection and colitis. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  233. Kaur S, Sehgal A, Wu A, Millard S, Batoon L, Sandrock C, et al. Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice. J Hematol Oncol. 2021;14:3 pubmed publisher
  234. Khaw Y, Majid D, Oh S, Kang E, Inoue M. Early-life-trauma triggers interferon-β resistance and neurodegeneration in a multiple sclerosis model via downregulated β1-adrenergic signaling. Nat Commun. 2021;12:105 pubmed publisher
  235. Suah A, Tran D, Khiew S, Andrade M, Pollard J, Jain D, et al. Pregnancy-induced humoral sensitization overrides T cell tolerance to fetus-matched allografts in mice. J Clin Invest. 2021;131: pubmed publisher
  236. Luo R, Cheng Y, Chang D, Liu T, Liu L, Pei G, et al. Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A. Theranostics. 2021;11:117-131 pubmed publisher
  237. Grand M, Waqasi M, Demarta Gatsi C, Wei Y, Peronet R, Commere P, et al. Hepatic Inflammation Confers Protective Immunity Against Liver Stages of Malaria Parasite. Front Immunol. 2020;11:585502 pubmed publisher
  238. Antony A, Lian Z, Perrard X, Perrard J, Liu H, Cox A, et al. Deficiency of Stat1 in CD11c+ Cells Alters Adipose Tissue Inflammation and Improves Metabolic Dysfunctions in Mice Fed a High-Fat Diet. Diabetes. 2021;70:720-732 pubmed publisher
  239. Li X, Zhang M, Huang X, Liang W, Li G, Lu X, et al. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Nat Commun. 2020;11:6364 pubmed publisher
  240. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  241. Harro C, Perez Sanz J, Costich T, Payne K, Anadon C, Chaurio R, et al. Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice. J Clin Invest. 2021;131: pubmed publisher
  242. Sanchez Felipe L, Vercruysse T, Sharma S, Ma J, Lemmens V, Van Looveren D, et al. A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate. Nature. 2021;590:320-325 pubmed publisher
  243. Meryk A, Grasse M, Balasco L, Kapferer W, Grubeck Loebenstein B, Pangrazzi L. Antioxidants N-Acetylcysteine and Vitamin C Improve T Cell Commitment to Memory and Long-Term Maintenance of Immunological Memory in Old Mice. Antioxidants (Basel). 2020;9: pubmed publisher
  244. Jensen I, Jensen S, Sjaastad F, Gibson Corley K, Dileepan T, Griffith T, et al. Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells. elife. 2020;9: pubmed publisher
  245. Gao L, Li B, Wang J, Shen D, Yang M, Sun R, et al. Activation of Liver X Receptor α Sensitizes Mice to T-Cell Mediated Hepatitis. Hepatol Commun. 2020;4:1664-1679 pubmed publisher
  246. Wang Y, Luo M, Chen Y, Wang Y, Zhang B, Ren Z, et al. ZMYND8 Expression in Breast Cancer Cells Blocks T-Lymphocyte Surveillance to Promote Tumor Growth. Cancer Res. 2021;81:174-186 pubmed publisher
  247. Myers D, Abram C, Wildes D, Belwafa A, Welsh A, Schulze C, et al. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity. Front Immunol. 2020;11:576310 pubmed publisher
  248. Rundqvist H, Veliça P, Barbieri L, Gameiro P, Bargiela D, Gojkovic M, et al. Cytotoxic T-cells mediate exercise-induced reductions in tumor growth. elife. 2020;9: pubmed publisher
  249. Lee H, Park J, Yoo H, Lee H, Lee B, Kim J. The Selenoprotein MsrB1 Instructs Dendritic Cells to Induce T-Helper 1 Immune Responses. Antioxidants (Basel). 2020;9: pubmed publisher
  250. Fujimori D, Kinoshita J, Yamaguchi T, Nakamura Y, Gunjigake K, Ohama T, et al. Established fibrous peritoneal metastasis in an immunocompetent mouse model similar to clinical immune microenvironment of gastric cancer. BMC Cancer. 2020;20:1014 pubmed publisher
  251. Pariser D, Hilt Z, Ture S, Blick Nitko S, Looney M, Cleary S, et al. Lung megakaryocytes are immune modulatory cells. J Clin Invest. 2021;131: pubmed publisher
  252. Kasuga A, Semba T, Sato R, Nobusue H, Sugihara E, Takaishi H, et al. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice. Cancer Sci. 2021;112:1822-1838 pubmed publisher
  253. Zahedi K, Brooks M, Barone S, Rahmati N, Murray Stewart T, Dunworth M, et al. Ablation of polyamine catabolic enzymes provokes Purkinje cell damage, neuroinflammation, and severe ataxia. J Neuroinflammation. 2020;17:301 pubmed publisher
  254. Lissner M, Cumnock K, Davis N, Vilches Moure J, Basak P, Navarrete D, et al. Metabolic profiling during malaria reveals the role of the aryl hydrocarbon receptor in regulating kidney injury. elife. 2020;9: pubmed publisher
  255. Lauver M, Goetschius D, Netherby Winslow C, Ayers K, Jin G, Haas D, et al. Antibody escape by polyomavirus capsid mutation facilitates neurovirulence. elife. 2020;9: pubmed publisher
  256. Ishii K, Pouzolles M, Chien C, Erwin Cohen R, Kohler M, Qin H, et al. Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients. J Clin Invest. 2020;130:5425-5443 pubmed publisher
  257. Zhao L, Hu S, Davila M, Yang J, Lin Y, Albanese J, et al. Coordinated co-migration of CCR10+ antibody-producing B cells with helper T cells for colonic homeostatic regulation. Mucosal Immunol. 2021;14:420-430 pubmed publisher
  258. Ricci B, Tycksen E, Celik H, Belle J, Fontana F, Civitelli R, et al. Osterix-Cre marks distinct subsets of CD45- and CD45+ stromal populations in extra-skeletal tumors with pro-tumorigenic characteristics. elife. 2020;9: pubmed publisher
  259. Li N, Kang Y, Wang L, Huff S, Tang R, Hui H, et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci U S A. 2020;117:20159-20170 pubmed publisher
  260. Li Z, Zhang H, Huang Y, Huang J, Sun P, Zhou N, et al. Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nat Commun. 2020;11:3806 pubmed publisher
  261. Runyan C, Welch L, Lecuona E, Shigemura M, Amarelle L, Abdala Valencia H, et al. Impaired phagocytic function in CX3CR1+ tissue-resident skeletal muscle macrophages prevents muscle recovery after influenza A virus-induced pneumonia in old mice. Aging Cell. 2020;: pubmed publisher
  262. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  263. Li H, Lu C, Zhang H, Hu Q, Zhang J, Cuevas I, et al. A PoleP286R mouse model of endometrial cancer recapitulates high mutational burden and immunotherapy response. JCI Insight. 2020;5: pubmed publisher
  264. Bhaskar A, Kumar S, Khan M, Singh A, Dwivedi V, Nandicoori V. Host sirtuin 2 as an immunotherapeutic target against tuberculosis. elife. 2020;9: pubmed publisher
  265. Peligero Cruz C, Givony T, Sebé Pedrós A, Dobes J, Kadouri N, Nevo S, et al. IL18 signaling promotes homing of mature Tregs into the thymus. elife. 2020;9: pubmed publisher
  266. Neuper T, Neureiter D, Sarajlic M, Strandt H, Bauer R, Schwarz H, et al. IL-31 transgenic mice show reduced allergen-induced lung inflammation. Eur J Immunol. 2021;51:191-196 pubmed publisher
  267. Robbins Y, Greene S, Friedman J, Clavijo P, Van Waes C, Fabian K, et al. Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells. elife. 2020;9: pubmed publisher
  268. Mahr B, Pilat N, Granofszky N, Muckenhuber M, Unger L, Weijler A, et al. Distinct roles for major and minor antigen barriers in chimerism-based tolerance under irradiation-free conditions. Am J Transplant. 2021;21:968-977 pubmed publisher
  269. Manils J, Webb L, Howes A, Janzen J, Boeing S, Bowcock A, et al. CARD14E138A signalling in keratinocytes induces TNF-dependent skin and systemic inflammation. elife. 2020;9: pubmed publisher
  270. Zhou T, Damsky W, Weizman O, McGeary M, Hartmann K, Rosen C, et al. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. Nature. 2020;583:609-614 pubmed publisher
  271. Seitz V, Kleo K, Dröge A, Schaper S, Elezkurtaj S, Bedjaoui N, et al. Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL. Sci Rep. 2020;10:10024 pubmed publisher
  272. Jansons J, Bayurova E, Skrastina D, Kurlanda A, Fridrihsone I, Kostyushev D, et al. Expression of the Reverse Transcriptase Domain of Telomerase Reverse Transcriptase Induces Lytic Cellular Response in DNA-Immunized Mice and Limits Tumorigenic and Metastatic Potential of Murine Adenocarcinoma 4T1 Cells. Vaccines (Basel). 2020;8: pubmed publisher
  273. Ho J, Angel M, Ma Y, Sloan E, Wang G, Martínez Romero C, et al. Hybrid Gene Origination Creates Human-Virus Chimeric Proteins during Infection. Cell. 2020;181:1502-1517.e23 pubmed publisher
  274. Ning Y, Ding J, Sun X, Xie Y, Su M, Ma C, et al. HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment. J Immunother Cancer. 2020;8: pubmed publisher
  275. Zhou S, Wu W, Wang Z, Wang Z, Su Q, Li X, et al. RelB regulates the homeostatic proliferation but not the function of Tregs. BMC Immunol. 2020;21:37 pubmed publisher
  276. Lubos N, van der Gaag S, Gerçek M, Kant S, Leube R, Krusche C. Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy. Basic Res Cardiol. 2020;115:42 pubmed publisher
  277. Domingo Gonzalez R, Zanini F, Che X, Liu M, Jones R, Swift M, et al. Diverse homeostatic and immunomodulatory roles of immune cells in the developing mouse lung at single cell resolution. elife. 2020;9: pubmed publisher
  278. Bekeschus S, Clemen R, Nießner F, Sagwal S, Freund E, Schmidt A. Medical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion. Adv Sci (Weinh). 2020;7:1903438 pubmed publisher
  279. Burfeind K, Zhu X, Norgard M, Levasseur P, Huisman C, Buenafe A, et al. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer. elife. 2020;9: pubmed publisher
  280. Sollberger G, Streeck R, Apel F, Caffrey B, Skoultchi A, Zychlinsky A. Linker histone H1.2 and H1.4 affect the neutrophil lineage determination. elife. 2020;9: pubmed publisher
  281. Fan Z, Tian Y, Chen Z, Liu L, Zhou Q, He J, et al. Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors. EMBO Mol Med. 2020;12:e11571 pubmed publisher
  282. Castiello M, Bosticardo M, Sacchetti N, Calzoni E, Fontana E, Yamazaki Y, et al. Efficacy and safety of anti-CD45-saporin as conditioning agent for RAG deficiency. J Allergy Clin Immunol. 2021;147:309-320.e6 pubmed publisher
  283. Yamamoto K, Venida A, Yano J, Biancur D, Kakiuchi M, Gupta S, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581:100-105 pubmed publisher
  284. Liu X, Kong W, Peterson C, McGrail D, Hoang A, Zhang X, et al. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nat Commun. 2020;11:2135 pubmed publisher
  285. Zheng D, Gao F, Cheng Q, Bao P, Dong X, Fan J, et al. A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy. Nat Commun. 2020;11:1985 pubmed publisher
  286. Dieterich L, Tacconi C, Menzi F, Proulx S, Kapaklikaya K, Hamada M, et al. Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis. Angiogenesis. 2020;23:411-423 pubmed publisher
  287. Zhu M, Ma Y, Tan K, Zhang L, Wang Z, Li Y, et al. Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts. BMC Immunol. 2020;21:19 pubmed publisher
  288. Ruscetti M, Morris J, Mezzadra R, Russell J, Leibold J, Romesser P, et al. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. 2020;181:424-441.e21 pubmed publisher
  289. Luoni M, Giannelli S, Indrigo M, Niro A, Massimino L, Iannielli A, et al. Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome. elife. 2020;9: pubmed publisher
  290. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  291. von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11:1508 pubmed publisher
  292. Gao M, Wang T, Ji L, Bai S, Tian L, Song H. Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer. Front Immunol. 2020;11:366 pubmed publisher
  293. Aaltonen N, Singha P, Jakupović H, Wirth T, Samaranayake H, Pasonen Seppänen S, et al. High-Resolution Confocal Fluorescence Imaging of Serine Hydrolase Activity in Cryosections - Application to Glioma Brain Unveils Activity Hotspots Originating from Tumor-Associated Neutrophils. Biol Proced Online. 2020;22:6 pubmed publisher
  294. Wuggenig P, Kaya B, Melhem H, Ayata C, Hruz P, Sayan A, et al. Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice. Commun Biol. 2020;3:130 pubmed publisher
  295. Zhang S, Liang W, Luo L, Sun S, Wang F. The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology. BMC Biol. 2020;18:29 pubmed publisher
  296. Yoshida S, Miyagawa S, Toyofuku T, Fukushima S, Kawamura T, Kawamura A, et al. Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation. Sci Rep. 2020;10:4593 pubmed publisher
  297. Donaldson D, Bradford B, Else K, Mabbott N. Accelerated onset of CNS prion disease in mice co-infected with a gastrointestinal helminth pathogen during the preclinical phase. Sci Rep. 2020;10:4554 pubmed publisher
  298. Chaurasiya S, Yang A, Kang S, Lu J, Kim S, Park A, et al. Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model. Oncoimmunology. 2020;9:1729300 pubmed publisher
  299. Doll J, Hoebe K, Thompson R, Sawtell N. Resolution of herpes simplex virus reactivation in vivo results in neuronal destruction. PLoS Pathog. 2020;16:e1008296 pubmed publisher
  300. Fu Y, Ding Y, Wang Q, Zhu F, Tan Y, Lu X, et al. Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2. Sci Adv. 2020;6:eaay9269 pubmed publisher
  301. Ramstead A, Wallace J, Lee S, Bauer K, Tang W, Ekiz H, et al. Mitochondrial Pyruvate Carrier 1 Promotes Peripheral T Cell Homeostasis through Metabolic Regulation of Thymic Development. Cell Rep. 2020;30:2889-2899.e6 pubmed publisher
  302. Kumar A, Chamoto K, Chowdhury P, Honjo T. Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy. elife. 2020;9: pubmed publisher
  303. Wei J, Mattapallil M, Horai R, Jittayasothorn Y, Modi A, Sen H, et al. A novel role for lipoxin A4 in driving a lymph node-eye axis that controls autoimmunity to the neuroretina. elife. 2020;9: pubmed publisher
  304. Simon S, Hu X, Panten J, Grees M, Renders S, Thomas D, et al. Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors. Oncoimmunology. 2020;9:1727116 pubmed publisher
  305. Martens R, Permanyer M, Werth K, Yu K, Braun A, Halle O, et al. Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance. Nat Commun. 2020;11:1114 pubmed publisher
  306. Luker A, Graham L, Smith T, Camarena C, Zellner M, Gilmer J, et al. The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer. BMC Immunol. 2020;21:8 pubmed publisher
  307. Lu Z, Zou J, Li S, Topper M, Tao Y, Zhang H, et al. Epigenetic therapy inhibits metastases by disrupting premetastatic niches. Nature. 2020;579:284-290 pubmed publisher
  308. Hu X, Deng Q, Ma L, Li Q, Chen Y, Liao Y, et al. Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res. 2020;30:229-243 pubmed publisher
  309. Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367: pubmed publisher
  310. Aslan K, Turco V, Blobner J, Sonner J, Liuzzi A, Núñez N, et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nat Commun. 2020;11:931 pubmed publisher
  311. Chen H, Cong X, Wu C, Wu X, Wang J, Mao K, et al. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9+ T cells. Sci Adv. 2020;6:eaax4690 pubmed publisher
  312. Abadie V, Kim S, Lejeune T, Palanski B, Ernest J, Tastet O, et al. IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease. Nature. 2020;578:600-604 pubmed publisher
  313. Jaynes J, Sable R, Ronzetti M, Bautista W, Knotts Z, Abisoye Ogunniyan A, et al. Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Sci Transl Med. 2020;12: pubmed publisher
  314. Tizian C, Lahmann A, Hölsken O, Cosovanu C, Kofoed Branzk M, Heinrich F, et al. c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells. elife. 2020;9: pubmed publisher
  315. Tzeng S, Patel K, Wilson D, Meyer R, Rhodes K, Green J. In situ genetic engineering of tumors for long-lasting and systemic immunotherapy. Proc Natl Acad Sci U S A. 2020;117:4043-4052 pubmed publisher
  316. Cohen G, Chandran P, Lorsung R, Tomlinson L, Sundby M, Burks S, et al. The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response. Cancers (Basel). 2020;12: pubmed publisher
  317. Theivanthiran B, Evans K, Devito N, Plebanek M, Sturdivant M, Wachsmuth L, et al. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy. J Clin Invest. 2020;130:2570-2586 pubmed publisher
  318. Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, et al. Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties. Nat Commun. 2020;11:609 pubmed publisher
  319. Williams G, Marmion D, Schonhoff A, Jurkuvenaite A, Won W, Standaert D, et al. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. Acta Neuropathol. 2020;139:855-874 pubmed publisher
  320. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed publisher
  321. Liu Z, Wen J, Wu C, Hu C, Wang J, Bao Q, et al. MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma. Aging (Albany NY). 2020;12:1213-1236 pubmed publisher
  322. Choi S, Bae H, Jeong S, Park I, Cho H, Hong S, et al. YAP/TAZ direct commitment and maturation of lymph node fibroblastic reticular cells. Nat Commun. 2020;11:519 pubmed publisher
  323. Yu M, Guo G, Huang L, Deng L, Chang C, Achyut B, et al. CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint. Nat Commun. 2020;11:515 pubmed publisher
  324. Singh K, Leu J, Barnoud T, Vonteddu P, Gnanapradeepan K, Lin C, et al. African-centric TP53 variant increases iron accumulation and bacterial pathogenesis but improves response to malaria toxin. Nat Commun. 2020;11:473 pubmed publisher
  325. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed publisher
  326. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  327. Bliss C, Parsons A, Nachbagauer R, Hamilton J, Cappuccini F, Ulaszewska M, et al. Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice. Mol Ther Methods Clin Dev. 2020;16:108-125 pubmed publisher
  328. Kimura S, Nakamura Y, Kobayashi N, Shiroguchi K, Kawakami E, Mutoh M, et al. Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity. Nat Commun. 2020;11:234 pubmed publisher
  329. Hayes M, Ward S, Crawford G, Seoane R, Jackson W, Kipling D, et al. Inflammation-induced IgE promotes epithelial hyperplasia and tumour growth. elife. 2020;9: pubmed publisher
  330. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  331. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed publisher
  332. Thiele Née Schrewe L, Guse K, Tietz S, Remlinger J, Demir S, Pedreiturria X, et al. Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis. J Neuroinflammation. 2020;17:9 pubmed publisher
  333. Enríquez Pérez J, Kopecky J, Visse E, Darabi A, Siesjo P. Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas. BMC Cancer. 2020;20:7 pubmed publisher
  334. Williford J, Ishihara J, Ishihara A, Mansurov A, Hosseinchi P, Marchell T, et al. Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Sci Adv. 2019;5:eaay1357 pubmed publisher
  335. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed publisher
  336. Guo C, Allen B, Hiam K, Dodd D, Van Treuren W, Higginbottom S, et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics. Science. 2019;366: pubmed publisher
  337. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  338. Ward L, Lee D, Sharma A, Wang A, Naouar I, Ma X, et al. Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury. JCI Insight. 2020;5: pubmed publisher
  339. Li A, Herbst R, Canner D, Schenkel J, Smith O, Kim J, et al. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development. Cell Rep. 2019;29:2998-3008.e8 pubmed publisher
  340. Shi L, Wang J, Ding N, Zhang Y, Zhu Y, Dong S, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nat Commun. 2019;10:5421 pubmed publisher
  341. Zhao Y, Yang Q, Jin C, Feng Y, Xie S, Xie H, et al. Changes of CD103-expressing pulmonary CD4+ and CD8+ T cells in S. japonicum infected C57BL/6 mice. BMC Infect Dis. 2019;19:999 pubmed publisher
  342. Reed M, Luissint A, Azcutia V, Fan S, O Leary M, Quirós M, et al. Epithelial CD47 is critical for mucosal repair in the murine intestine in vivo. Nat Commun. 2019;10:5004 pubmed publisher
  343. Strickley J, Messerschmidt J, Awad M, Li T, Hasegawa T, Ha D, et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019;: pubmed publisher
  344. Canon J, Rex K, Saiki A, Mohr C, Cooke K, Bagal D, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575:217-223 pubmed publisher
  345. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed publisher
  346. Chu C, Murdock M, Jing D, Won T, Chung H, Kressel A, et al. The microbiota regulate neuronal function and fear extinction learning. Nature. 2019;574:543-548 pubmed publisher
  347. Liberatore R, Mastrocola E, Cassella E, Schmidt F, Willen J, Voronin D, et al. Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection. elife. 2019;8: pubmed publisher
  348. Lin F, Meng X, Guo Y, Cao W, Liu W, Xia Q, et al. Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1. Sci Adv. 2019;5:eaax1608 pubmed publisher
  349. Helsley R, Varadharajan V, Brown A, Gromovsky A, Schugar R, Ramachandiran I, et al. Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. elife. 2019;8: pubmed publisher
  350. Mani V, Bromley S, Aijö T, Mora Buch R, Carrizosa E, Warner R, et al. Migratory DCs activate TGF-β to precondition naïve CD8+ T cells for tissue-resident memory fate. Science. 2019;366: pubmed publisher
  351. Shikama Y, Kurosawa M, Furukawa M, Ishimaru N, Matsushita K. Involvement of adiponectin in age-related increases in tear production in mice. Aging (Albany NY). 2019;11:8329-8346 pubmed publisher
  352. Ortega Molina A, Deleyto Seldas N, Carreras J, Sanz A, Lebrero Fernández C, Menéndez C, et al. Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR. Nat Metab. 2019;1:775-789 pubmed publisher
  353. Lecocq Q, Zeven K, De Vlaeminck Y, Martens S, Massa S, Goyvaerts C, et al. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use. Biomolecules. 2019;9: pubmed publisher
  354. Majer O, Liu B, Kreuk L, Krogan N, Barton G. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575:366-370 pubmed publisher
  355. Nelson C, Thompson E, Quarnstrom C, Fraser K, Seelig D, Bhela S, et al. Robust Iterative Stimulation with Self-Antigens Overcomes CD8+ T Cell Tolerance to Self- and Tumor Antigens. Cell Rep. 2019;28:3092-3104.e5 pubmed publisher
  356. Schreiber L, Urbiola C, Das K, Spiesschaert B, Kimpel J, Heinemann F, et al. The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer. Br J Cancer. 2019;121:647-658 pubmed publisher
  357. Aghajanian H, Kimura T, Rurik J, Hancock A, Leibowitz M, Li L, et al. Targeting cardiac fibrosis with engineered T cells. Nature. 2019;573:430-433 pubmed publisher
  358. Liu Z, Gu Y, Chakarov S, Blériot C, Kwok I, Chen X, et al. Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells. Cell. 2019;178:1509-1525.e19 pubmed publisher
  359. Zhang F, Parayath N, Ene C, Stephan S, Koehne A, Coon M, et al. Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers. Nat Commun. 2019;10:3974 pubmed publisher
  360. Rasoulouniriana D, Santana Magal N, Gutwillig A, Farhat Younis L, Wine Y, Saperia C, et al. A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. J Clin Invest. 2019;129:4151-4164 pubmed publisher
  361. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  362. Collins N, Han S, Enamorado M, Link V, Huang B, Moseman E, et al. The Bone Marrow Protects and Optimizes Immunological Memory during Dietary Restriction. Cell. 2019;178:1088-1101.e15 pubmed publisher
  363. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  364. Benci J, Johnson L, Choa R, Xu Y, Qiu J, Zhou Z, et al. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade. Cell. 2019;178:933-948.e14 pubmed publisher
  365. Rosshart S, Herz J, Vassallo B, Hunter A, Wall M, Badger J, et al. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science. 2019;365: pubmed publisher
  366. Verma V, Shrimali R, Ahmad S, Dai W, Wang H, Lu S, et al. PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Nat Immunol. 2019;20:1231-1243 pubmed publisher
  367. Niemann J, Woller N, Brooks J, Fleischmann Mundt B, Martin N, Kloos A, et al. Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy. Nat Commun. 2019;10:3236 pubmed publisher
  368. Ma L, Dichwalkar T, Chang J, Cossette B, Garafola D, Zhang A, et al. Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor. Science. 2019;365:162-168 pubmed publisher
  369. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  370. Lee Y, Riopel M, Cabrales P, Bandyopadhyay G. Hepatocyte-specific HIF-1α ablation improves obesity-induced glucose intolerance by reducing first-pass GLP-1 degradation. Sci Adv. 2019;5:eaaw4176 pubmed publisher
  371. Dulken B, Buckley M, Navarro Negredo P, Saligrama N, Cayrol R, Leeman D, et al. Single-cell analysis reveals T cell infiltration in old neurogenic niches. Nature. 2019;571:205-210 pubmed publisher
  372. Papaioannou E, Yanez D, Ross S, Lau C, Solanki A, Chawda M, et al. Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation. J Clin Invest. 2019;129:3153-3170 pubmed publisher
  373. Ponzetta A, Carriero R, Carnevale S, Barbagallo M, Molgora M, Perucchini C, et al. Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors. Cell. 2019;178:346-360.e24 pubmed publisher
  374. Leach S, Shinnakasu R, Adachi Y, Momota M, Makino Okamura C, Yamamoto T, et al. Requirement for memory B cell activation in protection from heterologous influenza virus reinfection. Int Immunol. 2019;: pubmed publisher
  375. Liu D, Yin X, Olyha S, Nascimento M, Chen P, White T, et al. IL-10-Dependent Crosstalk between Murine Marginal Zone B Cells, Macrophages, and CD8α+ Dendritic Cells Promotes Listeria monocytogenes Infection. Immunity. 2019;: pubmed publisher
  376. Ansaldo E, Slayden L, Ching K, Koch M, Wolf N, Plichta D, et al. Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science. 2019;364:1179-1184 pubmed publisher
  377. Khan O, Giles J, McDonald S, Manne S, Ngiow S, Patel K, et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature. 2019;: pubmed publisher
  378. Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C, et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7 pubmed publisher
  379. Pascual García M, Bonfill Teixidor E, Planas Rigol E, Rubio Perez C, Iurlaro R, Arias A, et al. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun. 2019;10:2416 pubmed publisher
  380. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed publisher
  381. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed publisher
  382. Wilkinson A, Ishida R, Kikuchi M, Sudo K, Morita M, Crisostomo R, et al. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature. 2019;: pubmed publisher
  383. Sivaram N, McLaughlin P, Han H, Petrenko O, Jiang Y, Ballou L, et al. Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. J Clin Invest. 2019;130: pubmed publisher
  384. Di Pilato M, Kim E, Cadilha B, Prüßmann J, Nasrallah M, Seruggia D, et al. Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy. Nature. 2019;570:112-116 pubmed publisher
  385. Harding J, Herbáth M, Chen Y, Rayasam A, Ritter A, Csóka B, et al. VEGF-A from Granuloma Macrophages Regulates Granulomatous Inflammation by a Non-angiogenic Pathway during Mycobacterial Infection. Cell Rep. 2019;27:2119-2131.e6 pubmed publisher
  386. Qiu J, Villa M, Sanin D, Buck M, O Sullivan D, Ching R, et al. Acetate Promotes T Cell Effector Function during Glucose Restriction. Cell Rep. 2019;27:2063-2074.e5 pubmed publisher
  387. Komuczki J, Tuzlak S, Friebel E, Hartwig T, Spath S, Rosenstiel P, et al. Fate-Mapping of GM-CSF Expression Identifies a Discrete Subset of Inflammation-Driving T Helper Cells Regulated by Cytokines IL-23 and IL-1β. Immunity. 2019;: pubmed publisher
  388. Sharma N, Vacher J, Allison J. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proc Natl Acad Sci U S A. 2019;116:10453-10462 pubmed publisher
  389. Takagaki S, Yamashita R, Hashimoto N, Sugihara K, Kanari K, Tabata K, et al. Galactosyl carbohydrate residues on hematopoietic stem/progenitor cells are essential for homing and engraftment to the bone marrow. Sci Rep. 2019;9:7133 pubmed publisher
  390. Ajina R, Zamalin D, Zuo A, Moussa M, Catalfamo M, Jablonski S, et al. SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice. Oncoimmunology. 2019;8:e1577127 pubmed publisher
  391. Cho C, Wang Y, Smallwood P, Williams J, Nathans J. Dlg1 activates beta-catenin signaling to regulate retinal angiogenesis and the blood-retina and blood-brain barriers. elife. 2019;8: pubmed publisher
  392. Rühl J, Citterio C, Engelmann C, Haigh T, Dzionek A, Dreyer J, et al. Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas. J Clin Invest. 2019;129:2071-2087 pubmed publisher
  393. Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells. Cell. 2019;177:1172-1186.e14 pubmed publisher
  394. Veglia F, Tyurin V, Blasi M, De Leo A, Kossenkov A, Donthireddy L, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019;569:73-78 pubmed publisher
  395. Knox T, Sahakian E, Banik D, Hadley M, Palmer E, Noonepalle S, et al. Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells. Sci Rep. 2019;9:6136 pubmed publisher
  396. Esterházy D, Canesso M, Mesin L, Muller P, de Castro T, Lockhart A, et al. Compartmentalized gut lymph node drainage dictates adaptive immune responses. Nature. 2019;569:126-130 pubmed publisher
  397. Eisemann T, Costa B, Peterziel H, Angel P. Podoplanin Positive Myeloid Cells Promote Glioma Development by Immune Suppression. Front Oncol. 2019;9:187 pubmed publisher
  398. LaFleur M, Nguyen T, Coxe M, Yates K, Trombley J, Weiss S, et al. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat Commun. 2019;10:1668 pubmed publisher
  399. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed publisher
  400. Pais H, Ruggero K, Zhang J, Al Assar O, Bery N, Bhuller R, et al. Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model. Sci Rep. 2019;9:5760 pubmed publisher
  401. Lytle N, Ferguson L, Rajbhandari N, Gilroy K, Fox R, Deshpande A, et al. A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. Cell. 2019;177:572-586.e22 pubmed publisher
  402. Li Y, Tinoco R, Elmén L, Segota I, Xian Y, Fujita Y, et al. Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5-/- mice. Nat Commun. 2019;10:1492 pubmed publisher
  403. Benz F, Wichitnaowarat V, Lehmann M, Germano R, Mihova D, Macas J, et al. Low wnt/β-catenin signaling determines leaky vessels in the subfornical organ and affects water homeostasis in mice. elife. 2019;8: pubmed publisher
  404. Wang Y, Sabbagh M, Gu X, Rattner A, Williams J, Nathans J. Beta-catenin signaling regulates barrier-specific gene expression in circumventricular organ and ocular vasculatures. elife. 2019;8: pubmed publisher
  405. Bottermann M, Foss S, Caddy S, Clift D, van Tienen L, Vaysburd M, et al. Complement C4 Prevents Viral Infection through Capsid Inactivation. Cell Host Microbe. 2019;25:617-629.e7 pubmed publisher
  406. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  407. Yao W, Rose J, Wang W, Seth S, Jiang H, Taguchi A, et al. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019;: pubmed publisher
  408. Pascutti M, Geerman S, Collins N, Brasser G, Nota B, Stark R, et al. Peripheral and systemic antigens elicit an expandable pool of resident memory CD8+ T cells in the bone marrow. Eur J Immunol. 2019;49:853-872 pubmed publisher
  409. Gong B, Kiyotani K, Sakata S, Nagano S, Kumehara S, Baba S, et al. Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer. J Exp Med. 2019;: pubmed publisher
  410. Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249-252 pubmed publisher
  411. Xing S, Gai K, Li X, Shao P, Zeng Z, Zhao X, et al. Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. J Exp Med. 2019;: pubmed publisher
  412. Chen J, López Moyado I, Seo H, Lio C, Hempleman L, Sekiya T, et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature. 2019;567:530-534 pubmed publisher
  413. Thompson P, Shah A, Ntranos V, Van Gool F, Atkinson M, Bhushan A. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes. Cell Metab. 2019;29:1045-1060.e10 pubmed publisher
  414. Straub T, Pircher H. Enhancing immunity prevents virus-induced T-cell-mediated immunopathology in B cell-deficient mice. Eur J Immunol. 2019;49:782-789 pubmed publisher
  415. Michaels Y, Barnkob M, Barbosa H, Baeumler T, Thompson M, Andre V, et al. Precise tuning of gene expression levels in mammalian cells. Nat Commun. 2019;10:818 pubmed publisher
  416. Anandagoda N, Willis J, Hertweck A, Roberts L, Jackson I, Gökmen M, et al. microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance. J Clin Invest. 2019;129:1257-1271 pubmed publisher
  417. Dosch M, Zindel J, Jebbawi F, Melin N, Sánchez Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. elife. 2019;8: pubmed publisher
  418. Salerno F, Guislain A, Freen van Heeren J, Nicolet B, Young H, Wolkers M. Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells. Oncoimmunology. 2019;8:e1532762 pubmed publisher
  419. Jin C, Lagoudas G, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell. 2019;176:998-1013.e16 pubmed publisher
  420. Davies A, Kim H, González Cano R, Choi J, Back S, Roh S, et al. Natural Killer Cells Degenerate Intact Sensory Afferents following Nerve Injury. Cell. 2019;176:716-728.e18 pubmed publisher
  421. Hendrikx S, Coso S, Prat Luri B, Wetterwald L, Sabine A, Franco C, et al. Endothelial Calcineurin Signaling Restrains Metastatic Outgrowth by Regulating Bmp2. Cell Rep. 2019;26:1227-1241.e6 pubmed publisher
  422. Yamamoto T, Lee P, Vodnala S, Gurusamy D, Kishton R, Yu Z, et al. T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019;129:1551-1565 pubmed publisher
  423. Martins J, Andoniou C, Fleming P, Kuns R, Schuster I, Voigt V, et al. Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation. Science. 2019;363:288-293 pubmed publisher
  424. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  425. Silva D, Yu S, Ulge U, Spangler J, Jude K, Labao Almeida C, et al. De novo design of potent and selective mimics of IL-2 and IL-15. Nature. 2019;565:186-191 pubmed publisher
  426. Lee Y, Ju J, Shon W, Oh S, Min C, Kang M, et al. Skewed Dendritic Cell Differentiation of MyD88-Deficient Donor Bone Marrow Cells, Instead of Massive Expansion as Myeloid-Derived Suppressor Cells, Aggravates GVHD. Immune Netw. 2018;18:e44 pubmed publisher
  427. Li J, He Y, Hao J, Ni L, Dong C. High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T Cells. Front Immunol. 2018;9:2981 pubmed publisher
  428. Ruscetti M, Leibold J, Bott M, Fennell M, Kulick A, Salgado N, et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 2018;362:1416-1422 pubmed publisher
  429. Mantri C, St John A. Immune synapses between mast cells and γδ T cells limit viral infection. J Clin Invest. 2019;129:1094-1108 pubmed publisher
  430. Chorro L, Suzuki M, Chin S, Williams T, Snapp E, Odagiu L, et al. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape. Nat Commun. 2018;9:5368 pubmed publisher
  431. Ishizuka J, Manguso R, Cheruiyot C, Bi K, Panda A, Iracheta Vellve A, et al. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Nature. 2019;565:43-48 pubmed publisher
  432. Lauron E, Yang L, Harvey I, Sojka D, Williams G, Paley M, et al. Viral MHCI inhibition evades tissue-resident memory T cell formation and responses. J Exp Med. 2019;216:117-132 pubmed publisher
  433. Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin G, Shurin M, et al. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci U S A. 2019;116:1361-1369 pubmed publisher
  434. Chea L, Wyatt L, Gangadhara S, Moss B, Amara R. Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses. J Virol. 2019;93: pubmed publisher
  435. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed publisher
  436. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  437. Gubernatorova E, Gorshkova E, Namakanova O, Zvartsev R, Hidalgo J, Drutskaya M, et al. Non-redundant Functions of IL-6 Produced by Macrophages and Dendritic Cells in Allergic Airway Inflammation. Front Immunol. 2018;9:2718 pubmed publisher
  438. Tordesillas L, Lozano Ojalvo D, Dunkin D, Mondoulet L, Agudo J, Merad M, et al. PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun. 2018;9:5238 pubmed publisher
  439. Quandt J, Schlude C, Bartoschek M, Will R, Cid Arregui A, Schölch S, et al. Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses. Oncoimmunology. 2018;7:e1500671 pubmed publisher
  440. Harrison O, Linehan J, Shih H, Bouladoux N, Han S, SMELKINSON M, et al. Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury. Science. 2019;363: pubmed publisher
  441. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  442. Uccellini M, Garcia Sastre A. ISRE-Reporter Mouse Reveals High Basal and Induced Type I IFN Responses in Inflammatory Monocytes. Cell Rep. 2018;25:2784-2796.e3 pubmed publisher
  443. Sorrelle N, Ganguly D, Dominguez A, Zhang Y, Huang H, Dahal L, et al. Improved Multiplex Immunohistochemistry for Immune Microenvironment Evaluation of Mouse Formalin-Fixed, Paraffin-Embedded Tissues. J Immunol. 2019;202:292-299 pubmed publisher
  444. Du X, de Almeida P, Manieri N, de Almeida Nagata D, Wu T, Harden Bowles K, et al. CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1. Proc Natl Acad Sci U S A. 2018;115:E11731-E11740 pubmed publisher
  445. Andre P, Denis C, Soulas C, Bourbon Caillet C, Lopez J, Arnoux T, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. 2018;175:1731-1743.e13 pubmed publisher
  446. Wiedemann G, Aithal C, Kraechan A, Heise C, Cadilha B, Zhang J, et al. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12:350-360 pubmed publisher
  447. Wu F, Xu P, Chow A, Man S, Kruger J, Khan K, et al. Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease. Br J Cancer. 2019;120:196-206 pubmed publisher
  448. Lopez M, Seyed Razavi Y, Jamali A, Harris D, Hamrah P. The Chemokine Receptor CXCR4 Mediates Recruitment of CD11c+ Conventional Dendritic Cells Into the Inflamed Murine Cornea. Invest Ophthalmol Vis Sci. 2018;59:5671-5681 pubmed publisher
  449. Muscate F, Stetter N, Schramm C, Schulze zur Wiesch J, Bosurgi L, Jacobs T. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018;9:2611 pubmed publisher
  450. Aarts S, Seijkens T, Kusters P, Van Tiel C, Reiche M, den Toom M, et al. Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis. J Pathol. 2019;247:471-480 pubmed publisher
  451. Inoue T, Ito Y, Nishizawa N, Eshima K, Kojo K, Otaka F, et al. RAMP1 in Kupffer cells is a critical regulator in immune-mediated hepatitis. PLoS ONE. 2018;13:e0200432 pubmed publisher
  452. Dong S, Harrington B, Hu E, Greene J, Lehman A, Tran M, et al. PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression. J Clin Invest. 2019;129:122-136 pubmed publisher
  453. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed publisher
  454. He Z, Zhang J, Huang Z, Du Q, Li N, Zhang Q, et al. Sumoylation of RORγt regulates TH17 differentiation and thymocyte development. Nat Commun. 2018;9:4870 pubmed publisher
  455. Casagrande F, de Souza Ferreira S, Nunes F, Romera L, Dos Santos S, Tessaro F, et al. Insulin Modulates Paracoccidioides brasiliensis-Induced Inflammation by Restoring the Populations of NK Cells, Dendritic Cells, and B Lymphocytes in Lungs. J Diabetes Res. 2018;2018:6209694 pubmed publisher
  456. James K, Cosway E, LUCAS B, White A, Parnell S, Carvalho Gaspar M, et al. Endothelial cells act as gatekeepers for LTβR-dependent thymocyte emigration. J Exp Med. 2018;215:2984-2993 pubmed publisher
  457. Walsh S, Bastin D, Chen L, Nguyen A, Storbeck C, Lefebvre C, et al. Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity. J Clin Invest. 2019;129:518-530 pubmed publisher
  458. Wilgenburg B, Loh L, Chen Z, Pediongco T, Wang H, Shi M, et al. MAIT cells contribute to protection against lethal influenza infection in vivo. Nat Commun. 2018;9:4706 pubmed publisher
  459. Ramanjulu J, Pesiridis G, Yang J, Concha N, Singhaus R, Zhang S, et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature. 2018;564:439-443 pubmed publisher
  460. Klement J, Paschall A, Redd P, Ibrahim M, Lu C, Yang D, et al. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128:5549-5560 pubmed publisher
  461. Nicol M, Campbell G, Shaw D, Dransfield I, Ligertwood Y, Beard P, et al. Lack of IFNγ signaling attenuates spread of influenza A virus in vivo and leads to reduced pathogenesis. Virology. 2019;526:155-164 pubmed publisher
  462. Hsu J, Dayaram T, Tovy A, De Braekeleer E, Jeong M, Wang F, et al. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy. Cell Stem Cell. 2018;23:700-713.e6 pubmed publisher
  463. Singh A, Khare P, Obaid A, Conlon K, Basrur V, Depinho R, et al. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2. Nat Commun. 2018;9:4515 pubmed publisher
  464. Bhagwandin C, Ashbeck E, Whalen M, Bandola Simon J, Roche P, Szajman A, et al. The E3 ubiquitin ligase MARCH1 regulates glucose-tolerance and lipid storage in a sex-specific manner. PLoS ONE. 2018;13:e0204898 pubmed publisher
  465. Meyer I, Goetzke C, Kespohl M, Sauter M, Heuser A, Eckstein V, et al. Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis. Front Immunol. 2018;9:2303 pubmed publisher
  466. Sheng C, Yao C, Wang Z, Chen H, Zhao Y, Xu D, et al. Cyclophilin J limits inflammation through the blockage of ubiquitin chain sensing. Nat Commun. 2018;9:4381 pubmed publisher
  467. Humblet Baron S, Barber J, Roca C, Lenaerts A, Koni P, Liston A. Murine myeloproliferative disorder as a consequence of impaired collaboration between dendritic cells and CD4 T cells. Blood. 2018;: pubmed publisher
  468. Noh J, Kim Y, Kim D, Hwang J, Kim K, Choi D, et al. Small heterodimer partner negatively regulates C-X-C motif chemokine ligand 2 in hepatocytes during liver inflammation. Sci Rep. 2018;8:15222 pubmed publisher
  469. Aydin E, Hallner A, Grauers Wiktorin H, Staffas A, Hellstrand K, Martner A. NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease. Oncogene. 2019;38:1534-1543 pubmed publisher
  470. Er J, Koean R, Ding J. Loss of T-bet confers survival advantage to influenza-bacterial superinfection. EMBO J. 2019;38: pubmed publisher
  471. Xu X, Xu J, Wu J, Hu Y, Han Y, Gu Y, et al. Phosphorylation-Mediated IFN-γR2 Membrane Translocation Is Required to Activate Macrophage Innate Response. Cell. 2018;175:1336-1351.e17 pubmed publisher
  472. Masuda J, Umemura C, Yokozawa M, Yamauchi K, Seko T, Yamashita M, et al. Dietary Supplementation of Selenoneine-Containing Tuna Dark Muscle Extract Effectively Reduces Pathology of Experimental Colorectal Cancers in Mice. Nutrients. 2018;10: pubmed publisher
  473. Luo H, Winkelmann E, Zhu S, Ru W, Mays E, Silvas J, et al. Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection. J Clin Invest. 2018;128:4980-4991 pubmed publisher
  474. Qiao G, Bucsek M, Winder N, Chen M, Giridharan T, Olejniczak S, et al. β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunol Immunother. 2019;68:11-22 pubmed publisher
  475. Williams G, Schonhoff A, Jurkuvenaite A, Thome A, Standaert D, Harms A. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease. J Neuroinflammation. 2018;15:244 pubmed publisher
  476. Schrand B, Clark E, Levay A, Capote A, Martínez O, Brenneman R, et al. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nat Commun. 2018;9:3348 pubmed publisher
  477. Cha J, Yang W, Xia W, Wei Y, Chan L, Lim S, et al. Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1. Mol Cell. 2018;71:606-620.e7 pubmed publisher
  478. Amôr N, de Oliveira C, Gasparoto T, Vilas Boas V, Perri G, Kaneno R, et al. ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate. Oncotarget. 2018;9:30894-30904 pubmed publisher
  479. Lin Y, Wang L, Lee C, Chen S. Flt3 ligand treatment reduces enterovirus A71 lethality in mice with enhanced B cell responses. Sci Rep. 2018;8:12184 pubmed publisher
  480. Zhao D, Kim Y, Jeong S, Greenson J, Chaudhry M, Hoepting M, et al. Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease. J Clin Invest. 2018;128:4970-4979 pubmed publisher
  481. White E, Gyulay G, Lhotak S, Szewczyk M, Chong T, Fuller M, et al. Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice. J Biol Chem. 2018;293:14689-14706 pubmed publisher
  482. Wang C, Oshima M, Sato D, Matsui H, Kubota S, Aoyama K, et al. Ezh2 loss propagates hypermethylation at T cell differentiation-regulating genes to promote leukemic transformation. J Clin Invest. 2018;128:3872-3886 pubmed publisher
  483. Stathopoulou C, Gangaplara A, Mallett G, Flomerfelt F, Liniany L, Knight D, et al. PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. Immunity. 2018;49:247-263.e7 pubmed publisher
  484. Poffenberger M, Metcalfe Roach A, Aguilar E, Chen J, Hsu B, Wong A, et al. LKB1 deficiency in T cells promotes the development of gastrointestinal polyposis. Science. 2018;361:406-411 pubmed publisher
  485. Baens M, Stirparo R, Lampi Y, Verbeke D, Vandepoel R, Cools J, et al. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice. Eur J Immunol. 2018;48:1728-1738 pubmed publisher
  486. Thyagarajan H, Lancaster J, Lira S, Ehrlich L. CCR8 is expressed by post-positive selection CD4-lineage thymocytes but is dispensable for central tolerance induction. PLoS ONE. 2018;13:e0200765 pubmed publisher
  487. Wan X, Zinselmeyer B, Zakharov P, Vomund A, Taniguchi R, Santambrogio L, et al. Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides. Nature. 2018;560:107-111 pubmed publisher
  488. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  489. Zhang C, Wang C, Jiang M, Gu C, Xiao J, Chen X, et al. Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun. 2018;9:2745 pubmed publisher
  490. Cho S, Lee H, Yu I, Choi Y, Huang H, Hashemifar S, et al. Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b. Nat Commun. 2018;9:2757 pubmed publisher
  491. Webster P, Dawes J, Dewchand H, Takacs K, Iadarola B, Bolt B, et al. Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidates. Nat Commun. 2018;9:2649 pubmed publisher
  492. Chute C, Yang X, Meyer K, Yang N, O Neil K, Kasza I, et al. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases. Breast Cancer Res. 2018;20:66 pubmed publisher
  493. Tan B, Shi X, Zhang J, Qin J, Zhang N, Ren H, et al. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization. Cancer Res. 2018;78:4929-4942 pubmed publisher
  494. Li J, Byrne K, Yan F, Yamazoe T, Chen Z, Baslan T, et al. Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity. 2018;49:178-193.e7 pubmed publisher
  495. Vendetti F, Karukonda P, Clump D, Teo T, Lalonde R, Nugent K, et al. ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation. J Clin Invest. 2018;128:3926-3940 pubmed publisher
  496. Kirkling M, Cytlak U, Lau C, Lewis K, Resteu A, Khodadadi Jamayran A, et al. Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells. Cell Rep. 2018;23:3658-3672.e6 pubmed publisher
  497. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
  498. Napolitano A, van der Veen A, Bunyan M, Borg A, Frith D, Howell S, et al. Cysteine-Reactive Free ISG15 Generates IL-1β-Producing CD8α+ Dendritic Cells at the Site of Infection. J Immunol. 2018;201:604-614 pubmed publisher
  499. Feng Y, Liao Y, Huang W, Lai X, Luo J, Du C, et al. Mesenchymal stromal cells-derived matrix Gla protein contribute to the alleviation of experimental colitis. Cell Death Dis. 2018;9:691 pubmed publisher
  500. Jones R, Cosway E, Willis C, White A, Jenkinson W, Fehling H, et al. Dynamic changes in intrathymic ILC populations during murine neonatal development. Eur J Immunol. 2018;48:1481-1491 pubmed publisher
  501. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  502. Baumgartner C, Toifl S, Farlik M, Halbritter F, Scheicher R, Fischer I, et al. An ERK-Dependent Feedback Mechanism Prevents Hematopoietic Stem Cell Exhaustion. Cell Stem Cell. 2018;22:879-892.e6 pubmed publisher
  503. Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360: pubmed publisher
  504. Kanneganti A, Malireddi R, Saavedra P, Vande Walle L, Van Gorp H, Kambara H, et al. GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever. J Exp Med. 2018;215:1519-1529 pubmed publisher
  505. Jun H, Yu H, Gong J, Jiang J, Qiao X, Perkey E, et al. An immune-beige adipocyte communication via nicotinic acetylcholine receptor signaling. Nat Med. 2018;24:814-822 pubmed publisher
  506. Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen H, Bastian D, Zhang M, et al. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018;128:2787-2801 pubmed publisher
  507. Pommier A, Anaparthy N, Memos N, Kelley Z, Gouronnec A, Yan R, et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science. 2018;360: pubmed publisher
  508. Huynh J, Lin C, Kimmey J, Jarjour N, Schwarzkopf E, Bradstreet T, et al. Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection. J Exp Med. 2018;215:1823-1838 pubmed publisher
  509. Bellelli R, Borel V, Logan C, Svendsen J, Cox D, Nye E, et al. Polε Instability Drives Replication Stress, Abnormal Development, and Tumorigenesis. Mol Cell. 2018;70:707-721.e7 pubmed publisher
  510. Stefani F, Eberstål S, Vergani S, Kristiansen T, Bengzon J. Low-dose irradiated mesenchymal stromal cells break tumor defensive properties in vivo. Int J Cancer. 2018;143:2200-2212 pubmed publisher
  511. Drobek A, Moudra A, Mueller D, Huranová M, Horková V, Pribikova M, et al. Strong homeostatic TCR signals induce formation of self-tolerant virtual memory CD8 T cells. EMBO J. 2018;37: pubmed publisher
  512. Borlido J, Sakuma S, Raices M, Carrette F, Tinoco R, Bradley L, et al. Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis. Nat Immunol. 2018;19:594-605 pubmed publisher
  513. Ubil E, Caskey L, Holtzhausen A, Hunter D, Story C, Earp H. Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response. J Clin Invest. 2018;128:2356-2369 pubmed publisher
  514. Takamori A, Nambu A, Sato K, Yamaguchi S, Matsuda K, Numata T, et al. IL-31 is crucial for induction of pruritus, but not inflammation, in contact hypersensitivity. Sci Rep. 2018;8:6639 pubmed publisher
  515. Gounder A, Yokoyama C, Jarjour N, Bricker T, Edelson B, Boon A. Interferon induced protein 35 exacerbates H5N1 influenza disease through the expression of IL-12p40 homodimer. PLoS Pathog. 2018;14:e1007001 pubmed publisher
  516. Emmerson A, Trevelin S, Mongue Din H, Becker P, Ortiz C, Smyth L, et al. Nox2 in regulatory T cells promotes angiotensin II-induced cardiovascular remodeling. J Clin Invest. 2018;128:3088-3101 pubmed publisher
  517. Anker J, Naseem A, Mok H, Schaeffer A, Abdulkadir S, Thumbikat P. Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy. Nat Commun. 2018;9:1591 pubmed publisher
  518. Tanaka S, Pfleger C, Lai J, Roan F, Sun S, Ziegler S. KAP1 Regulates Regulatory T Cell Function and Proliferation in Both Foxp3-Dependent and -Independent Manners. Cell Rep. 2018;23:796-807 pubmed publisher
  519. Silva M, Davoli Ferreira M, Medina T, Sesti Costa R, Silva G, Lopes C, et al. Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis. Nat Commun. 2018;9:1513 pubmed publisher
  520. Zheng X, Fang Z, Liu X, Deng S, Zhou P, Wang X, et al. Increased vessel perfusion predicts the efficacy of immune checkpoint blockade. J Clin Invest. 2018;128:2104-2115 pubmed publisher
  521. Foerster F, Boegel S, Heck R, Pickert G, R ssel N, Rosigkeit S, et al. Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells. Oncoimmunology. 2018;7:e1409929 pubmed publisher
  522. Peranzoni E, Lemoine J, Vimeux L, Feuillet V, Barrin S, Kantari Mimoun C, et al. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci U S A. 2018;115:E4041-E4050 pubmed publisher
  523. Carrasco S, Hu S, Imai D, Kumar R, Sandusky G, Yang X, et al. Toll-like receptor 3 (TLR3) promotes the resolution of Chlamydia muridarum genital tract infection in congenic C57BL/6N mice. PLoS ONE. 2018;13:e0195165 pubmed publisher
  524. Prado C, Gaiazzi M, Gonzalez H, Ugalde V, Figueroa A, Osorio Barrios F, et al. Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis. Front Immunol. 2018;9:571 pubmed publisher
  525. Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. 2018;173:634-648.e12 pubmed publisher
  526. Lee J, Park J, Nam T, Seo S, Kim J, Lee H, et al. Differences between immunodeficient mice generated by classical gene targeting and CRISPR/Cas9-mediated gene knockout. Transgenic Res. 2018;27:241-251 pubmed publisher
  527. Harker J, Wong K, Dallari S, Bao P, Dolgoter A, Jo Y, et al. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection. J Virol. 2018;92: pubmed publisher
  528. Xiao G, Chan L, Klemm L, Braas D, Chen Z, Geng H, et al. B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies. Cell. 2018;173:470-484.e18 pubmed publisher
  529. Xi J, Huang Q, Wang L, Ma X, Deng Q, Kumar M, et al. miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy. Oncogene. 2018;37:3151-3165 pubmed publisher
  530. Sun H, Lagarrigue F, Gingras A, Fan Z, Ley K, Ginsberg M. Transmission of integrin β7 transmembrane domain topology enables gut lymphoid tissue development. J Cell Biol. 2018;217:1453-1465 pubmed publisher
  531. Macdougall C, Wood E, Loschko J, Scagliotti V, Cassidy F, Robinson M, et al. Visceral Adipose Tissue Immune Homeostasis Is Regulated by the Crosstalk between Adipocytes and Dendritic Cell Subsets. Cell Metab. 2018;27:588-601.e4 pubmed publisher
  532. Tang C, Chang S, Paton A, Paton J, Gabrilovich D, Ploegh H, et al. Phosphorylation of IRE1 at S729 regulates RIDD in B cells and antibody production after immunization. J Cell Biol. 2018;217:1739-1755 pubmed publisher
  533. Metghalchi S, Vandestienne M, Haddad Y, Esposito B, Dairou J, Tedgui A, et al. Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet. PLoS ONE. 2018;13:e0193737 pubmed publisher
  534. Khan A, Carpenter B, Santos e Sousa P, Pospori C, Khorshed R, Griffin J, et al. Redirection to the bone marrow improves T cell persistence and antitumor functions. J Clin Invest. 2018;128:2010-2024 pubmed publisher
  535. Hailemichael Y, Woods A, Fu T, He Q, Nielsen M, Hasan F, et al. Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018;128:1338-1354 pubmed publisher
  536. Lee Y, Lee J, Jang Y, Seo S, Chang J, Seong B. Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine. Front Microbiol. 2018;9:83 pubmed publisher
  537. Kim I, Kim K, Lee E, Oh D, Park C, Park S, et al. Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality. J Exp Med. 2018;215:963-983 pubmed publisher
  538. A Verghese D, Demir M, Chun N, Fribourg M, Cravedi P, Llaudó I, et al. T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival. J Immunol. 2018;200:2186-2198 pubmed publisher
  539. Perry C, Muñoz Rojas A, Meeth K, Kellman L, Amezquita R, Thakral D, et al. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med. 2018;215:877-893 pubmed publisher
  540. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  541. Liang W, Mao S, Sun S, Li M, Li Z, Yu R, et al. Core Fucosylation of the T Cell Receptor Is Required for T Cell Activation. Front Immunol. 2018;9:78 pubmed publisher
  542. Fahl S, Coffey F, Kain L, Zarin P, Dunbrack R, Teyton L, et al. Role of a selecting ligand in shaping the murine γδ-TCR repertoire. Proc Natl Acad Sci U S A. 2018;115:1889-1894 pubmed publisher
  543. Mathew N, Baumgartner F, Braun L, O Sullivan D, Thomas S, Waterhouse M, et al. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med. 2018;24:282-291 pubmed publisher
  544. Böttcher J, Bonavita E, Chakravarty P, Blees H, Cabeza Cabrerizo M, Sammicheli S, et al. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. Cell. 2018;172:1022-1037.e14 pubmed publisher
  545. Anderson A, Baranowska Hustad M, Braathen R, Grodeland G, Bogen B. Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza. J Immunol. 2018;200:2057-2066 pubmed publisher
  546. Dejea C, Fathi P, Craig J, Boleij A, Taddese R, Geis A, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018;359:592-597 pubmed publisher
  547. Ellestad K, Thangavelu G, Haile Y, Lin J, Boon L, Anderson C. Prior to Peripheral Tolerance, Newly Generated CD4 T Cells Maintain Dangerous Autoimmune Potential: Fas- and Perforin-Independent Autoimmunity Controlled by Programmed Death-1. Front Immunol. 2018;9:12 pubmed publisher
  548. Doorduijn E, Sluijter M, Marijt K, Querido B, van der Burg S, van Hall T. T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy. Oncoimmunology. 2018;7:e1382793 pubmed publisher
  549. Ehlers L, Rohde S, Ibrahim S, Jaster R. Adoptive transfer of CD3+ T cells and CD4+ CD44high memory T cells induces autoimmune pancreatitis in MRL/MpJ mice. J Cell Mol Med. 2018;22:2404-2412 pubmed publisher
  550. Wheeler D, Sariol A, Meyerholz D, Perlman S. Microglia are required for protection against lethal coronavirus encephalitis in mice. J Clin Invest. 2018;128:931-943 pubmed publisher
  551. Solanki A, Yanez D, Ross S, Lau C, Papaioannou E, Li J, et al. Gli3 in fetal thymic epithelial cells promotes thymocyte positive selection and differentiation by repression of Shh. Development. 2018;145: pubmed publisher
  552. Delong J, Hall A, Konradt C, Coppock G, Park J, Harms Pritchard G, et al. Cytokine- and TCR-Mediated Regulation of T Cell Expression of Ly6C and Sca-1. J Immunol. 2018;200:1761-1770 pubmed publisher
  553. Scott J, Lebratti T, Richner J, Jiang X, Fernandez E, Zhao H, et al. Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice. J Virol. 2018;92: pubmed publisher
  554. Turner D, Goldklang M, Cvetkovski F, Paik D, Trischler J, Barahona J, et al. Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the Pathogenesis of Allergic Asthma. J Immunol. 2018;200:1561-1569 pubmed publisher
  555. Tang H, Liang Y, Anders R, Taube J, Qiu X, Mulgaonkar A, et al. PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression. J Clin Invest. 2018;128:580-588 pubmed publisher
  556. Tavazoie M, Pollack I, Tanqueco R, Ostendorf B, Reis B, Gonsalves F, et al. LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer. Cell. 2018;172:825-840.e18 pubmed publisher
  557. Ferdinand J, Richard A, Meylan F, Al Shamkhani A, Siegel R. Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells. J Immunol. 2018;200:1360-1369 pubmed publisher
  558. Kaufmann E, Sanz J, Dunn J, Khan N, Mendonça L, Pacis A, et al. BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis. Cell. 2018;172:176-190.e19 pubmed publisher
  559. Garaycoechea J, Crossan G, Langevin F, Mulderrig L, Louzada S, Yang F, et al. Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. Nature. 2018;553:171-177 pubmed publisher
  560. Nakashima H, Alayo Q, Penaloza MacMaster P, Freeman G, Kuchroo V, Reardon D, et al. Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells. Sci Rep. 2018;8:208 pubmed publisher
  561. Choi I, Wang Z, Ke Q, Hong M, Qian Y, Zhao X, et al. Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses. Proc Natl Acad Sci U S A. 2018;115:E686-E695 pubmed publisher
  562. Guarnerio J, Mendez L, Asada N, Menon A, Fung J, Berry K, et al. A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche. Nat Commun. 2018;9:66 pubmed publisher
  563. Pan D, Kobayashi A, Jiang P, Ferrari de Andrade L, Tay R, Luoma A, et al. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. Science. 2018;359:770-775 pubmed publisher
  564. Cowan J, Baik S, McCarthy N, Parnell S, White A, Jenkinson W, et al. Aire controls the recirculation of murine Foxp3+ regulatory T-cells back to the thymus. Eur J Immunol. 2018;48:844-854 pubmed publisher
  565. Lynch J, Werder R, Loh Z, Sikder M, Curren B, Zhang V, et al. Plasmacytoid dendritic cells protect from viral bronchiolitis and asthma through semaphorin 4a-mediated T reg expansion. J Exp Med. 2018;215:537-557 pubmed publisher
  566. Zhang Y, Khairallah C, Sheridan B, van der Velden A, Bliska J. CCR2+ Inflammatory Monocytes Are Recruited to Yersinia pseudotuberculosis Pyogranulomas and Dictate Adaptive Responses at the Expense of Innate Immunity during Oral Infection. Infect Immun. 2018;86: pubmed publisher
  567. Guimarães G, Gomes M, Campos P, Marinho F, de Assis N, Silveira T, et al. Immunoproteasome Subunits Are Required for CD8+ T Cell Function and Host Resistance to Brucella abortus Infection in Mice. Infect Immun. 2018;86: pubmed publisher
  568. Burrack A, Malhotra D, Dileepan T, Osum K, Swanson L, Fife B, et al. Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides. J Immunol. 2018;200:477-482 pubmed publisher
  569. Matsuo K, Nagakubo D, Yamamoto S, Shigeta A, Tomida S, Fujita M, et al. CCL28-Deficient Mice Have Reduced IgA Antibody-Secreting Cells and an Altered Microbiota in the Colon. J Immunol. 2018;200:800-809 pubmed publisher
  570. Medaglia C, Giladi A, Stoler Barak L, De Giovanni M, Salame T, Biram A, et al. Spatial reconstruction of immune niches by combining photoactivatable reporters and scRNA-seq. Science. 2017;358:1622-1626 pubmed publisher
  571. Pedros C, Canonigo Balancio A, Kong K, Altman A. Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity. JCI Insight. 2017;2: pubmed publisher
  572. Iseka F, Goetz B, Mushtaq I, An W, Cypher L, Bielecki T, et al. Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. J Immunol. 2018;200:483-499 pubmed publisher
  573. Kortlever R, Sodir N, Wilson C, Burkhart D, Pellegrinet L, Brown Swigart L, et al. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017;171:1301-1315.e14 pubmed publisher
  574. Engblom C, Pfirschke C, Zilionis R, da Silva Martins J, Bos S, Courties G, et al. Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils. Science. 2017;358: pubmed publisher
  575. Zhang J, Bu X, Wang H, Zhu Y, Geng Y, Nihira N, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature. 2018;553:91-95 pubmed publisher
  576. Mailer R, Gisterå A, Polyzos K, Ketelhuth D, Hansson G. Hypercholesterolemia Enhances T Cell Receptor Signaling and Increases the Regulatory T Cell Population. Sci Rep. 2017;7:15655 pubmed publisher
  577. Whitney P, Makhlouf C, MacLeod B, Ma J, Gressier E, Greyer M, et al. Effective Priming of Herpes Simplex Virus-Specific CD8+ T Cells In Vivo Does Not Require Infected Dendritic Cells. J Virol. 2018;92: pubmed publisher
  578. Robles Valero J, Lorenzo Martín L, Menacho Márquez M, Fernández Pisonero I, Abad A, Camos M, et al. A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia. Cancer Cell. 2017;32:608-623.e9 pubmed publisher
  579. Singh M, Vianden C, Cantwell M, Dai Z, Xiao Z, Sharma M, et al. Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain. Nat Commun. 2017;8:1447 pubmed publisher
  580. Kwak J, Laskowski J, Li H, McSharry M, Sippel T, Bullock B, et al. Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res. 2018;78:143-156 pubmed publisher
  581. Widjaja Adhi M, Palczewski G, Dale K, Knauss E, Kelly M, Golczak M, et al. Transcription factor ISX mediates the cross talk between diet and immunity. Proc Natl Acad Sci U S A. 2017;114:11530-11535 pubmed publisher
  582. Mao A, Ishizuka I, Kasal D, Mandal M, Bendelac A. A shared Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage development. Nat Commun. 2017;8:863 pubmed publisher
  583. Glasner A, Isaacson B, Viukov S, Neuman T, Friedman N, Mandelboim M, et al. Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression. Sci Rep. 2017;7:13090 pubmed publisher
  584. Capece T, Walling B, Lim K, Kim K, Bae S, Chung H, et al. A novel intracellular pool of LFA-1 is critical for asymmetric CD8+ T cell activation and differentiation. J Cell Biol. 2017;216:3817-3829 pubmed publisher
  585. Francis N, Every A, Ayodele B, Pike R, Mackie E, Pagel C. A T cell-specific knockout reveals an important role for protease-activated receptor 2 in lymphocyte development. Int J Biochem Cell Biol. 2017;92:95-103 pubmed publisher
  586. Sasaki F, Koga T, Saeki K, Okuno T, Kazuno S, Fujimura T, et al. Biochemical and immunological characterization of a novel monoclonal antibody against mouse leukotriene B4 receptor 1. PLoS ONE. 2017;12:e0185133 pubmed publisher
  587. Wallrapp A, Riesenfeld S, Burkett P, Abdulnour R, Nyman J, Dionne D, et al. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. Nature. 2017;549:351-356 pubmed publisher
  588. Jung K, Heishi T, Incio J, Huang Y, Beech E, Pinter M, et al. Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer. Proc Natl Acad Sci U S A. 2017;114:10455-10460 pubmed publisher
  589. Koyanagi N, Imai T, Shindo K, Sato A, Fujii W, Ichinohe T, et al. Herpes simplex virus-1 evasion of CD8+ T cell accumulation contributes to viral encephalitis. J Clin Invest. 2017;127:3784-3795 pubmed publisher
  590. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher
  591. Kumar B, Garcia M, Weng L, Jung X, Murakami J, Hu X, et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia. 2018;32:575-587 pubmed publisher
  592. Goel S, Decristo M, Watt A, BrinJones H, Sceneay J, Li B, et al. CDK4/6 inhibition triggers anti-tumour immunity. Nature. 2017;548:471-475 pubmed publisher
  593. Kim J, Kim Y, Kim J, Park D, Bae H, Lee D, et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017;127:3441-3461 pubmed publisher
  594. Cho C, Smallwood P, Nathans J. Reck and Gpr124 Are Essential Receptor Cofactors for Wnt7a/Wnt7b-Specific Signaling in Mammalian CNS Angiogenesis and Blood-Brain Barrier Regulation. Neuron. 2017;95:1056-1073.e5 pubmed publisher
  595. Sinclair C, Bommakanti G, Gardinassi L, Loebbermann J, Johnson M, Hakimpour P, et al. mTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation. Science. 2017;357:1014-1021 pubmed publisher
  596. Earl P, Americo J, Moss B. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection. J Virol. 2017;91: pubmed publisher
  597. Wang Y, Yun C, Gao B, Xu Y, Zhang Y, Wang Y, et al. The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation. Cell Rep. 2017;20:600-612 pubmed publisher
  598. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  599. Alloatti A, Rookhuizen D, Joannas L, Carpier J, Iborra S, Magalhaes J, et al. Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity. J Exp Med. 2017;214:2231-2241 pubmed publisher
  600. Lingel H, Wissing J, Arra A, Schanze D, Lienenklaus S, Klawonn F, et al. CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation. Cell Death Differ. 2017;24:1739-1749 pubmed publisher
  601. Hasan Z, Koizumi S, Sasaki D, Yamada H, Arakaki N, Fujihara Y, et al. JunB is essential for IL-23-dependent pathogenicity of Th17 cells. Nat Commun. 2017;8:15628 pubmed publisher
  602. Escribà Garcia L, Alvarez Fernández C, Tellez Gabriel M, Sierra J, Briones J. Dendritic cells combined with tumor cells and ?-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma. J Transl Med. 2017;15:115 pubmed publisher
  603. Mendoza A, Fang V, Chen C, Serasinghe M, Verma A, Muller J, et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature. 2017;546:158-161 pubmed publisher
  604. Mildner A, Schönheit J, Giladi A, David E, Lara Astiaso D, Lorenzo Vivas E, et al. Genomic Characterization of Murine Monocytes Reveals C/EBP? Transcription Factor Dependence of Ly6C- Cells. Immunity. 2017;46:849-862.e7 pubmed publisher
  605. Miyazaki M, Miyazaki K, Chen K, Jin Y, Turner J, Moore A, et al. The E-Id Protein Axis Specifies Adaptive Lymphoid Cell Identity and Suppresses Thymic Innate Lymphoid Cell Development. Immunity. 2017;46:818-834.e4 pubmed publisher
  606. Gordon S, Maute R, Dulken B, Hutter G, George B, McCracken M, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545:495-499 pubmed publisher
  607. Jinnohara T, Kanaya T, Hase K, Sakakibara S, Kato T, Tachibana N, et al. IL-22BP dictates characteristics of Peyer's patch follicle-associated epithelium for antigen uptake. J Exp Med. 2017;214:1607-1618 pubmed publisher
  608. Torcellan T, Hampton H, Bailey J, Tomura M, Brink R, Chtanova T. In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors. Proc Natl Acad Sci U S A. 2017;114:5677-5682 pubmed publisher
  609. Hara T, Nakaoka H, Hayashi T, Mimura K, Hoshino D, Inoue M, et al. Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes. Proc Natl Acad Sci U S A. 2017;114:E4416-E4424 pubmed publisher
  610. Kraakman M, Lee M, Al Sharea A, Dragoljevic D, Barrett T, Montenont E, et al. Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest. 2017;127:2133-2147 pubmed publisher
  611. Zhang C, Feng J, Du J, Zhuo Z, Yang S, Zhang W, et al. Macrophage-derived IL-1α promotes sterile inflammation in a mouse model of acetaminophen hepatotoxicity. Cell Mol Immunol. 2018;15:973-982 pubmed publisher
  612. Tang A, Choi J, Kotzin J, Yang Y, Hong C, Hobson N, et al. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature. 2017;545:305-310 pubmed publisher
  613. Miao T, Symonds A, Singh R, Symonds J, Ogbe A, Omodho B, et al. Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation. J Exp Med. 2017;214:1787-1808 pubmed publisher
  614. Kwan B, Zhu E, Tzeng A, Sugito H, Eltahir A, Ma B, et al. Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses. J Exp Med. 2017;214:1679-1690 pubmed publisher
  615. Chowdhary V, Krogman A, Tilahun A, Alexander M, David C, Rajagopalan G. Concomitant Disruption of CD4 and CD8 Genes Facilitates the Development of Double Negative ?? TCR+ Peripheral T Cells That Respond Robustly to Staphylococcal Superantigen. J Immunol. 2017;198:4413-4424 pubmed publisher
  616. Kammertoens T, Friese C, Arina A, Idel C, Briesemeister D, Rothe M, et al. Tumour ischaemia by interferon-? resembles physiological blood vessel regression. Nature. 2017;545:98-102 pubmed publisher
  617. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  618. Zhang H, Luo J, Alcorn J, Chen K, Fan S, Pilewski J, et al. AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality. J Immunol. 2017;198:4383-4393 pubmed publisher
  619. Ma S, Wan X, Deng Z, Shi L, Hao C, Zhou Z, et al. Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs. J Exp Med. 2017;214:1471-1491 pubmed publisher
  620. Lee H, Tian L, Bouladoux N, Davis J, Quinones M, Belkaid Y, et al. Dendritic cells expressing immunoreceptor CD300f are critical for controlling chronic gut inflammation. J Clin Invest. 2017;127:1905-1917 pubmed publisher
  621. Fu G, Xu Q, Qiu Y, Jin X, Xu T, Dong S, et al. Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1. J Exp Med. 2017;214:1453-1469 pubmed publisher
  622. Claser C, de Souza J, Thorburn S, Grau G, Riley E, Renia L, et al. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling. Infect Immun. 2017;85: pubmed publisher
  623. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  624. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  625. Chen Y, Wu K, Wu K, Wu K, Tsai H, Chen M, et al. Recombinant Adeno-Associated Virus-Mediated Expression of Methamphetamine Antibody Attenuates Methamphetamine-Induced Hyperactivity in Mice. Sci Rep. 2017;7:46301 pubmed publisher
  626. Bouziat R, Hinterleitner R, Brown J, Stencel Baerenwald J, Ikizler M, Mayassi T, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356:44-50 pubmed publisher
  627. Daniels B, Snyder A, Olsen T, Orozco S, Oguin T, Tait S, et al. RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation. Cell. 2017;169:301-313.e11 pubmed publisher
  628. Connolly N, Stokum J, Schneider C, Ozawa T, Xu S, Galisteo R, et al. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. PLoS ONE. 2017;12:e0174557 pubmed publisher
  629. Kitada S, Kayama H, Okuzaki D, Koga R, Kobayashi M, Arima Y, et al. BATF2 inhibits immunopathological Th17 responses by suppressing Il23a expression during Trypanosoma cruzi infection. J Exp Med. 2017;214:1313-1331 pubmed publisher
  630. Schweighoffer E, Nys J, Vanes L, Smithers N, Tybulewicz V. TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK. J Exp Med. 2017;214:1269-1280 pubmed publisher
  631. Guo Q, Minnier J, Burchard J, Chiotti K, Spellman P, Schedin P. Physiologically activated mammary fibroblasts promote postpartum mammary cancer. JCI Insight. 2017;2:e89206 pubmed publisher
  632. Thomas D, Clare S, Sowerby J, Pardo M, Juss J, Goulding D, et al. Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity. J Exp Med. 2017;214:1111-1128 pubmed publisher
  633. He W, Wang C, Mu R, Liang P, Huang Z, Zhang J, et al. MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles. Oncogene. 2017;36:4212-4223 pubmed publisher
  634. Liu Z, Ravindranathan R, Kalinski P, Guo Z, Bartlett D. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Nat Commun. 2017;8:14754 pubmed publisher
  635. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed publisher
  636. Klein J, Moses K, Zelinskyy G, Sody S, Buer J, Lang S, et al. Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth. Nat Commun. 2017;8:14600 pubmed publisher
  637. Bhattacharyya M, Penaloza MacMaster P. T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells. Immunology. 2017;151:340-348 pubmed publisher
  638. Ansa Addo E, Zhang Y, Yang Y, Hussey G, Howley B, Salem M, et al. Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling. J Clin Invest. 2017;127:1321-1337 pubmed publisher
  639. Ravindran D, Ridiandries A, Vanags L, Henriquez R, Cartland S, Tan J, et al. Chemokine binding protein 'M3' limits atherosclerosis in apolipoprotein E-/- mice. PLoS ONE. 2017;12:e0173224 pubmed publisher
  640. Pishesha N, Bilate A, Wibowo M, Huang N, Li Z, Deshycka R, et al. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proc Natl Acad Sci U S A. 2017;114:3157-3162 pubmed publisher
  641. Obeid S, Wankell M, Charrez B, Sternberg J, Kreuter R, Esmaili S, et al. Adiponectin confers protection from acute colitis and restricts a B cell immune response. J Biol Chem. 2017;292:6569-6582 pubmed publisher
  642. Ramos G, van den Berg A, Nunes Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A. 2017;114:E2420-E2429 pubmed publisher
  643. Guidi N, Sacma M, Ständker L, Soller K, Marka G, Eiwen K, et al. Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells. EMBO J. 2017;36:840-853 pubmed publisher
  644. Fisher S, Aston W, Chee J, Khong A, Cleaver A, Solin J, et al. Transient Treg depletion enhances therapeutic anti-cancer vaccination. Immun Inflamm Dis. 2017;5:16-28 pubmed publisher
  645. Ho T, Warr M, Adelman E, Lansinger O, Flach J, Verovskaya E, et al. Autophagy maintains the metabolism and function of young and old stem cells. Nature. 2017;543:205-210 pubmed publisher
  646. Rubtsova K, Rubtsov A, Thurman J, Mennona J, Kappler J, Marrack P. B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest. 2017;127:1392-1404 pubmed publisher
  647. Zhao Y, Carroll D, You Y, Chaiswing L, Wen R, Batinic Haberle I, et al. A novel redox regulator, MnTnBuOE-2-PyP5+, enhances normal hematopoietic stem/progenitor cell function. Redox Biol. 2017;12:129-138 pubmed publisher
  648. Sanges S, Jendoubi M, Kavian N, Hauspie C, Speca S, Crave J, et al. B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis. Front Immunol. 2017;8:53 pubmed publisher
  649. Rossey I, Gilman M, Kabeche S, Sedeyn K, Wrapp D, Kanekiyo M, et al. Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nat Commun. 2017;8:14158 pubmed publisher
  650. Knudson K, Pritzl C, Saxena V, Altman A, Daniels M, Teixeiro E. NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality. Proc Natl Acad Sci U S A. 2017;114:E1659-E1667 pubmed publisher
  651. Ying W, Wollam J, Ofrecio J, Bandyopadhyay G, El Ouarrat D, Lee Y, et al. Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling. J Clin Invest. 2017;127:1019-1030 pubmed publisher
  652. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  653. Cortez Toledo O, Schnair C, Sangngern P, Metzger D, Chao L. Nur77 deletion impairs muscle growth during developmental myogenesis and muscle regeneration in mice. PLoS ONE. 2017;12:e0171268 pubmed publisher
  654. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed publisher
  655. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed publisher
  656. Oh J, Oh D, Jung H, Lee H. A mechanism for the induction of type 2 immune responses by a protease allergen in the genital tract. Proc Natl Acad Sci U S A. 2017;114:E1188-E1195 pubmed publisher
  657. Ishiguro T, Fukawa T, Akaki K, Nagaoka K, Takeda T, Iwakura Y, et al. Absence of DCIR1 reduces the mortality rate of endotoxemic hepatitis in mice. Eur J Immunol. 2017;47:704-712 pubmed publisher
  658. van Nieuwenhuijze A, Dooley J, Humblet Baron S, Sreenivasan J, Koenders M, Schlenner S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74:2095-2106 pubmed publisher
  659. Berghoff S, Gerndt N, Winchenbach J, Stumpf S, Hosang L, Odoardi F, et al. Dietary cholesterol promotes repair of demyelinated lesions in the adult brain. Nat Commun. 2017;8:14241 pubmed publisher
  660. Edwards R, Kopp S, Ifergan I, Shui J, Kronenberg M, Miller S, et al. Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy. Invest Ophthalmol Vis Sci. 2017;58:282-291 pubmed publisher
  661. Welsby I, Detienne S, N kuli F, Thomas S, Wouters S, Bechtold V, et al. Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21. Front Immunol. 2016;7:663 pubmed publisher
  662. Yanagita T, Murata Y, Tanaka D, Motegi S, Arai E, Daniwijaya E, et al. Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy. JCI Insight. 2017;2:e89140 pubmed publisher
  663. Chamoto K, Chowdhury P, Kumar A, Sonomura K, Matsuda F, Fagarasan S, et al. Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity. Proc Natl Acad Sci U S A. 2017;114:E761-E770 pubmed publisher
  664. Zhu J, Cifuentes H, Reynolds J, Lamba D. Immunosuppression via Loss of IL2rγ Enhances Long-Term Functional Integration of hESC-Derived Photoreceptors in the Mouse Retina. Cell Stem Cell. 2017;20:374-384.e5 pubmed publisher
  665. Oben K, Gachuki B, Alhakeem S, McKenna M, Liang Y, St Clair D, et al. Radiation Induced Apoptosis of Murine Bone Marrow Cells Is Independent of Early Growth Response 1 (EGR1). PLoS ONE. 2017;12:e0169767 pubmed publisher
  666. Yamamura K, Uruno T, Shiraishi A, Tanaka Y, Ushijima M, Nakahara T, et al. The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction. Nat Commun. 2017;8:13946 pubmed publisher
  667. Ai J, Li J, Gessler D, Su Q, Wei Q, Li H, et al. Adeno-associated virus serotype rh.10 displays strong muscle tropism following intraperitoneal delivery. Sci Rep. 2017;7:40336 pubmed publisher
  668. Rowe A, Yun H, Treat B, Kinchington P, Hendricks R. Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen. J Immunol. 2017;198:1706-1717 pubmed publisher
  669. Atkin Smith G, Paone S, Zanker D, Duan M, Phan T, Chen W, et al. Isolation of cell type-specific apoptotic bodies by fluorescence-activated cell sorting. Sci Rep. 2017;7:39846 pubmed publisher
  670. Cañete A, Carmona R, Ariza L, Sanchez M, Rojas A, Muñoz Chápuli R. A population of hematopoietic stem cells derives from GATA4-expressing progenitors located in the placenta and lateral mesoderm of mice. Haematologica. 2017;102:647-655 pubmed publisher
  671. van der Weyden L, Arends M, Campbell A, Bald T, Wardle Jones H, Griggs N, et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature. 2017;541:233-236 pubmed publisher
  672. Larabee C, Desai S, Agasing A, Georgescu C, Wren J, Axtell R, et al. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis. Mol Vis. 2016;22:1503-1513 pubmed
  673. Engler J, Kursawe N, Solano M, Patas K, Wehrmann S, Heckmann N, et al. Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy. Proc Natl Acad Sci U S A. 2017;114:E181-E190 pubmed publisher
  674. Hayakawa M, Hayakawa H, Petrova T, Ritprajak P, Sutavani R, Jiménez Andrade G, et al. Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction. J Biol Chem. 2017;292:1762-1772 pubmed publisher
  675. Aguilera T, Rafat M, Castellini L, Shehade H, Kariolis M, Hui A, et al. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nat Commun. 2016;7:13898 pubmed publisher
  676. Lamprianou S, Gysemans C, Bou Saab J, Pontes H, Mathieu C, Meda P. Glibenclamide Prevents Diabetes in NOD Mice. PLoS ONE. 2016;11:e0168839 pubmed publisher
  677. Li M, Li Z, Yao Y, Jin W, Wood K, Liu Q, et al. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. Proc Natl Acad Sci U S A. 2017;114:E396-E405 pubmed publisher
  678. Karki R, Man S, Malireddi R, Kesavardhana S, Zhu Q, Burton A, et al. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Nature. 2016;540:583-587 pubmed publisher
  679. Wei Y, Lu C, Chen J, Cui G, Wang L, Yu T, et al. High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget. 2017;8:70-82 pubmed publisher
  680. Bieber K, Witte M, Sun S, Hundt J, Kalies K, Dräger S, et al. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita. Sci Rep. 2016;6:38357 pubmed publisher
  681. Ikawa T, Masuda K, Endo T, Endo M, Isono K, Koseki Y, et al. Conversion of T cells to B cells by inactivation of polycomb-mediated epigenetic suppression of the B-lineage program. Genes Dev. 2016;30:2475-2485 pubmed
  682. Moroishi T, Hayashi T, Pan W, Fujita Y, Holt M, Qin J, et al. The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. Cell. 2016;167:1525-1539.e17 pubmed publisher
  683. Semenkovich N, Planer J, Ahern P, Griffin N, Lin C, Gordon J. Impact of the gut microbiota on enhancer accessibility in gut intraepithelial lymphocytes. Proc Natl Acad Sci U S A. 2016;113:14805-14810 pubmed publisher
  684. Morita K, Okamura T, Inoue M, Komai T, Teruya S, Iwasaki Y, et al. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production. Proc Natl Acad Sci U S A. 2016;113:E8131-E8140 pubmed
  685. Swanson P, Hart G, Russo M, Nayak D, Yazew T, Pena M, et al. CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature. PLoS Pathog. 2016;12:e1006022 pubmed publisher
  686. Ma C, Mishra S, Demel E, Liu Y, Zhang N. TGF-? Controls the Formation of Kidney-Resident T Cells via Promoting Effector T Cell Extravasation. J Immunol. 2017;198:749-756 pubmed publisher
  687. Angela M, Endo Y, Asou H, Yamamoto T, Tumes D, Tokuyama H, et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR? directs early activation of T cells. Nat Commun. 2016;7:13683 pubmed publisher
  688. Kretzer N, Theisen D, Tussiwand R, Briseño C, Grajales Reyes G, Wu X, et al. RAB43 facilitates cross-presentation of cell-associated antigens by CD8?+ dendritic cells. J Exp Med. 2016;213:2871-2883 pubmed
  689. Khameneh H, Ho A, Spreafico R, Derks H, Quek H, Mortellaro A. The Syk-NFAT-IL-2 Pathway in Dendritic Cells Is Required for Optimal Sterile Immunity Elicited by Alum Adjuvants. J Immunol. 2017;198:196-204 pubmed
  690. Brinza L, Djebali S, Tomkowiak M, Mafille J, Loiseau C, Jouve P, et al. Immune signatures of protective spleen memory CD8 T cells. Sci Rep. 2016;6:37651 pubmed publisher
  691. Le Q, Yao W, Chen Y, Yan B, Liu C, Yuan M, et al. GRK6 regulates ROS response and maintains hematopoietic stem cell self-renewal. Cell Death Dis. 2016;7:e2478 pubmed publisher
  692. Wang X, Cao Q, Yu L, Shi H, Xue B, Shi H. Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity. JCI Insight. 2016;1:e87748 pubmed publisher
  693. Kuchmiy A, D Hont J, Hochepied T, Lamkanfi M. NLRP2 controls age-associated maternal fertility. J Exp Med. 2016;213:2851-2860 pubmed
  694. Sektioglu I, Carretero R, Bulbuc N, Bald T, Tüting T, Rudensky A, et al. Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells. Cancer Res. 2017;77:291-302 pubmed publisher
  695. Kimura Y, Inoue A, Hangai S, Saijo S, Negishi H, Nishio J, et al. The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis. Proc Natl Acad Sci U S A. 2016;113:14097-14102 pubmed
  696. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  697. Yu V, Yusuf R, Oki T, Wu J, Saez B, Wang X, et al. Epigenetic Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem Cells. Cell. 2016;167:1310-1322.e17 pubmed publisher
  698. Srivastava R, Khan A, Garg S, Syed S, Furness J, Vahed H, et al. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocula. J Virol. 2017;91: pubmed publisher
  699. Bassett E, Tokarew N, Allemano E, Mazerolle C, Morin K, Mears A, et al. Norrin/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation. elife. 2016;5: pubmed publisher
  700. Park K, Mikulski Z, Seo G, Andreyev A, Marcovecchio P, Blatchley A, et al. The transcription factor NR4A3 controls CD103+ dendritic cell migration. J Clin Invest. 2016;126:4603-4615 pubmed publisher
  701. Laurent C, Dorothee G, Hunot S, Martin E, Monnet Y, Duchamp M, et al. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain. 2017;140:184-200 pubmed publisher
  702. Hu Y, Kim J, He K, Wan Q, Kim J, Flach M, et al. Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion. J Exp Med. 2016;213:2759-2772 pubmed
  703. Zamora Pineda J, Kumar A, Suh J, Zhang M, Saba J. Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress. J Exp Med. 2016;213:2773-2791 pubmed
  704. Hirako I, Ataide M, Faustino L, Assis P, Sorensen E, Ueta H, et al. Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun. 2016;7:13277 pubmed publisher
  705. Kirschbaum K, Sonner J, Zeller M, Deumelandt K, Bode J, Sharma R, et al. In vivo nanoparticle imaging of innate immune cells can serve as a marker of disease severity in a model of multiple sclerosis. Proc Natl Acad Sci U S A. 2016;113:13227-13232 pubmed
  706. Jirmo A, Daluege K, Happle C, Albrecht M, Dittrich A, Busse M, et al. IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod). J Immunol. 2016;197:4219-4227 pubmed
  707. Coleman C, Sisk J, Halasz G, Zhong J, Beck S, Matthews K, et al. CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome. J Virol. 2017;91: pubmed publisher
  708. Teng O, Chen S, Hsu T, Sia S, Cole S, Valkenburg S, et al. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo. J Virol. 2017;91: pubmed publisher
  709. Calmette J, Bertrand M, Vétillard M, Ellouze M, Flint S, Nicolas V, et al. Glucocorticoid-Induced Leucine Zipper Protein Controls Macropinocytosis in Dendritic Cells. J Immunol. 2016;197:4247-4256 pubmed
  710. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  711. Sen D, Kaminski J, Barnitz R, Kurachi M, Gerdemann U, Yates K, et al. The epigenetic landscape of T cell exhaustion. Science. 2016;354:1165-1169 pubmed
  712. Bahal R, Ali McNeer N, Quijano E, Liu Y, Sulkowski P, Turchick A, et al. In vivo correction of anaemia in ?-thalassemic mice by ?PNA-mediated gene editing with nanoparticle delivery. Nat Commun. 2016;7:13304 pubmed publisher
  713. Starobinets H, Ye J, Broz M, Barry K, Goldsmith J, Marsh T, et al. Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. J Clin Invest. 2016;126:4417-4429 pubmed publisher
  714. Zhao J, Chen C, Guo M, Tao Y, Cui P, Zhou Y, et al. MicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4. Front Immunol. 2016;7:389 pubmed
  715. Kotschy A, Szlávik Z, Murray J, Davidson J, Maragno A, Le Toumelin Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477-482 pubmed publisher
  716. Massaad M, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest. 2016;126:4219-4236 pubmed publisher
  717. Clement M, Pearson J, Gras S, van den Berg H, Lissina A, Llewellyn Lacey S, et al. Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies. Sci Rep. 2016;6:35332 pubmed publisher
  718. Elgueta R, Tse D, Deharvengt S, Luciano M, CARRIERE C, Noelle R, et al. Endothelial Plasmalemma Vesicle-Associated Protein Regulates the Homeostasis of Splenic Immature B Cells and B-1 B Cells. J Immunol. 2016;197:3970-3981 pubmed
  719. Collinson Pautz M, Slawin K, Levitt J, Spencer D. MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity. PLoS ONE. 2016;11:e0164547 pubmed publisher
  720. Alves da Costa T, Di Gangi R, Thomé R, Barreto Felisbino M, Pires Bonfanti A, Lumi Watanabe Ishikawa L, et al. Severe Changes in Thymic Microenvironment in a Chronic Experimental Model of Paracoccidioidomycosis. PLoS ONE. 2016;11:e0164745 pubmed publisher
  721. Rantakari P, Jäppinen N, Lokka E, Mokkala E, Gerke H, Peuhu E, et al. Fetal liver endothelium regulates the seeding of tissue-resident macrophages. Nature. 2016;538:392-396 pubmed publisher
  722. Kimura T, Nada S, Takegahara N, Okuno T, Nojima S, Kang S, et al. Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals. Nat Commun. 2016;7:13130 pubmed publisher
  723. Lopez Guadamillas E, Fernandez Marcos P, Pantoja C, Muñoz Martin M, Martinez D, Gomez Lopez G, et al. p21Cip1 plays a critical role in the physiological adaptation to fasting through activation of PPAR?. Sci Rep. 2016;6:34542 pubmed publisher
  724. Xu X, Greenland J, Gotts J, Matthay M, Caughey G. Cathepsin L Helps to Defend Mice from Infection with Influenza A. PLoS ONE. 2016;11:e0164501 pubmed publisher
  725. Coursey T, Bian F, Zaheer M, Pflugfelder S, Volpe E, de Paiva C. Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells. Mucosal Immunol. 2017;10:743-756 pubmed publisher
  726. Swaminathan G, Thoryk E, Cox K, Smith J, Wolf J, Gindy M, et al. A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates. Sci Rep. 2016;6:34215 pubmed publisher
  727. Rothchild A, Sissons J, Shafiani S, Plaisier C, Min D, Mai D, et al. MiR-155-regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2016;113:E6172-E6181 pubmed
  728. Carnevale D, Perrotta M, Pallante F, Fardella V, Iacobucci R, Fardella S, et al. A cholinergic-sympathetic pathway primes immunity in hypertension and mediates brain-to-spleen communication. Nat Commun. 2016;7:13035 pubmed publisher
  729. Klotz L, Kuzmanov I, Hucke S, Gross C, Posevitz V, Dreykluft A, et al. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6182-E6191 pubmed
  730. Ishikawa E, Kosako H, Yasuda T, Ohmuraya M, Araki K, Kurosaki T, et al. Protein kinase D regulates positive selection of CD4+ thymocytes through phosphorylation of SHP-1. Nat Commun. 2016;7:12756 pubmed publisher
  731. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed publisher
  732. Takeshima T, Pop L, Laine A, Iyengar P, Vitetta E, Hannan R. Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF. Proc Natl Acad Sci U S A. 2016;113:11300-11305 pubmed
  733. Roncagalli R, Cucchetti M, Jarmuzynski N, Gregoire C, Bergot E, Audebert S, et al. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016;213:2437-2457 pubmed
  734. Kaneda M, Messer K, Ralainirina N, Li H, Leem C, Gorjestani S, et al. PI3Kγ is a molecular switch that controls immune suppression. Nature. 2016;539:437-442 pubmed publisher
  735. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  736. Huang M, Zhang W, Guo J, Wei X, Phiwpan K, Zhang J, et al. Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation. Sci Rep. 2016;6:33612 pubmed publisher
  737. Hirai Yuki A, Hensley L, McGivern D, Gonzalez Lopez O, Das A, Feng H, et al. MAVS-dependent host species range and pathogenicity of human hepatitis A virus. Science. 2016;353:1541-1545 pubmed
  738. Hu H, Umemori H, Hsueh Y. Postsynaptic SDC2 induces transsynaptic signaling via FGF22 for bidirectional synaptic formation. Sci Rep. 2016;6:33592 pubmed publisher
  739. Hay C, Sult E, Huang Q, Mulgrew K, Fuhrmann S, McGlinchey K, et al. Targeting CD73 in the tumor microenvironment with MEDI9447. Oncoimmunology. 2016;5:e1208875 pubmed publisher
  740. Bernard Valnet R, Yshii L, Quériault C, Nguyen X, Arthaud S, Rodrigues M, et al. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc Natl Acad Sci U S A. 2016;113:10956-61 pubmed publisher
  741. Takeda Y, Azuma M, Matsumoto M, Seya T. Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy. J Exp Clin Cancer Res. 2016;35:143 pubmed publisher
  742. Saranchova I, Han J, Huang H, Fenninger F, Choi K, Munro L, et al. Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33. Sci Rep. 2016;6:30555 pubmed publisher
  743. Boddupalli C, Nair S, Gray S, Nowyhed H, Verma R, Gibson J, et al. ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells. J Clin Invest. 2016;126:3905-3916 pubmed publisher
  744. Akk A, Springer L, Pham C. Neutrophil Extracellular Traps Enhance Early Inflammatory Response in Sendai Virus-Induced Asthma Phenotype. Front Immunol. 2016;7:325 pubmed publisher
  745. Lu X, Chen Q, Rong Y, Yang G, Li C, Xu N, et al. LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells. Nat Commun. 2016;7:12719 pubmed publisher
  746. Chew W, Tabebordbar M, Cheng J, Mali P, Wu E, Ng A, et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat Methods. 2016;13:868-74 pubmed publisher
  747. Ushiki T, Huntington N, Glaser S, Kiu H, Georgiou A, Zhang J, et al. Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells. PLoS ONE. 2016;11:e0162111 pubmed publisher
  748. Ladle B, Li K, Phillips M, Pucsek A, Haile A, Powell J, et al. De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation. Proc Natl Acad Sci U S A. 2016;113:10631-6 pubmed publisher
  749. Zhang S, Liu X, Mei L, Wang H, Fang F. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice. BMC Complement Altern Med. 2016;16:334 pubmed publisher
  750. Olsson A, Venkatasubramanian M, Chaudhri V, Aronow B, Salomonis N, Singh H, et al. Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature. 2016;537:698-702 pubmed publisher
  751. Kong S, Yang Y, Xu Y, Wang Y, Zhang Y, Melo Cardenas J, et al. Endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls B-cell immunity through degradation of the death receptor CD95/Fas. Proc Natl Acad Sci U S A. 2016;113:10394-9 pubmed publisher
  752. Uckelmann H, Blaszkiewicz S, Nicolae C, Haas S, Schnell A, Wurzer S, et al. Extracellular matrix protein Matrilin-4 regulates stress-induced HSC proliferation via CXCR4. J Exp Med. 2016;213:1961-71 pubmed publisher
  753. Proekt I, Miller C, Jeanne M, Fasano K, Moon J, Lowell C, et al. LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity. J Clin Invest. 2016;126:3758-3771 pubmed publisher
  754. Fabbiano S, Suárez Zamorano N, Rigo D, Veyrat Durebex C, Stevanovic Dokic A, Colin D, et al. Caloric Restriction Leads to Browning of White Adipose Tissue through Type 2 Immune Signaling. Cell Metab. 2016;24:434-446 pubmed publisher
  755. Vogel K, Bell L, Galloway A, Ahlfors H, Turner M. The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic ?-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression. J Immunol. 2016;197:2673-2685 pubmed publisher
  756. Bombeiro A, Thomé R, Oliveira Nunes S, Monteiro Moreira B, Verinaud L, Oliveira A. MHC-I and PirB Upregulation in the Central and Peripheral Nervous System following Sciatic Nerve Injury. PLoS ONE. 2016;11:e0161463 pubmed publisher
  757. Klose R, Krzywinska E, Castells M, Gotthardt D, Putz E, Kantari Mimoun C, et al. Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexia. Nat Commun. 2016;7:12528 pubmed publisher
  758. He C, Duan X, Guo N, Chan C, Poon C, Weichselbaum R, et al. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy. Nat Commun. 2016;7:12499 pubmed publisher
  759. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  760. Lund A, Wagner M, Fankhauser M, Steinskog E, Broggi M, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126:3389-402 pubmed publisher
  761. Belinson H, Savage A, Fadrosh D, Kuo Y, Lin D, Valladares R, et al. Dual epithelial and immune cell function of Dvl1 regulates gut microbiota composition and intestinal homeostasis. JCI Insight. 2016;1: pubmed publisher
  762. Moodley D, Yoshida H, Mostafavi S, Asinovski N, Ortiz Lopez A, Symanowicz P, et al. Network pharmacology of JAK inhibitors. Proc Natl Acad Sci U S A. 2016;113:9852-7 pubmed publisher
  763. Meliopoulos V, Van De Velde L, Van De Velde N, Karlsson E, Neale G, Vogel P, et al. An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens. PLoS Pathog. 2016;12:e1005804 pubmed publisher
  764. Waterstrat A, Rector K, Geiger H, Liang Y. Quantitative trait gene Slit2 positively regulates murine hematopoietic stem cell numbers. Sci Rep. 2016;6:31412 pubmed publisher
  765. Carow B, Gao Y, Coquet J, Reilly M, Rottenberg M. lck-Driven Cre Expression Alters T Cell Development in the Thymus and the Frequencies and Functions of Peripheral T Cell Subsets. J Immunol. 2016;197:2261-8 pubmed publisher
  766. Liu H, Jain R, Guan J, Vuong V, Ishido S, La Gruta N, et al. Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection. J Exp Med. 2016;213:1695-703 pubmed publisher
  767. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed publisher
  768. You L, Li L, Zou J, Yan K, Belle J, Nijnik A, et al. BRPF1 is essential for development of fetal hematopoietic stem cells. J Clin Invest. 2016;126:3247-62 pubmed publisher
  769. Shi L, Fu T, Guan B, Chen J, Blando J, Allison J, et al. Interdependent IL-7 and IFN-? signalling in T-cell controls tumour eradication by combined ?-CTLA-4+?-PD-1 therapy. Nat Commun. 2016;7:12335 pubmed publisher
  770. Shi Y, Wu W, Chai Q, Li Q, Hou Y, Xia H, et al. LTβR controls thymic portal endothelial cells for haematopoietic progenitor cell homing and T-cell regeneration. Nat Commun. 2016;7:12369 pubmed publisher
  771. Zhao Y, Chu X, Chen J, Wang Y, Gao S, Jiang Y, et al. Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nat Commun. 2016;7:12368 pubmed publisher
  772. Leong Y, Chen Y, Ong H, Wu D, Man K, Deléage C, et al. CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles. Nat Immunol. 2016;17:1187-96 pubmed publisher
  773. Imhof B, Jemelin S, Ballet R, Vesin C, Schapira M, Karaca M, et al. CCN1/CYR61-mediated meticulous patrolling by Ly6Clow monocytes fuels vascular inflammation. Proc Natl Acad Sci U S A. 2016;113:E4847-56 pubmed publisher
  774. Boucard Jourdin M, Kugler D, Endale Ahanda M, This S, De Calisto J, Zhang A, et al. ?8 Integrin Expression and Activation of TGF-? by Intestinal Dendritic Cells Are Determined by Both Tissue Microenvironment and Cell Lineage. J Immunol. 2016;197:1968-78 pubmed publisher
  775. Liu J, Liu J, Holmström K, Menazza S, Parks R, Fergusson M, et al. MICU1 Serves as a Molecular Gatekeeper to Prevent In Vivo Mitochondrial Calcium Overload. Cell Rep. 2016;16:1561-1573 pubmed publisher
  776. Chow K, Delconte R, Huntington N, Tarlinton D, Sutherland R, Zhan Y, et al. Innate Allorecognition Results in Rapid Accumulation of Monocyte-Derived Dendritic Cells. J Immunol. 2016;197:2000-8 pubmed publisher
  777. Seifert A, Zeng S, Zhang J, Kim T, Cohen N, Beckman M, et al. PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clin Cancer Res. 2017;23:454-465 pubmed publisher
  778. Barin J, Talor M, Schaub J, Diny N, Hou X, Hoyer M, et al. Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol. 2016;186:2337-52 pubmed publisher
  779. Schneider C, Nobs S, Heer A, Hirsch E, Penninger J, Siggs O, et al. Frontline Science: Coincidental null mutation of Csf2rα in a colony of PI3Kγ-/- mice causes alveolar macrophage deficiency and fatal respiratory viral infection. J Leukoc Biol. 2017;101:367-376 pubmed publisher
  780. Aryal B, Rotllan N, Araldi E, Ramírez C, He S, Chousterman B, et al. ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression. Nat Commun. 2016;7:12313 pubmed publisher
  781. Di Scala M, Otano I, Gil Farina I, Vanrell L, Hommel M, Olague C, et al. Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice. J Virol. 2016;90:8563-74 pubmed publisher
  782. Raguz J, Jerić I, Niault T, Nowacka J, Kuzet S, Rupp C, et al. Epidermal RAF prevents allergic skin disease. elife. 2016;5: pubmed publisher
  783. Xiao Y, Tang J, Guo H, Zhao Y, Tang R, Ouyang S, et al. Targeting CBLB as a potential therapeutic approach for disseminated candidiasis. Nat Med. 2016;22:906-14 pubmed publisher
  784. Rackov G, Hernandez Jimenez E, Shokri R, Carmona Rodríguez L, Manes S, Alvarez Mon M, et al. p21 mediates macrophage reprogramming through regulation of p50-p50 NF-?B and IFN-?. J Clin Invest. 2016;126:3089-103 pubmed publisher
  785. Baptista M, Keszei M, Oliveira M, Sunahara K, Andersson J, Dahlberg C, et al. Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells. Nat Commun. 2016;7:12175 pubmed publisher
  786. Xu Y, Zhao F, Qiu Q, Chen K, Wei J, Kong Q, et al. The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity. Nat Commun. 2016;7:12073 pubmed publisher
  787. Ibiza S, García Cassani B, Ribeiro H, Carvalho T, Almeida L, Marques R, et al. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. Nature. 2016;535:440-443 pubmed publisher
  788. Stifter K, Schuster C, Schlosser M, Boehm B, Schirmbeck R. Exploring the induction of preproinsulin-specific Foxp3(+) CD4(+) Treg cells that inhibit CD8(+) T cell-mediated autoimmune diabetes by DNA vaccination. Sci Rep. 2016;6:29419 pubmed publisher
  789. Zhang Y, Velez Delgado A, Mathew E, Li D, Mendez F, Flannagan K, et al. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 2017;66:124-136 pubmed publisher
  790. Riedel A, Shorthouse D, Haas L, Hall B, Shields J. Tumor-induced stromal reprogramming drives lymph node transformation. Nat Immunol. 2016;17:1118-27 pubmed publisher
  791. Keil M, Sonner J, Lanz T, Oezen I, Bunse T, Bittner S, et al. General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammation. J Neuroimmunol. 2016;297:117-26 pubmed publisher
  792. Iwasaki Y, Sugita S, Mandai M, Yonemura S, Onishi A, Ito S, et al. Differentiation/Purification Protocol for Retinal Pigment Epithelium from Mouse Induced Pluripotent Stem Cells as a Research Tool. PLoS ONE. 2016;11:e0158282 pubmed publisher
  793. Gorman M, Poddar S, Farzan M, Diamond M. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis. J Virol. 2016;90:8212-25 pubmed publisher
  794. Bombeiro A, Santini J, Thomé R, Ferreira E, Nunes S, Moreira B, et al. Enhanced Immune Response in Immunodeficient Mice Improves Peripheral Nerve Regeneration Following Axotomy. Front Cell Neurosci. 2016;10:151 pubmed publisher
  795. Orta Mascaró M, Consuegra Fernández M, Carreras E, Roncagalli R, Carreras Sureda A, Alvarez P, et al. CD6 modulates thymocyte selection and peripheral T cell homeostasis. J Exp Med. 2016;213:1387-97 pubmed publisher
  796. Allison K, Sajti E, Collier J, Gosselin D, Troutman T, Stone E, et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. elife. 2016;5: pubmed publisher
  797. Larocca R, Abbink P, Peron J, Zanotto P, Iampietro M, Badamchi Zadeh A, et al. Vaccine protection against Zika virus from Brazil. Nature. 2016;536:474-8 pubmed
  798. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  799. Shen J, Li Z, Li L, Lu L, Xiao Z, Wu W, et al. Vascular-targeted TNF? and IFN? inhibits orthotopic colorectal tumor growth. J Transl Med. 2016;14:187 pubmed publisher
  800. Rudolph H, Klopstein A, Gruber I, Blatti C, Lyck R, Engelhardt B. Postarrest stalling rather than crawling favors CD8(+) over CD4(+) T-cell migration across the blood-brain barrier under flow in vitro. Eur J Immunol. 2016;46:2187-203 pubmed publisher
  801. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed publisher
  802. Albarrán Juárez J, Kaur H, Grimm M, Offermanns S, Wettschureck N. Lineage tracing of cells involved in atherosclerosis. Atherosclerosis. 2016;251:445-453 pubmed publisher
  803. Lo T, Silveira P, Fromm P, Verma N, Vu P, Kupresanin F, et al. Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. J Immunol. 2016;197:885-98 pubmed publisher
  804. Stentzel S, Teufelberger A, Nordengrün M, Kolata J, Schmidt F, Van Crombruggen K, et al. Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus. J Allergy Clin Immunol. 2017;139:492-500.e8 pubmed publisher
  805. De Grove K, Provoost S, Hendriks R, McKenzie A, Seys L, Kumar S, et al. Dysregulation of type 2 innate lymphoid cells and TH2 cells impairs pollutant-induced allergic airway responses. J Allergy Clin Immunol. 2017;139:246-257.e4 pubmed publisher
  806. Priego N, Arechederra M, Sequera C, Bragado P, Vázquez Carballo A, Gutierrez Uzquiza A, et al. C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38? activation, while it impairs tumor growth through p38?-independent mechanisms. Oncotarget. 2016;7:45060-45078 pubmed publisher
  807. Mkhikian H, Mortales C, Zhou R, Khachikyan K, Wu G, Haslam S, et al. Golgi self-correction generates bioequivalent glycans to preserve cellular homeostasis. elife. 2016;5: pubmed publisher
  808. Seehus C, Kaye J. In vitro Differentiation of Murine Innate Lymphoid Cells from Common Lymphoid Progenitor Cells. Bio Protoc. 2016;6: pubmed
  809. Sinclair A, Park L, Shah M, Drotar M, Calaminus S, Hopcroft L, et al. CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood. 2016;128:371-83 pubmed publisher
  810. Ricard C, Tchoghandjian A, Luche H, Grenot P, Figarella Branger D, Rougon G, et al. Phenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice. Sci Rep. 2016;6:26381 pubmed publisher
  811. Martin S, Brown S, Wick D, Nielsen J, Kroeger D, Twumasi Boateng K, et al. Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines. PLoS ONE. 2016;11:e0155189 pubmed publisher
  812. Stein S, Mack E, Rome K, Pajcini K, Ohtani T, Xu L, et al. Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL. PLoS ONE. 2016;11:e0155408 pubmed publisher
  813. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  814. Brandstätter O, Schanz O, Vorac J, König J, Mori T, Maruyama T, et al. Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor. Sci Rep. 2016;6:26091 pubmed publisher
  815. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed publisher
  816. Rao E, Zhang Y, Li Q, Hao J, Egilmez N, Suttles J, et al. AMPK-dependent and independent effects of AICAR and compound C on T-cell responses. Oncotarget. 2016;7:33783-95 pubmed publisher
  817. Chikh G, Luu R, Patel S, Davis H, Weeratna R. Effects of KLK Peptide on Adjuvanticity of Different ODN Sequences. Vaccines (Basel). 2016;4: pubmed publisher
  818. Wen S, Dooner M, Cheng Y, Papa E, Del Tatto M, Pereira M, et al. Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cells. Leukemia. 2016;30:2221-2231 pubmed publisher
  819. Leuci V, Maione F, Rotolo R, Giraudo E, Sassi F, Migliardi G, et al. Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity. J Transl Med. 2016;14:119 pubmed publisher
  820. Reynaldi A, Smith N, Schlub T, Venturi V, Rudd B, Davenport M. Modeling the dynamics of neonatal CD8+ T-cell responses. Immunol Cell Biol. 2016;94:838-848 pubmed publisher
  821. Szalay G, Martinecz B, Lénárt N, Kornyei Z, Orsolits B, Judák L, et al. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun. 2016;7:11499 pubmed publisher
  822. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed publisher
  823. Li Y, Nishikawa T, Kaneda Y. Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent Platelet Aggregation. Sci Rep. 2016;6:25077 pubmed publisher
  824. Pietras E, Mirantes Barbeito C, Fong S, Loeffler D, Kovtonyuk L, Zhang S, et al. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat Cell Biol. 2016;18:607-18 pubmed publisher
  825. Li J, Chassaing B, Tyagi A, Vaccaro C, Luo T, Adams J, et al. Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest. 2016;126:2049-63 pubmed publisher
  826. Carofino B, Ayanga B, Tracey L, Brooke Bisschop T, Justice M. PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL. Biol Open. 2016;5:645-53 pubmed publisher
  827. Li Z, Hodgkinson T, Gothard E, Boroumand S, Lamb R, Cummins I, et al. Epidermal Notch1 recruits RORγ(+) group 3 innate lymphoid cells to orchestrate normal skin repair. Nat Commun. 2016;7:11394 pubmed publisher
  828. Ueno M, Ueno Nakamura Y, Niehaus J, Popovich P, Yoshida Y. Silencing spinal interneurons inhibits immune suppressive autonomic reflexes caused by spinal cord injury. Nat Neurosci. 2016;19:784-7 pubmed publisher
  829. O Leary C, Riling C, Spruce L, Ding H, Kumar S, Deng G, et al. Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells. Nat Commun. 2016;7:11226 pubmed publisher
  830. Goldstein J, Burlion A, Zaragoza B, Sendeyo K, Polansky J, Huehn J, et al. Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression. PLoS ONE. 2016;11:e0153682 pubmed publisher
  831. Itkin T, Gur Cohen S, Spencer J, Schajnovitz A, Ramasamy S, Kusumbe A, et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature. 2016;532:323-8 pubmed publisher
  832. Uto T, Fukaya T, Takagi H, Arimura K, Nakamura T, Kojima N, et al. Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity. Nat Commun. 2016;7:11273 pubmed publisher
  833. Verbist K, Guy C, Milasta S, Liedmann S, Kaminski M, Wang R, et al. Metabolic maintenance of cell asymmetry following division in activated T lymphocytes. Nature. 2016;532:389-93 pubmed publisher
  834. Vandenberk L, Garg A, Verschuere T, Koks C, Belmans J, Beullens M, et al. Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma. Oncoimmunology. 2016;5:e1083669 pubmed
  835. Lee S, Hong S, Verma V, Lee Y, Duong T, Jeong K, et al. Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer. Oncoimmunology. 2016;5:e1081328 pubmed
  836. Mall C, Sckisel G, Proia D, Mirsoian A, Grossenbacher S, Pai C, et al. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016;5:e1075114 pubmed
  837. Llopiz D, Aranda F, Díaz Valdés N, Ruiz M, Infante S, Belsue V, et al. Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination. Oncoimmunology. 2016;5:e1075113 pubmed
  838. Aaes T, Kaczmarek A, Delvaeye T, De Craene B, De Koker S, Heyndrickx L, et al. Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity. Cell Rep. 2016;15:274-87 pubmed publisher
  839. Seidel P, Remus M, Delacher M, Grigaravicius P, Reuss D, Frappart L, et al. Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitis. Oncotarget. 2016;7:23006-18 pubmed publisher
  840. Seifert L, Werba G, Tiwari S, Giao Ly N, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245-9 pubmed publisher
  841. Du C, Duan Y, Wei W, Cai Y, Chai H, Lv J, et al. Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination. Nat Commun. 2016;7:11120 pubmed publisher
  842. Seo J, Bang M, Kim G, Cho S, Park D. Erythronium japonicum attenuates histopathological lung abnormalities in a mouse model of ovalbumin-induced asthma. Int J Mol Med. 2016;37:1221-8 pubmed publisher
  843. Braun J, Meixner A, Brachner A, Foisner R. The GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse Hematopoiesis. PLoS ONE. 2016;11:e0152278 pubmed publisher
  844. Yang Y, Xu J, Chen H, Fei X, Tang Y, Yan Y, et al. MiR-128-2 inhibits common lymphoid progenitors from developing into progenitor B cells. Oncotarget. 2016;7:17520-31 pubmed publisher
  845. Qi X, Gurung P, Malireddi R, Karmaus P, Sharma D, Vogel P, et al. Critical role of caspase-8-mediated IL-1 signaling in promoting Th2 responses during asthma pathogenesis. Mucosal Immunol. 2017;10:128-138 pubmed publisher
  846. Mathewson N, Jenq R, Mathew A, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17:505-513 pubmed publisher
  847. O Rourke J, Bogdanik L, Yáñez A, Lall D, Wolf A, Muhammad A, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324-9 pubmed publisher
  848. Gomez de Agüero M, Ganal Vonarburg S, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016;351:1296-302 pubmed publisher
  849. Miller M, Rosten P, Lemieux M, Lai C, Humphries R. Meis1 Is Required for Adult Mouse Erythropoiesis, Megakaryopoiesis and Hematopoietic Stem Cell Expansion. PLoS ONE. 2016;11:e0151584 pubmed publisher
  850. Apostolidis S, Rodríguez Rodríguez N, Suárez Fueyo A, Dioufa N, Ozcan E, Crispín J, et al. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;17:556-64 pubmed publisher
  851. McFarland B, Marks M, Rowse A, Fehling S, Gerigk M, Qin H, et al. Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma. Oncotarget. 2016;7:20621-35 pubmed publisher
  852. Chattopadhyay A, Navab M, Hough G, Grijalva V, Mukherjee P, Fogelman H, et al. Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD. J Lipid Res. 2016;57:832-47 pubmed publisher
  853. Zheng H, Zhao W, Yan C, Watson C, Massengill M, Xie M, et al. HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma. Clin Cancer Res. 2016;22:4119-32 pubmed publisher
  854. Leeth C, Racine J, Chapman H, Arpa B, Carrillo J, Carrascal J, et al. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes. 2016;65:1977-1987 pubmed publisher
  855. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed publisher
  856. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  857. Miller M, Blystone S. Human Macrophages Utilize the Podosome Formin FMNL1 for Adhesion and Migration. Cellbio (Irvine, Calif). 2015;4:1-11 pubmed
  858. Marek I, Lichtneger T, Cordasic N, Hilgers K, Volkert G, Fahlbusch F, et al. Alpha8 Integrin (Itga8) Signalling Attenuates Chronic Renal Interstitial Fibrosis by Reducing Fibroblast Activation, Not by Interfering with Regulation of Cell Turnover. PLoS ONE. 2016;11:e0150471 pubmed publisher
  859. Crisan M, Solaimani Kartalaei P, Neagu A, Karkanpouna S, Yamada Inagawa T, Purini C, et al. BMP and Hedgehog Regulate Distinct AGM Hematopoietic Stem Cells Ex Vivo. Stem Cell Reports. 2016;6:383-95 pubmed publisher
  860. Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Rea D, Barbieri A, et al. A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice. J Transl Med. 2016;14:58 pubmed publisher
  861. Foy S, Sennino B, dela Cruz T, Cote J, Gordon E, Kemp F, et al. Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice. PLoS ONE. 2016;11:e0150084 pubmed publisher
  862. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  863. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed publisher
  864. Barry M, Wang Q, Jones K, Heffernan M, Buhaya M, Beaumier C, et al. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease. Hum Vaccin Immunother. 2016;12:976-87 pubmed publisher
  865. Pelly V, Kannan Y, Coomes S, Entwistle L, Rückerl D, Seddon B, et al. IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol. 2016;9:1407-1417 pubmed publisher
  866. Chen J, Miyanishi M, Wang S, Yamazaki S, Sinha R, Kao K, et al. Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche. Nature. 2016;530:223-7 pubmed publisher
  867. Roffê E, Marino A, Weaver J, Wan W, de Araújo F, Hoffman V, et al. Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice. Infect Immun. 2016;84:1123-1136 pubmed publisher
  868. Vieyra Garcia P, Wei T, Naym D, Fredholm S, Fink Puches R, Cerroni L, et al. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides. Clin Cancer Res. 2016;22:3328-39 pubmed publisher
  869. Howitt M, Lavoie S, Michaud M, Blum A, Tran S, Weinstock J, et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science. 2016;351:1329-33 pubmed publisher
  870. Azpilikueta A, Agorreta J, Labiano S, Pérez Gracia J, Sánchez Paulete A, Aznar M, et al. Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies. J Thorac Oncol. 2016;11:524-36 pubmed publisher
  871. Lin C, Bradstreet T, Schwarzkopf E, Jarjour N, Chou C, Archambault A, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213:251-71 pubmed publisher
  872. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  873. Bulla R, Tripodo C, Rami D, Ling G, Agostinis C, Guarnotta C, et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346 pubmed publisher
  874. Polansky J, Bahri R, Divivier M, Duitman E, Vock C, Goyeneche Patino D, et al. High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner. Sci Rep. 2016;6:19699 pubmed publisher
  875. Atkinson S, Hoffmann U, Hamann A, Bach E, Danneskiold Samsøe N, Kristiansen K, et al. Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade. Dis Model Mech. 2016;9:427-40 pubmed publisher
  876. Maelfait J, Roose K, Vereecke L, Mc Guire C, Sze M, Schuijs M, et al. A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus Infection. PLoS Pathog. 2016;12:e1005410 pubmed publisher
  877. Duhan V, Khairnar V, Friedrich S, Zhou F, Gassa A, Honke N, et al. Virus-specific antibodies allow viral replication in the marginal zone, thereby promoting CD8(+) T-cell priming and viral control. Sci Rep. 2016;6:19191 pubmed publisher
  878. Yabas M, Jing W, Shafik S, Bröer S, Enders A. ATP11C Facilitates Phospholipid Translocation across the Plasma Membrane of All Leukocytes. PLoS ONE. 2016;11:e0146774 pubmed publisher
  879. Luchsinger L, de Almeida M, Corrigan D, Mumau M, Snoeck H. Mitofusin 2 maintains haematopoietic stem cells with extensive lymphoid potential. Nature. 2016;529:528-31 pubmed publisher
  880. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  881. Metz P, Lopez J, Kim S, Akimoto K, Ohno S, Chang J. Regulation of Asymmetric Division by Atypical Protein Kinase C Influences Early Specification of CD8(+) T Lymphocyte Fates. Sci Rep. 2016;6:19182 pubmed publisher
  882. Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, et al. Sirt6 regulates dendritic cell differentiation, maturation, and function. Aging (Albany NY). 2016;8:34-49 pubmed
  883. Ito T, Itakura J, Takahashi S, Sato M, Mino M, Fushimi S, et al. Sprouty-Related Ena/Vasodilator-Stimulated Phosphoprotein Homology 1-Domain-Containing Protein-2 Critically Regulates Influenza A Virus-Induced Pneumonia. Crit Care Med. 2016;44:e530-43 pubmed publisher
  884. Yasuma K, Yasunaga J, Takemoto K, Sugata K, Mitobe Y, Takenouchi N, et al. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT). PLoS Pathog. 2016;12:e1005372 pubmed publisher
  885. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  886. Kindy M, Yu J, Zhu H, Smith M, Gattoni Celli S. A therapeutic cancer vaccine against GL261 murine glioma. J Transl Med. 2016;14:1 pubmed publisher
  887. Gallego Ortega D, Ledger A, Roden D, Law A, Magenau A, Kikhtyak Z, et al. ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells. PLoS Biol. 2015;13:e1002330 pubmed publisher
  888. Everts B, Tussiwand R, Dreesen L, Fairfax K, Huang S, Smith A, et al. Migratory CD103+ dendritic cells suppress helminth-driven type 2 immunity through constitutive expression of IL-12. J Exp Med. 2016;213:35-51 pubmed publisher
  889. Ulaganathan V, Sperl B, Rapp U, Ullrich A. Germline variant FGFR4  p.G388R exposes a membrane-proximal STAT3 binding site. Nature. 2015;528:570-4 pubmed publisher
  890. Ren Y, Wang N, Hu W, Zhang X, Xu J, Wan Y. Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination. Sci Rep. 2015;5:18099 pubmed publisher
  891. Kiermaier E, Moussion C, Veldkamp C, Gerardy Schahn R, de Vries I, Williams L, et al. Polysialylation controls dendritic cell trafficking by regulating chemokine recognition. Science. 2016;351:186-90 pubmed publisher
  892. Traka M, Podojil J, McCarthy D, Miller S, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016;19:65-74 pubmed publisher
  893. Shi H, Wang Y, Li X, Zhan X, Tang M, Fina M, et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat Immunol. 2016;17:250-8 pubmed publisher
  894. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  895. Wei R, Hu Y, Dong F, Xu X, Hu A, Gao G. Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells. Immunol Cell Biol. 2016;94:388-99 pubmed publisher
  896. Zhou Y, Williams J, Smallwood P, Nathans J. Sox7, Sox17, and Sox18 Cooperatively Regulate Vascular Development in the Mouse Retina. PLoS ONE. 2015;10:e0143650 pubmed publisher
  897. Schachtner H, Weimershaus M, Stache V, Plewa N, Legler D, Höpken U, et al. Loss of Gadkin Affects Dendritic Cell Migration In Vitro. PLoS ONE. 2015;10:e0143883 pubmed publisher
  898. Messaoudi S, He Y, Gutsol A, Wight A, Hébert R, Vilmundarson R, et al. Endothelial Gata5 transcription factor regulates blood pressure. Nat Commun. 2015;6:8835 pubmed publisher
  899. Riesenberg S, Groetchen A, Siddaway R, Bald T, Reinhardt J, Smorra D, et al. MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment. Nat Commun. 2015;6:8755 pubmed publisher
  900. Kim J, Phan T, Nguyen V, Dinh Vu H, Zheng J, Yun M, et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics. 2015;5:1328-42 pubmed publisher
  901. Ruan S, Samuelson D, Assouline B, Morre M, Shellito J. Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice. Infect Immun. 2016;84:108-19 pubmed publisher
  902. Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, et al. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med. 2015;21:1272-9 pubmed publisher
  903. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed publisher
  904. Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, et al. Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection. Eur J Immunol. 2016;46:464-79 pubmed publisher
  905. Black L, Srivastava R, Schoeb T, Moore R, Barnes S, KABAROWSKI J. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice. J Immunol. 2015;195:4685-98 pubmed publisher
  906. Jones D, Wilmore J, Allman D. Cellular Dynamics of Memory B Cell Populations: IgM+ and IgG+ Memory B Cells Persist Indefinitely as Quiescent Cells. J Immunol. 2015;195:4753-9 pubmed publisher
  907. Sewald X, Ladinsky M, Uchil P, Beloor J, Pi R, Herrmann C, et al. Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. Science. 2015;350:563-567 pubmed publisher
  908. Ladell K, Hazenberg M, Fitch M, Emson C, McEvoy Hein Asgarian B, Mold J, et al. Continuous Antigenic Stimulation of DO11.10 TCR Transgenic Mice in the Presence or Absence of IL-1?: Possible Implications for Mechanisms of T Cell Depletion in HIV Disease. J Immunol. 2015;195:4096-105 pubmed publisher
  909. Gonzalez N, Wennhold K, Balkow S, Kondo E, Bölck B, Weber T, et al. In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy. Oncoimmunology. 2015;4:e1038684 pubmed
  910. Murayama M, Kakuta S, Inoue A, Umeda N, Yonezawa T, Maruhashi T, et al. CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis. Nat Commun. 2015;6:8483 pubmed publisher
  911. McCormack R, de Armas L, Shiratsuchi M, Fiorentino D, Olsson M, Lichtenheld M, et al. Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria. elife. 2015;4: pubmed publisher
  912. Buerger S, Herrmann V, Mundt S, Trautwein N, Groettrup M, Basler M. The Ubiquitin-like Modifier FAT10 Is Selectively Expressed in Medullary Thymic Epithelial Cells and Modifies T Cell Selection. J Immunol. 2015;195:4106-16 pubmed publisher
  913. Wei T, Zhang N, Guo Z, Chi F, Song Y, Zhu X. Wnt4 signaling is associated with the decrease of proliferation and increase of apoptosis during age-related thymic involution. Mol Med Rep. 2015;12:7568-76 pubmed publisher
  914. Manlove L, Berquam Vrieze K, Pauken K, Williams R, Jenkins M, Farrar M. Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells. J Immunol. 2015;195:4028-37 pubmed publisher
  915. Hanot Mambres D, Machelart A, Vanderwinden J, De Trez C, Ryffel B, Letesson J, et al. In Situ Characterization of Splenic Brucella melitensis Reservoir Cells during the Chronic Phase of Infection in Susceptible Mice. PLoS ONE. 2015;10:e0137835 pubmed publisher
  916. Wang X, Zeng X, Yang B, Zhao S, Chen W, Guo X. Efficacy of thymosin α1 and interferon α for the treatment of severe acute pancreatitis in a rat model. Mol Med Rep. 2015;12:6775-81 pubmed publisher
  917. Guo L, Huang Y, Chen X, Hu Li J, Urban J, Paul W. Innate immunological function of TH2 cells in vivo. Nat Immunol. 2015;16:1051-9 pubmed publisher
  918. Pearce V, Bouabe H, MacQueen A, Carbonaro V, Okkenhaug K. PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes. J Immunol. 2015;195:3206-17 pubmed publisher
  919. Matsuda Y, Wang X, Oishi H, Guan Z, Saito M, Liu M, et al. Spleen Tyrosine Kinase Modulates Fibrous Airway Obliteration and Associated Lymphoid Neogenesis After Transplantation. Am J Transplant. 2016;16:342-52 pubmed publisher
  920. Boettler T, Schneider D, Cheng Y, Kadoya K, Brandon E, Martinson L, et al. Pancreatic Tissue Transplanted in TheraCyte Encapsulation Devices Is Protected and Prevents Hyperglycemia in a Mouse Model of Immune-Mediated Diabetes. Cell Transplant. 2016;25:609-14 pubmed publisher
  921. Smith K, Filbey K, Reynolds L, Hewitson J, Harcus Y, Boon L, et al. Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths. Mucosal Immunol. 2016;9:428-43 pubmed publisher
  922. Yoon K, Byun S, Kwon E, Hwang S, Chu K, Hiraki M, et al. Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science. 2015;349:1261669 pubmed publisher
  923. Littwitz Salomon E, Akhmetzyanova I, Vallet C, Francois S, Dittmer U, Gibbert K. Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology. 2015;12:66 pubmed publisher
  924. Jovicic N, Jeftic I, Jovanovic I, Radosavljevic G, Arsenijevic N, Lukic M, et al. Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding. PLoS ONE. 2015;10:e0134089 pubmed publisher
  925. Yang H, Yamazaki T, Pietrocola F, Zhou H, Zitvogel L, Ma Y, et al. STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells. Cancer Res. 2015;75:3812-22 pubmed publisher
  926. Ngiow S, Young A, Jacquelot N, Yamazaki T, Enot D, Zitvogel L, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75:3800-11 pubmed publisher
  927. Kaminsky L, Sei J, Parekh N, Davies M, Reider I, Krouse T, et al. Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection. J Virol. 2015;89:9974-85 pubmed publisher
  928. Bodogai M, Moritoh K, Lee Chang C, Hollander C, Sherman Baust C, Wersto R, et al. Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells. Cancer Res. 2015;75:3456-65 pubmed publisher
  929. Johnson V, Xiang M, Chen Z, Junge H. Neurite Mistargeting and Inverse Order of Intraretinal Vascular Plexus Formation Precede Subretinal Vascularization in Vldlr Mutant Mice. PLoS ONE. 2015;10:e0132013 pubmed publisher
  930. Lowe K, Navarro Núñez L, Bénézech C, Nayar S, Kingston B, Nieswandt B, et al. The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state. Eur J Immunol. 2015;45:2484-93 pubmed publisher
  931. Deng B, Deng W, Xiao P, Zeng K, Zhang S, Zhang H, et al. Nonadherent culture method downregulates stem cell antigen-1 expression in mouse bone marrow mesenchymal stem cells. Exp Ther Med. 2015;10:31-36 pubmed
  932. Pérez Girón J, Gómez Medina S, Lüdtke A, Munoz Fontela C. Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity. J Vis Exp. 2015;:e52803 pubmed publisher
  933. Vogel A, Brown D. Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells. Front Immunol. 2015;6:327 pubmed publisher
  934. Kim M, Taparowsky E, Kim C. Retinoic Acid Differentially Regulates the Migration of Innate Lymphoid Cell Subsets to the Gut. Immunity. 2015;43:107-19 pubmed publisher
  935. Puntambekar S, Hinton D, Yin X, Savarin C, Bergmann C, Trapp B, et al. Interleukin-10 is a critical regulator of white matter lesion containment following viral induced demyelination. Glia. 2015;63:2106-2120 pubmed publisher
  936. Herz J, Johnson K, McGavern D. Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J Exp Med. 2015;212:1153-69 pubmed publisher
  937. Weindel C, Richey L, Bolland S, Mehta A, Kearney J, Huber B. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation. Autophagy. 2015;11:1010-24 pubmed publisher
  938. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed publisher
  939. Singh N, Kotla S, Dyukova E, Traylor J, Orr A, Chernoff J, et al. Disruption of p21-activated kinase 1 gene diminishes atherosclerosis in apolipoprotein E-deficient mice. Nat Commun. 2015;6:7450 pubmed publisher
  940. Sasaki K, Takada K, Ohte Y, Kondo H, Sorimachi H, Tanaka K, et al. Thymoproteasomes produce unique peptide motifs for positive selection of CD8(+) T cells. Nat Commun. 2015;6:7484 pubmed publisher
  941. Wang J, Sun C, Gerdes N, Liu C, Liao M, Liu J, et al. Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter. Nat Med. 2015;21:820-6 pubmed publisher
  942. Onishi S, Adnan E, Ishizaki J, Miyazaki T, Tanaka Y, Matsumoto T, et al. Novel Autoantigens Associated with Lupus Nephritis. PLoS ONE. 2015;10:e0126564 pubmed publisher
  943. Xu G, Wu H, Zhang J, Li D, Wang Y, Wang Y, et al. Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med. 2015;87:15-25 pubmed publisher
  944. Kamimura D, Katsunuma K, Arima Y, Atsumi T, Jiang J, Bando H, et al. KDEL receptor 1 regulates T-cell homeostasis via PP1 that is a key phosphatase for ISR. Nat Commun. 2015;6:7474 pubmed publisher
  945. Stermann A, Huebener N, Seidel D, Fest S, Eschenburg G, Stauder M, et al. Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice. Cancer Immunol Immunother. 2015;64:1215-27 pubmed publisher
  946. Conde P, Rodriguez M, van der Touw W, Jimenez A, Burns M, Miller J, et al. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. Immunity. 2015;42:1143-58 pubmed publisher
  947. Deppisch N, Ruf P, Eissler N, Neff F, Buhmann R, Lindhofer H, et al. Efficacy and Tolerability of a GD2-Directed Trifunctional Bispecific Antibody in a Preclinical Model: Subcutaneous Administration Is Superior to Intravenous Delivery. Mol Cancer Ther. 2015;14:1877-83 pubmed publisher
  948. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed publisher
  949. Durrans A, Gao D, Gupta R, Fischer K, Choi H, El Rayes T, et al. Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC. PLoS ONE. 2015;10:e0129123 pubmed publisher
  950. Holtzhausen A, Zhao F, Evans K, Tsutsui M, Orabona C, Tyler D, et al. Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy. Cancer Immunol Res. 2015;3:1082-95 pubmed publisher
  951. Khan I, Perrard X, Brunner G, Lui H, Sparks L, Smith S, et al. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance. Int J Obes (Lond). 2015;39:1607-18 pubmed publisher
  952. Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A, et al. FOXP3+ T Cells Recruited to Sites of Sterile Skeletal Muscle Injury Regulate the Fate of Satellite Cells and Guide Effective Tissue Regeneration. PLoS ONE. 2015;10:e0128094 pubmed publisher
  953. Williams B, Tebbutt N, Buchert M, Putoczki T, Doggett K, Bao S, et al. Glycoprotein A33 deficiency: a new mouse model of impaired intestinal epithelial barrier function and inflammatory disease. Dis Model Mech. 2015;8:805-15 pubmed publisher
  954. Vinue A, Andrés Blasco I, Herrero Cervera A, Piqueras L, Andres V, Burks D, et al. Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling. Biochim Biophys Acta. 2015;1852:1729-42 pubmed publisher
  955. Deberge M, Ely K, Wright P, Thorp E, Enelow R. Shedding of TNF receptor 2 by effector CD8⁺ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection. J Leukoc Biol. 2015;98:423-34 pubmed publisher
  956. Chuprin A, Avin A, Goldfarb Y, Herzig Y, Levi B, Jacob A, et al. The deacetylase Sirt1 is an essential regulator of Aire-mediated induction of central immunological tolerance. Nat Immunol. 2015;16:737-45 pubmed publisher
  957. Chen H, Sun J, Huang Z, Hou H, Arcilla M, Rakhilin N, et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat Biotechnol. 2015;33:656-60 pubmed publisher
  958. McCully M, Collins P, Hughes T, Thomas C, Billen J, O Donnell V, et al. Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells. J Immunol. 2015;195:96-104 pubmed publisher
  959. Teo T, Her Z, Tan J, Lum F, Lee W, Chan Y, et al. Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology. J Virol. 2015;89:7955-69 pubmed publisher
  960. Huang H, Chan Y, Hui C, Wu J, Wu C, Chen J. Use of tilapia piscidin 3 (TP3) to protect against MRSA infection in mice with skin injuries. Oncotarget. 2015;6:12955-69 pubmed
  961. Jacque E, Schweighoffer E, Tybulewicz V, Ley S. BAFF activation of the ERK5 MAP kinase pathway regulates B cell survival. J Exp Med. 2015;212:883-92 pubmed publisher
  962. Peske J, Thompson E, Gemta L, Baylis R, Fu Y, Engelhard V. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015;6:7114 pubmed publisher
  963. Kato Nagaoka N, Shimada S, Yamakawa Y, Tsujibe S, Naito T, Setoyama H, et al. Enhanced differentiation of intraepithelial lymphocytes in the intestine of polymeric immunoglobulin receptor-deficient mice. Immunology. 2015;146:59-69 pubmed publisher
  964. Berent Maoz B, Montecino Rodriguez E, Fice M, Casero D, Seet C, Crooks G, et al. The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS ONE. 2015;10:e0125414 pubmed publisher
  965. Vuillefroy de Silly R, Ducimetière L, Yacoub Maroun C, Dietrich P, Derouazi M, Walker P. Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cells. Eur J Immunol. 2015;45:2263-75 pubmed publisher
  966. Brindle N, Joyce J, Rostker F, Lawlor E, Swigart Brown L, Evan G, et al. Deficiency for the cysteine protease cathepsin L impairs Myc-induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancer. PLoS ONE. 2015;10:e0120348 pubmed publisher
  967. Becker P, Hervouet C, Mason G, KWON S, Klavinskis L. Skin vaccination with live virus vectored microneedle arrays induce long lived CD8(+) T cell memory. Vaccine. 2015;33:4691-8 pubmed publisher
  968. Bouchery T, Kyle R, Camberis M, Shepherd A, Filbey K, Smith A, et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun. 2015;6:6970 pubmed publisher
  969. Sharma S, Chintala N, Vadrevu S, Patel J, Karbowniczek M, Markiewski M. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J Immunol. 2015;194:5529-38 pubmed publisher
  970. Opata M, Carpio V, Ibitokou S, Dillon B, Obiero J, Stephens R. Early effector cells survive the contraction phase in malaria infection and generate both central and effector memory T cells. J Immunol. 2015;194:5346-54 pubmed publisher
  971. Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015;520:692-6 pubmed publisher
  972. Olguín J, Fernández J, Salinas N, Juárez I, Rodriguez Sosa M, Campuzano J, et al. Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated Th1 immune response. Microbes Infect. 2015;17:586-95 pubmed publisher
  973. Bian F, Barbosa F, Corrales R, Pelegrino F, Volpe E, Pflugfelder S, et al. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome. Arthritis Res Ther. 2015;17:53 pubmed publisher
  974. Gardner J, Mamotte C, Patel P, Yeoh T, Jackaman C, Nelson D. Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function. PLoS ONE. 2015;10:e0123563 pubmed publisher
  975. Crawford G, Boldison J, Copland D, Adamson P, Gale D, Brandt M, et al. The role of lipoprotein-associated phospholipase A2 in a murine model of experimental autoimmune uveoretinitis. PLoS ONE. 2015;10:e0122093 pubmed publisher
  976. Martner A, Wiktorin H, Lenox B, Ewald Sander F, Aydin E, Aurelius J, et al. Histamine promotes the development of monocyte-derived dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidase. J Immunol. 2015;194:5014-21 pubmed publisher
  977. Boding L, Hansen A, Nielsen M, Meroni G, Braunstein T, Woetmann A, et al. Midline 1 controls polarization and migration of murine cytotoxic T cells. Immun Inflamm Dis. 2014;2:262-71 pubmed publisher
  978. Wan W, Liu Q, Lionakis M, Marino A, Anderson S, Swamydas M, et al. Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice. Cardiovasc Res. 2015;106:478-87 pubmed publisher
  979. Rouhani S, Eccles J, Riccardi P, Peske J, Tewalt E, Cohen J, et al. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat Commun. 2015;6:6771 pubmed publisher
  980. Tsou Y, Lin Y, Shao H, Yu S, Wu S, Lin H, et al. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease. PLoS Negl Trop Dis. 2015;9:e0003692 pubmed publisher
  981. Li C, Li W, Xiao J, Jiao S, Teng F, Xue S, et al. ADAP and SKAP55 deficiency suppresses PD-1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti-tumor immunotherapy. EMBO Mol Med. 2015;7:754-69 pubmed publisher
  982. Iwai H, Funatogawa K, Matsumura K, Kato Miyazawa M, Kirikae F, Kiga K, et al. MicroRNA-155 knockout mice are susceptible to Mycobacterium tuberculosis infection. Tuberculosis (Edinb). 2015;95:246-50 pubmed publisher
  983. Lal G, Nakayama Y, Sethi A, Singh A, Burrell B, Kulkarni N, et al. Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance. Transplantation. 2015;99:1817-28 pubmed publisher
  984. Koh F, Lizama C, Wong P, Hawkins J, Zovein A, Ramalho Santos M. Emergence of hematopoietic stem and progenitor cells involves a Chd1-dependent increase in total nascent transcription. Proc Natl Acad Sci U S A. 2015;112:E1734-43 pubmed publisher
  985. Cheah M, Chen J, Sahoo D, Contreras Trujillo H, Volkmer A, Scheeren F, et al. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proc Natl Acad Sci U S A. 2015;112:4725-30 pubmed publisher
  986. Napier R, Norris B, Swimm A, Giver C, Harris W, Laval J, et al. Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity. PLoS Pathog. 2015;11:e1004770 pubmed publisher
  987. Povinelli B, Kokolus K, Eng J, Dougher C, Curtin L, Capitano M, et al. Standard sub-thermoneutral caging temperature influences radiosensitivity of hematopoietic stem and progenitor cells. PLoS ONE. 2015;10:e0120078 pubmed publisher
  988. Hu Lieskovan S, Mok S, Homet Moreno B, Tsoi J, Robert L, Goedert L, et al. Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma. Sci Transl Med. 2015;7:279ra41 pubmed publisher
  989. Van Den Ham K, Shio M, Rainone A, Fournier S, Krawczyk C, Olivier M. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis. PLoS ONE. 2015;10:e0118451 pubmed publisher
  990. Wiesner D, Specht C, Lee C, Smith K, Mukaremera L, Lee S, et al. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog. 2015;11:e1004701 pubmed publisher
  991. Boulay A, Mazeraud A, Cisternino S, Saubaméa B, Mailly P, Jourdren L, et al. Immune quiescence of the brain is set by astroglial connexin 43. J Neurosci. 2015;35:4427-39 pubmed publisher
  992. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed publisher
  993. Maione F, Oliaro Bosso S, Meda C, Di Nicolantonio F, Bussolino F, Balliano G, et al. The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination. Sci Rep. 2015;5:9054 pubmed publisher
  994. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  995. Sakala I, Chaudhri G, Eldi P, Buller R, Karupiah G. Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection. PLoS ONE. 2015;10:e0118685 pubmed publisher
  996. Kishimoto M, Matsuda T, Yanase S, Katsumi A, Suzuki N, Ikejiri M, et al. Rhof promotes murine marginal zone B cell development. Nagoya J Med Sci. 2014;76:293-305 pubmed
  997. Pone E, Lam T, Lou Z, Wang R, Chen Y, Liu D, et al. B cell Rab7 mediates induction of activation-induced cytidine deaminase expression and class-switching in T-dependent and T-independent antibody responses. J Immunol. 2015;194:3065-78 pubmed publisher
  998. Matsuda T, Yanase S, Takaoka A, Maruyama M. The immunosenescence-related gene Zizimin2 is associated with early bone marrow B cell development and marginal zone B cell formation. Immun Ageing. 2015;12:1 pubmed publisher
  999. Thomas A, Palma J, Shea L. Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries. J Control Release. 2015;204:1-10 pubmed publisher
  1000. Choi E, Park H, Sul O, Rajasekaran M, Yu R, Choi H. Carbon monoxide reverses adipose tissue inflammation and insulin resistance upon loss of ovarian function. Am J Physiol Endocrinol Metab. 2015;308:E621-30 pubmed publisher
  1001. Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S, et al. TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015;6:6329 pubmed publisher
  1002. Gong W, Shou D, Cheng F, Shi J, Ge F, Liu D. Tolerance induced by IL-6 deficient donor heart is significantly involved in myeloid-derived suppressor cells (MDSCs). Transpl Immunol. 2015;32:72-5 pubmed publisher
  1003. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed publisher
  1004. Drees J, Mertensotto M, Liu G, Panyam J, Leonard A, Augustin L, et al. Attenuated Salmonella enterica Typhimurium reduces tumor burden in an autochthonous breast cancer model. Anticancer Res. 2015;35:843-9 pubmed
  1005. Sell S, Dietz M, Schneider A, Holtappels R, Mach M, Winkler T. Control of murine cytomegalovirus infection by γδ T cells. PLoS Pathog. 2015;11:e1004481 pubmed publisher
  1006. Bang M, Seo J, Seo J, Jo G, Jung S, Yu R, et al. Bacillus subtilis KCTC 11782BP-produced alginate oligosaccharide effectively suppresses asthma via T-helper cell type 2-related cytokines. PLoS ONE. 2015;10:e0117524 pubmed publisher
  1007. Buchwald Z, Yang C, Nellore S, Shashkova E, Davis J, Cline A, et al. A Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3+ CD8 T Cells. J Bone Miner Res. 2015;30:1508-22 pubmed publisher
  1008. Valle A, Barbagiovanni G, Jofra T, Stabilini A, Pérol L, Baeyens A, et al. Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation. J Immunol. 2015;194:2117-27 pubmed publisher
  1009. Häusler D, Nessler S, Kruse N, Brück W, Metz I. Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model. Neuropathol Appl Neurobiol. 2015;41:814-31 pubmed publisher
  1010. Maione F, Giraudo E. Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer. Methods Mol Biol. 2015;1267:349-65 pubmed publisher
  1011. Crncec I, Pathria P, Svinka J, Eferl R. Induction of colorectal cancer in mice and histomorphometric evaluation of tumors. Methods Mol Biol. 2015;1267:145-64 pubmed publisher
  1012. Hu W, Dooley J, Chung S, Chandramohan D, Cimmino L, Mukherjee S, et al. miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a. Blood. 2015;125:2206-16 pubmed publisher
  1013. Franckaert D, Schlenner S, Heirman N, Gill J, Skogberg G, Ekwall O, et al. Premature thymic involution is independent of structural plasticity of the thymic stroma. Eur J Immunol. 2015;45:1535-47 pubmed publisher
  1014. Jing W, Gershan J, Weber J, Tlomak D, McOlash L, Sabatos Peyton C, et al. Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma. J Immunother Cancer. 2015;3:2 pubmed publisher
  1015. Evans E, Jonason A, Bussler H, Torno S, Veeraraghavan J, Reilly C, et al. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. Cancer Immunol Res. 2015;3:689-701 pubmed publisher
  1016. Kanayama M, Inoue M, Danzaki K, Hammer G, He Y, Shinohara M. Autophagy enhances NFκB activity in specific tissue macrophages by sequestering A20 to boost antifungal immunity. Nat Commun. 2015;6:5779 pubmed publisher
  1017. Voron T, Colussi O, Marcheteau E, Pernot S, Nizard M, Pointet A, et al. VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors. J Exp Med. 2015;212:139-48 pubmed publisher
  1018. Bergot A, Monnet N, Le Tran S, Mittal D, Al Kouba J, Steptoe R, et al. HPV16 E7 expression in skin induces TSLP secretion, type 2 ILC infiltration and atopic dermatitis-like lesions. Immunol Cell Biol. 2015;93:540-7 pubmed publisher
  1019. Sun C, Schattgen S, Pisitkun P, Jorgensen J, Hilterbrand A, Wang L, et al. Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection. J Immunol. 2015;194:1819-31 pubmed publisher
  1020. Minkah N, Macaluso M, Oldenburg D, Paden C, White D, McBride K, et al. Absence of the uracil DNA glycosylase of murine gammaherpesvirus 68 impairs replication and delays the establishment of latency in vivo. J Virol. 2015;89:3366-79 pubmed publisher
  1021. Karsten C, Laumonnier Y, Eurich B, Ender F, Bröker K, Roy S, et al. Monitoring and cell-specific deletion of C5aR1 using a novel floxed GFP-C5aR1 reporter knock-in mouse. J Immunol. 2015;194:1841-55 pubmed publisher
  1022. Liu Z, Zhao S, Chen Q, Yan K, Liu P, Li N, et al. Roles of Toll-like receptors 2 and 4 in mediating experimental autoimmune orchitis induction in mice. Biol Reprod. 2015;92:63 pubmed publisher
  1023. Singh K, Hjort M, Thorvaldson L, Sandler S. Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naïve mice. Sci Rep. 2015;5:7767 pubmed publisher
  1024. Spada R, Rojas J, Pérez Yagüe S, Mulens V, Cannata Ortiz P, Bragado R, et al. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery. J Leukoc Biol. 2015;97:583-98 pubmed publisher
  1025. Sullivan B, Teijaro J, de la Torre J, Oldstone M. Early virus-host interactions dictate the course of a persistent infection. PLoS Pathog. 2015;11:e1004588 pubmed publisher
  1026. Shindo Y, Unsinger J, Burnham C, Green J, Hotchkiss R. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock. 2015;43:334-43 pubmed publisher
  1027. Singh S, Nehete P, Yang G, He H, Nehete B, Hanley P, et al. Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines (Basel). 2014;2:686-706 pubmed publisher
  1028. Sakaguchi S, Hombauer M, Hassan H, Tanaka H, Yasmin N, Naoe Y, et al. A novel Cd8-cis-regulatory element preferentially directs expression in CD44hiCD62L+ CD8+ T cells and in CD8αα+ dendritic cells. J Leukoc Biol. 2015;97:635-44 pubmed publisher
  1029. Hu Z, Molloy M, Usherwood E. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose. Cell Mol Immunol. 2016;13:82-93 pubmed publisher
  1030. Bassi M, Kongsgaard M, Steffensen M, Fenger C, Rasmussen M, Skjødt K, et al. CD8+ T cells complement antibodies in protecting against yellow fever virus. J Immunol. 2015;194:1141-53 pubmed publisher
  1031. Skripuletz T, Manzel A, Gropengießer K, Schäfer N, Gudi V, Singh V, et al. Pivotal role of choline metabolites in remyelination. Brain. 2015;138:398-413 pubmed publisher
  1032. Ikeda T, Hirata S, Takamatsu K, Haruta M, Tsukamoto H, Ito T, et al. Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells. PLoS ONE. 2014;9:e115198 pubmed publisher
  1033. LUCAS B, White A, Ulvmar M, Nibbs R, Sitnik K, Agace W, et al. CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. Eur J Immunol. 2015;45:574-83 pubmed publisher
  1034. Karamitros D, Patmanidi A, Kotantaki P, Potocnik A, Bähr Ivacevic T, Benes V, et al. Geminin deletion increases the number of fetal hematopoietic stem cells by affecting the expression of key transcription factors. Development. 2015;142:70-81 pubmed publisher
  1035. Harmon E, Fronhofer V, Keller R, Feustel P, Zhu X, Xu H, et al. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques. J Am Heart Assoc. 2014;3:e001232 pubmed publisher
  1036. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed publisher
  1037. Kim J, Li W, Choi Y, Lewin S, Verbeke C, Dranoff G, et al. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat Biotechnol. 2015;33:64-72 pubmed publisher
  1038. Nacer A, Movila A, Sohet F, Girgis N, Gundra U, Loke P, et al. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier. PLoS Pathog. 2014;10:e1004528 pubmed publisher
  1039. Naik A, Hawwari A, Krangel M. Specification of Vδ and Vα usage by Tcra/Tcrd locus V gene segment promoters. J Immunol. 2015;194:790-4 pubmed publisher
  1040. Rutz S, Kayagaki N, Phung Q, Eidenschenk C, Noubade R, Wang X, et al. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature. 2015;518:417-21 pubmed publisher
  1041. Mang Y, Zhao Z, Zeng Z, Wu X, Li Z, Zhang L. Efficient elimination of CD103-expressing cells by anti-CD103 antibody drug conjugates in immunocompetent mice. Int Immunopharmacol. 2015;24:119-27 pubmed publisher
  1042. Her Z, Teng T, Tan J, Teo T, Kam Y, Lum F, et al. Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response. EMBO Mol Med. 2015;7:24-41 pubmed publisher
  1043. Frossard C, Asigbetse K, Burger D, Eigenmann P. Gut T cell receptor-γδ(+) intraepithelial lymphocytes are activated selectively by cholera toxin to break oral tolerance in mice. Clin Exp Immunol. 2015;180:118-30 pubmed publisher
  1044. Martin P, Dubois C, Jacquier E, Dion S, Mancini Bourgine M, Godon O, et al. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice. Gut. 2015;64:1961-71 pubmed publisher
  1045. Svatek R, Zhao X, Morales E, Jha M, Tseng T, Hugen C, et al. Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial. Clin Cancer Res. 2015;21:303-11 pubmed publisher
  1046. Kobold S, Steffen J, Chaloupka M, Grassmann S, Henkel J, Castoldi R, et al. Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer. J Natl Cancer Inst. 2015;107:364 pubmed publisher
  1047. Nakamura Y, Sato K, Yamamoto H, Matsumura K, Matsumoto I, Nomura T, et al. Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans. Infect Immun. 2015;83:671-81 pubmed publisher
  1048. Peters A, Burkett P, Sobel R, Buckley C, Watson S, Bettelli E, et al. Podoplanin negatively regulates CD4+ effector T cell responses. J Clin Invest. 2015;125:129-40 pubmed publisher
  1049. Rattner A, Wang Y, Zhou Y, Williams J, Nathans J. The role of the hypoxia response in shaping retinal vascular development in the absence of Norrin/Frizzled4 signaling. Invest Ophthalmol Vis Sci. 2014;55:8614-25 pubmed publisher
  1050. van Blijswijk J, Schraml B, Rogers N, Whitney P, Zelenay S, Acton S, et al. Altered lymph node composition in diphtheria toxin receptor-based mouse models to ablate dendritic cells. J Immunol. 2015;194:307-15 pubmed publisher
  1051. Venkatanarayan A, Raulji P, Norton W, Chakravarti D, Coarfa C, Su X, et al. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. Nature. 2015;517:626-30 pubmed publisher
  1052. Baptista A, Roozendaal R, Reijmers R, Koning J, Unger W, Greuter M, et al. Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation. elife. 2014;3: pubmed publisher
  1053. Uchiyama M, Jin X, Yin E, Shimokawa T, Niimi M. Treadmill exercise induces murine cardiac allograft survival and generates regulatory T cell. Transpl Int. 2015;28:352-62 pubmed publisher
  1054. Buchan S, Manzo T, Flutter B, Rogel A, Edwards N, Zhang L, et al. OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence. J Immunol. 2015;194:125-133 pubmed publisher
  1055. Schwartz C, Turqueti Neves A, Hartmann S, Yu P, Nimmerjahn F, Voehringer D. Basophil-mediated protection against gastrointestinal helminths requires IgE-induced cytokine secretion. Proc Natl Acad Sci U S A. 2014;111:E5169-77 pubmed publisher
  1056. Taniguchi T, Asano Y, Akamata K, Noda S, Takahashi T, Ichimura Y, et al. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice. Arthritis Rheumatol. 2015;67:517-26 pubmed publisher
  1057. Cui Z, Han D, Sun X, Zhang M, Feng X, Sun C, et al. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity. Appl Microbiol Biotechnol. 2015;99:667-80 pubmed publisher
  1058. Kern J, Drutel R, Leanhart S, Bogacz M, Pacholczyk R. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome. PLoS ONE. 2014;9:e112467 pubmed publisher
  1059. Jurkin J, Henkel T, Nielsen A, Minnich M, Popow J, Kaufmann T, et al. The mammalian tRNA ligase complex mediates splicing of XBP1 mRNA and controls antibody secretion in plasma cells. EMBO J. 2014;33:2922-36 pubmed publisher
  1060. Mouchacca P, Chasson L, Frick M, Foray C, Schmitt Verhulst A, Boyer C. Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes. Immunology. 2015;145:24-33 pubmed publisher
  1061. Backer R, Helbig C, Gentek R, Kent A, Laidlaw B, Dominguez C, et al. A central role for Notch in effector CD8(+) T cell differentiation. Nat Immunol. 2014;15:1143-51 pubmed publisher
  1062. Johnson H, Willenbring R, Jin F, Manhart W, Lafrance S, Pirko I, et al. Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption. PLoS ONE. 2014;9:e111401 pubmed publisher
  1063. Behler F, Maus R, Bohling J, Knippenberg S, Kirchhof G, Nagata M, et al. Macrophage-inducible C-type lectin Mincle-expressing dendritic cells contribute to control of splenic Mycobacterium bovis BCG infection in mice. Infect Immun. 2015;83:184-96 pubmed publisher
  1064. Sakamoto H, Takeda N, Arai F, Hosokawa K, García P, Suda T, et al. Determining c-Myb protein levels can isolate functional hematopoietic stem cell subtypes. Stem Cells. 2015;33:479-90 pubmed publisher
  1065. Edwards C, Best S, Gun S, Claser C, James K, de Oca M, et al. Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection. Eur J Immunol. 2015;45:130-41 pubmed publisher
  1066. Becker A, Walcheck B, Bhattacharya D. ADAM17 limits the expression of CSF1R on murine hematopoietic progenitors. Exp Hematol. 2015;43:44-52.e1-3 pubmed publisher
  1067. Hoelzinger D, Dominguez A, Cohen P, Gendler S. Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges. Cancer Res. 2014;74:6845-55 pubmed publisher
  1068. Maneva Radicheva L, Amatya C, Parker C, Ellefson J, Radichev I, Raghavan A, et al. Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1. PLoS ONE. 2014;9:e107213 pubmed publisher
  1069. Tassi I, Claudio E, Wang H, Tang W, Ha H, Saret S, et al. The NF-κB regulator Bcl-3 governs dendritic cell antigen presentation functions in adaptive immunity. J Immunol. 2014;193:4303-11 pubmed publisher
  1070. Bertin S, Lozano Ruiz B, Bachiller V, García Martínez I, Herdman S, Zapater P, et al. Dual-specificity phosphatase 6 regulates CD4+ T-cell functions and restrains spontaneous colitis in IL-10-deficient mice. Mucosal Immunol. 2015;8:505-15 pubmed publisher
  1071. Castro Rojas C, Deason K, Hussain R, Hayardeny L, Cravens P, Yarovinsky F, et al. Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance. J Neuroimmunol. 2014;276:232-5 pubmed publisher
  1072. Cao Y, Slaney C, Bidwell B, Parker B, Johnstone C, Rautela J, et al. BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity. Cancer Res. 2014;74:5091-102 pubmed publisher
  1073. Carty S, Koretzky G, Jordan M. Interleukin-4 regulates eomesodermin in CD8+ T cell development and differentiation. PLoS ONE. 2014;9:e106659 pubmed publisher
  1074. Wei F, Yang D, Tewary P, Li Y, Li S, Chen X, et al. The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant. Cancer Res. 2014;74:5989-98 pubmed publisher
  1075. Pickup M, Hover L, Polikowsky E, Chytil A, Gorska A, Novitskiy S, et al. BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation. Mol Oncol. 2015;9:179-91 pubmed publisher
  1076. Naik E, Webster J, DeVoss J, Liu J, Suriben R, Dixit V. Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X. J Exp Med. 2014;211:1947-55 pubmed publisher
  1077. Herranz D, Ambesi Impiombato A, Palomero T, Schnell S, Belver L, Wendorff A, et al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat Med. 2014;20:1130-7 pubmed publisher
  1078. Meraz I, Savage D, Segura Ibarra V, Li J, Rhudy J, Gu J, et al. Adjuvant cationic liposomes presenting MPL and IL-12 induce cell death, suppress tumor growth, and alter the cellular phenotype of tumors in a murine model of breast cancer. Mol Pharm. 2014;11:3484-91 pubmed publisher
  1079. Kobayashi T, Hamaguchi Y, Hasegawa M, Fujimoto M, Takehara K, Matsushita T. B cells promote tumor immunity against B16F10 melanoma. Am J Pathol. 2014;184:3120-9 pubmed publisher
  1080. Schwartz M, Kolhatkar N, Thouvenel C, Khim S, Rawlings D. CD4+ T cells and CD40 participate in selection and homeostasis of peripheral B cells. J Immunol. 2014;193:3492-502 pubmed publisher
  1081. Parker K, Sinha P, Horn L, Clements V, Yang H, Li J, et al. HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells. Cancer Res. 2014;74:5723-33 pubmed publisher
  1082. Smith T, Verdeil G, Marquardt K, Sherman L. Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms. J Immunol. 2014;193:3409-16 pubmed publisher
  1083. Chen J, Zhao Y, Zhang C, Chen H, Feng J, Chi X, et al. Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice. Cell Res. 2014;24:1050-66 pubmed publisher
  1084. Dai M, Yip Y, Hellstrom I, Hellstrom K. Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies. Clin Cancer Res. 2015;21:1127-38 pubmed publisher
  1085. Rauen J, Kreer C, Paillard A, van Duikeren S, Benckhuijsen W, Camps M, et al. Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice. PLoS ONE. 2014;9:e103755 pubmed publisher
  1086. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed publisher
  1087. Ishihara M, Seo N, Mitsui J, Muraoka D, Tanaka M, Mineno J, et al. Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor. PLoS ONE. 2014;9:e104669 pubmed publisher
  1088. Denton A, Roberts E, Linterman M, Fearon D. Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells. Proc Natl Acad Sci U S A. 2014;111:12139-44 pubmed publisher
  1089. Zhou Y, Wang Y, TISCHFIELD M, Williams J, Smallwood P, Rattner A, et al. Canonical WNT signaling components in vascular development and barrier formation. J Clin Invest. 2014;124:3825-46 pubmed publisher
  1090. Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014;74:5057-69 pubmed publisher
  1091. Reeh K, Cardenas K, Bain V, Liu Z, LAURENT M, Manley N, et al. Ectopic TBX1 suppresses thymic epithelial cell differentiation and proliferation during thymus organogenesis. Development. 2014;141:2950-8 pubmed publisher
  1092. Boding L, Hansen A, Meroni G, Johansen B, Braunstein T, Bonefeld C, et al. Midline 1 directs lytic granule exocytosis and cytotoxicity of mouse killer T cells. Eur J Immunol. 2014;44:3109-18 pubmed publisher
  1093. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  1094. Chandran P, Keller A, Weinmann L, Seida A, Braun M, Andreev K, et al. The TGF-?-inducible miR-23a cluster attenuates IFN-? levels and antigen-specific cytotoxicity in human CD8? T cells. J Leukoc Biol. 2014;96:633-45 pubmed publisher
  1095. Knuschke T, Bayer W, Rotan O, Sokolova V, Wadwa M, Kirschning C, et al. Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protective immunity during acute and chronic retroviral infection. Nanomedicine. 2014;10:1787-98 pubmed publisher
  1096. Furugaki K, Cui L, Kunisawa Y, Osada K, Shinkai K, Tanaka M, et al. Intraperitoneal administration of a tumor-associated antigen SART3, CD40L, and GM-CSF gene-loaded polyplex micelle elicits a vaccine effect in mouse tumor models. PLoS ONE. 2014;9:e101854 pubmed publisher
  1097. Price P, Luckow B, Torres Domínguez L, Brandmüller C, Zorn J, Kirschning C, et al. Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara. J Virol. 2014;88:10840-50 pubmed publisher
  1098. Knoop K, McDonald K, McCrate S, McDole J, Newberry R. Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon. Mucosal Immunol. 2015;8:198-210 pubmed publisher
  1099. Owens P, Pickup M, Novitskiy S, Giltnane J, Gorska A, Hopkins C, et al. Inhibition of BMP signaling suppresses metastasis in mammary cancer. Oncogene. 2015;34:2437-49 pubmed publisher
  1100. Honjo K, Kubagawa Y, Suzuki Y, Takagi M, Ohno H, Bucy R, et al. Enhanced auto-antibody production and Mott cell formation in Fc?R-deficient autoimmune mice. Int Immunol. 2014;26:659-72 pubmed publisher
  1101. Boyoglu Barnum S, Chirkova T, Todd S, Barnum T, Gaston K, Jorquera P, et al. Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice. J Virol. 2014;88:10569-83 pubmed publisher
  1102. Siurala M, Bramante S, Vassilev L, Hirvinen M, Parviainen S, Tähtinen S, et al. Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma. Int J Cancer. 2015;136:945-54 pubmed publisher
  1103. Kühnisch J, Seto J, Lange C, Stumpp S, Kobus K, Grohmann J, et al. Neurofibromin inactivation impairs osteocyte development in Nf1Prx1 and Nf1Col1 mouse models. Bone. 2014;66:155-62 pubmed publisher
  1104. Au Yeung B, Melichar H, Ross J, Cheng D, Zikherman J, Shokat K, et al. Quantitative and temporal requirements revealed for Zap70 catalytic activity during T cell development. Nat Immunol. 2014;15:687-94 pubmed publisher
  1105. Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M, et al. Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res. 2014;74:4258-69 pubmed publisher
  1106. Alsadeq A, Hobeika E, Medgyesi D, Kläsener K, Reth M. The role of the Syk/Shp-1 kinase-phosphatase equilibrium in B cell development and signaling. J Immunol. 2014;193:268-76 pubmed publisher
  1107. Geem D, Medina Contreras O, McBride M, Newberry R, Koni P, Denning T. Specific microbiota-induced intestinal Th17 differentiation requires MHC class II but not GALT and mesenteric lymph nodes. J Immunol. 2014;193:431-8 pubmed publisher
  1108. Chen Z, Ozbun L, Chong N, Wallecha A, Berzofsky J, Khleif S. Episomal expression of truncated listeriolysin O in LmddA-LLO-E7 vaccine enhances antitumor efficacy by preferentially inducing expansions of CD4+FoxP3- and CD8+ T cells. Cancer Immunol Res. 2014;2:911-22 pubmed publisher
  1109. Smith N, Wissink E, Wang J, Pinello J, Davenport M, Grimson A, et al. Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life. J Immunol. 2014;193:177-84 pubmed publisher
  1110. Kitagawa K, Shibata K, Matsumoto A, Matsumoto M, Ohhata T, Nakayama K, et al. Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development. Mol Cell Biol. 2014;34:2732-44 pubmed
  1111. Vargas A, Zhou S, Ethier Chiasson M, Flipo D, Lafond J, Gilbert C, et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J. 2014;28:3703-19 pubmed publisher
  1112. Assi H, Espinosa J, Suprise S, SOFRONIEW M, Doherty R, Zamler D, et al. Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM. PLoS ONE. 2014;9:e96318 pubmed publisher
  1113. Sreedharan R, Chen S, Miller M, Haribhai D, Williams C, Van Why S. Mice with an absent stress response are protected against ischemic renal injury. Kidney Int. 2014;86:515-24 pubmed publisher
  1114. Zhang Y, Mena P, Romanov G, Bliska J. Effector CD8+ T cells are generated in response to an immunodominant epitope in type III effector YopE during primary Yersinia pseudotuberculosis infection. Infect Immun. 2014;82:3033-44 pubmed publisher
  1115. Zhang Y, Yan W, Mathew E, Bednar F, Wan S, Collins M, et al. CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice. Cancer Immunol Res. 2014;2:423-35 pubmed publisher
  1116. Richardson M, Fu C, Pennington L, Honeycutt J, Odegaard J, Odegaard J, et al. A new mouse model for female genital schistosomiasis. PLoS Negl Trop Dis. 2014;8:e2825 pubmed publisher
  1117. Smolarchuk C, Zhu L, Chan W, Anderson C. T cells generated in the absence of a thoracic thymus fail to establish homeostasis. Eur J Immunol. 2014;44:2263-73 pubmed publisher
  1118. Ebert S, Becker M, Lemmermann N, Büttner J, Michel A, Taube C, et al. Mast cells expedite control of pulmonary murine cytomegalovirus infection by enhancing the recruitment of protective CD8 T cells to the lungs. PLoS Pathog. 2014;10:e1004100 pubmed publisher
  1119. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed publisher
  1120. Meraz I, Hearnden C, Liu X, Yang M, Williams L, Savage D, et al. Multivalent presentation of MPL by porous silicon microparticles favors T helper 1 polarization enhancing the anti-tumor efficacy of doxorubicin nanoliposomes. PLoS ONE. 2014;9:e94703 pubmed publisher
  1121. Pick J, Arra A, Lingel H, Hegel J, Huber M, Nishanth G, et al. CTLA-4 (CD152) enhances the Tc17 differentiation program. Eur J Immunol. 2014;44:2139-52 pubmed publisher
  1122. Dupont C, Christian D, Selleck E, Pepper M, Leney Greene M, Harms Pritchard G, et al. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathog. 2014;10:e1004047 pubmed publisher
  1123. Könnecke I, Serra A, El Khassawna T, Schlundt C, Schell H, Hauser A, et al. T and B cells participate in bone repair by infiltrating the fracture callus in a two-wave fashion. Bone. 2014;64:155-65 pubmed publisher
  1124. Inoue M, Arikawa T, Chen Y, Moriwaki Y, Price M, Brown M, et al. T cells down-regulate macrophage TNF production by IRAK1-mediated IL-10 expression and control innate hyperinflammation. Proc Natl Acad Sci U S A. 2014;111:5295-300 pubmed publisher
  1125. Cochain C, Chaudhari S, Koch M, Wiendl H, Eckstein H, Zernecke A. Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice. PLoS ONE. 2014;9:e93280 pubmed publisher
  1126. Ntranos A, Hall O, Robinson D, Grishkan I, Schott J, Tosi D, et al. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway. J Neuroimmunol. 2014;270:13-21 pubmed publisher
  1127. Koga T, Hedrich C, Mizui M, Yoshida N, Otomo K, Lieberman L, et al. CaMK4-dependent activation of AKT/mTOR and CREM-? underlies autoimmunity-associated Th17 imbalance. J Clin Invest. 2014;124:2234-45 pubmed publisher
  1128. Takei S, Omoto C, Kitagawa K, Morishita N, Katayama T, Shigemura K, et al. Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice. Vaccine. 2014;32:3066-74 pubmed publisher
  1129. Li J, Arévalo M, Chen Y, Posadas O, Smith J, Zeng M. Intranasal immunization with influenza antigens conjugated with cholera toxin subunit B stimulates broad spectrum immunity against influenza viruses. Hum Vaccin Immunother. 2014;10:1211-20 pubmed publisher
  1130. Yan J, Villarreal D, Racine T, Chu J, Walters J, Morrow M, et al. Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine. Vaccine. 2014;32:2833-42 pubmed publisher
  1131. Fu H, Kishore M, Gittens B, Wang G, Coe D, Komarowska I, et al. Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation. Nat Commun. 2014;5:3436 pubmed publisher
  1132. Le Saout C, Hasley R, Imamichi H, Tcheung L, Hu Z, Luckey M, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014;10:e1003976 pubmed publisher
  1133. Hirayama T, Asano Y, Iida H, Watanabe T, Nakamura T, Goitsuka R. Meis1 is required for the maintenance of postnatal thymic epithelial cells. PLoS ONE. 2014;9:e89885 pubmed publisher
  1134. Martins K, Steffens J, Van Tongeren S, Wells J, Bergeron A, Dickson S, et al. Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation. PLoS ONE. 2014;9:e89735 pubmed publisher
  1135. Vanoaica L, Richman L, Jaworski M, Darshan D, Luther S, Kühn L. Conditional deletion of ferritin h in mice reduces B and T lymphocyte populations. PLoS ONE. 2014;9:e89270 pubmed publisher
  1136. Nakahata S, Ichikawa T, Maneesaay P, Saito Y, Nagai K, Tamura T, et al. Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers. Nat Commun. 2014;5:3393 pubmed publisher
  1137. Lee J, Walsh M, Hoehn K, James D, Wherry E, Choi Y. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J Immunol. 2014;192:3190-9 pubmed publisher
  1138. Russell T, Tscharke D. Strikingly poor CD8+ T-cell immunogenicity of vaccinia virus strain MVA in BALB/c mice. Immunol Cell Biol. 2014;92:466-9 pubmed publisher
  1139. Ataide M, Andrade W, Zamboni D, Wang D, Souza M, Franklin B, et al. Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. PLoS Pathog. 2014;10:e1003885 pubmed publisher
  1140. Misumi I, Whitmire J. B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection. J Immunol. 2014;192:1597-608 pubmed publisher
  1141. Mercadante A, Perobelli S, Alves A, Gonçalves Silva T, Mello W, Gomes Santos A, et al. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol. 2014;192:1928-37 pubmed publisher
  1142. Joedicke J, Dietze K, Zelinskyy G, Dittmer U. The phenotype and activation status of regulatory T cells during Friend retrovirus infection. Virol Sin. 2014;29:48-60 pubmed publisher
  1143. Brenndörfer E, Brass A, Karthe J, Ahlen G, Bode J, Sallberg M. Cleavage of the T cell protein tyrosine phosphatase by the hepatitis C virus nonstructural 3/4A protease induces a Th1 to Th2 shift reversible by ribavirin therapy. J Immunol. 2014;192:1671-80 pubmed publisher
  1144. Gaughan A, Wang J, Pelletier R, Nadasdy T, Brodsky S, Roy S, et al. Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts. Am J Transplant. 2014;14:284-94 pubmed publisher
  1145. Yang M, Rainone A, Shi X, Fournier S, Zhang J. A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome. Acta Neuropathol Commun. 2014;2:5 pubmed publisher
  1146. Costa R, Bergwerf I, Santermans E, De Vocht N, Praet J, Daans J, et al. Distinct in vitro properties of embryonic and extraembryonic fibroblast-like cells are reflected in their in vivo behavior following grafting in the adult mouse brain. Cell Transplant. 2015;24:223-33 pubmed publisher
  1147. Saligrama N, Case L, Krementsov D, Teuscher C. Histamine H₂ receptor signaling × environment interactions determine susceptibility to experimental allergic encephalomyelitis. FASEB J. 2014;28:1898-909 pubmed publisher
  1148. Kim E, Gasper D, Lee S, Plisch E, Svaren J, Suresh M. Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice. J Immunol. 2014;192:985-95 pubmed publisher
  1149. Cavnar M, Zeng S, Kim T, Sorenson E, Ocuin L, Balachandran V, et al. KIT oncogene inhibition drives intratumoral macrophage M2 polarization. J Exp Med. 2013;210:2873-86 pubmed publisher
  1150. Salem H, Trojanowski B, Fiedler K, Maier H, Schirmbeck R, Wagner M, et al. Long-term IKK2/NF-?B signaling in pancreatic ?-cells induces immune-mediated diabetes. Diabetes. 2014;63:960-75 pubmed publisher
  1151. Murphy K, Erickson J, Johnson C, Seiler C, Bedi J, Hu P, et al. CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma. J Immunol. 2014;192:224-33 pubmed publisher
  1152. Gujar S, Clements D, Dielschneider R, Helson E, Marcato P, Lee P. Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms. Br J Cancer. 2014;110:83-93 pubmed publisher
  1153. Diaz de Durana Y, Lau J, Knee D, Filippi C, Londei M, McNamara P, et al. IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes. PLoS ONE. 2013;8:e78483 pubmed publisher
  1154. Griffiths K, Stylianou E, Poyntz H, Betts G, Fletcher H, McShane H. Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice. PLoS ONE. 2013;8:e78312 pubmed publisher
  1155. Moriya T, Fukatsu K, Noguchi M, Okamoto K, Murakoshi S, Saitoh D, et al. Intravenous administration of high-dose Paclitaxel reduces gut-associated lymphoid tissue cell number and respiratory immunoglobulin A concentrations in mice. Surg Infect (Larchmt). 2014;15:50-7 pubmed publisher
  1156. Schmitt E, Haribhai D, Jeschke J, Co D, Ziegelbauer J, Yan K, et al. Chronic follicular bronchiolitis requires antigen-specific regulatory T cell control to prevent fatal disease progression. J Immunol. 2013;191:5460-76 pubmed publisher
  1157. Iwata A, Kawashima S, Kobayashi M, Okubo A, Kawashima H, Suto A, et al. Th2-type inflammation instructs inflammatory dendritic cells to induce airway hyperreactivity. Int Immunol. 2014;26:103-14 pubmed publisher
  1158. Brunner S, Schiechl G, Kesselring R, Martin M, Balam S, Schlitt H, et al. IL-13 signaling via IL-13R?2 triggers TGF-?1-dependent allograft fibrosis. Transplant Res. 2013;2:16 pubmed publisher
  1159. Weng T, Huang S, Yen M, Lin C, Chen Y, Lin C, et al. A novel cancer therapeutic using thrombospondin 1 in dendritic cells. Mol Ther. 2014;22:292-302 pubmed publisher
  1160. Harimoto H, Shimizu M, Nakagawa Y, Nakatsuka K, Wakabayashi A, Sakamoto C, et al. Inactivation of tumor-specific CD8? CTLs by tumor-infiltrating tolerogenic dendritic cells. Immunol Cell Biol. 2013;91:545-55 pubmed publisher
  1161. Bittner Eddy P, Fischer L, Costalonga M. Identification of gingipain-specific I-A(b) -restricted CD4+ T cells following mucosal colonization with Porphyromonas gingivalis in C57BL/6 mice. Mol Oral Microbiol. 2013;28:452-66 pubmed publisher
  1162. Povinelli B, Nemeth M. Wnt5a regulates hematopoietic stem cell proliferation and repopulation through the Ryk receptor. Stem Cells. 2014;32:105-15 pubmed publisher
  1163. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed publisher
  1164. Fuertbauer E, Zaujec J, Uhrin P, Raab I, Weber M, Schachner H, et al. Thymic medullar conduits-associated podoplanin promotes natural regulatory T cells. Immunol Lett. 2013;154:31-41 pubmed publisher
  1165. Lappalainen S, Tamminen K, Vesikari T, Blazevic V. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles. Hum Vaccin Immunother. 2013;9:1991-2001 pubmed publisher
  1166. Ke F, Bouillet P, Kaufmann T, Strasser A, Kerr J, Voss A. Consequences of the combined loss of BOK and BAK or BOK and BAX. Cell Death Dis. 2013;4:e650 pubmed publisher
  1167. Wu X, Satpathy A, Kc W, Liu P, Murphy T, Murphy K. Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo. PLoS ONE. 2013;8:e64800 pubmed publisher
  1168. Cravens P, Kieseier B, Hussain R, Herndon E, Arellano B, Ben L, et al. The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis. J Neuroinflammation. 2013;10:67 pubmed publisher
  1169. Roy S, Stevens M, So L, Edinger A. Reciprocal effects of rab7 deletion in activated and neglected T cells. Autophagy. 2013;9:1009-23 pubmed publisher
  1170. He L, Marneros A. Macrophages are essential for the early wound healing response and the formation of a fibrovascular scar. Am J Pathol. 2013;182:2407-17 pubmed publisher
  1171. Xiao H, Shen H, Liu W, Xiong R, Li P, Meng G, et al. Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy. PLoS ONE. 2013;8:e60173 pubmed publisher
  1172. Gerber S, Sedlacek A, Cron K, Murphy S, Frelinger J, Lord E. IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor. Am J Pathol. 2013;182:2345-54 pubmed publisher
  1173. Billich A, Baumruker T, Beerli C, Bigaud M, Bruns C, Calzascia T, et al. Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis. PLoS ONE. 2013;8:e59630 pubmed publisher
  1174. Zinselmeyer B, Heydari S, Sacristán C, Nayak D, Cammer M, Herz J, et al. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J Exp Med. 2013;210:757-74 pubmed publisher
  1175. Vink P, Smout W, Driessen Engels L, de Bruin A, Delsing D, Krajnc Franken M, et al. In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammation. PLoS ONE. 2013;8:e57348 pubmed publisher
  1176. Gómez Herreros F, Romero Granados R, Zeng Z, Alvarez Quilón A, Quintero C, Ju L, et al. TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo. PLoS Genet. 2013;9:e1003226 pubmed publisher
  1177. Hogan T, Shuvaev A, Commenges D, Yates A, Callard R, Thiebaut R, et al. Clonally diverse T cell homeostasis is maintained by a common program of cell-cycle control. J Immunol. 2013;190:3985-93 pubmed publisher
  1178. Koning J, Kooij G, de Vries H, Nolte M, Mebius R. Mesenchymal stem cells are mobilized from the bone marrow during inflammation. Front Immunol. 2013;4:49 pubmed publisher
  1179. Li J, Xiong T, Xiao R, Xiong A, Chen J, Altaf E, et al. Anti-CCL25 antibody prolongs skin allograft survival by blocking CCR9 expression and impairing splenic T-cell function. Arch Immunol Ther Exp (Warsz). 2013;61:237-44 pubmed publisher
  1180. Toker A, Engelbert D, Garg G, Polansky J, Floess S, Miyao T, et al. Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus. J Immunol. 2013;190:3180-8 pubmed publisher
  1181. Khan O, Akula M, Skålén K, Karlsson C, Ståhlman M, Young S, et al. Targeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice. Circulation. 2013;127:782-90 pubmed publisher
  1182. Kipari T, Hadoke P, Iqbal J, Man T, Miller E, Coutinho A, et al. 11?-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis. FASEB J. 2013;27:1519-31 pubmed publisher
  1183. Diken M, Kreiter S, Selmi A, Tureci O, Sahin U. Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studies. Methods Mol Biol. 2013;969:235-46 pubmed publisher
  1184. Bergmann H, Yabas M, Short A, Miosge L, Barthel N, Teh C, et al. B cell survival, surface BCR and BAFFR expression, CD74 metabolism, and CD8- dendritic cells require the intramembrane endopeptidase SPPL2A. J Exp Med. 2013;210:31-40 pubmed publisher
  1185. Cevik S, Keskin N, Belkaya S, Ozlu M, Deniz E, Tazebay U, et al. CD81 interacts with the T cell receptor to suppress signaling. PLoS ONE. 2012;7:e50396 pubmed publisher
  1186. Oldstone M, Edelmann K, McGavern D, Cruite J, Welch M. Molecular anatomy and number of antigen specific CD8 T cells required to cause type 1 diabetes. PLoS Pathog. 2012;8:e1003044 pubmed publisher
  1187. Sag D, Wingender G, Nowyhed H, Wu R, Gebre A, Parks J, et al. ATP-binding cassette transporter G1 intrinsically regulates invariant NKT cell development. J Immunol. 2012;189:5129-38 pubmed publisher
  1188. Mathew R, Seiler M, Scanlon S, Mao A, Constantinides M, Bertozzi Villa C, et al. BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature. 2012;491:618-21 pubmed publisher
  1189. Yassai M, Cooley B, Gorski J. Developmental dynamics of post-selection thymic DN iNKT. PLoS ONE. 2012;7:e43509 pubmed publisher
  1190. Pagán A, Pepper M, Chu H, Green J, Jenkins M. CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs. J Immunol. 2012;189:2909-17 pubmed publisher
  1191. Zhang N, Bevan M. TGF-? signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol. 2012;13:667-73 pubmed publisher
  1192. Jenkins C, Shevchuk O, Giambra V, Lam S, Carboni J, Gottardis M, et al. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein. Exp Hematol. 2012;40:715-723.e6 pubmed publisher
  1193. Chevrier S, Genton C, Malissen B, Malissen M, Acha Orbea H. Dominant Role of CD80-CD86 Over CD40 and ICOSL in the Massive Polyclonal B Cell Activation Mediated by LAT(Y136F) CD4(+) T Cells. Front Immunol. 2012;3:27 pubmed publisher
  1194. Barral P, Sanchez Nino M, Van Rooijen N, Cerundolo V, Batista F. The location of splenic NKT cells favours their rapid activation by blood-borne antigen. EMBO J. 2012;31:2378-90 pubmed publisher
  1195. Hurez V, Daniel B, Sun L, Liu A, Ludwig S, Kious M, et al. Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice. Cancer Res. 2012;72:2089-99 pubmed publisher
  1196. Lumsden J, Nurmukhambetova S, Klein J, Sattabongkot J, Bennett J, Bertholet S, et al. Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice. Vaccine. 2012;30:3311-9 pubmed publisher
  1197. Loebbermann J, Schnoeller C, Thornton H, Durant L, Sweeney N, Schuijs M, et al. IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS ONE. 2012;7:e32371 pubmed publisher
  1198. Sun L, Hurez V, Thibodeaux S, Kious M, Liu A, Lin P, et al. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells. Aging Cell. 2012;11:509-19 pubmed publisher
  1199. Dutra R, Leite D, Bento A, Manjavachi M, Patrício E, Figueiredo C, et al. The role of kinin receptors in preventing neuroinflammation and its clinical severity during experimental autoimmune encephalomyelitis in mice. PLoS ONE. 2011;6:e27875 pubmed publisher
  1200. Salti S, Hammelev E, Grewal J, Reddy S, Zemple S, Grossman W, et al. Granzyme B regulates antiviral CD8+ T cell responses. J Immunol. 2011;187:6301-9 pubmed publisher
  1201. Badeaux A, Yang Y, Cardenas K, Vemulapalli V, Chen K, Kusewitt D, et al. Loss of the methyl lysine effector protein PHF20 impacts the expression of genes regulated by the lysine acetyltransferase MOF. J Biol Chem. 2012;287:429-37 pubmed publisher
  1202. Wang R, Xie H, Huang Z, Ma J, Fang X, Ding Y, et al. T cell factor 1 regulates thymocyte survival via a RORγt-dependent pathway. J Immunol. 2011;187:5964-73 pubmed publisher
  1203. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park J, et al. Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J. 2012;31:366-77 pubmed publisher
  1204. Suliman S, Tan J, Xu K, Kousis P, Kowalski P, Chang G, et al. Notch3 is dispensable for thymocyte ?-selection and Notch1-induced T cell leukemogenesis. PLoS ONE. 2011;6:e24937 pubmed publisher
  1205. Bunnell T, Burbach B, Shimizu Y, Ervasti J. ?-Actin specifically controls cell growth, migration, and the G-actin pool. Mol Biol Cell. 2011;22:4047-58 pubmed publisher
  1206. Ota N, Wong K, Valdez P, Zheng Y, Crellin N, Diehl L, et al. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat Immunol. 2011;12:941-8 pubmed publisher
  1207. Kastenmuller W, Gasteiger G, Subramanian N, Sparwasser T, Busch D, Belkaid Y, et al. Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J Immunol. 2011;187:3186-97 pubmed publisher
  1208. Sun J, Sukhova G, Zhang J, Chen H, Sjoberg S, Libby P, et al. Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol. 2012;32:15-23 pubmed publisher
  1209. Clement M, Ladell K, Ekeruche Makinde J, Miles J, Edwards E, Dolton G, et al. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining. J Immunol. 2011;187:654-63 pubmed publisher
  1210. Wojno E, Hosken N, Stumhofer J, O Hara A, Mauldin E, Fang Q, et al. A role for IL-27 in limiting T regulatory cell populations. J Immunol. 2011;187:266-73 pubmed publisher
  1211. Goldstein J, Balderas R, Marodon G. Continuous activation of the CD122/STAT-5 signaling pathway during selection of antigen-specific regulatory T cells in the murine thymus. PLoS ONE. 2011;6:e19038 pubmed publisher
  1212. Zimmerman M, Haskins K, Bradley B, Gilman J, Gamboni Robertson F, Flores S. Autoimmune-mediated vascular injury occurs prior to sustained hyperglycemia in a murine model of type I diabetes mellitus. J Surg Res. 2011;168:e195-202 pubmed publisher
  1213. Murapa P, Ward M, Gandhapudi S, Woodward J, D Orazio S. Heat shock factor 1 protects mice from rapid death during Listeria monocytogenes infection by regulating expression of tumor necrosis factor alpha during fever. Infect Immun. 2011;79:177-84 pubmed publisher
  1214. Gibbert K, Dietze K, Zelinskyy G, Lang K, Barchet W, Kirschning C, et al. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease. J Immunol. 2010;185:6179-89 pubmed publisher
  1215. Weisel F, Appelt U, Schneider A, Horlitz J, Van Rooijen N, Korner H, et al. Unique requirements for reactivation of virus-specific memory B lymphocytes. J Immunol. 2010;185:4011-21 pubmed publisher
  1216. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  1217. Charles E, Joshi S, Ash J, Fox B, Farris A, Bzik D, et al. CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect Immun. 2010;78:3484-92 pubmed publisher
  1218. Mohr C, Arapovic J, Mühlbach H, Panzer M, Weyn A, Dölken L, et al. A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination. J Virol. 2010;84:7730-42 pubmed publisher
  1219. Böiers C, Buza Vidas N, Jensen C, Pronk C, Kharazi S, Wittmann L, et al. Expression and role of FLT3 in regulation of the earliest stage of normal granulocyte-monocyte progenitor development. Blood. 2010;115:5061-8 pubmed publisher
  1220. Thompson J, Chu Y, Glass J, Tapp A, Brown S. The manganese superoxide dismutase mimetic, M40403, protects adult mice from lethal total body irradiation. Free Radic Res. 2010;44:529-40 pubmed publisher
  1221. Zavitz C, Bauer C, Gaschler G, Fraser K, Strieter R, Hogaboam C, et al. Dysregulated macrophage-inflammatory protein-2 expression drives illness in bacterial superinfection of influenza. J Immunol. 2010;184:2001-13 pubmed publisher
  1222. Schuhmann M, Stegner D, Berna Erro A, Bittner S, Braun A, Kleinschnitz C, et al. Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation. J Immunol. 2010;184:1536-42 pubmed publisher
  1223. Fahl S, Crittenden R, Allman D, Bender T. c-Myb is required for pro-B cell differentiation. J Immunol. 2009;183:5582-92 pubmed publisher
  1224. Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Ruegg C, Christofori G. Myeloid cells contribute to tumor lymphangiogenesis. PLoS ONE. 2009;4:e7067 pubmed publisher
  1225. Thompson J, Chu Y, Glass J, Brown S. Absence of IL-23p19 in donor allogeneic cells reduces mortality from acute GVHD. Bone Marrow Transplant. 2010;45:712-22 pubmed publisher
  1226. Wu S, Rhee K, Albesiano E, RABIZADEH S, Wu X, Yen H, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15:1016-22 pubmed publisher
  1227. Hu X, Shen H, Tian C, Yu H, Zheng G, XuFeng R, et al. Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model. Blood. 2009;114:3783-92 pubmed publisher
  1228. Holcmann M, Stoitzner P, Drobits B, Luehrs P, Stingl G, Romani N, et al. Skin inflammation is not sufficient to break tolerance induced against a novel antigen. J Immunol. 2009;183:1133-43 pubmed publisher
  1229. Garidou L, Heydari S, Truong P, Brooks D, McGavern D. Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection. J Virol. 2009;83:8905-15 pubmed publisher
  1230. Seavey M, Mosmann T. Estradiol-induced vaginal mucus inhibits antigen penetration and CD8(+) T cell priming in response to intravaginal immunization. Vaccine. 2009;27:2342-9 pubmed publisher
  1231. Schaeffer M, Han S, Chtanova T, van Dooren G, Herzmark P, Chen Y, et al. Dynamic imaging of T cell-parasite interactions in the brains of mice chronically infected with Toxoplasma gondii. J Immunol. 2009;182:6379-93 pubmed publisher
  1232. Moon J, Chu H, Hataye J, Pagán A, Pepper M, McLachlan J, et al. Tracking epitope-specific T cells. Nat Protoc. 2009;4:565-81 pubmed publisher
  1233. Tseng K, Chung C, H ng W, Wang S. Early infection termination affects number of CD8+ memory T cells and protective capacities in listeria monocytogenes-infected mice upon rechallenge. J Immunol. 2009;182:4590-600 pubmed publisher
  1234. Rajasagi N, Kassim S, Kollias C, Zhao X, Chervenak R, Jennings S. CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1. J Virol. 2009;83:5256-68 pubmed publisher
  1235. Hamada H, Garcia Hernandez M, Reome J, Misra S, Strutt T, McKinstry K, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182:3469-81 pubmed publisher
  1236. Rogers N, Lees M, Gabriel L, Maniati E, Rose S, Potter P, et al. A defect in Marco expression contributes to systemic lupus erythematosus development via failure to clear apoptotic cells. J Immunol. 2009;182:1982-90 pubmed publisher
  1237. Merck E, Voyle R, MacDonald H. Ly49D engagement on T lymphocytes induces TCR-independent activation and CD8 effector functions that control tumor growth. J Immunol. 2009;182:183-92 pubmed
  1238. Koehn B, Ford M, Ferrer I, Borom K, Gangappa S, Kirk A, et al. PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue. J Immunol. 2008;181:5313-22 pubmed
  1239. Wells J, Cowled C, Farzaneh F, Noble A. Combined triggering of dendritic cell receptors results in synergistic activation and potent cytotoxic immunity. J Immunol. 2008;181:3422-31 pubmed
  1240. Serada S, Fujimoto M, Mihara M, Koike N, Ohsugi Y, Nomura S, et al. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2008;105:9041-6 pubmed publisher
  1241. Waskow C, Liu K, Darrasse Jèze G, Guermonprez P, Ginhoux F, Merad M, et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol. 2008;9:676-83 pubmed publisher
  1242. Westphal K, Leschner S, Jablonska J, Loessner H, Weiss S. Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res. 2008;68:2952-60 pubmed publisher
  1243. Mochimaru H, Usui T, Yaguchi T, Nagahama Y, Hasegawa G, Usui Y, et al. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2. Invest Ophthalmol Vis Sci. 2008;49:2172-7 pubmed publisher
  1244. Sridhar S, Reyes Sandoval A, Draper S, Moore A, Gilbert S, Gao G, et al. Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A. J Virol. 2008;82:3822-33 pubmed publisher
  1245. Ahonen C, Wasiuk A, Fuse S, Turk M, Ernstoff M, Suriawinata A, et al. Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood. 2008;111:3116-25 pubmed publisher
  1246. Willoughby J, Costello P, Nicolas R, Robinson N, Stamp G, Powrie F, et al. Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development. J Immunol. 2007;179:6836-44 pubmed
  1247. Venanzi E, Gray D, Benoist C, Mathis D. Lymphotoxin pathway and Aire influences on thymic medullary epithelial cells are unconnected. J Immunol. 2007;179:5693-700 pubmed
  1248. Tyznik A, Bevan M. The surprising kinetics of the T cell response to live antigenic cells. J Immunol. 2007;179:4988-95 pubmed
  1249. Jeannet G, Scheller M, Scarpellino L, Duboux S, Gardiol N, Back J, et al. Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. Blood. 2008;111:142-9 pubmed
  1250. Peng J, Kitchen S, West R, Sigler R, Eisenmann K, Alberts A. Myeloproliferative defects following targeting of the Drf1 gene encoding the mammalian diaphanous related formin mDia1. Cancer Res. 2007;67:7565-71 pubmed
  1251. Chen X, Vodanovic Jankovic S, Johnson B, Keller M, Komorowski R, Drobyski W. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood. 2007;110:3804-13 pubmed
  1252. Moulton R, Mashruwala M, Smith A, Lindsey D, Wetsel R, Haviland D, et al. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice. J Leukoc Biol. 2007;82:956-67 pubmed
  1253. Lepenies B, Cramer J, Burchard G, Wagner H, Kirschning C, Jacobs T. Induction of experimental cerebral malaria is independent of TLR2/4/9. Med Microbiol Immunol. 2008;197:39-44 pubmed
  1254. Iwabuchi N, Takahashi N, Xiao J, Miyaji K, Iwatsuki K. In vitro Th1 cytokine-independent Th2 suppressive effects of bifidobacteria. Microbiol Immunol. 2007;51:649-60 pubmed
  1255. Kueng H, Leb V, Haiderer D, Raposo G, Thery C, Derdak S, et al. General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. J Virol. 2007;81:8666-76 pubmed
  1256. Wu J, Luo L. A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining. Nat Protoc. 2006;1:2110-5 pubmed
  1257. Kasler H, Verdin E. Histone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytes. Mol Cell Biol. 2007;27:5184-200 pubmed
  1258. Wu J, Luo L. A protocol for mosaic analysis with a repressible cell marker (MARCM) in Drosophila. Nat Protoc. 2006;1:2583-9 pubmed
  1259. Hamm S, Heit A, Koffler M, Huster K, Akira S, Busch D, et al. Immunostimulatory RNA is a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo. Int Immunol. 2007;19:297-304 pubmed
  1260. de Jersey J, Snelgrove S, Palmer S, Teteris S, Mullbacher A, Miller J, et al. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice. Proc Natl Acad Sci U S A. 2007;104:1295-300 pubmed
  1261. Hofmann M, Brinkmann V, Zerwes H. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Int Immunopharmacol. 2006;6:1902-10 pubmed
  1262. Taylor P, Tsoni S, Willment J, Dennehy K, Rosas M, Findon H, et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol. 2007;8:31-8 pubmed
  1263. Chang S, Wang K, Lu Y, Yang L, Chen W, Lin Y, et al. Characterization of early gamma interferon (IFN-gamma) expression during murine listeriosis: identification of NK1.1+ CD11c+ cells as the primary IFN-gamma-expressing cells. Infect Immun. 2007;75:1167-76 pubmed
  1264. Yang Z, Day Y, Toufektsian M, Xu Y, Ramos S, Marshall M, et al. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation. 2006;114:2056-64 pubmed
  1265. Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, et al. Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol. 2006;7:819-26 pubmed
  1266. McLoughlin R, Solinga R, Rich J, Zaleski K, Cocchiaro J, Risley A, et al. CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc Natl Acad Sci U S A. 2006;103:10408-10413 pubmed publisher
  1267. Chapatte L, Ayyoub M, Morel S, Peitrequin A, Lévy N, Servis C, et al. Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses. Cancer Res. 2006;66:5461-8 pubmed
  1268. Hofmann M, Zerwes H. Identification of organ-specific T cell populations by analysis of multiparameter flow cytometry data using DNA-chip analysis software. Cytometry A. 2006;69:533-40 pubmed
  1269. Irie J, Wu Y, Wicker L, Rainbow D, Nalesnik M, Hirsch R, et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med. 2006;203:1209-19 pubmed
  1270. Chapatte L, Colombetti S, Cerottini J, Lévy F. Efficient induction of tumor antigen-specific CD8+ memory T cells by recombinant lentivectors. Cancer Res. 2006;66:1155-60 pubmed
  1271. Ola T, Williams N. Protection of non-obese diabetic mice from autoimmune diabetes by Escherichia coli heat-labile enterotoxin B subunit. Immunology. 2006;117:262-70 pubmed
  1272. Zhang J, Raper A, Sugita N, Hingorani R, Salio M, Palmowski M, et al. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood. 2006;107:3600-8 pubmed
  1273. Haque A, Easton A, Smith D, O GARRA A, Van Rooijen N, Lertmemongkolchai G, et al. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis. 2006;193:370-9 pubmed
  1274. Fukatsu K, Sakamoto S, Hara E, Ueno C, Maeshima Y, Matsumoto I, et al. Gut ischemia-reperfusion affects gut mucosal immunity: a possible mechanism for infectious complications after severe surgical insults. Crit Care Med. 2006;34:182-7 pubmed
  1275. Tsunoda I, Kuang L, Kobayashi Warren M, Fujinami R. Central nervous system pathology caused by autoreactive CD8+ T-cell clones following virus infection. J Virol. 2005;79:14640-6 pubmed
  1276. Krieg C, Han P, Stone R, Goularte O, Kaye J. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J Immunol. 2005;175:6420-7 pubmed
  1277. Lu M, Tayu R, Ikawa T, Masuda K, Matsumoto I, Mugishima H, et al. The earliest thymic progenitors in adults are restricted to T, NK, and dendritic cell lineage and have a potential to form more diverse TCRbeta chains than fetal progenitors. J Immunol. 2005;175:5848-56 pubmed
  1278. Garcia Ojeda M, Dejbakhsh Jones S, Chatterjea Matthes D, Mukhopadhyay A, BitMansour A, Weissman I, et al. Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus. J Immunol. 2005;175:4363-73 pubmed
  1279. Irwin S, Izzo A, Dow S, Skeiky Y, Reed S, Alderson M, et al. Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun. 2005;73:5809-16 pubmed
  1280. Koyama K. Dendritic cell expansion occurs in mesenteric lymph nodes of B10.BR mice infected with the murine nematode parasite Trichuris muris. Parasitol Res. 2005;97:186-90 pubmed
  1281. Rohrbach F, Weth R, Kursar M, Sloots A, Mittrücker H, Wels W. Targeted delivery of the ErbB2/HER2 tumor antigen to professional APCs results in effective antitumor immunity. J Immunol. 2005;174:5481-9 pubmed
  1282. Tivol E, Komorowski R, Drobyski W. Emergent autoimmunity in graft-versus-host disease. Blood. 2005;105:4885-91 pubmed
  1283. Gray P, Arimilli S, Palmer E, Parks G, Alexander Miller M. Altered function in CD8+ T cells following paramyxovirus infection of the respiratory tract. J Virol. 2005;79:3339-49 pubmed
  1284. Kohu K, Sato T, Ohno S, Hayashi K, Uchino R, Abe N, et al. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage. J Immunol. 2005;174:2627-36 pubmed
  1285. Koneru M, Schaer D, Monu N, Ayala A, Frey A. Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function. J Immunol. 2005;174:1830-40 pubmed
  1286. Hoffmann P, Kench J, Vondracek A, Kruk E, Daleke D, Jordan M, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol. 2005;174:1393-404 pubmed
  1287. Mischenko V, Kapina M, Eruslanov E, Kondratieva E, Lyadova I, Young D, et al. Mycobacterial dissemination and cellular responses after 1-lobe restricted tuberculosis infection of genetically susceptible and resistant mice. J Infect Dis. 2004;190:2137-45 pubmed
  1288. Ito F, Li Q, Shreiner A, Okuyama R, Jure Kunkel M, Teitz Tennenbaum S, et al. Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines. Cancer Res. 2004;64:8411-9 pubmed
  1289. van Santen H, Benoist C, Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med. 2004;200:1221-30 pubmed
  1290. Zheng S, Jiang J, Shen H, Chen Y. Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice. J Immunol. 2004;173:5652-8 pubmed
  1291. Dalton J, Howell G, Pearson J, Scott P, Carding S. Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells. J Immunol. 2004;173:3660-7 pubmed
  1292. Prockop S, Petrie H. Regulation of thymus size by competition for stromal niches among early T cell progenitors. J Immunol. 2004;173:1604-11 pubmed
  1293. Seroogy C, Soares L, Ranheim E, Su L, Holness C, Bloom D, et al. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. J Immunol. 2004;173:79-85 pubmed
  1294. Mattner J, Wandersee Steinhäuser A, Pahl A, Rollinghoff M, Majeau G, Hochman P, et al. Protection against progressive leishmaniasis by IFN-beta. J Immunol. 2004;172:7574-82 pubmed
  1295. Zhang T, He X, Tsang T, Harris D. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function. Cancer Gene Ther. 2004;11:487-96 pubmed
  1296. Hequet O, Vocanson M, Saint Mezard P, Kaiserlian D, Nicolas J, Berard F. CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease. Am J Transplant. 2004;4:872-8 pubmed
  1297. Yuan Y, Shen H, Franklin D, Scadden D, Cheng T. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat Cell Biol. 2004;6:436-42 pubmed
  1298. Cabarrocas J, Piaggio E, Zappulla J, Desbois S, Mars L, Lassmann H, et al. A transgenic mouse model for T-cell ignorance of a glial autoantigen. J Autoimmun. 2004;22:179-89 pubmed
  1299. Steptoe R, Stankovic S, Lopaticki S, Jones L, Harrison L, Morahan G. Persistence of recipient lymphocytes in NOD mice after irradiation and bone marrow transplantation. J Autoimmun. 2004;22:131-8 pubmed
  1300. Ishihara K, Sawa S, Ikushima H, Hirota S, Atsumi T, Kamimura D, et al. The point mutation of tyrosine 759 of the IL-6 family cytokine receptor gp130 synergizes with HTLV-1 pX in promoting rheumatoid arthritis-like arthritis. Int Immunol. 2004;16:455-65 pubmed
  1301. Chen B, Cui X, Sempowski G, Domen J, Chao N. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood. 2004;103:4344-52 pubmed
  1302. Schleicher U, Mattner J, Blos M, Schindler H, Rollinghoff M, Karaghiosoff M, et al. Control of Leishmania major in the absence of Tyk2 kinase. Eur J Immunol. 2004;34:519-29 pubmed
  1303. Eruslanov E, Majorov K, Orlova M, Mischenko V, Kondratieva T, Apt A, et al. Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge. Clin Exp Immunol. 2004;135:19-28 pubmed
  1304. Morin J, Faideau B, Gagnerault M, Lepault F, Boitard C, Boudaly S. Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice. Clin Exp Immunol. 2003;134:388-95 pubmed
  1305. Turley S, Poirot L, Hattori M, Benoist C, Mathis D. Physiological beta cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model. J Exp Med. 2003;198:1527-37 pubmed
  1306. Choi E, Chen J, Wooldridge L, Salio M, Lissina A, Lissin N, et al. High avidity antigen-specific CTL identified by CD8-independent tetramer staining. J Immunol. 2003;171:5116-23 pubmed
  1307. Chen B, Cui X, Sempowski G, Chao N. Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice. Exp Hematol. 2003;31:953-8 pubmed
  1308. Lugering A, Kucharzik T, Soler D, Picarella D, Hudson J, Williams I. Lymphoid precursors in intestinal cryptopatches express CCR6 and undergo dysregulated development in the absence of CCR6. J Immunol. 2003;171:2208-15 pubmed
  1309. Wang Z, Morelli A, Hackstein H, Kaneko K, Thomson A. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb. Transplantation. 2003;76:562-71 pubmed
  1310. Germeraad W, Kawamoto H, Itoi M, Jiang Y, Amagai T, Katsura Y, et al. Development of thymic microenvironments in vitro is oxygen-dependent and requires permanent presence of T-cell progenitors. J Histochem Cytochem. 2003;51:1225-35 pubmed
  1311. Richards M, Liu F, Iwasaki H, Akashi K, Link D. Pivotal role of granulocyte colony-stimulating factor in the development of progenitors in the common myeloid pathway. Blood. 2003;102:3562-8 pubmed
  1312. Chatterjea Matthes D, Garcia Ojeda M, Dejbakhsh Jones S, Jerabek L, Manz M, Weissman I, et al. Early defect prethymic in bone marrow T cell progenitors in athymic nu/nu mice. J Immunol. 2003;171:1207-15 pubmed
  1313. Norris H, Lybarger L, Martin A, Andersen H, Chervenak D, Chervenak R. TCRbeta enhancer activation occurs in some but not all cells with T cell lineage developmental potential. Cell Immunol. 2003;222:164-74 pubmed
  1314. Blos M, Schleicher U, Soares Rocha F, Meissner U, Rollinghoff M, Bogdan C. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. Eur J Immunol. 2003;33:1224-34 pubmed
  1315. Koyama K. NK1.1+ cell depletion in vivo fails to prevent protection against infection with the murine nematode parasite Trichuris muris. Parasite Immunol. 2002;24:527-33 pubmed
  1316. Egan P, Lawlor K, Alexander W, Wicks I. Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest. 2003;111:915-24 pubmed
  1317. Kawamoto H, Ohmura K, Fujimoto S, Lu M, Ikawa T, Katsura Y. Extensive proliferation of T cell lineage-restricted progenitors in the thymus: an essential process for clonal expression of diverse T cell receptor beta chains. Eur J Immunol. 2003;33:606-15 pubmed
  1318. Shinkai K, Mohrs M, Locksley R. Helper T cells regulate type-2 innate immunity in vivo. Nature. 2002;420:825-9 pubmed
  1319. Angulo I, Jiménez Díaz M, García Bustos J, Gargallo D, de las Heras F, Muñoz Fernández M, et al. Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production. Cell Immunol. 2002;218:46-58 pubmed
  1320. Culley F, Pollott J, Openshaw P. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med. 2002;196:1381-6 pubmed
  1321. Hsu S, Wu C, Han J, Lai M. Involvement of p38 mitogen-activated protein kinase in different stages of thymocyte development. Blood. 2003;101:970-6 pubmed
  1322. Cawthon A, Alexander Miller M. Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity. J Immunol. 2002;169:3492-8 pubmed
  1323. Litvinova E, Maury S, Boyer O, Bruel S, Benard L, Boisserie G, et al. Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease. Blood. 2002;100:2020-5 pubmed
  1324. Carrithers M, Visintin I, Viret C, Janeway C. Role of genetic background in P selectin-dependent immune surveillance of the central nervous system. J Neuroimmunol. 2002;129:51-7 pubmed
  1325. Yu C, Feng M, Shih H, Lai M. Increased p300 expression inhibits glucocorticoid receptor-T-cell receptor antagonism but does not affect thymocyte positive selection. Mol Cell Biol. 2002;22:4556-66 pubmed
  1326. Prasad S, Goodnow C. Cell-intrinsic effects of non-MHC NOD genes on dendritic cell generation in vivo. Int Immunol. 2002;14:677-84 pubmed
  1327. Carter R, Campbell I, O Donnel K, Wicks I. Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking. Clin Exp Immunol. 2002;128:44-51 pubmed
  1328. Walzer T, Arpin C, Beloeil L, Marvel J. Differential in vivo persistence of two subsets of memory phenotype CD8 T cells defined by CD44 and CD122 expression levels. J Immunol. 2002;168:2704-11 pubmed
  1329. Martin P, Ruiz S, Del Hoyo G, Anjuere F, Vargas H, López Bravo M, et al. Dramatic increase in lymph node dendritic cell number during infection by the mouse mammary tumor virus occurs by a CD62L-dependent blood-borne DC recruitment. Blood. 2002;99:1282-8 pubmed
  1330. Martinez del Hoyo G, Martin P, Arias C, Marín A, Ardavin C. CD8alpha+ dendritic cells originate from the CD8alpha- dendritic cell subset by a maturation process involving CD8alpha, DEC-205, and CD24 up-regulation. Blood. 2002;99:999-1004 pubmed
  1331. Grabbe S, Varga G, Beissert S, Steinert M, Pendl G, Seeliger S, et al. Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells. J Clin Invest. 2002;109:183-92 pubmed
  1332. Wu T, Lee J, Lai Y, Hsu J, Tsai C, Lee Y, et al. Reduced expression of Bcl-2 in CD8+ T cells deficient in the IL-15 receptor alpha-chain. J Immunol. 2002;168:705-12 pubmed
  1333. Chen B, Cui X, Sempowski G, Gooding M, Liu C, Haynes B, et al. A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution. Blood. 2002;99:364-71 pubmed
  1334. O Connell P, Li W, Wang Z, Specht S, Logar A, Thomson A. Immature and mature CD8alpha+ dendritic cells prolong the survival of vascularized heart allografts. J Immunol. 2002;168:143-54 pubmed
  1335. Das G, Sheridan S, Janeway C. The source of early IFN-gamma that plays a role in Th1 priming. J Immunol. 2001;167:2004-10 pubmed
  1336. Roach D, Martin E, Bean A, Rennick D, Briscoe H, Britton W. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand J Immunol. 2001;54:163-70 pubmed
  1337. Zhang J, Kabra N, Cado D, Kang C, Winoto A. FADD-deficient T cells exhibit a disaccord in regulation of the cell cycle machinery. J Biol Chem. 2001;276:29815-8 pubmed
  1338. Lan F, Zeng D, Huie P, Higgins J, Strober S. Allogeneic bone marrow cells that facilitate complete chimerism and eliminate tumor cells express both CD8 and T-cell antigen receptor-alphabeta. Blood. 2001;97:3458-65 pubmed
  1339. Ohmura K, Kawamoto H, Lu M, Ikawa T, Ozaki S, Nakao K, et al. Immature multipotent hemopoietic progenitors lacking long-term bone marrow-reconstituting activity in the aorta-gonad-mesonephros region of murine day 10 fetuses. J Immunol. 2001;166:3290-6 pubmed
  1340. Leite De Moraes M, Hameg A, Pacilio M, Koezuka Y, Taniguchi M, van Kaer L, et al. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J Immunol. 2001;166:945-51 pubmed
  1341. Shimizu C, Kawamoto H, Yamashita M, Kimura M, Kondou E, Kaneko Y, et al. Progression of T cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity. Int Immunol. 2001;13:105-17 pubmed
  1342. Izeradjene K, Revillard J, Genestier L. Inhibition of thymidine synthesis by folate analogues induces a Fas-Fas ligand-independent deletion of superantigen-reactive peripheral T cells. Int Immunol. 2001;13:85-93 pubmed
  1343. Hayashi K, Natsume W, Watanabe T, Abe N, Iwai N, Okada H, et al. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells. J Immunol. 2000;165:6816-24 pubmed
  1344. Martin P, del Hoyo G, Anjuere F, Ruiz S, Arias C, Marín A, et al. Concept of lymphoid versus myeloid dendritic cell lineages revisited: both CD8alpha(-) and CD8alpha(+) dendritic cells are generated from CD4(low) lymphoid-committed precursors. Blood. 2000;96:2511-9 pubmed
  1345. Bauman S, Nichols K, Murphy J. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J Immunol. 2000;165:158-67 pubmed
  1346. Feng C, Britton W, Palendira U, Groat N, Briscoe H, Bean A. Up-regulation of VCAM-1 and differential expansion of beta integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection. J Immunol. 2000;164:4853-60 pubmed
  1347. de Oca R, Buendia A, Del Rio L, Sanchez J, Salinas J, Navarro J. Polymorphonuclear neutrophils are necessary for the recruitment of CD8(+) T cells in the liver in a pregnant mouse model of Chlamydophila abortus (Chlamydia psittaci serotype 1) infection. Infect Immun. 2000;68:1746-51 pubmed
  1348. Lepault F, Gagnerault M. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol. 2000;164:240-7 pubmed
  1349. Dejbakhsh Jones S, Strober S. Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow. Proc Natl Acad Sci U S A. 1999;96:14493-8 pubmed
  1350. Ikawa T, Kawamoto H, Fujimoto S, Katsura Y. Commitment of common T/Natural killer (NK) progenitors to unipotent T and NK progenitors in the murine fetal thymus revealed by a single progenitor assay. J Exp Med. 1999;190:1617-26 pubmed
  1351. Ohmura K, Kawamoto H, Fujimoto S, Ozaki S, Nakao K, Katsura Y. Emergence of T, B, and myeloid lineage-committed as well as multipotent hemopoietic progenitors in the aorta-gonad-mesonephros region of day 10 fetuses of the mouse. J Immunol. 1999;163:4788-95 pubmed
  1352. Kang J, Coles M, Raulet D. Defective development of gamma/delta T cells in interleukin 7 receptor-deficient mice is due to impaired expression of T cell receptor gamma genes. J Exp Med. 1999;190:973-82 pubmed
  1353. Penttilä J, Anttila M, Varkila K, Puolakkainen M, Sarvas M, Makela P, et al. Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology. 1999;97:490-6 pubmed
  1354. Inaba M, Kurasawa K, Mamura M, Kumano K, Saito Y, Iwamoto I. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells. J Immunol. 1999;163:1315-20 pubmed
  1355. Deeths M, Kedl R, Mescher M. CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. J Immunol. 1999;163:102-10 pubmed
  1356. Pihlgren M, Arpin C, Walzer T, Tomkowiak M, Thomas A, Marvel J, et al. Memory CD44(int) CD8 T cells show increased proliferative responses and IFN-gamma production following antigenic challenge in vitro. Int Immunol. 1999;11:699-706 pubmed
  1357. Masurier C, Pioche Durieu C, Colombo B, Lacave R, Lemoine F, Klatzmann D, et al. Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: implications for anti-tumoral cell therapy. Immunology. 1999;96:569-77 pubmed
  1358. Zeng D, Lewis D, Dejbakhsh Jones S, Lan F, Garcia Ojeda M, Sibley R, et al. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med. 1999;189:1073-81 pubmed
  1359. Kawamoto H, Ohmura K, Fujimoto S, Katsura Y. Emergence of T cell progenitors without B cell or myeloid differentiation potential at the earliest stage of hematopoiesis in the murine fetal liver. J Immunol. 1999;162:2725-31 pubmed
  1360. Sasaki T, Kanke Y, Kudoh K, Misawa Y, Shimizu J, Takita T. Effects of dietary docosahexaenoic acid on surface molecules involved in T cell proliferation. Biochim Biophys Acta. 1999;1436:519-30 pubmed
  1361. Batteux F, Tourneur L, Trebeden H, Charreire J, Chiocchia G. Gene therapy of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for Fas ligand. J Immunol. 1999;162:603-8 pubmed
  1362. Samoilova E, Horton J, Hilliard B, Liu T, Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol. 1998;161:6480-6 pubmed
  1363. Bix M, Wang Z, Thiel B, Schork N, Locksley R. Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism. J Exp Med. 1998;188:2289-99 pubmed
  1364. Spiekermann G, Nagler Anderson C. Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue. J Immunol. 1998;161:5825-31 pubmed
  1365. Ferrero I, Anjuere F, Azcoitia I, Renno T, MacDonald H, Ardavin C. Viral superantigen-induced negative selection of TCR transgenic CD4+ CD8+ thymocytes depends on activation, but not proliferation. Blood. 1998;91:4248-54 pubmed
  1366. Guttormsen H, Wetzler L, Finberg R, Kasper D. Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model. Infect Immun. 1998;66:2026-32 pubmed
  1367. Contractor N, Bassiri H, Reya T, Park A, Baumgart D, Wasik M, et al. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J Immunol. 1998;160:385-94 pubmed
  1368. Salomon B, Cohen J, Masurier C, Klatzmann D. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J Immunol. 1998;160:708-17 pubmed
  1369. Samoilova E, Horton J, Bassiri H, Zhang H, Linsley P, Carding S, et al. B7 blockade prevents activation-induced cell death of thymocytes. Int Immunol. 1997;9:1663-8 pubmed
  1370. Aiba Y, Hirayama F, Ogawa M. Clonal proliferation and cytokine requirement of murine progenitors for natural killer cells. Blood. 1997;89:4005-12 pubmed
  1371. Postel Vinay M, de Mello Coelho V, Gagnerault M, Dardenne M. Growth hormone stimulates the proliferation of activated mouse T lymphocytes. Endocrinology. 1997;138:1816-20 pubmed
  1372. Barrat F, Lesourd B, Louise A, Boulouis H, Vincent Naulleau S, Thibault D, et al. Surface antigen expression in spleen cells of C57B1/6 mice during ageing: influence of sex and parity. Clin Exp Immunol. 1997;107:593-600 pubmed
  1373. Pihlgren M, Dubois P, Tomkowiak M, Sjogren T, Marvel J. Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro. J Exp Med. 1996;184:2141-51 pubmed
  1374. Hattori N, Kawamoto H, Katsura Y. Isolation of the most immature population of murine fetal thymocytes that includes progenitors capable of generating T, B, and myeloid cells. J Exp Med. 1996;184:1901-8 pubmed
  1375. Steeber D, Green N, Sato S, Tedder T. Lyphocyte migration in L-selectin-deficient mice. Altered subset migration and aging of the immune system. J Immunol. 1996;157:1096-106 pubmed
  1376. Sumita S, Ozaki S, Okazaki T, Sobajima J, Nakao K. A vascular smooth muscle-specific CD4+ T cell line that induces pulmonary vasculitis in MRL-+/+ mice. Clin Exp Immunol. 1996;105:163-8 pubmed
  1377. Pear W, Aster J, Scott M, Hasserjian R, Soffer B, Sklar J, et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med. 1996;183:2283-91 pubmed
  1378. Locksley R, Reiner S, Hatam F, Littman D, Killeen N. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science. 1993;261:1448-51 pubmed
  1379. Mixter P, Russell J, Durie F, Budd R. Decreased CD4-CD8- TCR-alpha beta + cells in lpr/lpr mice lacking beta 2-microglobulin. J Immunol. 1995;154:2063-74 pubmed
  1380. Laouar Y, Ezine S. In vivo CD4+ lymph node T cells from lpr mice generate CD4-CD8-B220+TCR-beta low cells. J Immunol. 1994;153:3948-55 pubmed
  1381. Godfrey D, Kennedy J, Mombaerts P, Tonegawa S, Zlotnik A. Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8- thymocyte differentiation. J Immunol. 1994;152:4783-92 pubmed
  1382. Ledbetter J, Rouse R, Micklem H, Herzenberg L. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med. 1980;152:280-95 pubmed
  1383. Diamond M, Staunton D, Marlin S, Springer T. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell. 1991;65:961-71 pubmed
  1384. Vremec D, Zorbas M, Scollay R, Saunders D, Ardavin C, Wu L, et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med. 1992;176:47-58 pubmed
  1385. Takahashi K, Nakata M, Tanaka T, Adachi H, Nakauchi H, Yagita H, et al. CD4 and CD8 regulate interleukin 2 responses of T cells. Proc Natl Acad Sci U S A. 1992;89:5557-61 pubmed
  1386. Schuyler M, Gott K, Shopp G, Crooks L. CD3+ and CD4+ cells adoptively transfer experimental hypersensitivity pneumonitis. Am Rev Respir Dis. 1992;146:1582-8 pubmed
  1387. Ledbetter J, Herzenberg L. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev. 1979;47:63-90 pubmed